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Abstract
Background: Generic preference-based measures (PBMs), such as the EQ-
5D and SF-6D, are widely used for the estimation of Quality Adjusted Life
Years in cost-utility analyses of healthcare interventions. However, their
relevance in some disease areas, including mental health, has been
questioned.
Objective of the thesis: To derive a PBM specific to mental health problems
from an existing condition-specific measure (CSM)
Methods: A systematic literature review was conducted to identify an
appropriate CSM for the derivation of a health state classification. Derivation of
the new measure was achieved using novel methodology developed for this
purpose, due to the high correlation across the items of the original CSM.
Selected health states were valued by members of the public. Regression
analysis was employed to predict utility values for all states of the health state
classification. Psychometric and qualitative assessments evaluated the
performance of the new PBM compared with generic PBMs and the original
CSM.
Results: The Clinical Outcomes in Routine Evaluation – Outcome Measure
(CORE-OM) was selected as the basis for the derivation of the new PBM.
Application of novel methodology based primarily on Rasch analysis resulted
in the development of CORE-6D, a health state classification that consists of a
5-item emotional component and a physical item. Rasch analysis was used to
select plausible health states for valuation. A highly predictive regression
model was used to attach utility values to all CORE-6D health states. The new
PBM has shown promising results regarding its psychometric properties
compared with generic PBMs and suffers from little loss of information relative
to the original measure, CORE-OM. Further research needs to validate these
findings.
Conclusion: The CORE-6D preference-based index will enable cost-utility
analysis of mental health interventions using existing and prospective CORE-
OM datasets. The new methodology for deriving PBMs from existing
instruments can be useful for the derivation of PBMs from other instruments
with highly correlated dimensions.
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Overview [executive summary]
Background: Economic evaluation of healthcare interventions in the form
of cost-utility analysis is increasingly advocated by regulatory bodies
worldwide, including the National Institute for Health and Care Excellence
(NICE) in England and Wales. The most commonly used outcome measure in
this type of analysis is the Quality Adjusted Life Year (QALY). Generic
preference-based measures (PBMs), such as the EQ-5D, the SF-6D and the
HUI-3 are widely used for the estimation of QALYs. These measures consist of
a health state classification describing Health-Related Quality of Life (HRQoL),
and an algorithm converting the HRQoL in each health state into a utility value,
based on public preferences elicited in a valuation survey. Despite their wide
use, generic measures of health may be inappropriate or insensitive in
capturing relevant aspects of HRQoL in some medical conditions. On the other
hand, condition-specific measures (CSMs) of outcome focus on specific
symptoms and aspects of HRQoL characterising a disease area, and therefore
are expected to be more relevant and sensitive than generic measures in
capturing the impact of the disease on patients’ HRQoL. However, the majority
of the available CSMs are not preference-based, and therefore are not suitable
for calculation of QALYs. Over the last years, there has been an increased
interest in the development of PBMs directly from existing CSMs. One area
where concerns about the relevance and sensitivity of generic measures have
been expressed is mental health, leading to proposals for the development of
a mental health-specific ‘generic’ PBM that can be used across the full
spectrum of mental disorders.
Aims and objectives: The aim of this thesis was the derivation of a
PBM that is relevant to people with mental health problems from an existing
CSM that is currently used in mental health research and practice. Specific
objectives of the thesis were as follows:
1. To assess the use and psychometric performance of generic PBMs in
mental health research and practice, in order to explore in depth the
appropriateness of using such measures in cost-utility analyses
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conducted in the area of mental health and to confirm the need for a
new PBM developed specifically for this area
2. To identify an appropriate CSM used in the area of mental health with
proven validity, sensitivity and acceptability that is able to capture a
wide range of symptoms and HRQoL aspects that are relevant to
people with mental disorders, to use as the basis for the derivation of a
PBM specifically designed for use in mental health, in particular within
the UK National Health Service (NHS) context.
3. To derive a new health state classification from the selected CSM and
subsequently attach appropriate utility values to all health states
described by the new measure, so as to develop a PBM for people with
mental health problems.
4. To evaluate the performance of the new PBM relative to generic ones,
the loss of information relative to the original CSM which it was derived
from, and its relevance to people with mental health problems.
Methods and results: In order to fulfil the specific objectives of the
thesis, four pieces of work were undertaken. An overview of methods and
results is provided separately for each piece of work:
1. Assessment of the use and psychometric performance of generic
PBMs in mental health research and practice
Methods: A systematic literature review of the use and psychometric
performance of the EQ-5D, SF-6D and HUI-3 in mental health research and
practice was undertaken. The review included literature reviews that reported
data on the use and psychometric properties of generic PBMs in adults with a
primary diagnosis of a mental disorder.
Results: EQ-5D and SF-6D perform satisfactorily in depression and, to a
lesser extent, in anxiety and personality disorders. Results were mixed in
schizophrenia and bipolar disorder. Results suggest that EQ-5D may be
picking depressive symptoms (or comorbid depression) rather than core
symptoms associated with a range of conditions, including anxiety and
schizophrenia. No reviews on the use and properties of HUI-3 in the area of
mental health were identified. A review of qualitative evidence revealed that
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generic PBMs fail to address the complexity of quality of life measurement and
the broad range of domains that are important to people with mental health
problems. Evidence also suggests that mental health professionals are rather
reluctant to using generic measures for the measurement of HRQoL in clinical
research and practice, as CSMs are deemed more appropriate for and
sensitive to capturing relevant aspects of HRQoL.
2. Identification of an appropriate CSM to be used as the basis for the
derivation of a PBM specific to mental health problems
Methods: A systematic literature review on outcome measures used in mental
health research and practice was carried out. The review included literature
reviews reporting on the use and properties of instruments used for outcome
measurement and monitoring of adults with mental disorders, including
symptoms, functioning and HRQoL. The most appropriate CSM of those
identified in the systematic review was selected for the derivation of the new
PBM, based on a number of considerations:
 Broad coverage of symptoms and aspects of HRQoL, including both
mental and physical health aspects
 Psychometric properties: established construct validity and
responsiveness
 Wide coverage within the British NHS
 Applicability across primary and secondary settings
 Free use
 Patient-reported
 Applicability across a range of mental disorders
Results: The review of reviews identified a wide range of instruments used for
outcome measurement and monitoring of people with mental health problems.
Of these, the Clinical Outcomes in Routine Evaluation – Outcome Measure
(CORE-OM) and the Health of the Nation Outcome Scales (HoNOS) appeared
to fulfil all or most of the set criteria that were used to determine the
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appropriateness of a CSM to serve as the basis for the derivation of a new
PBM that is specific to mental health.
HoNOS is a valid, reliable and responsive outcome measure. It can be used
for free within the British NHS and is widely used in the UK clinical practice.
HoNOS has not been designed for use in primary care. It is a measure of
severe and enduring mental illness and as such it may not be appropriate for
use in people with mild and moderate mental illness. Moreover, HoNOS is
clinician-rated, whereas PBMs are traditionally patient-reported, and this was
considered a major disadvantage against its use as the basis for the derivation
of a mental health-specific PBM.
CORE-OM is a valid and responsive measure with wide coverage within the
British NHS. It is free to use and is applicable across primary and secondary
settings. In contrast to HoNOS, CORE-OM is patient-reported, which is a big
advantage for its use in the derivation of a mental health-specific PBM. The
CORE-OM has been designed for outcome measurement in people with
common mental health problems such as depression and anxiety disorders,
which, nevertheless, are the most prevalent mental disorders in the UK.
Qualitative assessment indicated that the CORE-OM items tap the majority of
areas of HRQoL that are considered important by people with mental health
problems. Based on these criteria, CORE-OM was selected as the basis for
the derivation of a new PBM that is relevant to people with common mental
health problems.
3. Derivation of a new health state classification, valuation and modelling
of utility values, leading to the development of a new PBM for people with
mental health problems
Methods: A further systematic review was conducted, to explore and assess
the different methods that have been reported in the literature for the derivation
of health state classifications that are amenable to valuation from existing,
longer measures (either generic or condition-specific), aiming to identify
appropriate methodologies that might contribute to the derivation of a new
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health state classification from the CORE-OM. However, due to the high
correlation across the domains of CORE-OM, which precluded the use of
standard methodology for the selection of dimensions and items for the health
state classification, a novel methodology was developed and applied, which
was primarily based on Rasch analysis, supplemented by a range of
psychometric tests undertaken on each item of CORE-OM, including
acceptability, degree of floor and ceiling effects, responsiveness to change
over time, and correlation with the CORE-OM. Following the development of
the health state classification, a valuation survey of 220 members of the public
in South Yorkshire was subsequently undertaken using the time trade-off
(TTO) method. The selection of the health states valued in the survey was also
based on Rasch analysis. Finally, regression analysis was undertaken in order
to predict utility values for all states described by the new health state
classification.
Results: The proposed novel methodology resulted in the development of
CORE-6D, a 2-dimensional health state classification consisting of a
unidimensional 5-item emotional component and a physical item. Inspection of
the Rasch item threshold map of the emotional component helped identify a
set of 11 plausible emotional health states that are frequently observed and
cover the full range of symptom severity in the study population, that is, in
people with common mental health problems. These 11 emotional health
states combined with the 3 response levels of the physical item of CORE-6D
generate 33 plausible health states, 18 of which were selected for valuation. A
number of multivariate regression models at the mean (aggregate) level were
used to analyse the results of the valuation survey in order to predict values for
all health states defined by CORE-6D, using the Rasch logit value of the
emotional state and the response level of the physical item as independent
variables. A cubic model with high predictive value (adjusted R2 0.990) was
selected to predict utility values for all 729 CORE-6D health states, resulting in
the development of a new PBM for people with common mental health
problems.
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4. Evaluation of the performance of the new PBM relative to generic ones,
the degree of loss of information relative to the original CSM, and its
relevance to people with mental health problems.
Methods: A series of psychometric tests, statistical analyses and qualitative
assessments were performed in order to evaluate the performance and the
properties of CORE-6D. CORE-6D was compared with the generic PBMs EQ-
5D and SF-6D and with the original CORE-OM in three datasets: a dataset
derived from participants in a British national psychiatric morbidity survey; a
dataset of people with mild to moderate anxiety and/or depression participating
in a randomised controlled trial (RCT) assessing self-directed psychological
therapy; and a dataset of postnatal women recruited for a multicentre RCT that
evaluated psychological interventions for postnatal depression. CORE-6D was
compared with generic PBMs in terms of acceptability, floor and ceiling effects,
responsiveness to change over time, and construct validity (known groups and
convergent); agreement between CORE-6D and generic PBMs and
differences in the content of their items were also assessed. Furthermore, the
content validity of CORE-6D and generic PBMs in the area of mental health
was assessed by comparing the items of each measure against the 7 themes
of HRQoL that have been found to be most important in people with mental
disorders. The degree of loss of information was assessed by comparing the
responsiveness and known groups validity of CORE-6D with those of CORE-
OM.
Results: CORE-6D was shown to have comparable acceptability with generic
PBMs and no floor or any significant ceiling effects. Results of analyses that
tested its construct validity and responsiveness relative to generic PBMs were
promising. CORE-6D shows acceptable agreement with generic PBMs and, in
contrast to them, it broadly covers all 7 major themes of HRQoL that have
been found to be important to people with mental disorders, although it is
unable to capture some important sub-themes such as subjective well-being.
CORE-6D showed small loss of information relative to the CORE-OM.
Analyses suffer from a number of limitations that should be addressed in future
research.
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Discussion and conclusion: The CORE-6D is a promising PBM that
appears to be relevant, valid and responsive in people with common mental
health problems. CORE-6D will enable economic evaluation of mental health
interventions in the form of cost-utility analysis, using existing and prospective
CORE-OM datasets. The use of condition-specific PBMs instead of generic
ones in the wider resource allocation context has raised concerns relating to
their narrow scope and their inability to capture side effects from treatment or
comorbidities, the distortions created in the valuation process by focusing
effects, and potential bias in valuation resulting from naming the condition.
Nevertheless, CORE-6D addresses some of the expressed concerns by
covering physical problems to some extent. The novel methodology proposed
in this thesis for the derivation of CORE-6D from the CORE-OM, including the
role of Rasch analysis in the development of the health state classification, the
selection of plausible health states and the subsequent modelling of utility
values may be useful for similar processes using other instruments with highly
correlated dimensions.
Areas for further research:
 To further explore the role of Rasch analysis in the development and
valuation of health state classifications
 To conduct larger valuation surveys and explore the preferences of
people with common mental health problems for HRQoL levels
described by CORE-6D
 To further test and validate the applicability and performance of CORE-
6D in other mental health conditions
 To map CORE-10 and CORE-5 onto CORE-6D so as to allow cost-
utility analysis in studies that use CORE-10 or CORE-5 but not CORE-
OM
 To explore the potential use of CORE-6D as an independent measure,
when CORE-OM is not used in a study
 To expand the use of CORE-6D outside the UK
 To develop de novo a generic PBM measure for mental disorders
1Chapter 1. Introduction and background
1.1 Introduction
Economic evaluation of healthcare technologies aims at optimal allocation of
healthcare resources in order to maximise the health of the population.
Resources are finite and thus choices on how to spend them in the most
efficient way need to be constantly made. Formal economic evaluation allows
a consistent, standardised way for making such choices, aiming at achieving
the best possible overall health status for the population. Cost-utility analysis is
a type of economic evaluation in which health outcomes are expressed in the
form of a generic summary measure that combines length of life with
preferences for different states of health experienced through life, on a single
scale. The most commonly used outcome measure in cost-utility analysis is the
Quality Adjusted Life Year (QALY), which expresses a person’s life expectancy
weighted by the ‘utility value’ of the health-related quality of life (HRQoL)
experienced in each period of life. Utility values reflect people’s preferences for
HRQoL, measured on a scale anchored between zero (death) and one (full
health), with negative values being attached to health states deemed worse
than death (Brazier et al., 2007). When the QALY is used as the measure of
outcome, then the output of cost-utility analysis is an incremental cost
effectiveness ratio (ICER) expressed as ‘cost per QALY gained’.
Generic preference-based measures (PBMs) such as the EQ-5D (Dolan,
1997), the SF-6D (Brazier et al., 2002) and the HUI-3 (Feeny et al., 2002) are
widely used for the estimation of QALYs. However, their relevance in some
disease areas, including mental health, has been questioned (Brazier, 2010;
Brazier & Tsuchiya, 2010). This thesis is concerned with the development of a
PBM that is relevant and sensitive to people with mental health problems. This
chapter begins with an overview of the concept of mental health and its impact
on people’s lives and briefly discusses some issues on outcome measurement
in mental health research and practice, focusing on the use, categories and
methods of assessment of patient-reported outcome measures (PROMs). It
then moves on to give a summary of the steps required for the development of
PBMs which are used for outcome measurement in cost-utility analysis, a brief
2description of the three most commonly used generic PBMs, and a note on the
role of condition-specific measures (CSMs) in the estimation of QALYs.
Subsequently it sets the context in which this thesis was undertaken, in terms
of the burden of mental disease in the UK and the current levels of research in
this area; after a short discussion of the concerns that have been raised
regarding the suitability of generic PBMs in mental health populations, it
provides the rationale for and the objective of this thesis. Finally, it presents an
overview of the key stages of research undertaken to fulfil the main objective
of the thesis, along with an outline of this thesis report.
1.2 Defining and measuring mental health – the
role of patient-reported outcome measures
1.2.1 Mental health and its importance in people’s well-
being
According to the World Health Organization (WHO), health is defined as a
“state of complete physical, mental, and social well-being and not merely the
absence of disease and infirmity” (World Health Organization, 1958). This
definition emphasises the importance of mental health as an integral
component of health and well-being. Mental health is described as “a state of
well-being in which every individual realizes his or her own potential, can cope
with the normal stresses of life, can work productively and fruitfully, and is able
to make a contribution to her or his community” (World Health Organization,
2010).
Mental illness is one of the leading causes of disability globally, especially in
high-income countries. Depression alone accounts for 4.3% of the global
burden of disease and is among the largest single causes of disability
worldwide (World Health Organization, 2008). People with mental disorders
experience disproportionately higher rates of disability and mortality owing to
physical health problems that are often left unattended (such as cancer,
diabetes, cardiovascular disease and HIV infection) and suicide. Suicide is the
second most common cause of death among young people worldwide. Mental
disorders often affect, and are affected by, other diseases such as cancer,
3cardiovascular disease and HIV infection / AIDS (World Health Organization,
2013).
Recently, WHO developed a mental health action plan, with the vision of “a
world in which mental health is valued, promoted, and protected, mental
disorders are prevented and persons affected by these disorders are able to
exercise the full range of human rights and to access high-quality, culturally
appropriate health and social care […] in order to attain the highest possible
level of health” (World Health Organization, 2013). In order to achieve this,
WHO set forth four major objectives: more effective leadership and
governance for mental health; the provision of comprehensive, integrated
mental health and social care services in community-based settings;
implementation of strategies for promotion and prevention; and strengthened
information systems, evidence and research. The last objective requires,
among other interventions and strategies, collecting information on indicators
of mental health, including data on suicide and premature mortality, as well as
improvements related to clinical symptoms, levels of disability, overall
functioning and quality of life (World Health Organization, 2013).
Looking at WHO’s mental health action plan, it is evident that measurement of
clinical symptoms, disability, functioning and HRQoL is considered to be
important for the promotion of mental health and the prevention and treatment
of mental illness.
1.2.2 Outcome measurement in mental health
The purpose of outcome measurement in medical research and practice is to
evaluate the relative effectiveness and cost-effectiveness between treatments,
interventions and technologies, to inform individual clinical decisions in routine
practice by identifying and monitoring clinical conditions, to enable clinical
audit, and to assess and monitor the health needs of a population (Gilbody et
al., 2003). In the area of mental health, outcome measurement involves the
verification and quantification of a wide range of psychiatric phenomena that
cannot be externally observed or verified and are subjective in their nature
(Gilbody et al., 2003). A broad category of instruments developed for
diagnosing mental disorders, identifying and also quantifying mental symptom
4severity comprises standardised, symptom-based psychopathology rating
scales; these measures are usually clinician-rated and are routinely used in
mental health research and practice (Gilbody et al., 2003).
Despite their value in assessing the existence and severity of symptoms,
clinician-rated measures cannot assess the full impact of disease on patients’
lives. In response to this need, PROMs have emerged in healthcare research
and practice, including mental healthcare. These measures are completed by
patients themselves rather than by clinicians or carers on their behalf, in an
attempt to “move the focus of healthcare evaluation from ‘technical’ outcome
measures assessed by health professionals to those outcomes and aspects of
health valued by the recipients of care” (Jenkinson & McGee, 1998), giving the
latter the opportunity to be involved in judgements regarding the effectiveness
of services (Fitzpatrick et al., 2007). There is evidence that patients may
consider distress associated with the effects of disease on their daily activity to
be more disturbing than the discomfort associated with their symptoms
(Janson-Bjerklie et al., 1992), indicating that the perceived burden of disease,
expressed in the form of a disability or handicap, is possibly more important
than the symptoms of the disease in determining the patients’ HRQoL
(Bowling, 1997).
The common element of PROMs or ‘HRQoL’ measures, or ‘health status’
measures (terms that have often been used interchangeably in the literature) is
an attempt to directly capture patients’ subjective perceptions and experiences
of important aspects of their health status, including their physical,
psychological and social functioning and well-being (Fitzpatrick et al., 2007;
Leidy et al., 1999; McDowell & Newell, 1996). More specifically, HRQoL
measures designed for use in people with mental disorders “cover patients’
perspectives on what they have, how they are doing and how they feel about
their life circumstances”; such perspectives include the sense of wellbeing,
functional status, access to resources and opportunities (Lehman & Lasalvia,
2010). PROMs usually take the form of questionnaires with several items that
cover the broad nature of health status, disease or injury; usually each item
5gets a score depending on the response level, and item scores are summed to
give a total score (Fitzpatrick et al., 2007).
PROMs are increasingly used for a broad range of purposes, including
research, routine patient monitoring, population studies, audit and quality
assurance, as well as at resource allocation decision-making (Fitzpatrick et al.,
2007; Jenkinson & McGee, 1998). Advisory and regulatory bodies worldwide
have published guidance on the use of PROMs. The Department of Health in
the UK has introduced a PROMS programme in England, aiming to assess the
quality of care provided by the National Health Service (NHS) from the patient
perspective (Department of Health, 2008). Mental health services in the UK
also include the routine assessment of PROMs in psychological services, via
the Improved Access to Psychological Therapies (IAPT) initiative (IAPT, 2011).
In the US, the Food and Drug Administration, that is, the consumer protection
agency of the US Government that monitors the safety and effectiveness of
human and veterinary drugs among other products, has published guidance on
the use of PROMs in supporting labelling claims for approved medical products
(US Department of Health and Human Services, Food and Drug
Administration, 2009).
1.2.3 Generic and specific patient-reported outcome
measures
PROMs are divided into two broad categories: generic and specific (Fitzpatrick
et al., 2007). Generic measures aim to cover multiple domains of HRQoL
applicable to a wide range of disease areas and populations, and therefore
allow comparisons of treatments provided to different patient groups with a
variety of conditions, thus enabling assessment of comparative effectiveness
(Fitzpatrick et al., 1998). An advantage of generic measures is that they can be
useful in the identification of comorbidities and side-effects of treatment that
cannot be captured by specific instruments (Fitzpatrick et al., 2007). This
property makes them suitable for assessing the impact of new healthcare
interventions, where the therapeutic effects may be uncertain or even unknown
(Cox et al., 1992; Fletcher, 1988). On the other hand, generic measures are
designed to capture broad aspects of HRQoL and therefore may be less
relevant to specific conditions, as it is not possible to capture all particular
6dimensions of HRQoL relating to every disease area. Consequently, in such
cases they may have lower responsiveness to small but important changes in
HRQoL (Fitzpatrick et al., 1998 & 2007). The most commonly used generic
measures are the EQ-5D (Brooks, 1996), the Short Form (36) Health Survey
(SF-36) (Ware et al., 1993) and its shorter forms SF-20 (Ware et al., 1992) and
SF-12 (Ware et al., 1995), and the Health Utilities Index [HUI] system
(Torrance et al., 1995).
In contrast to generic measures, specific instruments concentrate on a
particular disease area, patient population, symptom, function, aspect of
HRQoL, or part of the body and are therefore very relevant to their intended
focused field (Fitzpatrick et al., 1998 & 2007). Thus they have been argued to
show high sensitivity in detecting small but significant changes in HRQoL
observed in the area of interest (Wiebe et al., 2003). Due to their relevance to
a particular situation, specific instruments are deemed to be more acceptable
to the respective patient population (Fitzpatrick et al., 1998). Their main
disadvantage is that they do not allow comparisons of treatment outcomes
across patients with different health problems. They also lack the ability to
capture symptoms and side effects of treatment that are unusual or
unexpected in the area which they have been specifically designed for
(Fitzpatrick et al., 1998 & 2007).
1.2.4 Criteria for evaluating patient-reported outcome
measures
Classical psychometric tests are widely used for the assessment of PROMS.
These tests are applications of standard psychometric criteria against which an
instrument should be examined. Although all of these criteria are important in
evaluating PROMs, some of these are more frequently listed on respective
assessment checklists (for example, Mokkink et al., 2010; Terwee et al., 2007).
Such criteria are also relevant and have been used in assessing measures
utilised in economic evaluation (Brazier et al., 1999). Some of these criteria
can also be used at the selection of ‘best performing’ items for the derivation of
a health state classification system from a larger questionnaire, an application
that is discussed in Chapter 3 (section 3.3.1). The psychometric criteria and
7the respective psychometric tests available for the evaluation of PROMs are
(Fitzpatrick et al., 1998):
Appropriateness
The content of an outcome measure needs to be appropriate to the aims of a
particular study. Appropriateness is difficult to evaluate and mainly relies on
researchers’ judgement as to whether the content of an instrument (and its
individual items) is in line with the study questions, after taking into
consideration the nature of the study intervention, the study population, and
the health outcomes to be captured. Although appropriateness is an essential
characteristic of a PROM, no standard psychometric tests are available to
directly evaluate this criterion, and other psychometric criteria of those listed
below need to be examined to indirectly assess the appropriateness of a
measure (Fitzpatrick et al., 1998).
Reliability
Reliability is the ability of an instrument to provide measurement results free
from random error. Reliability is directly related to the internal consistency of a
measure and its reproducibility.
Internal consistency refers to the homogeneity of a measure, that is, “the
extent to which all its items measure aspects of a single attribute or construct”
(Streiner & Norman, 1995). Consequently, all individual items of an internally
consistent measure are expected to be highly correlated with each other and
with the total score of the measure (summed score of its items). There are two
main psychometric tests used to assess internal consistency: one approach is
to randomly divide the items of an instrument into two groups and to assess
the degree of agreement (correlation) between the two halves (split-half
reliability). An extension to this approach is the estimation of Coefficient alpha
(Cronbach’s α), which estimates the average level of agreement of all possible 
ways of performing split-half tests (Cronbach, 1951). Cronbach’s α needs to be 
high enough to ensure sufficient internal validity of a measure; on the other
hand, perfect correlation of items indicates that these capture a rather narrow
8aspect of an attribute. For this reason, a value of Cronbach’s α between 0.70 
and 0.90 has been suggested as optimal (Streiner & Norman, 1995).
Reproducibility is the ability of a measure to reproduce the same results if it is
repeatedly administered to the same population, when the latter has not
changed with respect to the characteristics being measured. A measure with
perfect reproducibility should be able to provide results free from random error.
Reproducibility is assessed by test-retest reliability, which examines the
agreement between scores of two assessments on the same study sample
between two different time points, during which the study sample is unlikely to
remember their previous responses but at the same time it is also unlikely to
have changed with regards to the health dimension assessed. Test-retest
reliability is evaluated by a correlation coefficient, such as the intra-class
correlation coefficient, which uses analysis of variance to determine the extent
of total variability between the two scores that is due to true differences
between respondents and due to variability in measurements (Fitzpatrick et al.,
1998).
Validity
Validity refers to the extent to which an instrument measures what it is
intended to measure. There are several ways to assess the validity of an
instrument, such as face validity, content validity, construct validity, criterion
validity and predictive validity. The first three aspects of validity are by far the
most relevant and widely used criteria for the assessment of PROMs
(Fitzpatrick et al., 1998).
Face validity examines whether an instrument “appears to be measuring what
it is intended to measure” (Guyatt et al., 1993). This assessment relies mainly
on judgement of the content of an instrument.
Content validity examines the extent to which the characteristic of interest (e.g.
HRQoL) is comprehensively captured by the items of the instrument (Guyatt et
al., 1993). As with face validity, content validity cannot be directly assessed by
9psychometric tests and therefore judgement (by either researchers or patients)
is required to estimate whether a measure is characterised by this attribute.
Construct validity refers to the extent to which an instrument is able to measure
the underlying ‘construct’ which it was designed to assess. Construct validity
can be assessed by the ability of the measure to distinguish between groups
that are known to differ in the underlying construct (‘known groups validity’), or
by examining the correlations of the instrument with a set of other variables
that have been designed to measure the same (‘convergent validity’) or a
different (‘discriminant validity’) construct (Fitzpatrick et al., 1998 & 2007).
Criterion validity assesses whether an instrument correlates with another
instrument that is accepted as an accurate measure of the attribute under
measurement. Ideally the instrument should be compared against a ‘gold-
standard’ measure (‘criterion variable’), which, nevertheless, rarely exists in the
area of health status measurement (Fitzpatrick et al., 1998).
Predictive validity is an attribute relating to the ability of the measure to
correlate with future values of the criterion variable (Fitzpatrick et al., 1998).
Responsiveness
Responsiveness expresses the ability of an instrument to “detect important
changes within individuals that may reflect therapeutic effects” (Kirshner &
Guyatt, 1985). Responsiveness of an instrument can be assessed by
employment of various statistical methods, such as (Fitzpatrick et al., 1998):
• Correlation of the change score of an instrument over time with change
scores of other measures that are intended to capture the same changes
• Effect size (ES), defined as the change score of a measure divided by the
standard deviation at baseline
• Standardised response mean (SRM), defined as the change score of a
measure divided by the standard deviation of the change score
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The responsiveness of a measure can be affected by factors ‘internal’ to the
content of a questionnaire. One example is the presence of ‘floor’ or ‘ceiling’
effects. These may exist when the instrument is not well targeted to the study
population, in the sense that it cannot measure the whole range of severity of
the health dimension in question. Therefore, a measure may be unable to
capture significant improvement or deterioration if the initial or final point of
change lies beyond the range of severity the instrument is able to capture
(Fitzpatrick et al., 1998).
Precision
Precision of an instrument relates to its ability to distinguish among different
levels and aspects of the health dimension under assessment. There are
various aspects related to the precision of an outcome measure (Fitzpatrick et
al., 1998):
Precision of response categories: Precision of an instrument is improved when
item responses are graded across multiple rather binary response categories,
as in this case it is possible to capture more accurately the various levels of the
health dimension under assessment.
Precision of numerical values: This type of precision relates to the ability of
numerical values of a PROM in accurately capturing subjective experiences.
Numerical values can take two forms: simple ordinal values, where for
example degrees of agreement with a statement are attached a progressively
increasing or decreasing value; and weighted numerical values, which are
given to individual items following judgements on their relative severity/
importance.
Even distribution of item responses over true range: a PROM needs to capture
the full range of the severity of the examined dimension and distinguish well
across intermediate severity levels, that is, it needs to be well targeted to the
patient population. Inability to capture the full range of symptoms can affect the
responsiveness of an instrument, as discussed above.
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Floor and ceiling effects: these are related to the distribution of items over the
full range of severity of the health dimension examined, and their presence
affects negatively the precision of an instrument in capturing differences
across the levels of the health dimension. Floor and ceiling effects indicate a
high proportion of responses at the lower and higher end of a scale,
respectively.
Precision of scales: this type of precision relates to whether an instrument
measures the construct which it is aimed to assess rather than other unrelated
aspects. Ideally, for this purpose, the scales of an instrument should be
unidimensional. One method to assess the dimensionality of an instrument is
by factor analysis, which is described in detail in Chapter 3 (section 3.3.1).
Interpretability
PROMs may be more difficult to interpret compared to physical/ clinical
measures such as, for example, blood pressure or blood sugar levels.
Interpretability of a PROM is increased if the measure’s scores are correlated
to other human experiences with a clear and more objective meaning, such as
side effects from treatment and stressful life events (Testa et al., 1993).
Another approach suggested for increasing the interpretability of PROM scores
is to determine a minimal clinically important difference, defined as “the
smallest difference in score which patients perceive as beneficial and which
would mandate, in the absence of troublesome side effects and excessive
costs, the patient’s management” (Jaeschke et al., 1989). Comparison of
PROM scores between a clinical population and the general population can
also enhance interpretability of the results (Fitzpatrick et al., 1998).
Acceptability
Acceptability to patients is an important attribute of a PROM. Acceptability of a
measure relates to the distress potentially caused to patients completing a
questionnaire. An instrument may be less acceptable if it is difficult to
understand or requires a long time to complete. Acceptability of an instrument
can be indirectly assessed by estimation of completion rates following
administration; acceptability of certain items of an instrument can be examined
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by measuring the proportion of missing data in completed questionnaires.
Time to complete an instrument may also be an indicator of patients’
acceptability for a measure (Fitzpatrick et al., 1998).
Feasibility
Feasibility refers to the “time and resources required to collect, process and
analyse a patient-based outcome measure” (Fitzpatrick et al., 1998). The
length and complexity of a questionnaire are factors affecting its feasibility.
1.3 Outcome measurement in cost-utility analysis
PBMs comprise a special type of PROM developed to provide an estimate of
patients’ preferences for different levels and aspects of HRQoL (Fitzpatrick et
al., 1998). They consist of a health state descriptive system describing aspects
of HRQoL, and a scoring algorithm converting the HRQoL in each health state
into a utility value, based on preferences elicited in a valuation survey. As
noted in section 1.1, PBMs are essential for the estimation of QALYs in cost-
utility analysis.
1.3.1 Steps in the estimation of utility values
Estimation of preferences for different health states is a 3-step process,
consisting of identification and description of the health states characterising a
disease area, population or condition; valuation of a selection of those health
state descriptions; and, finally, application of modelling techniques to valuation
data in order to attach preferences to all relevant health states described by a
health state descriptive system.
Description of health states
Health states can be described using, mainly, a generic or condition-specific
outcome measure. A health state is constructed by selecting one response
level from each item of the measure, and combining all item responses.
Outcome measures that are used for the description of health states comprise
health state classifications. In a health state classification each item typically
represents a separate dimension. Health states used for measurement and
valuation of HRQoL should focus on functional status (physical, emotional and
social) rather than clinical characteristics or laboratory test results (Torrance,
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1986) and should therefore be derived from PROMs rather than clinician-rated
outcome measures.
Health states can also be described by vignettes; the latter are usually
narrative descriptions constructed based on interviews with patients and
clinical experts, capturing various aspects of HRQoL, such as clinical
symptoms, level of physical and social functioning, treatment and side effects
(Brazier et al., 2007). Vignettes are in principle condition- and treatment-
specific. Finally, sometimes health states are not described, but instead
patients are asked to value their own health.
The characteristics, advantages and disadvantages of generic and condition-
specific HRQoL measures have been briefly described in section 1.2.3 of this
chapter and are discussed in detail in Chapter 8 (section 8.4.1). The
drawbacks of vignettes include their inability to describe the full range of health
states that are usually observed in a patient population, as each vignette
describes only one state. Therefore, although vignettes can provide detailed
descriptions of specific health states, they often lack the sensitivity to capture
small variations in HRQoL. Moreover, vignettes may be difficult to link to
outcomes reported in clinical trials. Finally, the psychometric properties of
vignettes are more difficult to empirically assess compared with standardised
measures (Brazier et al., 2007).
Valuation of health states
Valuation of a health state refers to attaching a preference to the HRQoL
represented by the state. Preferences may be elicited by patients, their carers,
health professionals, or members of the general public. Until recently, there
were 3 main methods for preference elicitation: the Visual Analogue Scale
(VAS); the Standard Gamble technique (SG); and the Time Trade-Off
technique (TTO). More recently, there is an increasing interest for valuation of
health states by methods that are based on collection of ordinal information,
such as ranking and Discrete Choice Experiments (DCEs) (Ali & Ronaldson,
2012; Brazier et al., 2007). It has been argued that preferences express
‘values’ if the framing of the question does not involve uncertainty, as in the
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VAS and TTO, and ‘utilities’ if the question requires consideration of
uncertainty, as in the SG (Drummond et al., 2005). In this thesis, the term
‘utility value’ will be used more generally to describe preferences elicited from
valuation studies, regardless of the method of valuation and the framing of the
question.
Visual Analogue Scale
The VAS is a simple line with defined anchor states, such as ‘full health’ or
‘best health state’ on the one side of the line and ‘death’ or ‘worst possible
health state’ on the other. Respondents are asked to place their preference for
specific health states along the line. The scale has interval properties, so that
the distances between the placements of health states correspond to the
respondents’ relative differences in preference between the states (Neumann
et al., 2000; Torrance, 1986). Anchoring the scale between ‘best imaginable
state’ and ‘worst imaginable state’ allows valuation of the ‘death’ state and
elicitation of preferences for states considered worse than death (Feeny et al.,
2002; Gudex et al., 1996). It has been argued that using clear and
unambiguous endpoints on the scale ensures comparability of judgements
between respondents (Brazier et al., 2007). A simple graphic example of VAS
is shown in Figure 1.
Figure 1. Illustration of a Visual Analogue Scale
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Standard Gamble
The SG technique asks respondents to consider the level of risk which they
are willing to take with their life in a certain health state in order to return to full
health. It is based on the axioms of the von Neumann-Morgenstern utility
theory, according to which when rational individuals are faced with a choice
between options they will choose the option that maximises their expected
value of utility (von Neumann & Morgenstern, 1953). SG gives the respondent
a choice between a certain intermediate outcome and the uncertainty of a
gamble between two possible situations, one of which is better than the certain
outcome and the other is worse. For chronic health states considered better
than death, alternative 1 involves a gamble between life in full health for t
years (probability p) or immediate death (probability 1 – p); alternative 2 is the
certain outcome of life in the health state for t years. The probability p is varied
until the respondent is indifferent between the gamble and the certain
outcome. At this point the probability p expresses the utility value attached on
the health state. For chronic health states considered worse than death,
alternative 1 involves a gamble between life in full health for t years (probability
p) or life in the health state in question for t years (probability 1 – p); alternative
2 involves the certain outcome of immediate death. The probability p is varied
until the respondent is indifferent between the gamble and the certain
outcome. The utility value of a health state deemed worse than death is then
given by the formula –p/(1-p) (Brazier et al., 2007; Torrance, 1986).
A schematic diagram of the SG task for chronic health states is provided in
Figure 2.
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Figure 2. Schematic diagram of standard gamble for a chronic health
state a) preferred to death and b) considered worse than death
Time Trade-Off
The TTO technique was suggested by Torrance and colleagues (1972) as an
alternative to SG that is simpler to use but provides similar results. Unlike SG,
TTO elicits decisions under certainty. The TTO task asks respondents to trade
HRQoL for life-years. More specifically, for a specified health state (hi) that is
worse than full health but better than death respondents are asked to choose
either to live for a period of t years in this state, or to shorten their lifespan to x
years in full health, where x < t. The number of x years in full health is varied,
until the point where the respondent is indifferent or switches preferences
between the two alternatives. The utility value given to the state hi is then x/t
(Brazier et al., 2007).
For health states considered worse than death, the TTO task can be modified.
For example, in the Measurement and Valuation of Health study (MVH) (MVH
Group, 1995) that was used at the valuation of EQ-5D (Dolan et al., 1996),
respondents were first asked whether they preferred to live in a specified
health state hi for a period of t years after which they would die, or die
immediately. This question determined whether respondents valued the health
a.
b.
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state as better, worse, or equal to being dead. Subsequently, for health states
considered worse than death, respondents were asked to choose between two
alternatives: alternative 1 involved immediate death, while alternative 2
involved life in the health state for y years followed by life in full health for x
years (with y + x = t) followed by death. Years in full health (x) were varied
concurrently with years in the health state (y) so that t remained constant, until
respondents were indifferent between the two alternatives. The utility value
given to the health state in this case is –x/y (Brazier et al., 2007; Torrance,
1986). However, this formula may produce very low values (in the case of
MVH TTO protocol where t = 10 the lowest possible value for a state worse
than death can reach -39), which creates problems when modelling valuation
data, as values corresponding to states worse than death have a larger impact
on the model predictions than values of states better than death (Rowen &
Brazier, 2011). It has been therefore suggested that utility values for states
considered worse than death be rescaled, so that they are bounded by a value
of -1 (Torrance, 1984), and this approach was followed at the valuation of EQ-
5D, where utility values of states worse than death were calculated by the
formula -x/t (Dolan, 1997; Dolan et al., 1996).
A schematic diagram of the TTO task for chronic health states is shown in
Figure 3.
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Figure 3. Schematic diagram of time trade-off for a chronic health state a)
preferred to death and b) worse than death
Comparison between main valuation methods
The three main techniques for valuing health states (VAS, SG and TTO) have
demonstrated satisfactory reliability and high acceptability to respondents
(Green et al., 2000). However, they have been shown to result in different sets
of values for the same health state descriptions (Hornberger et al., 1992; Read
et al., 1984; Torrance, 1976). Various arguments in favour of or against the
use of each of them have been expressed in the published literature:
a.
b.
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The VAS method appears to be the easiest to comprehend and most
acceptable to respondents (Drummond et al., 2005; Green et al., 2000).
However, as the method does not require respondents to make a choice by
trading-off different arguments in their utility function, it has been regarded as
theoretically inferior to the choice-based TTO and SG (Dolan, 2001). In
addition, VAS is subject to measurement bias, as elicited scores often lack
interval properties (Drummond et al., 2005). This may explain why VAS values
have only poor to moderate correlation with values derived from TTO and SG
undertaken at the same time, while TTO and SG correlate reasonably well with
each other (Green et al., 2000). Other problems characterising VAS include
the ‘end-of-scale’ bias, meaning that respondents tend to avoid using the two
ends of the scale, and ‘spacing out’ bias, in which respondents tend to spread
their preferences on the scale, regardless of the nature of the health states
(Drummond et al., 2005). Due to the types of bias inherent in the method, it
has been argued that raw (unadjusted) VAS values cannot provide a valid
basis for estimating preferences for health states (Brazier et al., 2007).
Nevertheless, other researchers have argued that VAS valuations do involve
choice-making, as respondents weigh-up pairs of health state descriptions with
potentially small differences across the described HRQoL dimensions against
the ‘anchor’ states and other health states included in valuation, and this
decision actually involves making choices and trading-off between
improvement in one HRQoL dimension and deterioration in another (Parkin &
Devlin, 2006). Moreover, appropriate transformation of raw VAS data may
remove bias resulting from ‘end-of-scale’ and ‘spacing out’ phenomena (Parkin
& Devlin, 2006).
The SG has been advocated by economists because it entails making
decisions under uncertainty, which also surrounds most decisions about health
care (Mehrez & Gafni, 1993). Yet, it has been argued that the appropriateness
of a valuation method should be determined by its ability to act as a proxy for
utility and not by its capacity to model the situation being valued (Dolan, 2001).
SG may be compromised by probability weighting, according to which
respondents tend to overweight small probabilities and underweight large
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ones; if the probability weighting function is inverse S shaped as indicated by
empirical evidence, and the point where the function changes from
overweighting to underweighting probabilities approximates 0.35 as suggested
in the literature, then SG tends to overestimate utility values given that the
probabilities reported in SG exercises overall tend to exceed 0.35 (Bleichrodt,
2002). Moreover, SG is also affected by risk aversion resulting in SG values
being pushed upwards, and scale compatibility (this is where respondents
assign more weight to attributes that have higher compatibility with the
response scale used) resulting on respondents’ focusing on the probability
rather than the health state valued; and because there are more than one
probabilities involved in the task, the direction of bias in estimation of utility
values cannot be predetermined (Bleichrodt, 2002).
TTO has been considered the most appropriate valuation method, as it
incorporates the relationship between the health state, its duration and its
value into a single measure (Dolan, 2001). There is evidence, however, that
TTO values are prone to duration and time preference effects; in other words,
the period of time spent in a health state and the point in time a health state is
experienced (e.g. at the beginning or end of a time period) affect the way the
state is perceived by respondents and therefore have an impact on utility
values (Dolan & Gudex, 1995). Moreover, TTO assumes that utility is linear in
duration, and given that utility has been empirically shown to be concave, the
TTO task tends to systematically underestimate utility values (Bleichrodt,
2002). The assumption of linearity is more strongly violated in end-of-life
scenarios (Garau et al., 2011). Another issue is that TTO is affected by
attitudes such as loss aversion (so that respondents tend to be more reluctant
to give up healthy life-years), and scale compatibility (so that respondents
place more weight on the duration of a health state, which is the response
scale of the task, rather than to the health state itself); both phenomena result
in an overestimation of utility values (Bleichrodt, 2002).
Currently, TTO and SG are the most widely used techniques for valuation of
health states (Brazier et al., 2007). Nevertheless, VAS has often been used for
respondents’ warming-up prior to TTO and SG exercises, so as to familiarise
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respondents with descriptions of health states and give them an opportunity to
start considering their preferences (e.g. Brazier et al., 1998; Dolan et al.,
1996).
Valuation methods based on ordinal data: Ranking and Discrete Choice
Experiments
Valuation methods using ordinal data are increasingly used due to a number of
advantages compared with the ‘standard’ TTO and SG techniques, including
their ease of administration and comprehension by the respondents and the
avoidance of responses being affected by risk aversion, time preference, and
other biases characterising TTO and SG (Ali & Ronaldson, 2012; Brazier et al.,
2007). In ranking, respondents are asked to order a number of health states
from the best to the worst. In DCEs, respondents are asked to make stated
choices and select one state between two alternatives or make choices
amongst a larger set of alternative options. Questions may be framed as the
state the respondent would select to live in for a defined period of time, or the
state that corresponds to the best health level. Ordinal data can be
subsequently transformed into cardinal data (utility values) using statistical
methods such as logit and probit modelling (Ali & Ronaldson, 2012; Brazier et
al., 2007; de Bekker-Grob et al., 2012). A key problem with this method is how
to anchor the values on the 0-1 scale required to generate QALYs, where 1 is
for full health and 0 for states as bad as being dead. There is ongoing research
looking at the use of duration as an additional attribute (e.g. Bansback et al.,
2012).
Modelling valuation data
The process of valuation cannot be applied to all potential health states
described by an instrument, as this would be extremely time- and resource-
consuming due to the high number of health states that can be described by
one instrument. For example, EQ-5D can describe 243 different health states,
while the number of health states that are described by SF-6D reaches 18,000.
Instead, a number of health states described by an instrument are selected for
valuation; subsequently, using the utility data obtained in the valuation survey,
modelling techniques are employed to attach an appropriate utility value to
every health state described by the measure. There are two main approaches
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for modelling utility values: the composite approach, which uses statistical
modelling to estimate an algorithm for valuing all health states described by an
instrument using utility data derived from valuation of selected health states;
and the decomposed approach, which employs Multi-Attribute Utility Theory
(MAUT) to determine the functional form underlying the relationship between
single dimensions as well as the sample of states to be valued (Brazier et al.,
2007). A prerequisite for using any of the two approaches is the
multidimensionality of the instrument to be valued, i.e. each item of the
instrument needs to be independent from the rest items and express a
different dimension of HRQoL.
The composite approach for modelling valuation data has been used in the
valuation of the EQ-5D (Dolan, 1997), the SF-6D (Brazier et al., 2002), and
several condition-specific PBMs (for example Brazier et al., 2008; Yang et al.,
2009 & 2011). The first step of this approach relies on the identification and
selection of a set of health states described by the instrument, in order to be
included in a valuation survey. Selection of health states can be achieved
using a statistical design such as an orthogonal array, which allows the
statistical testing of several factors without testing every combination of factor
levels (Hedayat et al., 1999). Alternatively, a balanced approach can be
adopted, which allows any response level of each dimension to have an equal
chance of being combined with the various response levels of all the other
dimensions comprising the instrument (for example Yang et al., 2011). As the
number of selected health states can be still quite large, the selected health
states may be divided in smaller subsets that are valued by different groups of
the valuation survey participants. Following the survey, a number of regression
models are fitted to the valuation data, aiming to identify the model that best
describes the relationship between the valued health states and the utility
values obtained from the survey, which is then used to predict utility values for
all states described by the instrument (Brazier et al., 2007). The model
specifications can be quite complex, as they need to take into account the non-
normality and the quite commonly observed skewness of the utility data, the
non-continuity of the data distribution, and the fact that different states are
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valued by different survey participants, so data are also likely to reflect
differences in participants’ preferences (Brazier et al., 2007).
A general model used to predict utility values for all potential health states of
an instrument using valuation survey utility data was described for the
statistical modelling of utility values of SF-6D (Brazier et al., 2002), and is
defined as follows:
yij = g (β΄xi + θ΄ri + δ΄zj) + εij
where i = 1, 2, …, n represents individual health state values and j = 1, 2, …,
m represents respondents. The dependent variable, yij is the adjusted utility
value for health state i valued by respondent j, x is a vector of binary dummy
explanatory variables (xδλ) for each level λ of dimension δ of the instrument; r 
is a vector of terms to account for interactions between the levels of different
dimensions and z is a vector of personal characteristics such as age, gender
and education, which may affect values placed by an individual on a health
state; g is a function specifying the appropriate functional form and εij is an
error term whose autocorrelation structure and distributional properties depend
on the assumptions underlying the particular model used. This model
specification represents a simple additive function, as it imposes no further
restrictions on the relationship between dimension levels of the instrument
(e.g. it does not impose an interval scale between the levels of each
dimension) (Brazier et al., 2007).
Statistical modelling is possible to consider individual respondent data, or data
at an aggregate (population) level (Brazier et al., 2002 & 2007). Models
analysing individual respondent data can take into account the impact of
respondent background characteristics, such as gender, age, socioeconomic
status, etc., on health state valuations. The ordinary least squares (OLS)
model, which allows prediction of utility values by linear regression, is the
simplest model that can be used for the analysis of individual respondent data;
this model specification ignores the between-respondent variation and
assumes that each individual utility value is an independent observation,
regardless of which respondent it was elicited from (Brazier et al., 2007). A
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more sophisticated model, which takes into account the variation in valuation
data both within and between respondents, is the one-way error components
random effects model; this model assumes that the error is distributed between
respondent-specific variation, and an error term for every health state valued
by each respondent, both of which are assumed to be random across
individual respondents. Such a specification can be estimated using a
generalised least squares or a maximum likelihood model (Brazier et al.,
2007).
The aggregate model ignores individual respondent characteristics and instead
analyses population-level (mean or median) utility values; such specification is
also estimated by an OLS model. Although statistical modelling that considers
individual respondent data would be expected to predict utility values more
accurately since it increases the number of degrees of freedom available for
analysis (Brazier et al., 2007), valuation of SF-6D showed that this is not
necessarily the case, as OLS aggregate models were shown to perform better
than individual ones (Brazier et al., 2002). Since then, other modelling studies
have replicated this finding (Brazier et al., 2008; McKenna et al., 2008; Yang et
al., 2009).
The decomposed approach is based on MAUT, which has been mainly used at
the development of the HUI utility system (Feeny et al., 2002; Torrance et al.,
1996). MAUT uses simplifying assumptions about the underlying relationship
between dimensions, determining how dimensions and dimension levels can
interact with each other; the most commonly used specifications are the
additive, the multiplicative and the multi-linear functional forms. The additive
functional form assumes that dimensions are independent, and does not allow
for any interactions between them; it simply adds up the utility ‘decrements’
associated with loss of HRQoL within each dimension. The multiplicative
function permits limited interaction between dimensions, by assuming
preference dependence to be the same between dimensions. When the
combined decrement between any two dimensions is assumed to exceed the
sum of the individual effects of the two dimensions, then dimensions are
substitutes; when the combined decrement between any two dimensions is
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assumed to be lower than the sum of the individual effects of the two
dimensions, then the dimensions are complements. The multi-linear function is
the least restrictive among the MAUT functional forms, as it allows interactions
between pairs of states, as well as higher order interactions, to be estimated
independently, without imposing any restrictions on the direction of the
preference dependence. Its drawback is that it requires a substantial amount
of valuation work in order to be parameterised (Brazier et al., 2007). The
application of MAUT involves three steps in the valuation process: first, every
dimension of a measure is valued separately, assuming that all other
dimensions are at the best response level, so as to obtain single-attribute utility
values; next, ‘corner’ multidimensional states are valued, which consist of one
dimension at one extreme (usually the worst response level) and the remaining
dimensions at the other extreme (usually the best response level), requiring
that dimensions are independent from each other in order to create meaningful
health states; finally, a set of multidimensional states are valued, the choice of
which is determined by the selected model specification. A simple additive
model requires valuation of two multidimensional states only; an extra state is
required when a multiplicative model is used, to allow estimation of the
interaction between the states. Following valuation, prediction of utility values
for all potential health states described by the measure can be achieved by
solving a system of equations that allows calculations of utility decrements for
every dimension and every parameter that reflects the preference interactions
specified in the model (Brazier et al., 2007).
Valuation of health states and subsequent modelling of utility values for every
possible health state described by a health state classification results in the
development of a PBM that allows not only measuring but also valuing the
HRQoL associated with a health condition, according to expressed
preferences.
1.3.2 Generic preference-based measures
Generic PBMs, such as the EQ-5D (Brooks, 1996), the SF-6D (Brazier et al.,
2002), and the HUI-3 (Feeny et al., 2002), are most widely used for the
estimation of QALYs in cost-utility analysis. A brief description of these
measures follows.
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EQ-5D
The EQ-5D is a 5-item instrument capturing 5 dimensions: mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression; in the original
structure of EQ-5D, each item has 3 response levels, ranging from no
problems to extreme problems or inability to perform a task (Brooks, 1996).
The EQ-5D health state classification can thus describe 35 = 243 unique health
states. A number of health states have been valued by a representative
sample of the general population in the UK (as well as in a number of other
countries) using VAS (Gudex et al., 1996) and TTO (Dolan et al., 1996).
Further econometric modelling has resulted in the development of an algorithm
that links each health state described by EQ-5D with an appropriate utility
value, thus allowing the use of EQ-5D in cost-utility analysis (Dolan, 1997).
More recently, a 5-level response version of EQ-5D was developed by the
EuroQol Group (Herdman et al., 2011) with valuation being under way.
SF-6D
The SF-6D can be derived from the SF-36 (Brazier et al., 1998 & 2002) as well
as from its shortened version SF-12 (Brazier & Roberts, 2004). It has 6
dimensions (physical functioning, role limitations, social functioning, bodily
pain, mental health, vitality). When derived from the SF-36, physical
functioning and bodily pain have 6 levels of severity, role limitations 4 and the
rest 3 dimensions have 5 levels of severity each, which, combined, can
describe 18,000 unique health states. When derived from the SF-12, SF-6D
includes 3 levels of response for physical functioning, 4 levels of response for
role limitations, and 5 levels of response for each of the remaining dimensions,
resulting in the formation of 7,500 unique health states. A number of SF-6D
health states have been valued by members of the general population in the
UK (as well as in other countries) using SG (Brazier & Roberts, 2004; Brazier
et al., 2002). Further econometric modelling has led to the development of an
algorithm that can predict an appropriate utility value for each health state
described by SF-6D.
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HUI-3
HUI-3 belongs to a family of health state classification systems (Torrance et
al., 1995) and has been designed specifically for use in adult populations. It
covers 8 attributes, including cognition, vision, hearing, speech, ambulation,
dexterity, emotion and pain (Feeny et al., 2002). Each attribute has 5 or 6
response levels. HUI-3 can describe 972,000 unique health states. Utility
values for all states have been predicted using MAUT, following a valuation
survey of members of the general population in Canada, which used VAS and
SG.
The structure of the EQ-5D, SF-6D and HUI-3 health state classifications is
presented in Appendix 1.
1.3.3 The role of condition-specific measures in the
estimation of QALYs
Despite their widespread use, generic PBMs may be inappropriate or
insensitive in capturing relevant aspects of HRQoL in some medical conditions
(Brazier & Tsuchiya, 2010; Brazier et al., 1999), including hearing loss (Yang
et al., 2013b), visual impairment due to macular degeneration (Espallargues et
al., 2005), venous leg ulcers (Walters et al., 1999), urinary incontinence
(Haywood et al., 2008) and overactive bladder (Kobelt et al., 1999), chronic
obstructive pulmonary disease (Harper et al., 1997), and chronic schizophrenia
(van de Willige et al., 2005). In such cases CSMs can be used instead, in order
to capture more accurately and responsively changes in HRQoL.
However, the vast majority of the available CSMs have been developed in
order to describe and measure rather than value HRQoL (that is, they are not
preference-based), and therefore are not suitable for the calculation of QALYs
in cost-utility analysis. There are two main approaches in order to overcome
this problem and enable use of CSMs for estimation of QALYs: one approach
is the “mapping” from CSMs directly onto generic PBMs (Brazier et al., 2010);
the other approach is the development of preference-based CSMs either de
novo (for example Revicki et al., 1998a & 1998b) or from existing CSMs (for
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example Brazier et al., 2005, 2008 & 2010; Rowen et al., 2011; Sundaram et
al., 2010; Yang et al., 2009 & 2011).
Mapping
Mapping from a non-PBM onto an existing PBM refers to the estimation of a
relationship between the two measures, which can be made using expert
opinion or empirically, using statistical association (Brazier et al., 2007).
Mapping based on expert opinion relies on the judgements of professionals or
researchers and has been criticised for its arbitrariness and, usually, for lack of
any validity testing (Brazier et al., 2007). Empirical estimation of a mapping
function between a non-PBM and an existing PBM is achieved by employing
regression techniques, which are used in a dataset containing patient-level
data on both the non-PBM and the PBM to determine a statistical relationship
between the two measures. The estimated mapping function can be utilised in
datasets that contain only the non-PBM, in order to indirectly estimate utility
values derived from the PBM index (Brazier et al., 2007).
The mapping function can be determined using a simple additive model, where
the total score of the non-PBM is regressed onto the PBM. The limitation of
such a model is that it implicitly assumes that all dimensions of the non-PMB
are equally important, all its items carry the same weight, and the item
response levels have interval-scale properties (Brazier et al., 2007). More
complex model specifications may take into account the dimension scores,
item scores or item response levels of the non-PBM as independent variables
and are possible to introduce interaction terms between dimensions and
between items (Brazier et al., 2010). The drawback of such approaches is that
they can result in a large number of independent variables, which,
nevertheless, can be limited if, for example, items with non-significant
coefficients are excluded. Another complex modelling approach is to estimate
separate regression models between the non-PBM and each dimension of the
PBM (Brazier et al., 2010).
Mapping suffers from a number of limitations, such as limited performance in
terms of model fit (Tsuchiya et al., 2002) and inability to accurately predict
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values across the spectrum of symptom severity (for example Gray et al.,
2006). A major limitation inherent to the approach is that it assumes that the
PBM covers all aspects of HRQoL captured by the non-PBM. However, where
there is not sufficient overlap between the two measures the validity of the
resulting mapping function is limited. For the above reasons, there has been
an increased interest in the development of preference-based CSMs (Brazier
et al., 2010).
Development of preference-based condition-specific measures
Development of a preference-based CSM requires a 3-step approach,
consisting of the construction of a health state classification, valuation of a
selection of health states, and employment of modelling techniques that allow
prediction of utility values for all health states described by the classification,
using the results of the valuation survey. Health state classifications amenable
to valuation can be developed de novo or derived from existing, non-
preference-based CSMs. Development of a de novo health state classification
requires a procedure that involves interviews with patients in order to identify
aspects of HRQoL that are important to them and related to the condition
examined, followed by a process of testing and refinement using psychometric
methods and focus groups, until the final classification system is developed.
The new measure needs to be assessed for its psychometric properties, such
as its construct validity and responsiveness. The advantage of such a process
is that the new measure can be best suited to the purpose it was constructed
for; on the other hand, such a task can be time-consuming and costly. Another
drawback of the approach is that the newly developed measure cannot be
used in retrospective economic evaluations using existing datasets (Brazier et
al., 2007).
Derivation of a health state classification from an existing instrument relies on
the selection of a sample of the most representative domains and best
performing items within each domain of the original measure and possibly a
modification of the item response levels, using a number of psychometric and
other statistical methods. Selection of items and response levels is essential so
that health states described by the new measure are amenable to valuation;
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retaining all items included in the original CSM would likely lead to a large
number of health states that consist of multiple statements, which would be
impossible to handle in a valuation survey. On the other hand, omitting items
from the original measure entails the danger of loss of descriptive information
(Brazier et al., 2007). Derivation of a health state classification from an existing
CSM may be a more pragmatic approach when an appropriate measure for the
condition examined is available. This approach is most useful when the
original measure is a validated measure that is widely used in clinical practice
and research; in this case, derivation of a PBM from the original measure
increases its scope, as it allows not only assessment of clinical effectiveness of
interventions and programmes, but also economic evaluation alongside clinical
studies. Derivation of a new PBM from an existing CSM is useful when the
original measure is more relevant and sensitive to the changes in HRQoL in
the study population and more acceptable to patients, clinicians and
researchers than a generic measure (Brazier et al., 2007).
The development and use of condition-specific PBMs raises concerns
regarding comparability across different conditions and patient populations,
which have been (and are still) expressed in an on-going debate (Brazier &
Fitzpatrick, 2002; Brazier & Tsuchiya, 2010; Dowie, 2002a & 2002b; Feeny,
2002; Guyatt, 2002). This issue is discussed in more detail in Chapter 8
(section 8.4.1).
1.3.4 Recommendations on the use of preference-based
measures in economic evaluation of healthcare
interventions
Several regulatory and advisory bodies worldwide (for example in England and
Wales, Ireland, Spain, Portugal, Italy, France, Germany, Belgium, the
Netherlands, Denmark, Sweden, Norway, Poland, Russia, Canada, US, Brazil,
Australia, New Zealand, South Africa, Egypt, China, Taiwan and Thailand)
have developed recommendations on the use of PBMs for the estimation of
QALYs in cost-utility analyses of healthcare interventions, with several bodies
advocating the use of generic PBMs
(http://www.ispor.org/PEguidelines/index.asp). The National Institute for Health
and Care Excellence (NICE) in England and Wales has explicitly expressed a
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preference for the EQ-5D for the estimation of QALYs in cost-utility analyses of
healthcare technologies for adults, in order to ensure consistency and
comparability across the Institute’s appraisal programme. NICE, however,
acknowledges that EQ-5D data may be unavailable or inappropriate for the
condition or effects of treatment. When EQ-5D data are not available, NICE
proposes the use of mapping in order to link available HRQoL measures to
EQ-5D utility values; in this case an adequate mapping function needs to be
demonstrated and validated. NICE also accepts the use of alternative,
standardised and validated PBMs in cases where EQ-5D is unavailable and
mapping is not possible or where EQ-5D is inappropriate, but requests that the
reason for the use of the alternative measure be fully explained and supported
by empirical evidence of its properties. When alternative PBMs are selected for
use in cost-utility analysis, the institute recommends that measurement of
changes in HRQoL be reported directly from patients, and the respective utility
values be based on public preferences, elicited from a representative sample
of the UK general population using a choice-based method [i.e. TTO or SG],
with ‘full health’ as upper anchor, so as to retain methodological consistency
with the methods adopted at the valuation of EQ-5D (National Institute for
Health and Care Excellence, 2013).
1.4 Setting the context for this thesis
1.4.1 The societal burden of mental disorders and
current levels of mental health research in the UK
Mental illness is an important cause of disability in the UK. In 2006, there were
nearly one million recipients of incapacity benefit due to mental and
behavioural disorders, comprising 40% of total incapacity benefit recipients in
the country. Over the same year, more than 10 million working days were lost
due to stress, depression and anxiety (Oxford Economics, 2007). In England,
8.65 million people were estimated to be suffering from mental health
disorders in 2007, incurring costs for their management and associated
productivity losses totalling £48.6 billion (McCrone et al., 2008). The respective
projected figures for 2026, reflecting an expected increase in the population by
15.1%, were 9.88 million people with mental disorders incurring £60.69 million
in 2007 prices (McCrone et al., 2008).
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The importance of mental health for the personal and societal well-being has
been acknowledged by the Coalition Government, which has set up a strategy
for the improvement of mental health outcomes in people of all ages (HM
Government & Department of Health, 2011). However, despite the substantial
financial and disability burden caused by mental disorders, mental health is an
area largely neglected in terms of research in the UK: it has been estimated
that, although 15% of disability resulting from disease is attributable to mental
illness, only 6% of medical research is currently directed into mental health
(Medical Research Council, 2010). This dearth in mental health research is
possibly reflected in the extent of clinical and economic appraisal of
interventions and programmes for people with mental disorders treated in the
NHS in England and Wales: since its establishment in 1999 and up to March
2013, NICE had produced 15 Technology Appraisals and 26 Clinical
Guidelines relating to interventions and care pathways for people with mental
disorders (available from www.nice.org.uk). The amount of mental health-
related guidance is surprisingly limited compared with the total number of
Technology Appraisals (277) and Clinical Guidelines (165) published by the
Institute over the same period, potentially indicating a lower interest of policy-
makers in mental health care compared with other disease areas, or
considerable limitations in the quantity and quality of clinical and economic
data in the area of mental health, which prevent the development of useful
guidance.
1.4.2 Rationale for and objective of this thesis
Mental health is one broad area where the appropriateness of the use of
generic PBMs in order to generate QALYs for use in economic evaluation has
been questioned (Brazier, 2008 & 2010; Chisholm et al., 1997; Knapp &
Mangalore, 2007). This is because generic measures have been primarily
designed to capture physical health problems and may miss important aspects
of HRQoL of people with mental disorders. For example, EQ-5D focuses on
physical health, with only one item addressing mental health problems
(depression/anxiety). Due to their limited perceived relevance in this area,
generic measures have been found to be less acceptable to patients and
clinicians (Crawford et al., 2010; Gilbody et al., 2003), and this result may
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explain their limited use in clinical practice and research (Gilbody et al., 2003).
The scepticism on the use of generic measures in mental health has led to
arguments towards the development of a mental health-specific PBM, which
will be relevant to the course of illness of people with mental disorders and
sensitive to changes in their HRQoL status (Brazier, 2008; Chisholm et al.,
1997; Knapp & Mangalore, 2007).
However, the vast majority of condition-specific measures in mental health are
not preference-based (that is, they are not linked to utility values) and are thus
not suitable for estimation of QALYs in economic evaluation. Given this gap
between the necessity for economic evaluation of mental health interventions
in the UK setting and the unavailability of an appropriate PBM that is able to
capture important aspects of HRQoL of people with mental disorders, the main
objective of this thesis was the development of a preference-based CSM for
mental health problems, as a more appropriate and sensitive measure of
HRQoL compared with generic PBMs in this area. Considering the plethora of
validated CSMs that are available in the area of mental health, the aim was not
to develop a new PBM de novo, but, instead to derive it from an existing valid,
responsive, acceptable and widely used CSM, with the expectation that the
new PBM will enable wider assessment of healthcare interventions and
programmes for the management of mental health disorders in the form of
cost-utility analysis, both prospectively and retrospectively, using historical
data.
1.4.3 Key stages and outline of the thesis
In order to achieve the main objective of the thesis, the following key stages of
research were undertaken, the methods and results of which are reported in
the remaining chapters of this thesis report.
1. A systematic literature review of the use and psychometric performance of
generic PBMs in mental health research and practice was carried out first,
in order to explore in depth the appropriateness of using generic measures
in populations with mental health problems. The methods and results of
this piece of research are reported in Chapter 2.
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2. A systematic literature review of outcome measures used in mental health
research and clinical practice was also undertaken, aiming at identifying
appropriate measures with proven validity, sensitivity and acceptability and
able to capture a wide range of symptoms and HRQoL aspects that are
relevant to people with mental disorders, as candidates for the derivation
of a mental health-specific PBM. The most appropriate CSM of those
identified in the literature was subsequently determined according to a
number of criteria. Chapter 2 provides the details and the results of this
review and, ultimately, focuses on the description of the properties and the
applications of the Clinical Outcomes in Routine Evaluation – Outcome
Measure (CORE-OM), which was selected for the derivation of a mental
health-specific PBM based on its being a suitable, widely used and
acceptable PROM in mental health research and practice, particularly
within the British NHS context.
3. A further systematic literature review was conducted to identify and
critically appraise methods reported in the literature for the derivation of
health state classifications amenable to valuation from existing, longer
measures (either generic or condition-specific), aiming to identify
appropriate methodologies that might contribute to the derivation of a new
health state classification from the CORE-OM. The methods and findings
of this review are reported in Chapter 3.
4. A new health state classification was derived from the CORE-OM,
following the development and application of new methodology, which was
essential because of the nature of the original measure, which was
characterised by highly correlated domains. The specific methods
developed and applied in order to derive a health state classification from
the CORE-OM are described in Chapter 4. Chapter 5 provides detailed
results of the process that led to the derivation of a new health state
classification named CORE-6D (Clinical Outcomes in Routine Evaluation –
6-dimensional health state classification).
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5. A valuation survey using TTO was undertaken to elicit preferences from
members of the general population for selected health states described by
the CORE-6D. Subsequently, econometric modelling attached utility values
to all health states described by CORE-6D, leading to the construction of a
preference-based index that can be used for the estimation of QALYs in
cost-utility analysis. The methods and results of the valuation survey and
the techniques employed for modelling the valuation data are reported in
Chapter 6.
6. A series of psychometric tests, statistical analyses and qualitative
assessments were conducted to assess the performance of the new PBM
in terms of construct and content validity and responsiveness relative to
the generic EQ-5D and SF-6D; CORE-6D was also compared with CORE-
OM regarding its construct validity and responsiveness, in order to
evaluate the degree of loss of information resulting from moving from a 34-
item instrument to a 6-item one. The results of these analyses are provided
in Chapter 7.
Finally, Chapter 8 discusses the contribution of this thesis to the broader
methodology for the derivation of PBMs from existing measures, describes the
implications for policy deriving from the development of the new PBM, points to
some broader issues on the role of condition-specific PBMs in the wider
healthcare resource allocation environment and the role of patients’
preferences in the economic assessment of healthcare interventions, and
proposes areas for further research.
36
Chapter 2. Generic and condition-
specific outcome measures in mental
health. Selecting an appropriate outcome
measure for the derivation of a mental
health-specific preference-based
measure
2.1 Introduction
As discussed in Chapter 1, generic PBMs have been advocated by regulatory
and advisory bodies for the estimation of QALYs in cost-utility analysis of
healthcare interventions. NICE has expressed a preference on the use of EQ-
5D to ensure consistency across its appraisal programme. However, there are
concerns that, due to their focus on physical health, EQ-5D and other generic
PBMs may not be appropriate for use in the area of mental health, leading to
proposals for the use of a mental health-specific PBM in economic evaluations
of mental health interventions and programmes (Brazier, 2008 & 2010;
Chisholm et al., 1997; Knapp & Mangalore, 2007).
Currently, over 1,400 outcome measures are used in adult mental health
research and practice (National Institute for Mental Health in England, 2008).
These include measures that have been designed for the identification,
assessment or monitoring of a particular mental disorder, and ‘generic’ mental
health measures, which are applicable across a range of mental disorders
(National Institute for Mental Health in England, 2008). At the moment, the vast
majority of outcome measures in mental health are not preference-based and
thus cannot be used for the estimation of QALYs in cost-utility analysis of
mental health interventions. A small number of PBMs specific to major mental
health conditions have been developed, including the McSad utility measure, a
PBM the was developed de novo for use in unipolar major depression (Bennett
et al., 2000a & 2000b); a vignette-based descriptive system that estimates
utility scores for patients with schizophrenia using their scores on the clinician-
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rated Positive and Negative Syndrome Scale (PANSS) (Lenert et al., 2004);
and two utility measures derived from DEMQOL and DEMQOL-proxy that
measure utility of patients with dementia and their carers, respectively
(Mulhern et al., 2012b; Rowen et al., 2012). In addition, a small number of
studies have reported utility values for mental health state descriptions that
have been based on vignettes; such vignettes have been developed, for
example, for unipolar depression (Revicki & Wood, 1998; Schaffer et al.,
2002), bipolar disorder (Revicki et al., 2005), and schizophrenia (Briggs et al.,
2008; Revicki et al., 1996). However, the scope of the above measures and
vignette-based utilities is narrow and their use is restricted to the economic
assessment of interventions for the specific mental condition for which they
were constructed and cannot be expanded to cost-utility analyses in different
mental health areas. Ideally, a mental health-specific PBM should be ‘generic’
in the sense that it should be able to capture a variety of mental health
symptoms and aspects of HRQoL across a wide range of mental disorders,
thus enhancing comparability across cost-utility analyses conducted in
different areas of mental health.
A generic mental health-specific PBM can be developed de novo, or derived
from an existing CSM for mental health. A de novo PBM (i.e. a new health
state classification system) can be developed based on in-depth interviews
with experts, patients and carers, in order to identify the important aspects of
HRQoL under the condition the new measure aims to capture. Such qualitative
techniques for the identification and selection of relevant dimensions and items
of the new measure ensure its content validity. Subsequently, quantitative
psychometric methods can be used to develop and refine the new measure
(Brazier et al., 2007). Although this process can lead to the development of a
measure with high validity, reliability and responsiveness (concepts that are
defined in section 1.2.4 of Chapter 1), developing a de novo PROM is a
lengthy process. Moreover, a de novo PBM must be used in addition to other
instruments that measure symptoms and other health-related aspects, and this
requires extra time for its completion which may potentially reduce the
acceptability of the new measure to both patients and clinicians/researchers.
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Nevertheless, as reported above, mental health is an area where a variety of
outcome measures is currently being used (National Institute for Mental Health
in England, 2008). The breadth of measures that are valid, sensitive and
acceptable indicates that it is possible to derive an appropriate PBM from an
existing CSM for mental health, provided that the new measure maintains the
properties of the original one (Brazier et al., 2007). The new PBM can be
applied to datasets containing the original measure without requiring extra time
for its completion and with the further advantage that it allows cost-utility
analysis based on retrospective datasets containing the original measure
(Brazier et al., 2007). A desired property of the existing CSM (and the derived
PBM) is to cover a wide range of dimensions, as health state classifications
with a narrow coverage of symptoms and/or aspects of HRQoL may create
distortions in preferences elicited in a valuation survey; this may occur if, for
example, respondents focus on the narrow perspective of the health state
description and ignore other aspects of HRQoL or if the new PBM fails to
capture side effects and comorbidities. For the same reason, it has been
suggested that CSMs selected for the derivation of PBMs describe HRQoL
rather than symptoms, as measures describing HRQoL are likely to be broader
in coverage of dimensions (Brazier et al., 2012). The policy issues arising from
the use of condition-specific PBMs, especially those with narrow coverage of
dimensions, are discussed in Chapter 8.
Following the above considerations, the objective of this chapter is three-fold:
a. To systematically review the psychometric properties of generic PBMs
in a range of mental disorders, so as to explore whether the concerns
expressed regarding the appropriateness of use of generic PBMs in
mental health are justified
b. To systematically review outcome measures used in mental health
research and practice, aiming at identifying mental health-specific
measures with proven validity, sensitivity and acceptability, able to
capture a wide range of symptoms and HRQoL aspects that are
relevant to people with mental disorders
c. To select one of the CSMs identified from the systematic literature
review as the basis for the derivation of a PBM specifically designed for
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use across different mental disorders, in particular within the British
NHS context.
2.2 Systematic literature reviews: methods and
overview of results
One highly specific systematic search of the literature was conducted to
identify evidence on the appropriateness of use and psychometric properties of
the 3 most widely used generic PBMs (i.e. EQ-5D, SF-6D and HUI-3) in mental
health conditions (systematic review 1), and also to review outcome measures
used in mental health research and clinical practice aiming at identifying
appropriate measures for the derivation of a generic mental health-specific
PBM (systematic review 2). The following databases were searched for this
purpose:
Via OVID interface
1. EMBASE (1980 to current)
2. MEDLINE
3. PsycInfo
4. Health Management Information Consortium (HMIC)
Via Wiley interface
5. Cochrane Database of Systematic Reviews (CDSR)
6. Cochrane Methodology Register
7. Health Technology Assessment (HTA) database
8. Database of Abstracts of Reviews of Effects (DARE)
The systematic search was initially performed in March 2007. The search was
updated in December 2012, after work on the development of the new PBM
that was undertaken for this thesis was completed, to provide a more
comprehensive picture of the performance of generic PBMs in the area of
mental health and of outcome measures used in mental health that would be
appropriate to use for the derivation of a new generic mental health-specific
PBM. Therefore, some of the retrieved evidence had a more confirmatory
rather than exploratory role, since indications on the inappropriateness of
generic PBMs for use in mental health conditions and the appropriateness of
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the finally selected CSM for the derivation of a mental health-specific PBM
were already present prior to the results of the review update.
One common search strategy was developed for the two systematic reviews,
which adopted and/or modified search terms included in the search strategies
of two reports published by the University of York, both of which explored
outcome measurement in mental health research and practice (Gilbody et al.,
2003; Jacobs, 2009). Additional search terms for quality of life and generic
PBMs were also added, given the extended scope of the search. The search
strategy used for the systematic search of the literature is provided in Appendix
2.
The following inclusion/exclusion criteria were applied to select studies
identified by the search for further consideration:
 Only literature reviews were included in each of the two reviews; this was
decided because a preliminary search had captured a high number of hits
(approximately 30,000), and, at the same time, had identified an adequate
number of reviews addressing the research questions
 Studies published from 2002 onwards were included, to reflect recent
trends in outcome measurement in mental health research and practice
 Only papers published in English language were considered
 Only studies assessing generic PBMs (EQ-5D, SF-6D, HUI-3) or condition-
specific outcome measures in adults with mental disorders were included;
studies focusing on children and adolescents were excluded from the
reviews
 The populations examined in the studies should have a primary diagnosis
of a mental disorder in a community, primary, secondary or tertiary setting
 The instruments described and appraised in systematic review 2 should be
used for outcome measurement and monitoring of people with mental
disorders, including symptoms, functioning and quality of life; measures
aiming at case identification were not of interest
 The reviews should focus on the use and properties of generic PBMs or
CSMs in the area of mental health, and not on the assessment of the
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underlying attributes the measures aimed to capture; that is, studies aiming
to describe and analyse the symptoms, functioning, HRQoL or overall
course of illness of people with mental disorders as reflected in outcome
measurement were not included in the reviews
 Conference abstracts and poster presentations were excluded from
consideration, as they did not provide sufficient details of methods and
results.
In addition to the systematic search of the literature, experts in the field were
contacted for potential studies that were on-going or unpublished at the time
the final search was performed or for additional reports and studies not
identified by the search. The Health Economics and Decision Science (HEDS)
discussion paper database of University of Sheffield
(http://www.shef.ac.uk/scharr/sections/heds/discussion) was also searched.
The systematic search identified 11,615 references in total. After excluding
2,047 duplicates, 9,568 titles and/or accompanying abstracts were screened
for relevance against the set inclusion/exclusion criteria. Full texts of studies
potentially meeting inclusion criteria (including those for which eligibility was
not clear from the abstract) were obtained. Moreover, 4 additional studies
meeting inclusion criteria were identified by contacting experts in the field and
by searching the HEDS discussion paper database. After excluding studies
clearly not relevant to the topic and studies not meeting inclusion criteria, 15
publications were included in the review, consisting of 6 publications reviewing
the performance and properties of generic PBMs in mental health and 9
publications reviewing outcome measurement in mental health research and
practice. A flow diagram showing the systematic process for selecting papers
for the review is provided in Figure 4.
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Figure 4. Flow diagram of the selection of publications in the systematic
review of generic preference-based measures and outcome measures
used in mental health research and practice
Additional studies identified by contacting experts in the field and by searching the
HEDS discussion paper database N = 4
Exclude duplicates N = 2,047
Search result N = 11,615
Evaluation of titles, abstracts or full text where needed N = 9,568
Exclude not relevant studies or studies not meeting inclusion criteria N = 9,557
Articles included in the two systematic reviews N = 15
Publications assessing the use of generic preference-based measures in mental health N = 6
Publications assessing outcome measurement in mental health N = 9
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2.3 The appropriateness of using generic
preference-based measures in mental health –
results of systematic review 1
2.3.1 Overview of search results
The systematic search of the literature identified 6 review publications
reporting on the appropriateness and psychometric properties of generic PBMs
in mental health populations. Five of these studies examined the psychometric
properties of EQ-5D and SF-6D, and one focused specifically on EQ-5D. No
review assessing the appropriateness and psychometric properties of HUI-3 in
the area of mental health was identified by the search.
One of the seven studies identified (Brazier et al., 2014) was a large study with
many components that were relevant to this review, the majority of which have
been published separately in other publications identified by the search. The
study by Brazier and colleagues (2014) included a systematic review aiming to
assess the precision, construct validity and responsiveness of generic
measures (EQ-5D, SF-36, SF-12 and SF-6D) in five mental health conditions,
that is, depression and anxiety (with detailed results being reported by
Peasgood and colleagues, 2012); schizophrenia (detailed results of which
have been reported by Papaioannou and colleagues, 2011); personality
disorders (detailed results reported by Papaioannou and colleagues, 2013);
and bipolar disorder. Construct validity was assessed in terms of known
groups validity and convergent validity. Responsiveness to change over time
was measured by the ES, SRM, and the correlation of the generic measure’s
change score with change scores of other measures that were considered
relevant in measuring symptoms and/or HRQoL aspects associated with the
underlying mental condition.
In addition to the quantitative assessment of the psychometric properties of
generic measures, Brazier and colleagues (2014) examined the content
validity of generic measures in the area of mental health. For this purpose the
authors carried out a systematic review of qualitative studies reporting the
views of people with mental health problems on mental symptoms and related
aspects of HRQoL. Subsequently, the authors undertook framework analysis
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to identify common patterns of themes within and across different qualitative
studies, so as to establish themes of HRQoL that are important to people with
mental disorders. The items of generic measures were subsequently
compared, in a qualitative manner, against these themes. The results of this
review have also been made available by Connell and colleagues (2012).
Further to this large study by Brazier and colleagues (2014) and its separately
published components, the systematic search conducted for this thesis
identified one review examining the psychometric properties of EQ-5D
(feasibility, precision, construct validity and reliability) in dementia, regarding
both patient and proxy (carers’ or clinicians’) ratings (Hounsome et al., 2011).
Feasibility of EQ-5D was assessed by the rates and time of completion.
Precision was examined by the level of ceiling and floor effects. Construct
validity was assessed in terms of known groups validity and convergent
validity. Reliability was assessed by test-retest reliability. Agreement
(correlation) between patient and proxy ratings as well as between ratings of
different proxies was also measured.
It must be noted that the objective of the review of reviews conducted for this
thesis was to evaluate the appropriateness and psychometric properties of
generic PBMs. Thus, only data relating to the properties of EQ-5D and SF-6D
(regarding the health state classifications and the utility indices) were extracted
from the existing reviews. Reported data on EQ-VAS (a VAS administered
alongside EQ-5D for recording an individual’s rating of their current state of
HRQoL), SF-36 or SF-12 were not considered. Table 1 provides an overview
of the review studies considered in this review of reviews, including the mental
disorders and the generic PBMs that were examined in each review, the
psychometric properties assessed and a summary of each study’s findings.
Table 1. Studies included in the systematic review of reviews examining the properties of generic preference-based measures
in mental health populations – overview of study methods and results
Review study reference Mental healtharea
Generic
PBM Psychometric properties assessed and overview of findings
Brazier et al., 2014;
Peasgood et al., 2012
Depression
and anxiety
EQ-5D [k=21]
SF-6D [k=8]
Known groups validity
Convergent validity
Responsiveness
good - both measures
strong in depression; moderate in anxiety (moderate correlation to
depression measures, small correlation to anxiety measures) - both
measures
good - both measures
Brazier et al., 2014;
Papaioannou et al., 2011
Schizophrenia EQ-5D [k=9]
SF-6D [k=1]
Known groups validity
Convergent validity
Responsiveness
good - EQ-5D
mixed evidence - EQ-5D; moderate - SF-6D
mixed evidence - EQ-5D; poor - SF-6D
Brazier et al., 2014;
Papaioannou et al., 2013
Personality
disorders
EQ-5D [k=6] Known groups validity
Convergent validity
Responsiveness
moderate
moderate
moderate to high
Brazier et al., 2014 Bipolar
disorder
EQ-5D [k=4] Known groups validity
Convergent validity
Responsiveness
mixed evidence
mixed evidence
no evidence
Hounsome et al., 2011 Dementia EQ-5D
[k=17; 14 on
self-ratings,
15 on proxy
ratings]
Feasibility
Precision
Known groups validity
Convergent validity
Test-retest reliability
Agreement
good in mild dementia, low to moderate in more severe dementia - self-
ratings; good - proxy rating
ceiling effects - self-rating
poor - self-rating; good - proxy rating
poor - self-rating; good - proxy rating
good in mild and moderate dementia - self-rating; overall good - proxy
rating
poor between self-/proxy ratings and between different proxies
Brazier et al., 2014;
Connell et al., 2012
General EQ-5D [NA]
SF-6D [NA]
Content validity lack of coverage of various relevant aspects of HRQoL
*k = number of primary studies assessing each generic PBM in each review
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2.3.2 Psychometric properties of EQ-5D and SF-6D in
people with mental disorders
Depression and anxiety
The systematic literature review on the properties of generic measures
conducted by Brazier and colleagues (2014) identified 26 primary studies on
patients with a primary diagnosis of depression and/or anxiety. Of these, 21
studies reported data on EQ-5D and 8 studies included SF-6D data.
According to the review findings, which have been reported in detail by
Peasgood and colleagues (2012), EQ-5D was able to identify a reduction in
HRQoL in people with depression and anxiety, and could detect significant
changes in HRQoL across different symptom severity levels. The loss of
HRQoL was more evident in the domains of depression and anxiety, pain and
discomfort, and usual activities, and less so in mobility and self-care. In people
with depression EQ-5D correlated strongly with clinician-rated measures of
depression severity and moderately with measures of functioning, patient-
reported severity and patient-reported quality of life. In people with anxiety EQ-
5D had moderate correlations to depression measures (such as the Back
Depression Index -BDI-) but only small to moderate correlations to anxiety
measures. EQ-5D was very responsive in both depression and anxiety, with a
similar degree of responsiveness to symptom, functioning and quality of life
measures.
SF-6D was also able to detect loss of HRQoL in people with major depression
and anxiety disorders and to distinguish across different symptom severity
groups. For people with depression, SF-6D captured a considerable loss in
HRQoL in the domains of mental health, vitality, role limitations, social
functioning and bodily pain and a lower HRQoL loss in physical functioning.
SF-6D was found to correlate well with the Patient Health Questionnaire – 9
items (PHQ-9), a measure of depression, but less so with anxiety scales. SF-
6D was found to be responsive in major depression and in a mixed population
of people with depression and/or anxiety.
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Comparison between EQ-5D and SF-6D in studies that used both measures
revealed that SF-6D was better at capturing mild depression and anxiety,
whereas EQ-5D was better in identifying more severe symptom levels.
Conclusively, EQ-5D and SF-6D showed good known groups validity in people
with depression and anxiety. Both measures demonstrated good convergent
validity in people with depression; in people with anxiety, EQ-5D and SF-6D
were able to capture changes in HRQoL relating to depressive symptoms or
comorbid depression but were less effective in tapping anxiety symptoms. Both
measures showed high responsiveness.
Schizophrenia
Brazier and colleagues (2014) also conducted a systematic literature review to
assess the construct validity and responsiveness of EQ-5D, SF-36, SF-12 and
SF-6D in people with schizophrenia, the results of which have been reported in
detail by Papaioannou and colleagues (2011). The review included 33 primary
studies; of these, 9 assessed the psychometric properties of the EQ-5D and
only one study assessed the validity of SF-6D.
EQ-5D had good known groups validity as it was able to distinguish between
patients with ‘severe’ or ‘less severe’ symptomatology, defined by various
CSMs including the PANSS, the Hamilton Depression Rating Scale (HAM-D)
and the Global Assessment of Functioning (GAF). Regarding convergent
validity, EQ-5D appeared to correlate moderately to strongly with the Health of
the Nation Outcome Scales (HoNOS), the Symptom Checklist-90-Revised
(SCL-90-R), the Brief Psychiatric Rating Scale (BPRS), the Schizophrenia
Quality of Life questionnaire (S-QoL), and the Clinical Global Impression
Severity of Illness Scale (CGI-S), and weakly to moderately with the Global
Assessment of Relational Functioning (GARF). There was also limited
evidence suggesting moderate to strong associations between EQ-5D and
depression or anxiety symptom measures; however, there was mixed evidence
for the measure’s correlation with PANSS, GAF and the Social and
Occupational Functioning Assessment Scale (SOFAS), with some evidence
suggesting moderate to strong correlation with these measures and other
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evidence indicating weak to non-existent association. EQ-5D was not
correlated to the Quality of Life Scale (QLS), a schizophrenia-specific quality of
life measure. Data on responsiveness were also mixed: EQ-5D was
responsive to change over time, but at the same time it did not respond to
changes in most symptom or functioning measures, apart from significant
correlations with a few measures, including the PANSS positive subscale.
Moreover, EQ-5D changes were found not to correlate with BPRS changes,
unless the latter were greater than 25%.
The limited evidence for SF-6D indicated that the measure correlated
moderately with BPRS; however, SF-6D change scores correlated only weakly
with BPRS changes, and only when the latter were greater than 25%.
Overall, evidence suggests a good known groups validity but rather
inadequate convergent validity of generic PBMs in schizophrenia. The
responsiveness of EQ-5D and SF-6D is not satisfactory either. Generic PBMs
are probably unable to adequately capture changes in HRQoL of people with
schizophrenia.
Personality disorders
Brazier and colleagues (2014) conducted a systematic review of the construct
validity and responsiveness of generic measures (EQ-5D, SF-36, SF-12 and
SF-6D) in people with personality disorders, the detailed results of which have
been reported by Papaioannou and colleagues (2013). The review included 10
studies, 6 of which included EQ-5D data; none of the studies assessed SF-6D.
EQ-5D was able to capture HRQoL loss in people with a borderline,
narcissistic, obsessive-compulsive, depressive, negativistic, or mixed
personality disorder; however, it was the number of personality disorders
rather than their type per se, that made a significant effect on the EQ-5D
score. When controlling for the number of the disorders, only depressive
personality disorder appeared to have a significant effect on EQ-5D. EQ-5D
correlated moderately with the Global Severity Index (GSI) and showed
moderate to high responsiveness to change over time; EQ-5D change scores
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correlated well with change scores on the Borderline Personality Disorder
Severity Index-IV (BPDSI-IV), a measure of the severity of borderline
personality disorder.
The limited available evidence overall indicates that EQ-5D is a valid and
responsive measure in people with personality disorders.
Bipolar disorder
The systematic review of the psychometric properties of generic measures
(EQ-5D, SF-36, SF-12 and SF-6D) conducted by Brazier and colleagues
(2014) included 22 studies; of these, 4 studies contained data on EQ-5D and
no study reported data on SF-6D. Evidence was mixed with some findings
supporting the known groups and convergent validity of EQ-5D and some
findings questioning it. There was no available evidence on the
responsiveness of EQ-5D in people with bipolar disorder.
Dementia
Hounsome and colleagues (2011) carried out a systematic review to assess
the acceptability, precision, validity and reliability of EQ-5D in people with
dementia and their carers. The review included 17 papers that focused on
patients with dementia, 14 of which used the EQ-5D for patient self-
assessment, and 15 for proxy assessment by family carers, institutional carers
or healthcare professionals; in 12 studies, EQ-5D was used for both self- and
proxy assessments.
According to the results of the review, feasibility of EQ-5D was high in people
with mild dementia, as demonstrated by high completion rates, but low to
moderate in people with moderate or severe dementia. The mean completion
time of self-reported EQ-5D ranged from 4 minutes to more than an hour. In
patients with mild and moderate dementia, the self-reported EQ-5D showed
good to average test-retest reliability, but lower than carers’ proxy ratings. A
good proportion of patients (more than one-third) rated their HRQoL at the
highest level for several or all EQ-5D dimensions, indicating a potential ceiling
effect for EQ-5D. Patient-reported EQ-5D was not able to distinguish across
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different severity levels of dementia. Of the 5 EQ-5D dimensions, only
depression/anxiety had a positive correlation with the Mini-Mental State
Examination (MMSE), a scale measuring cognitive impairment. EQ-5D
correlated better with measures of depression and anxiety, rather than with
physical activity and cognitive function.
There was evidence for good feasibility, reliability and construct (known groups
and convergent) validity of EQ-5D proxy ratings. Such ratings correlated well
with other HRQoL measures such as the Quality of Well Being scale (QWB)
and HUI, and also with patients’ cognitive function. However, different proxies
provided different ratings: EQ-5D ratings provided by clinicians had higher
construct validity in the mobility and self-care dimensions; ratings provided by
carers had higher construct validity in usual activities and depression/anxiety
dimensions. The level of agreement between carers and physicians was poor,
especially for the dimensions of pain and depression/anxiety. On the other
hand, patient self-assessment provided significantly higher EQ-5D scores than
proxy assessments, and this discrepancy was not attributable to cognitive
impairment alone.
Based on the results of their review, the authors concluded that, despite the
feasibility and reliability of EQ-5D (both self- and proxy rated), there were
problems with the validity of self-rated data, demonstrated by lack of
association between patient and proxy ratings; moreover, there were important
discrepancies in ratings among different proxies, making interpretation of EQ-
5D scores in the area of dementia problematic.
2.3.3 Qualitative evidence – content validity of generic
preference-based measures in people with mental
disorders
The study by Brazier and colleagues (2014) also included a systematic review
of qualitative research undertaken on people with mental health problems,
aiming to identify the domains of HRQoL that are important to this population.
The methods and the results of this review have been made available in
Connell and colleagues (2012). The methods of this review are described in
more detail here because this comprised a high quality synthesis of qualitative
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research, and its findings formed the basis for the assessment of the content
validity not only of generic PBMs in the area of mental health, but also of the
new mental health-specific PBM that was developed for this thesis. The
systematic review included 13 studies that gathered qualitative evidence
through interviews and focus groups; in these primary studies adults with
mental health problems were explicitly asked what they considered to be
important to their quality of life or how their quality of life had been affected by
their mental health problems. Findings across the 13 studies was synthesised
using a framework approach, which comprises a highly structured method for
organising and analysing data that allows the expansion and refinement of an
a-priori framework to incorporate new themes that emerge from the data
(Connell et al., 2012). Framework analysis allowed the identification of
common and variable patterns of themes within and across different studies
and consisted of five stages: familiarisation with the studies; identification of
initial themes for a thematic framework; data organisation; examination of each
initial theme and identification and documentation of further sub-themes within
the framework chart; and mapping across the sub-themes in order to make
connections between them, and assist in the development of the final themes
(Connell et al., 2012).
This work identified six domains that were important to people with mental
disorders: well-being and ill-being; control, autonomy and choice; self-
perception; social well-being, belonging and relationships; activity and
functioning; hope and hopelessness. Each domain includes positive and
negative aspects. A seventh theme, that of physical health, was identified by
direct interviews with users of mental health services.
Well-being was defined by high levels of pleasant emotions and moods and
low levels of unpleasant ones. Ill-being was defined by general feelings of
distress, experience of psychotic or manic symptoms (including hallucinations
and delusions, reality disorientation, mania, discomfort, weirdness and
irritability), depressed mood, fear and anxiety, and problems with energy and
motivation.
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Control referred to the availability of external resources which enabled choice
and control, including medication and treatment, support, information and
finances. An important issue for people with mental disorders was the relief
and management of most distressing symptoms of their condition, achieved
mainly through medication. People with mental illness found important being
informed and having an insight about the condition and what to expect from it
in the future, as well as being able to develop strategies to effectively manage
their illness. A balance between support and independence was deemed
important for the autonomy of people with mental disorders. Choice was raised
in the context of availability of financial resources and employment
opportunities.
Self-perception was identified as an important aspect of HRQoL, in terms of
self-efficacy (a belief and confidence in own abilities as opposed to feelings of
uselessness, failure and helplessness), self-identity (a good perception of own
self), and self-esteem (having a sense of self-worth and self-respect), with all
concepts being linked to self-acceptance (as opposed to self-stigmatisation
and not feeling normal).
Social well-being and belonging comprised the need for integration within the
social environment and the experience of feeling valued, needed and
accepted. Relationships, including family and friends as well as social
relationships in the community, played a central role in this social integration
and acceptance. At the opposite end, stigmatisation and the perception of
negative reactions from family, friends and the community was highlighted as
placing a considerable burden to people with mental disorders.
Activity and functioning were identified as an important aspect of HRQoL and
included both employment and leisure activity. Participating in an activity was
deemed to help achieving a sense of self, interacting with others and giving a
sense of belonging and participating in the external world. Activity also
improved mood, provided a distraction from problems, increased self-esteem,
provided routine and structure, and enabled people to take control of their
lives.
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Hope was defined as having dreams and goals, having meaning and purpose,
and moving forward in life. On the opposite end, past losses, including the loss
of life roles in general, and the loss of work, relationships, skills, time, finances,
and, ultimately, the loss of self-identity, led to a pervasive feeling of distress
and hopelessness, characterised by a view that life would never change for the
better, which placed a burden upon the HRQoL of people with mental
disorders..
The review revealed the complexity of the factors that determine the HRQoL in
people with mental health problems and the difficulty in separating mental
symptoms from other aspects of HRQoL in this population. The authors
acknowledged as a limitation of the review the fact that the included studies
focused on the HRQoL of people with severe mental illness, particularly
schizophrenia. However, further interviews with people with a wide range of
mental health problems, including milder mental illness, confirmed these
findings.
The evidence from this review was used to determine the content validity of
generic measures EQ-5D, SF-36 and SF-6D and of a new generic measure of
capability in adults, the ICECAP-A, in the study by Brazier and colleagues
(2014). The content validity of each measure was judged by the extent to
which its items of each measure represent the areas that have the greatest
impact on the HRQoL of people with mental health problems.
The assessment of the content validity of generic measures in the area of
mental health against the 7 domains of HRQoL that were identified as
important to people with mental disorders concluded that EQ-5D covered little
of the content of these 7 domains due to its focus on physical health. Of the 7
domains EQ-5D captures well the one on physical health (by items on mobility,
self-care, usual activities and pain). Activity and functioning is roughly covered
by the EQ-5D item on usual activities. Social well-being, belonging and
relationships is only partially captured by the EQ-5D item on usual activities.
Subjective ill-being (but not well-being) is broadly reflected in the EQ-5D item
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on depression and anxiety. EQ-5D is not able to represent the remaining 3
domains of HRQoL that are important to people with mental disorders, that is,
control, autonomy and choice; self-perception; and hope and hopelessness.
Compared with EQ-5D, SF-6D covers a wider range of the 7 HRQoL domains
that are relevant to mental health, as it is more balanced in tapping both
physical and mental health aspects. SF-6D captures the domain of physical
health through its questions on physical functioning, vitality, and bodily pain
and its sub-question on role limitations due to physical problems. Activity and
functioning is covered by SF-6D items on physical functioning and role
limitations. Social well-being, belonging and relationships is broadly captured
by the social functioning item of SF-6D. Subjective well-being and ill-being is
covered by the mental health and the vitality SF-6D items and, partly, by the
sub-question on role limitations due to emotional problems. Similar to EQ-5D,
SF-6D is unable to capture the remaining 3 domains of HRQoL that are
important to people with mental disorders, that is, control, autonomy and
choice; self-perception; and hope and hopelessness.
Although Brazier and colleagues (2014) did not evaluate the content validity of
HUI-3 in mental health populations, it was possible to do so for this thesis
using the themes and the approach described in that report. HUI-3 covers
physical health aspects by its items on vision, hearing, pain, ambulation and
dexterity. The domain on activity and functioning is only indirectly covered by
the HUI-3 items on vision, hearing, speech, ambulation, dexterity, cognition;
however, these items cover mainly physical and not mental aspects of activity
and functioning. HUI-3 items on vision, hearing and speech may affect social
well-being, belonging and relationships, but again they capture only physical
aspects that may interact with this domain. Similarly, most HUI-3 items,
including hearing, vision, speech, ambulation, dexterity and cognition affect the
domain control, autonomy and choice, but basically capture physical factors
affecting control and autonomy. The domain of subjective well-being and ill-
being is partially captured by the HUI-3 item on emotion. HUI-3 is unable to
capture self-perception as well as hope and hopelessness.
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The conclusion from the assessment of the content validity of generic PBMs is
that these measures are not able to fully capture the HRQoL aspects that are
most important to people with mental disorders.
2.3.4 Conclusion on the appropriateness of using of
generic preference-based measures in mental health
The review of the psychometric properties of generic PBMs suggest that EQ-
5D and SF-6D perform satisfactorily in depression, but less so in anxiety and
personality disorders (for the latter, only evidence on the EQ-5D was
available). Results were mixed in schizophrenia and bipolar disorder. Results
suggest that generic PBMs may be picking depressive symptoms (or comorbid
depression) rather than core symptoms associated with a range of conditions,
including anxiety and schizophrenia. In dementia, self-reported EQ-5D
performs satisfactorily on some psychometric tests (feasibility, reliability) but its
validity is questionable. The validity of proxy EQ-5D ratings seems to be
higher, but there is poor agreement between patient- and proxy ratings as well
as ratings across different proxies. The review of qualitative evidence on
important aspects of HRQoL for people with mental health problems leads to
the conclusion that generic PBMs fail to address the complexity of quality of life
measurement and the broad range of domains that are important to people
with mental health problems.
The systematic search for reviews did not identify any evidence on the
psychometric properties of HUI-3 in people with mental disorders. Regarding
the other two generic PBMs, EQ-5D and, in particular, SF-6D, available
evidence varied from limited to non-existent in some areas, and therefore safe
conclusions could not be always drawn. Moreover, a number of mental
disorders such as Obsessive Compulsive Disorder (OCD), panic disorder,
generalised and specific phobias were not covered in the review, as no
relevant evidence was identified. Another limitation of the findings is that
validity and responsiveness were mostly assessed by correlations of the
generic PBMs with other measures that were considered relevant in measuring
symptoms and/or HRQoL aspects associated with the underlying mental
condition. However, not all of these measures that were used as ‘gold
standards’ have proven validity and responsiveness in populations with mental
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problems, and therefore results need to be interpreted with caution.
Nevertheless, results indicate that generic PBMs may not be appropriate to
use for the assessment of HRQoL in people with mental health problems.
In addition to the findings of this review of reviews, one systematic review on
outcome measurement in mental health reported that only a negligible portion
of Randomised Controlled Trials (RCTs) conducted in mental health research
(approximately 1%) use generic measures, although it needs to be
acknowledged that this review was published a decade ago (Gilbody et al.,
2003). The authors attributed their finding to the focus of generic measures on
physical functioning with questions that are irrelevant to people with mental
health problems, whilst aspects of social and role functioning that are
important to them are ignored, resulting in generic measures being probably
insensitive to underlying change in health status and also unacceptable to
respondents. Besides, use of generic instruments in addition to CSMs creates
extra burden to clinicians and patients alike. Based on their findings, the
authors concluded that “there is no robust research evidence to support the
value [of generic measures] as routine measures of outcome in psychiatric
settings”.
Thus, as Brazier and colleagues (2014) argue, “overall findings suggest that
there seems to be a case for developing a new preference-based measure
specific to mental health”. The authors acknowledge that “it may not be
possible to cover all dimensions of physical and mental health with the same
level of coverage in one measure, but the new measure would need to
incorporate the impact of both physical and mental health problems”.
Therefore, the rest of this chapter aims to identify an appropriate mental
health-specific measure with proven validity, sensitivity and acceptability and a
wide coverage of mental health symptoms and aspects of HRQoL to be used
as the basis for the derivation of a PBM specifically designed for use in mental
health.
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2.4 Outcome measurement in mental health
research and clinical practice – results of
systematic review 2
2.4.1 Overview of search results
The systematic search of the literature identified 9 studies that reviewed
available outcome measures in the area of adult mental health. Of these, 5
studies examined outcome measures used in any area of mental health, either
generic mental health measures, that could be used across different mental
disorders, or applicable to specific disorders (Flynn, 2002; Gilbody et al., 2003;
Hampson et al., 2011; Jacobs, 2009; National Institute for Mental Health in
England, 2008), one study reviewed outcome measures used in major
depression (Flynn, 2004) and 3 studies reviewed outcome measures used in
schizophrenia (Burns & Patrick, 2007; Flynn, 2003; McCabe et al., 2007). It
must be noted that, given the objective of this review, which was to ultimately
identify an appropriate CSM as the basis for the derivation of a generic mental
health PBM, its focus was on generic mental health measures, that is, on
measures that are applicable across a wide range of mental disorders.
Nevertheless, studies reviewing outcome measures used in specific mental
disorders such as depression and schizophrenia were still considered in the
review, because it was possible that they examined mental health measures
that are applicable to a wider range of mental disorders and not only to those
particular disorders examined in these studies. Furthermore, the review gave
higher emphasis to UK-based studies, as one of the desired properties of the
CSM was to be widely used in the UK mental health research and practice.
Table 2 provides an overview of the studies included in the review, their
potential focus on specific mental disorders, the aims of each study that are
relevant to this review and the methodology adopted in each of them. In the
text reporting the detailed findings of this review of reviews that follows, all
outcome measures that are shown in bold characters are those that
a. were identified in each review as most commonly used or most
appropriate for use in mental health populations (depending on the
review’s objective)
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b. can be used across a range of mental disorders (and may thus be
considered as generic mental health measures) and
c. have wide enough scope in terms of capturing various aspects of
HRQoL.
Table 2. Studies included in the systematic review of outcome measurement in mental health
Study reference Focus on specificmental disorder? Summary of study aims relevant to this review and methodology
Burns & Patrick, 2007 Yes – Schizophrenia Aim: to identify outcome measures used most frequently to assess social functioning in schizophrenia and to assess their
psychometric properties
Methodology: systematic literature review
Flynn, 2002 No Aim: to identify suitable generic measures of mental health status, psychiatric symptoms and functioning for use by the US
Veterans Health Administration (VHA) mental health services
Methodology: systematic literature review and application of psychometric & practicality criteria
Flynn, 2003 Yes – Schizophrenia Aim: to identify suitable outcome measures appropriate for schizophrenia for use by the US Veterans Health Administration
(VHA) mental health services
Methodology: review of existing compendia and reviews and application of psychometric & practicality criteria
Flynn, 2004 Yes - Major
depression
Aim: to identify suitable outcome measures appropriate for depression for use by the US Veterans Health Administration
(VHA) mental health services
Methodology: review of existing compendia and reviews and application of psychometric & practicality criteria
Gilbody et al., 2003 No Aim: to explore the most widely used outcome measures in psychiatric research and UK psychiatric routine practice, with
particular reference to patient-reported outcomes
Methodology: systematic literature review and survey of UK consultant psychiatrists
Hampson et al., 2011 No Aim: to provide guidance on the use of outcome measures in mental health based on what is of clinical value to patients
and clinicians and what is feasible in practice
Methodology: literature review of government and other national reports
Jacobs, 2009 No Aim: to identify the most commonly used outcome measures in the UK mental health services that would be suitable to
convert into a preference-based measure, based on a number of set criteria
Methodology: systematic literature review and interviews with policymakers, academics and NHS staff involved in outcome
measurement in adult mental health services
McCabe et al., 2007 Yes - Schizophrenia Aim: to identify patient-reported outcome measures in schizophrenia and to assess their psychometric properties
Methodology: non-systematic literature review
National Institute for Mental
Health in England, 2008
No Aim: to provide a comprehensive list of mental health outcome measures, their use, properties, advantages and
disadvantages, in order to support health professionals and inform service users and carers
Methodology: literature review, consultation with stakeholders and development of a scoring system assessing each
measure’s quality
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2.4.2 Studies evaluating outcome measurement in
mental health with a focus on UK research and clinical
practice
Gilbody and colleagues, 2003
The aim of this report was to explore outcome measurement in psychiatric
research and practice, with particular reference to PROMs. For this purpose
the authors carried out a systematic review to identify the most commonly used
outcome measures in randomised clinical trials in psychiatry conducted
between the years 1956-2000. In addition, in order to identify the most
commonly used outcome measures in UK routine practice they conducted a
survey of UK consultant psychiatrists. Based on the results of their review, the
authors classified outcome measures used in RCTs into 6 categories:
a. Psychopathological rating scales, measuring predominantly symptoms;
these were the most commonly used outcome measures in psychiatric
research
b. Global outcome measures, which measure the overall (global) severity
of the disorder or its impact on overall functioning; such measures were
used in less than half of RCTs in psychiatry
c. Generic PROMs, e.g. EQ-5D and SF-36; only 1% of the trials had used
such measures
d. Disease-specific PROMs, which examine various domains of HRQoL
and are relevant to specific patient groups or disease areas; such
measures were used approximately in 2.5% and 16% of RCTs
evaluating drugs and psychosocial interventions, respectively
e. Domain-specific PROMs, examining a specific domain associated with
HRQoL; around 6% and 30% of RCTs evaluating drugs and
psychosocial interventions, respectively, used this type of outcomes
f. Other outcomes: these may include relapse, mortality, service use, etc.
Table 3 presents the outcome measures most commonly used in psychiatric
research and UK routine psychiatric practice according to Gilbody and
colleagues (2003).
Table 3. Outcome measures most widely used in psychiatric research and UK clinical practice (Gilbody et al., 2003)
A. Psychiatric research (systematic reviews of 490 RCTs conducted between 1956 – 2000)
Type of outcome measure Most widely used outcome measures
Psychopathological rating scales Schizophrenia and related disorders: BPRS, PANSS
Depression and related disorders: HDRS
Global outcome measures GAF, GAS
Generic patient-reported outcome measures SF-36
Disease-specific patient-reported outcome measures QLS, QOLI, OQLQ
Domain-specific patient-rated
outcome measures
Social functioning SAS, KAS, SFS, REHAB scale
Role functioning ADL, KPS
Perceptions of wellbeing RSES
Satisfaction CSQ
Physical Health PDI
B. Psychiatric routine practice (survey of 340 UK consultant psychiatrists)
Type of mental disorder
Purpose of measurement
Case identification & severity
assessment
Social functioning, quality of life,
assessment of patient needs
Assessment of clinical change over time &
therapeutic response
Depressive and anxiety disorders BDI, HADS, HDRS HoNOS, SAS, SFS BDI, HADS, HDRS, HoNOS
Cognitive impairment MMSE HoNOS MMSE, HoNOS
Psychotic illnesses PANSS, HoNOS, BPRS PANSS, BPRS, HoNOS PANSS, BPRS, HoNOS
drugs and alcohol problems CAGE questionnaire HoNOS HoNOS
ADL: Katz Index of Independence in Activities of Daily Living; BDI: Beck Depression Inventory; BPRS: Brief Psychiatric Rating Scale; CSQ: Client Satisfaction Questionnaire; GAF:
Global Assessment of Functioning; GAS: Global Assessment Scale; HADS: Hospital Anxiety and Depression Scale; HDRS: Hamilton Depression Rating Scale; HoNOS: Health of
the Nation Outcomes Scales; KAS: Katz Adjustment Scale; KPS: Karnofsky Performance Scale; MMSE: Mini Mental State Examination; OQLQ: Oregon Quality of Life
Questionnaire; PANSS: Positive And Negative Syndrome Scale; PDI: Pain and Disability Index; QLS: Heinrich’s Quality of Life Scale; QOLI: Lehman Quality of Life Interview; RSES:
Rosenberg’s Self Esteem Scale; SAS: Social Adjustment Scale; SFS: Social Functioning Scale
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Looking at Table 3, it appears that there are a number of outcomes that can be
considered generic mental health measures, in the sense that they can be
used across different mental disorders. These include BPRS, HoNOS, GAF
and its precursor Global Assessment Scale (GAS). Domain-specific measures,
although applicable across different disorders, were not deemed
comprehensive enough, as they focus on one domain of HRQoL, and thus
were not considered as candidates for derivation of a generic mental health
PBM. It must be noted that the measures listed as most commonly used in
psychiatric research and UK routine practice by Gilbody and colleagues (2003)
were not subject to any assessment in the report.
Mental Health Outcomes Compendium
The Mental Health Outcomes Compendium (National Institute for Mental
Health in England, 2008) comprises a comprehensive, though not exhaustive,
collection of outcome measures that can be used across adult mental health
services, aiming to support clinicians and inform service users and carers. The
report provides information on a range of available measures in mental health
practice, their use, properties, advantages and disadvantages, thus allowing
stakeholders to make an informed choice. The list of measures was compiled
based on a literature review that identified the most popular and evidenced
outcome measures and further consultation with stakeholders to identify
additional instruments that were of clinical value or were recommended by
service users; subsequently a scoring system was developed to summarise
the quality of the included measures in terms of their psychometric properties
(such as validity, reliability and responsiveness), stakeholders’ priorities
(including clinical utility, appropriateness and acceptability), the existing
evidence base, and the measure’s availability (determined by practicality,
training requirements, copyright issues or permissions for their use and
associated costs).
The compendium included 188 measures in total. Based on their quality
scores and stakeholders’ recommendations, 69 measures were shortlisted, for
which more detailed information on their properties and use was provided in
the report. The shortlisted measures were organised in 18 distinct diagnostic /
therapeutic areas, which can be further grouped in 5 broad ‘themes’
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representing aspects of health and health care, and these are presented in
Table 4.
The authors of the report acknowledged that some measures belonged to
more than one diagnostic / therapeutic area. Furthermore, a number of
measures fitted also in areas beyond the 18 areas reported; for example, the
authors expressed the view that some of the shortlisted instruments, such as
the Camberwell Assessment of Need Short Appraisal Schedule (CANSAS),
the Clinical Outcomes in Routine Evaluation (CORE) measurement tools, the
Functional Assessment of the Care Environment (FACE), the HoNOS and the
Threshold Assessment Grid (TAG) were essentially global severity measures
that were not restricted to exclusively measuring ‘outcome of psychological
therapies’ (CORE measurement tools) or ‘health care and needs assessment’
(CANSAS, FACE, HoNOS, TAG) and could in practice be used across
different diagnostic / therapeutic areas.
Looking at the identified areas in Table 4, it appears that CSMs belonging in
the broader themes of ‘social functioning and overall well-being’ and ‘services’
are more likely to comprise appropriate candidate measures for the derivation
of a generic mental health PBM, in particular those comprising global severity
measures, such as CANSAS, CORE measurement tools, FACE, HoNOS and
TAG. It must be noted that, of the global severity measures, the CORE
measurement tools, HoNOS and TAG were shortlisted in the Compendium
based on both a high quality score and stakeholders’ recommendations.
Table 4. Outcome measures included in the Mental Health Outcomes Compendium, shortlisted according to their quality
score and/or stakeholders’ recommendations (National Institute for Mental Health in England, 2008)
Aspects of health
and health care Diagnostic / therapeutic areas Outcome measures
Mental disorder
areas and/or
symptoms
Addictions Addiction Severity Scale/Index; AUDIT; The Severity Dependence Scale; Maudsley Addiction Profile
Anxiety and depressive disorders Amritsar Depression Inventory; BDI; Beck Hopelessness Scale; Centre for Epidemiological Studies
Depression Scale; EPDS; Fear Questionnaire; GAD-7; Geriatric Depression Scale; GHQ-12; HADS; HAI;
Liebowitz social anxiety scale; MADRS; Mobility Inventory for Agoraphobia; OCI; Panic Rating Scale; Penn
State Worry; PHQ-9; POMS; SPIN; Y-BOCS
Bipolar disorder Internal State Scale
Eating disorders EDE-Q
Personality disorders BPDSI; Zanarini scale for Borderline
Post-traumatic stress disorder Impact of Events Scale
Psychotic symptoms Auditory Hallucination Rating Scale; CAARMS; PANSS; Psychotic Symptom Rating Scales: Delusions
Physical
symptoms
Adverse effects Abnormal Involuntary Movement Scale
Fatigue Chronic Fatigue Questionnaire
Social functioning
and overall well-
being
Employment Work and Social Adjustment Scale
Quality of life, social functioning, well-being EQ-5D; PSYCHLOPS; SF-36; The How are you scale; Life Satisfaction Index
Social functioning & functioning disabilities RFS; SDS; Schwartz Outcome Scale; Social Adaptation Self-Evaluation Scale; Social Adjustment Scale;
Social Functioning Scale; Social Summary Rating Scale
Services: settings,
evaluation,
organisation of
care and related
patient views
Forensic Historical Clinical Risk 20
Healthcare and needs assessment CANSAS; CUES; FACE; HoNOS; TAG; Maslach Burnout Inventory
Patient perceptions of care IPQ; Client Satisfaction Questionnaire; PEQ Part 1; PEQ Part 2
Outcome of psychological therapies CORE (several measures); Outcome Rating Scale; Session Rating Scale; The Barrett Lennard Inventory;
The Inventory of Interpersonal Problems
Recovery (and interaction with services) DREEM; Mental Health Recovery Star; Ohio consumer assessment I & II
Service planning WHO DAS-S
AUDIT: Alcohol Use Disorder Identification Test; BDI: Beck Depression Inventory; BPDSI: Borderline Personality Disorder Severity Index; CAARMS: Comprehensive Assessment of
At Risk Mental States; CANSAS: Camberwell Assessment of Needs Short Appraisal Schedule; CORE: Clinical Outcomes in Routine Evaluation; CUES: Carers & Users Expectations
of Service; DREEM: Developing Recovery Enhancing Environments Measure; EDE-Q: Eating Disorders Examination Questionnaire; EPDS: Edinburgh Postnatal Depression Scale;
FACE: Functional Assessment of the Care Environment; GAD-7: Generalised Anxiety Disorder - 7 items; GHQ-12: General Health Questionnaire - 12 items; HADS: Hospital Anxiety
and Depression Scale; HAI: Health Anxiety Inventory; HoNOS: Health of the Nation Outcomes Scales; IPQ: Illness Perception Questionnaire; MADRS: Montgomery & Asberg
Depression rating tool; OCI: Obsessive Compulsive Inventory; PANSS: Positive And Negative Syndrome Scale; PEQ: Patient Experience Questionnaire; PHQ-9: Patient Health
Questionnaire - 9 items; POMS: Profile of Mood States; PSYCLOPS: Psychological Outcome Profiles; RFS: Role Functioning Scale; SDS: Sheehan Disability Scale; SPIN: Social
Phobia Inventory; TAG: Threshold Assessment Grid; WHO DAS-S: World Health Organization Short Disability Assessment Schedule; Y-BOCS: Yale-Brown Obsessive-Compulsive
Scale
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Jacobs, 2009
The objective of the study conducted by Jacobs (2009) was to identify the
most commonly used outcome measures in the UK mental health services that
would be suitable to convert into a PBM. The author used the following criteria
in order to identify suitable measures for this purpose:
 Ability to capture a wide range of mental health problems, so it is
possible to use as generic mental health CSMs
 Wide (national) coverage in British NHS services
 Applicability in a number of care settings
 Routine collection in clinical practice
 High level of linking to activity data
 Feasibility of conversion into a PBM
 Availability of time series data
Coverage in NHS services was assessed based on the results of a systematic
literature review and interviews with policymakers, academics and NHS staff
involved in outcome measurement in adult mental health services. Based on
the above criteria, two measures were identified as good candidates for
translation into a utility index: HoNOS and the Clinical Outcomes in Routine
Evaluation – Outcome Measure (CORE-OM). The study findings indicated that
both HoNOS and CORE-OM were used in routine clinical practice and were
probably the measures with the widest coverage in the NHS at the time the
study was conducted, even though this coverage was somewhat patchy and in
some areas non-existent. Regarding applicability across different health
settings, the author acknowledged that this was difficult to achieve as most
instruments considered appropriate in one setting might be inappropriate in
another. HoNOS, which is a clinician-rated measure, was found to be mainly
used in secondary care settings for patients with severe and enduring mental
illness, while CORE-OM, which is patient-reported, covered patients that were
primarily treated in the community setting or received psychological therapy
(mostly people with depression and anxiety disorders). Time series data on
activity and outcome were available for both HoNOS and CORE-OM, but it
was reported that data quality was a concern and access to CORE-OM would
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need to be negotiated. The author expressed the opinion that the valuation of
either HoNOS or CORE-OM in order to derive a PBM would be an ‘extremely
complex’ task.
Finally, the aim of the report by Hampson and colleagues (2011) was to
provide guidance on the use of outcome measures in mental health based on
what is of clinical value to patients and clinicians and what is feasible in
practice. The report suggested a list of CSMs as a guide to clinicians and
patients, which were selected from measures that had been shortlisted in the
Mental Health Outcomes Compendium (National Institute for Mental Health in
England, 2008).
2.4.3 Other studies evaluating outcome measurement in
mental health (not UK-focused)
The review by Flynn (2002) was the first in a series of systematic reviews of
available standardised mental health outcome measures to identify those most
suitable for use by the US Veterans Health Administration (VHA) mental health
services. The review focused on generic measures of mental health status,
psychiatric symptoms and functioning that could be used in conjunction with
disease-specific ones to monitor treatment effectiveness for clinical planning.
Suitability of the measures in all reviews of the series was determined by a
number of selection criteria, including:
 congruence of the original purpose of the measure with VHA intended
use
 ability of the measure to capture multiple aspects of disease including
both symptoms and functioning (‘multidimensionality’)
 applicability to serious mental illness (such as schizophrenia and major
depression)
 reliability
 validity
 responsiveness to change
 feasibility for routine use (i.e. imposing minimal burden to clinicians and
patients)
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 interpretability by non-professionals
 availability in electronic form (for entry and analysis)
 reasonable cost
Based on the above criteria, the author shortlisted 5 generic mental health
measures that met all criteria and were recommended as most appropriate for
use by the US VHA mental health services, that is, the Behaviour and
Symptom Identification scale-12 item (BASIS-12), BPRS, the Compass Out-
Patient (Compass-OP), GAF and HoNOS, Two further measures, the
Camberwell Assessment of Need (CAN) and TAG met almost all criteria,
missing only the criterion for availability in electronic form, and thus were also
considered for use by the US VAH mental health services.
Flynn (2004) reviewed existing compendia and reviews to inform the US VAH
mental health services on outcome measures most appropriate for depression,
using the same criteria listed above. The author identified 15 appropriate
measures, 10 specific to depression and 5 generic ones. Of the 5 generic
measures, 2 were not specific to mental health; these were the SF-36 and the
QWB, including the self-administered version (QWB-SA). The other 3 were
generic mental health measures and included GAF, the Mental Health
Inventory (MHI) and the Sheehan Disability Scale (SDS); the latter is a tool
focusing on functioning status in the areas of work/school, social life and family
life in people with mental disorders (mainly depression and anxiety), and
therefore is considered too narrow in scope to form the basis of a generic
mental health PBM.
Finally, Flynn (2003) reviewed existing compendia and reviews to inform the
US VAH mental health services on outcome measures most appropriate for
schizophrenia, using the same set criteria described for the previous two
reports. The author identified 13 appropriate measures, of which 10 are
specific to schizophrenia and 3 are generic mental health measures. The latter
included the Clinical Global Impression scale (CGI), the Role Functioning
Scale (RFS), and BPRS.
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Burns and Patrick (2007) conducted a systematic literature review to identify
outcome measures used most frequently to assess social functioning in
schizophrenia, and to assess their psychometric properties. Of the 3 measures
that were identified as the most widely used for this purpose, 2 were measures
of functioning used in general psychiatry, that is, GAF and GAS. GAF was
identified as the most widely used social functioning scale for people with
schizophrenia, providing a reliable assessment of psychological, social and
occupational functioning. GAS is precursor of GAF.
McCabe and colleagues (2007) conducted a non-systematic review to identify
PROMs in schizophrenia and to assess their psychometric properties. The
authors identified 20 measures in total. Of these, 6 focused on symptoms and
needs assessment, 9 assessed the clinician-patient therapeutic relationship,
the patients’ attitude toward therapy and their satisfaction with services, and
another 5 aimed to capture the psychological well-being of patients. Of the 6
measures focusing on symptoms and needs assessment, 4 were generic
mental health measures that can be used across different mental disorders;
these included the Brief Symptom Inventory (BSI), the SCL-90-R, CAN and
CANSAS. BSI was reported to have high internal consistency, test-retest
reliability, and construct (convergent and known groups) validity. Evidence for
SCL-90-R indicated high internal consistency and adequate test-retest
reliability. Both CAN and its shortened version, CANSAS, were found to have
high face validity and reliability. The 9 measures assessing patients’ views and
attitude toward therapy and services have a narrow scope and were deemed
not appropriate to form the basis for a generic mental health PBM; therefore
these are not discussed further in this chapter. Finally, all 5 PROMs of
psychological well-being were generic measures that can be used across
different mental disorders; these included the Empowerment Scale, the Self-
Esteem Scale, the Sense of Coherence Scale (SOC), the Mental Health
Recovery Measure (MHRM) and the Recovery Assessment Scale (RAS).
These measures have a narrow scope, focusing on specific aspects of
psychological well-being rather than capturing a range of aspects that
constitute a person’s HRQoL and thus were not regarded suitable candidates
for the derivation of a PBM.
69
2.4.4 Identification of appropriate outcome measures as
candidates for the derivation of a mental health specific
preference-based measure
The systematic review of existing reviews revealed that there is a range of
validated CSMs that can be used as generic measures across different mental
disorders, have quite a wide scope (i.e. they are not limited to capturing a
specific aspect of HRQoL), and therefore could potentially form the basis for a
generic mental health PBM. Among the most widely used and/or
recommended measures were the BPRS, CAN and its shorter form CANSAS,
the CORE measurement tools, GAF and its precursor GAS, HoNOS and TAG.
BPRS is a clinician-rated scale designed to measure major psychotic and non-
psychotic symptoms (Overall & Gorham, 1962); it is mainly used in patients
with schizophrenia.
CAN (and its shortened form, CANSAS) is a clinician-rated measure aiming to
assess the needs of people with severe mental illness (Phelan et al., 1995).
The CORE measurement tools, which consist of CORE-OM (Evans et al.,
2000) and a number of other inter-dependent measures that have been
developed around the CORE-OM, are PROMs designed to measure aspects
of psychological distress, including relevant symptoms and well-being, before
and after therapy, thus providing a routine outcome measurement system for
psychological therapies and some areas of psychiatry.
GAF (and its precursor, GAS) is a clinician-rated scale that evaluates patients’
psychological, social and occupational functioning covering a range from
positive mental health to severe psychopathology (Jones et al., 1995).
HoNOS is a clinician-rated measure designed to measure the health status
and social functioning of people with severe mental illness (Wing et al., 1998).
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TAG is also clinician-rated, and is designed to evaluate the severity of
symptoms in people with mental disorders, so as to prioritise those in need for
specialist mental health care (Slade et al., 2000).
In selecting an appropriate measure of those briefly described above as the
basis for the derivation of a generic mental health PBM, emphasis was given
to reviews that had a special focus on the UK mental health research and/or
practice, as these examined factors such as coverage, routine collection and
views of psychiatrists and patients in the British NHS context.
The most relevant of the reviews considered was the one by Jacobs (2009), as
the aim of that review reflected the objective of the review of reviews
conducted for this thesis, i.e. it aimed to identify the most commonly used
outcome measures in the UK mental health services that would be suitable to
convert into a PBM. The author identified HoNOS and CORE-OM as the two
most suitable measures based on their ability to capture a wide range of
mental health problems, coverage and routine collection in NHS services,
availability of activity and time series data, and applicability in various care
settings.
In addition to the recommendation by Jacobs (2009), HoNOS was shortlisted
in the Mental Health Outcomes Compendium for receiving a high quality
scoring and being recommended by stakeholders (National Institute for Mental
Health in England, 2008). It was also identified as one of the most widely used
outcome measures in psychiatric research and practice by Gilbody and
colleagues (2003). Finally, with regard to US guidelines, it was one of the
generic mental health measures recommended by Flynn (2002) for use by
VAH mental health services.
The CORE measurement tools (which include the CORE-OM) were also
shortlisted in the Mental Health Outcomes Compendium for receiving a high
quality scoring and being recommended by stakeholders (National Institute for
Mental Health in England, 2008). The CORE-OM was not identified as a widely
used measure in the review by Gilbody and colleagues (2003), but this is
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possibly attributable to the fact that CORE-OM was not developed until 1998,
and this review covered the years 1956-2000, while the interviews with UK
psychiatrists must have taken place before 2002, when CORE-OM use was
likely not widespread yet. CORE-OM was not among the recommended
measures in the non-UK focused reviews, most likely because either a. these
considered evidence available up to early 2000s, when CORE-OM was not
fully validated and/or widely used or b. these focused on outcome measures
for patients with schizophrenia, whereas CORE-OM has not been designed for
use in this patient population.
2.5 Selection of an appropriate outcome measure
as the basis for the derivation of a generic mental
health-specific preference-based measure
This section reviews in more detail the properties, usage and applications of
HoNOS and the CORE-OM, which appeared to be the leading candidates for
the derivation of a generic mental health PBM following the findings of the
review of reviews. The aim of this section is to justify the selection of CORE-
OM as the most appropriate between the two measures for the derivation of a
new PBM specific to mental health.
2.5.1 The Health of the Nation Outcome Scales (HoNOS)
HoNOS is a clinician-rated questionnaire developed by the Royal College of
Psychiatrists’ Research Unit in consultation with clinical experts, following its
commissioning by the UK Department of Health in 1993 “to develop scales to
measure the health and social functioning of people with severe mental
illness”.1 HoNOS was developed in 4 phases (Wing et al., 1998). Phase I
comprised a literature review of existing measures and the development of a
draft measure after consultation with clinical experts. In Phase II, the drafted
measure HoNOS-I was shortened to version HoNOS-II, following pilot tests on
simplicity in structure, acceptability to clinicians, and sensitivity to change.
HoNOS-II was tested against using the same criteria and was modified to
version HoNOS-III, which was subsequently tested in field trials comprising
Phase III of the project. These larger scale trials assessed the properties that
1 http://www.rcpsych.ac.uk/crtu/healthofthenation.aspx [Accessed 22 April 2013].
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were previously tested in Phase II, plus the reliability of the measure and the
ability of HoNOS-III ratings to describe distinct clinical profiles for different
diagnostic groups. Results of these trials led to further amendments and the
development of the final scale, the HoNOS, which was then re-tested in Phase
IV on all previous attributes plus its comparability to existing validated larger
measures.
HoNOS includes 12 items, each with 5 levels of response: ‘no problem’, ‘minor
problem requiring no action’, ‘mild problem but definitely present’, ‘moderately
severe problem’ and ‘severe to very severe problem’. The 12 items cover 4
domains: ‘behaviour’, ‘impairment’, ‘symptoms’ and ‘social functioning’ (Wing
et al., 1998). Depending on the level of response, each item can get a score
from 0 (‘no problem’) to 4 (‘severe to very severe problem’). The sums of item
ratings represent a clinical judgement of severity of the mental disorder: for
example, the more 0s the lower the severity, the more 4s the greater the
severity. Item scores in each domain can also be added to give a total
subscale score. Changes in subscale scores between two time points, most
typically between the start and the end of an episode of care, provide an
indication of change in the patient’s health status specific to each domain. A
total scale score can be derived by adding all item scores and can get a value
between 0 (best possible score) and 48 (worst possible score). However, the
developers advise against estimation of a total scale score, because the 12
items are so wide in their coverage that significant improvements in one
domain may be cancelled out by deterioration in another, thus potentially
giving the wrong impression that no improvement has occurred within a time
period, e.g. over a completed episode of care. The domain structure of HoNOS
is shown in Table 5.
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Table 5. The domain structure of HoNOS
Domain Item
Behaviour 1. Overactive, aggressive, disruptive or agitated behaviour
2. Non-accidental self-injury
3. Problem-drinking or drug-taking
Impairment 4. Cognitive problems
5. Physical illness or disability problems
Symptoms 6. Problems associated with hallucinations and delusions
7. Problems with depressed mood
8. Other mental and behavioural problems
Social
functioning
9. Problems with relationships
10. Problems with activities of daily living
11. Problems with living conditions
12. Problems with occupation and activities
HoNOS versions are available for children and adolescents (Gowers et al.,
1999), older people (Burns et al., 1999), people with learning disabilities (Roy
et al., 2002), people in forensic services (Dickens et al., 2007), and people with
acquired brain injury (Fleminger et al., 2005). Copyright of HoNOS is owned by
the Royal College of Psychiatrists. The College allows the free use, copy and
reproduction of HoNOS score-sheets for use in NHS-funded care without
requested permission. However, commercial copying, renting and adaptation
are prohibited.
Overall, HoNOS has been shown to be a valid, reliable and responsive
measure, acceptable to clinicians and appropriate for routine outcome
measurement (Amin et al., 1999; Andreas et al., 2010; Eagar et al., 2005;
Kisely et al., 2007 & 2010; Kodagalli et al., 2012; McClelland et al., 2000;
Oiesvold et al., 2011; Orrell et al., 1999; Page et al., 2001; Pirkis et al., 2005),
although concerns regarding its reliability and sensitivity have been expressed
by a number of researchers, questioning its usefulness as a routine outcome
measure in mental health services (Audin et al., 2001; Bebbington et al., 1999;
Brooks, 2000; Duke, 2010; Orrell et al., 1999; Sharma et al., 1999; Slade et al.,
1999; Trauer et al., 1999). HoNOS correlates moderately with other widely
used validated measures such as the EQ-5D index (Kodagalli et al., 2012),
CANSAS (Slade et al., 1999), and CORE-OM (Leach et al., 2005), but its
correlation with other measures such as the mental component score of SF-36
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(Brooks, 2000) and the SCL-90-R (Brooks, 2000; Oiesvold et al., 2011) has
been found to be weak.
Over the years, HoNOS has been recommended as the main outcome
measure for use in mental health services by a number of advisory bodies and
strategic plans including the English National Service Framework for Mental
Health (Department of Health, 1999), the working group to the Department of
Health on outcome indicators for severe mental illnesses (Charlwood et al.,
1999), and the Outcomes Reference Group, a group established by the
Department of Health in 2002 to advise on best practice guidance (Fonagy et
al., 2004). More recently, the strategic plan on mental health designed by the
coalition government ‘No health without mental health’ recommends the use of
HoNOS for measuring outcome in people with severe mental illness and
acknowledges the measure’s widespread use and acceptability (HM
Government & Department of Health, 2011). HoNOS is one of the
recommended quality and outcomes indicators to be used as part of the
introduction of the Payment by Results currencies and local tariffs for mental
health services, and the only indicator of those recommended that is routinely
collected across NHS services (Quality and Outcomes Sub Group of the
Product Review Group for Mental Health Payment by Results, 2011). It needs
to be noted, though, that, according to its developers, HoNOS has not been
designed for use in primary care; consequently, it may not be appropriate for
outcome measurement in people with mild or moderate mental disorders that
are treatable in primary care settings.
Further to the lack of applicability of HoNOS in primary care, its main
disadvantage in being used as the basis for a generic mental health PBM is
the fact that it is clinician-rated and not patient-reported. PBMs like EQ-5D, SF-
6D and HUI-3 have been traditionally patient-reported, i.e. they collect
information on HRQoL from patients themselves (rather than clinicians); these
HRQoL ratings have been subsequently linked to utility values expressing the
preferences of members of the general population. In this sense, PBMs can be
regarded as a special form of PROMs (Stevens & Palfreyman, 2012). To this
direction, NICE explicitly requires measurement of HRQoL changes be elicited
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from patients, and, if this is not possible, from their carers, rather than
healthcare professionals (National Institute for Health and Care Excellence,
2013). Consequently, the clinician-rated HoNOS was not considered
appropriate for the derivation of a generic mental health PBM.
2.5.2 The Clinical Outcomes in Routine Evaluation -
Outcome Measure (CORE-OM)
The CORE-OM is a PROM that was developed by a multicentre collaborative
group as a result of winning a competitive tender to develop an outcome
measure at a conference for the Mental Health Foundation in 1993.2 The
rationale for developing a new measure was the “need for a pragmatic, user-
friendly measure that taps pan-theoretical ‘core’ components of patients’
distress” that would be “implemented on a broad basis across adult mental
health services in order to enable benchmarking and standardise outcome”
(Barkham et al., 1998). Development of CORE-OM was carried out in 4
phases (Barkham et al., 2001). Phase I involved a survey of the views of
providers and purchasers of mental health services about the current use of
outcome measures in the services and the desirable aspects of a new
outcome measure. In Phase II, 6 independent groups of raters assessed the
results of the survey undertaken in Phase I. In Phase III the development team
designed the criteria that the new measure should meet and drafted the items
of the new measure based on the results of the previous 2 phases. The drafted
items were then tested for qualitative feedback from a wider group of more
than 40 therapists, researchers and lay people. The CORE-OM was finalised
in Phase IV of the project.
The CORE-OM is a measure of psychological distress that was designed to
evaluate the effectiveness of psychological therapies across multidisciplinary
services in the UK (Barkham et al., 2001; Evans et al., 2000). It consists of 34
items, each with 5 levels of response: ‘not at all’, ‘only occasionally’,
‘sometimes’, ‘often’, and ‘most or all the time’. The items tap 4 domains
considered by practitioners to be necessary components in a ‘core’ measure:
‘subjective well-being’ (4 items), ‘problems’ (4 items on depression, 4 items on
2 http://www.coreims.co.uk/index.html [Accessed 25 April 2013].
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anxiety, 2 items on physical symptoms and 2 items on trauma), ‘functioning’ (4
items on general functioning, 4 items on close relationships and 4 items on
social relationships) and ‘risk’ (4 items on risk-to-self and 2 items on risk-to-
others). Eight of the items are positively worded. Depending on the level of
response, each item is scored from 0 (‘not at all’) to 4 (‘most or all the time’),
with the exception of positively worded items, the scores of which are
reversed. The CORE-OM clinical score is then calculated by adding all 34-item
scores, multiplying by 10 and dividing by 34. The CORE-OM clinical score can
get values between 0-40, with 10 being considered the cut-off point between
clinical and non-clinical cases. A clinical score 10 to <15 indicates mild
psychological distress, 15 to <20 moderate distress, 20 to <25 moderate to
severe distress, and 25 to 40 severe psychological distress (Barkham et al.,
2006). The 34 items of CORE-OM categorised by domain and sub-domain are
presented in Table 6.
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Table 6. The conceptual domain structure of CORE-OM
Domain Item No Item description
Subjective
Well Being
4 I have felt ok about myself
14 I have felt like crying
17 I have felt overwhelmed by my problems
31 I have felt optimistic about my future
Symptoms –
anxiety
2 I have felt tense, anxious or nervous
11 Tension/anxiety have prevented me doing important things
15 I have felt panic or terror
20 My problems have been impossible to put to one side
Symptoms –
depression
5 I have felt totally lacking in energy and enthusiasm
23 I have felt despairing or hopeless
27 I have felt unhappy
30 I have thought I am to blame for my problems & difficulties
Symptoms –
physical
8 I have been troubled by aches, pains, physical problems
18 I have had difficulty of getting to sleep or staying asleep
Symptoms –
trauma
13 I have been disturbed by unwanted thoughts and feelings
28 Unwanted images or memories have been distressing me
Functioning –
general
7 I have felt able to cope when things go wrong
12 I have been happy with the things I’ve done
21 I have been able to do most things I needed to
32 I have achieved the things I wanted to
Functioning –
close
relationships
1 I have felt terribly alone and isolated
3 I have felt I have someone to turn to for support when needed
19 I have felt warmth or affection for someone
26 I have thought I have no friends
Functioning –
social
relationships
10 Talking to people has felt too much for me
25 I have felt criticised by other people
29 I have been irritable when with other people
33 I have felt humiliated or shamed by other people
Risk/harm to
self
9 I have thought of hurting myself
16 I made plans to end my life
24 I have thought it would be better if I were dead
34 I have hurt myself physically or taken risks with my health
Risk/harm to
others
6 I have been physically violent to others
22 I have threatened or intimidated another person
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In addition to CORE-OM, other CORE system products are available for
outcome measurement (Gray & Mellor-Clark, 2007). These include the short
form A (CORE - SFA) and short form B (CORE - SFB) which consist of 18
items each and are usually used in research studies at alternate sessions
instead of the CORE-OM to reduce memory effects (Cahill et al., 2006), the
brief form CORE-10 used in routine practice for initial screening and session-
by-session monitoring (Barkham et al., 2013), the even shorter CORE-5 used
also in routine practice for session-by-session monitoring, the CORE-GP for
measuring the mental health of the general or student population (Sinclair et
al., 2005), the YP-CORE appropriate for young people (Twigg et al., 2009), the
CORE-LD for use in people with learning disabilities (Brooks et al., 2013;
Marshall & Willoughby-Booth, 2007), the CORE Goal Attainment Form for
tracking goal attainment (Proctor & Hargate, 2013), and the ARM-5, which is a
measure of therapeutic alliance. Further to these, the CORE System includes
also a therapy assessment form (CORE-A) (Barkham et al., 2005b) and an
end of therapy form (Connell et al., 2006), which have been adapted for use
with young persons, at workplace, and in further and higher education. The
CORE system is supported by special software (CORE-PC and CORE-NET),
as well as training and backup services provided by the CORE Information
Management Systems (CORE IMS).
The CORE System Trust, a not-for-profit company, holds the copyright of
CORE measures. CORE measures may be photocopied freely provided that
they are not modified or used for financial gain. However, creating electronic
versions for inclusion in software systems other than those provided by CORE
IMS requires written permission from the Trustees of the CORE System Trust.
CORE-OM comprises a valid, reliable, responsive and acceptable
effectiveness measure across a wide range of practice settings offering
psychological therapies, including primary and secondary care (Barkham et al.,
2001 & 2005b; Evans et al., 2002 & 2003). It has been validated in older
populations (Barkham et al., 2005a). Its diagnostic value for depression is as
good as clinician-rated measures (Gilbody et al., 2007) and its correlation with
other widely used CSMs such as the BDI (Cahill et al., 2006; Leach et al.,
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2006), the HoNOS (Leach et al., 2005) the HAM-D (Cahill et al., 2006), and the
Clinical Interview Schedule - Revised (CIS-R) (Connell et al., 2007) is
moderate to high. CORE-OM has been administered to both general
population and clinical samples in the UK to assess normative values and find
appropriate cut-offs between clinical and non-clinical cases; this has led to the
construction of normative tables with distinct severity levels for clinical and
non-clinical UK population (Barkham et al., 2006; Connell et al., 2007; Evans
et al., 2002). CORE System outcome measurements have also been used to
establish benchmarks against which services can review their own data,
contributing to service assessment and improvement in the quality of care
(Barkham et al., 2001; Evans et al., 2003; Mellor-Clark et al., 2006; Mullin et
al., 2006).
Jacobs (2009) reported that CORE-OM was considered the most widely used
outcome measure in psychological therapy and counselling services in the UK,
with the CORE IMS database covering around 100,000 patients per annum.
According to the CORE System website, in 2010 CORE-OM software was
used by over 250 organisations, including 40 primary care services, 40
secondary and tertiary care services, 30 workplace services, 80 voluntary
sector services, 30 university and 10 private services.
The Improving Access to Psychological Therapies (IAPT) programme was
initiated in 2006, aiming to support the British NHS in delivering evidence-
based psychological therapies for people with depression and anxiety
disorders, ensuring wide and timely access to services and treatments,
improvement in service users’ health and well-being, employment, benefit, and
social inclusion status, as well as increased patient choice and high levels of
satisfaction. The current IAPT data handbook (IAPT, 2011) recommends the
use of 4 measures on all patients seen in IAPT at minimum, based on their
suitability, free access and wide use. Of these, 3 are specific to depression
(PHQ-9), generalised anxiety (Generalised Anxiety Disorder - 7 items – GAD-
7) and phobias (IAPT Phobia Scales), and one is a social functioning measure
(Worker and Social Adjustment Scale - WSAS). Nevertheless, the 2008/2009
IAPT toolkit (IAPT, 2008) acknowledged CORE-OM as a measure widely used
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to monitor changes in psychological health and well-being, that covered a
wider range of client-presenting problems than the disorder-specific measures
PHQ-9 and GAD-7. Although the CORE-OM was not part of the minimum IAPT
dataset, the IAPT toolkit encouraged sites already using CORE-OM to
continue its use pre- and post-treatment in addition to measures
recommended by IAPT. Sites that continued use of the CORE-OM were
advised to supplement its use with shorter versions, such as the CORE-10, in
order to save time and record outcomes and recovery data for as many
patients as possible.
Compared with HoNOS, the CORE-OM has wider applicability across service
settings, as it has been validated for use in both primary and secondary care.
More importantly, in contrast to HoNOS, it is a PROM and therefore it is more
suitable than HoNOS to form the basis for the derivation of a new PBM.
One disadvantage of the CORE-OM is that by design it is suitable for use in
people with common mental health problems; these include various types of
depression and anxiety, including unipolar depression, GAD, mixed anxiety
and depressive disorder, phobias, OCD and panic disorder. CORE-OM has not
been designed for use in people with severe mental illness such as
schizophrenia, bipolar and personality disorders, and therefore it may not be
appropriate to use in such populations. Consequently, CORE-OM cannot form
the basis for a generic mental health PBM that can be used across all mental
disorders. On the other hand, the review of reviews did not identify any other
CSM that has all the advantages of CORE-OM (patient-reported, broad
coverage of symptoms and aspects of HRQoL, valid and responsive, wide use
within the NHS, applicability to primary and secondary care settings) and can
be used as a generic mental health measure across the full range of mental
disease. In any case, common mental health problems alone have a
prevalence that reaches 18% in people aged 16-64 years living in England (for
comparison, psychotic disorders are prevalent in only 0.4% of this population)
(McManus et al., 2009). Therefore, CORE-OM is applicable to the large
majority of people with mental disorders, including those with common mental
health problems and potentially to a range of populations with more severe
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mental illness. For this reason, and considering its advantages compared with
other candidate CSMs, CORE-OM was selected for the derivation of a mental
health-specific PBM for people with common mental health problems.
Given that the CORE System includes forms that are more concise than the
CORE-OM, such as CORE-SFA and CORE-SFB, and, in particular, CORE-10
and CORE-5, there was the question of whether to derive the PBM from these
shorter forms, or, indeed, whether these shorter forms could directly form a
PBM, following a valuation survey. After reviewing these shorter forms, the
purpose of their development and the methods employed for their construction,
it was decided that it was preferable to assess the full pool of the 34 CORE
items for their appropriateness and suitability for inclusion in a PBM, rather
than to limit the pool of items or to use existing brief forms of the CORE-OM
that were developed for different purposes. Furthermore, it was felt that the
new PBM should be derived from the original CORE-OM by adopting and/or
adapting validated approaches described in the literature for this purpose.
In addition to the review of its psychometric properties, its coverage and
applicability across different service settings, the appropriateness of CORE-
OM to form the basis for the derivation of a generic mental health PBM was
examined by assessment of its content validity by matching its items against
the 7 themes identified as having the greatest impact on HRQoL in people with
mental disorders (Brazier et al., 2014; Connell et al., 2012). Each item was
matched to one ‘primary’ HRQoL domain, although some items could be
potentially matched to more than one domain. Table 7 shows the results of this
assessment.
Table 7. Content validation of CORE-OM against the main domains of health-related quality of life that are important to people
with mental disorders [as identified by Brazier and colleagues (2014) and Connell and colleagues (2012)]
Domain Sub-theme and summary description CORE-OM item
Subjective
well-being & ill-
being
Distress; associated with depression, experience of psychosis and mania and anxiety
Depressive mood; associated with poor concentration, low energy and poor motivation
Fear or panic and anxiety; can be caused by stressful social situations
Psychosis-related distress; caused by critical voices, difficult to differentiate from reality
Positive well-being: happiness and enjoyment; feeling peaceful, calm, relaxed and safe
Energy and motivation (lack of both often caused by lack of sleep)
2
5
13
14
15
17
18
20
27
28
I have felt tense, anxious or nervous
I have felt totally lacking in energy and enthusiasm
I have been disturbed by unwanted thoughts and feelings
I have felt like crying
I have felt panic or terror
I have felt overwhelmed by my problems
I have had difficulty of getting to sleep or staying asleep
My problems have been impossible to put to one side
I have felt unhappy
Unwanted images or memories have been distressing me
Activity &
functioning
Positive: work, hobbies or social interaction
Negative: stressful if too demanding; fear of stress may result in avoiding enjoyable activities
11
32
Tension/anxiety have prevented me doing important things
I have achieved the things I wanted to
Social well-
being,
belonging &
relationships
Relationships: close friends and family
Social relationships
Reactions of others – understanding, acceptance and stigma
Sense of belonging
1
3
6
10
19
22
25
26
29
33
I have felt terribly alone and isolated
I have felt I have somebody to turn to for support when needed
I have been physically violent to others
Talking to people has felt too much for me
I have felt warmth or affection for someone
I have threatened or intimidated another person
I have felt criticised by other people
I have thought I have no friends
I have been irritable when with other people
I have felt humiliated or shamed by other people
Self-perception Self-identity
Self-efficacy, self-esteem and self-acceptance
Self-stigma
4
9
12
30
34
I have felt ok about myself
I have thought of hurting myself
I have been happy with the things I’ve done
I have thought I am to blame for my problems & difficulties
I have hurt myself physically or taken risks with my health
Control,
autonomy &
choice
Dependence and independence – relating to support
Self-control: mainly related to relief / management of symptoms, usually through medication
Choice: money and access to resources
7
21
I have felt able to cope when things go wrong
I have been able to do most things I needed to
Hope &
hopelessness
Dreams and goals, involvement in activities that give meaning and purpose
Hopelessness; lowering of aspirations
16
23
24
31
I made plans to end my life
I have felt despairing or hopeless
I have thought it would be better if I were dead
I have felt optimistic about my future
Physical health Physical comorbidity or experience associated with mental health problem 8 I have been troubled by aches, pains, physical problems
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CORE-OM appears to cover all major domains of HRQoL that are important to
people with mental disorders. Several of its items express subjective well-
being and capture symptoms of anxiety and depression that are relevant to ill-
being. One of its anxiety items (11. Tension/anxiety have prevented me doing
important things) covers negative aspects of activities & functioning, while
another item (32. I have achieved the things I wanted to) is implicitly related to
positive aspects of this domain. CORE-OM has several items capturing close
and social relationships and belonging. Risk-to-other items can also be
considered relevant to this theme. Regarding self-perception, CORE-OM has a
number of items relating to self-esteem, whereas the self-harming items can
be regarded as indicative of lack of self-esteem and self-acceptance. CORE-
OM does not directly capture control, autonomy and choice, although two of its
items (7. I have been able to cope when things go wrong and 21. I have been
able to do most things I needed to) suggest autonomy and control over life.
CORE-OM includes items with explicit reference to feelings of hope/optimism
and hopelessness; items expressing thoughts of suicide are also indicative of
feelings of hopelessness. Finally, item 8 of CORE-OM (I have been troubled by
aches, pains, physical problems) captures the theme of physical health.
The CORE Outcome Measure form is provided in Appendix 3.
2.5.3 Conclusion
Following a systematic review of published reviews of outcome measurement
in mental health, HoNOS and CORE-OM were identified as the leading
candidates for the derivation of a generic mental health PBM.
HoNOS is a measure of severe and enduring mental illness. Its psychometric
properties have been tested and generally it is considered a valid, reliable and
responsive outcome measure. It can be used for free within the British NHS,
and in fact is a widely used measure in the UK clinical practice that has been
advocated by many advisory bodies for routine outcome measurement.
HoNOS has not been designed for use in primary care, and therefore may not
be appropriate for use in people with mild and moderate mental illness.
HoNOS is clinician-rated, whereas PBMS are traditionally patient-reported, and
this was considered a major disadvantage against its use as the basis for the
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derivation of a generic mental health PBM. Therefore, HoNOS was excluded
from further consideration.
On the other hand, the CORE-OM was selected as the basis for the derivation
of a new mental health-specific PBM based on its following properties and
characteristics:
 Broad coverage of symptoms and aspects of HRQoL, including both
mental and physical health aspects
 Psychometric properties: established construct validity, responsiveness,
reliability and acceptability
 Wide coverage within the British NHS
 Applicability across primary and secondary settings
 Free use
 Being patient-reported
 Representation of the areas of HRQoL that have been identified to be
important in people with mental disorders (content validity)
 Appropriate for outcome measurement in people with common mental
health problems, which are the most prevalent mental disorders in the
UK
2.6 Overall conclusion
The findings of the systematic review of reviews on the performance of generic
PBMs in people with mental disorders seem to justify the concerns that have
been expressed regarding the appropriateness of generic PBM use in the area
of mental health. The limited available evidence indicates that generic PBMs
perform satisfactorily in depression, but less so in anxiety and personality
disorders. The picture is mixed in schizophrenia and bipolar disorder.
Qualitative evidence suggests that generic PBMs fail to capture aspects of
HRQoL that are important to people with mental disorders.
The systematic review of reviews of outcome measurement in mental health
revealed that there is a breadth of validated measures in this area, which vary
in focus (psychopathology/symptoms versus impact on patients’ lives/HRQoL
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aspects), scope (global versus disorder- or domain-specific), purpose
(assessment of symptom severity versus assessment of patient needs) and
intended rating population (patient-reported versus clinician-rated). Based on
its psychometric properties, broad coverage of a range of symptoms and
aspects of HRQoL that are relevant to mental health populations, wide and
free usage within the British NHS, applicability across primary and secondary
settings and the fact that it is patient-reported, CORE-OM was selected as the
basis for the derivation of a mental health-specific PBM that is relevant to
people with common mental health problems.
The next chapter reviews the methods reported in the literature for the
derivation of health state classifications amenable to valuation from existing
longer measures. Chapters 4, 5 and 6 report the methods adopted and the
process that was followed in this thesis in order to derive a new PBM that is
relevant to people with common mental health problems from the CORE-OM.
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Chapter 3. Methods for deriving health
state descriptions from existing longer
outcome measures – systematic
literature review
3.1 Introduction
As reported in Chapter 2, following a review of the properties of generic PBMs
in the area of mental health and confirmation of their inadequacy to capture
relevant aspects of HRQoL in people with mental health problems, the CORE-
OM was selected for the derivation of a new PBM that is relevant to people
with common mental health problems. Development of a PBM is a 3-step
process that involves the description of health states usually by a health state
classification system, the valuation of a selection of health states in a valuation
survey, and further econometric modelling that allows attaching an appropriate
utility value to every health state described by the health state classification. It
has been suggested that respondents can receive, process and remember
about seven pieces of information plus or minus two, depending on the
complexity of the statements (Miller, 1956). Therefore, health state
classifications amenable to valuation need to be concise, comprising a
manageable number of items and response levels; at the same time, they must
be comprehensive enough to capture a range of relevant aspects and levels of
HRQoL.
The CORE-OM consists of 34 items with 5 levels of response each that cover
4 major conceptual domains. Inclusion of all items of the CORE-OM in the
health state classification system of the new PBM would result in the
description of a massive number of potential health states that would be
impractical to use and complicated to value in a valuation survey. As discussed
in Chapter 1 (section 1.3.3), a concise health state descriptive system can be
derived from a long measure such as the CORE-OM by selecting appropriate
domains, items and levels. The selection process needs to identify the most
representative domains and items of the CORE-OM to ensure that the new
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health state classification retains to an acceptable degree the properties of the
original measure and is characterised by minimum loss of information relative
to the CORE-OM (Brazier et al., 2007).
The aim of this chapter is to systematically review methods that have been
reported in the literature for the derivation of health state descriptive systems
amenable to valuation from existing longer outcome measures, in order to
identify and adopt or adapt appropriate methods that could be used for the
derivation of a health state classification from the CORE-OM. A systematic
search of the literature was undertaken for this purpose. This chapter provides
an overview of the methods and the results of the systematic literature search
and subsequently describes and critically reviews the methods proposed in the
literature for the derivation of health state descriptive systems from existing,
non-preference-based outcome measures.
3.2 Systematic search of the literature: methods
and overview of results
The systematic search of the literature aimed to identify studies reporting
methods for the derivation of health state descriptions amenable to valuation
from existing outcome measures. The following databases were searched from
inception for this purpose:
Via OVID interface
1. EMBASE (1980 to current)
2. MEDLINE
3. PsycInfo
4. Health Management Information Consortium (HMIC)
Via Wiley interface
5. Cochrane Database of Systematic Reviews (CDSR)
6. Cochrane Methodology Register
7. Health Technology Assessment (HTA) database
8. Database of Abstracts of Reviews of Effects (DARE)
The systematic search was initially carried out in March 2007 and updated in
December 2012, after completion of the development of the new PBM that was
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the subject of this thesis, in order to explore and describe recent trends in the
derivation of health state descriptions from existing outcome measures. The
search strategy used is an adaptation of the strategy reported in Brazier and
colleagues (2012), which was employed for the identification of PBMs derived
from existing CSMs. The review undertaken for this thesis considered not only
PBMs but also health state descriptions amenable to valuation that were
derived from existing measures, regardless of whether valuation of health
states had been subsequently undertaken or reported in the literature. Thus, in
the search strategy constructed for this thesis extra terms relating to health
state descriptions were added. Moreover, the review undertaken for this thesis
was not confined to health state descriptions (or PBMs) derived from CSMs, as
appropriate methods that could be adopted or adapted in order to derive a
PBM from the CORE-OM might have been used in the literature for the
derivation of health state descriptions from generic measures as well. The
search strategy used for the systematic search of the literature is provided in
Appendix 4.
The following inclusion/exclusion criteria were applied to select studies
identified by the search for further consideration:
 Papers were included provided that they described psychometric or other
statistical methods for the derivation of health state descriptions amenable
to valuation from existing measures (either generic or condition-specific).
Papers reporting on vignettes derived from existing measures were also
included in the review, if derivation of vignettes was based on statistical
analysis of data, including psychometric methods.
 The purpose of the derivation of new health state descriptions should be
their consideration in a valuation survey; studies reporting derivation of new
measures from longer ones without aiming at developing health state
descriptions to be used in valuation surveys were not considered.
 Measures derived from existing instruments where the selection of
dimensions, items and levels was based on focus groups, expert opinion or
on simple consideration of their relative ‘importance’ were not included in
the review.
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 Vignettes either developed ad hoc or described using items from existing
instruments selected by focus groups were also not considered in the
review
 Studies reporting de novo development of health state descriptive systems
amenable to valuation were excluded
 Studies needed to provide adequate detail of the methods that would
enable their adoption or adaption in order to derive a health state
descriptive system from the CORE-OM
 Studies reporting mapping algorithms linking non-PBMs to existing generic
PBMs were excluded
 Only papers published in English were considered
 No conference abstracts or poster presentations were considered in the
review, as these did not describe methods in adequate detail
The systematic search identified 1,533 references in total. After excluding 198
duplicates, 1,335 titles and/or accompanying abstracts were screened for
relevance against the set inclusion/exclusion criteria. Full texts of studies
potentially meeting inclusion criteria (including those for which eligibility was
not clear from the abstract) were obtained. After excluding studies clearly not
relevant to the topic and studies not meeting inclusion criteria (for example,
studies describing mapping approaches; de novo PBMs; ad hoc vignettes;
elicitation of preferences using existing measures; extension of existing
measures by adding extra dimensions and/or items; studies reporting
regression analysis between patients’ valuation of own health state and their
responses to items of an existing measure; or studies in which methods were
inadequately reported), 31 publications remained for inclusion in the review,
describing 24 newly developed health state classifications or vignettes derived
from existing measures using psychometric or other statistical methods (some
newly constructed measures were described in more than one publications,
each reporting on different stages of the new measure’s development). A flow
diagram showing the systematic process for selecting papers for the review is
provided in Figure 5.
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Figure 5. Flow diagram of the selection of publications in the systematic
review of studies reporting methods for the derivation of health state
descriptions amenable to valuation from existing outcome measures
A summary of the studies included in the systematic literature review,
categorised according to the overall methodology used, is shown in Table 8.
The systematic search update identified one publication relating to the content
of this thesis, i.e. the derivation of a health state classification from the CORE-
OM (Mavranezouli et al., 2011), as well as another 5 studies that used broadly
the same methodology with that developed for this thesis [1 study by Young
and colleagues (2010), 2 studies by Versteegh and colleagues (2012) and 1
study by Kowalski and colleagues (2012) who adopted the methods reported
by Mavranezouli and colleagues (2011); and 1 study by Sundaram and
colleagues (2009 & 2010) who proposed a similar methodology with that
developed for this thesis independently and in parallel]. The methods used in
these studies (which are shaded in grey in Table 8) are not reported in this
chapter, since detailed description of the methodology developed for this
thesis is provided in Chapter 4. Instead, these studies are briefly discussed in
relation to the methodology developed for this thesis in Chapter 8 (section 8.2).
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3.3 A critical review of the methods suggested in
the literature for the derivation of health state
descriptions from existing measures
The systematic literature review identified 2 broad approaches for the
derivation of health state descriptions from existing measures. Both
approaches rely on a combination of standard psychometric criteria and other
statistical techniques, supplemented by expert opinion. The main approach
that is widely reported in the literature is the construction of health state
classifications that are typically multidimensional. An alternative approach for
the derivation of health state descriptions from existing measures involves the
development of plausible health state descriptions that cover a range of
HRQoL levels in the form of vignettes. Finally, a hybrid approach that produces
plausible health state descriptions from newly derived health state
classifications has also been reported in the literature.
3.3.1 Derivation of health state classifications
Health state classifications are descriptive systems usually composed of a
number of multilevel, single item dimensions that together can describe a
universe of health states (Brazier et al., 2007). For example, EQ-5D (Brooks,
1996) has 5 items each covering a different dimension (mobility, self-care,
usual activities, pain / discomfort, anxiety / depression); in the original form of
EQ-5D, each item has 3 response levels (no problems - moderate problems -
extreme problems). Consequently EQ-5D can describe 35 = 243 different
health states. Health state classifications contain a limited number of
statements describing HRQoL and are therefore convenient to use; moreover,
the number of resulting health states is manageable to value.
Concise health state classifications can be derived from existing measures
using various statistical techniques in a 3-stage process that involves 1)
assessment of the dimensionality of the original measure and selection of
appropriate dimensions for the health state classification; 2) selection of items
and item response levels for inclusion in the health state classification; and 3)
validation of the new health state descriptive system (Brazier et al., 2012).
Table 8. Studies reporting the derivation of health state descriptions from existing measures
A. Development of new health state classifications
i. Development of multidimensional health state classifications
Primary methodology used Condition Original measure (new
measure)
Relevant references
 FA / PCA for the identification of dimensions
 ± Correlations between items and between items and
original measure
 Qualitative review of items and response levels for
suitability and relevance – expert opinion for the
selection / exclusion of items
General health SF-36, SF-12 (SF-6D) Brazier & Roberts, 2004; Brazier et al.,
1998 & 2002
Benign prostatic
obstruction
IPSS Kok et al., 2002
Lung cancer FACT-L Kind & Macran, 2005; Lamers et al.,
2007
 Classical psychometric criteria for the selection of items
from each dimension/domain
 ± IRT for selection of items
 Expert opinion for the reduction of dimensions and/or
items
Menopause Un-named Brazier et al., 2005b
Urinary incontinence KHQ Brazier et al., 2008
Sexual quality of life SQOL (SQOL-3D) Ratcliffe et al., 2009
Paediatric atopic
dermatitis
Un-named Stevens et al., 2005
 PCA for the establishment of dimensions/domains
 Rasch analysis for the selection/exclusion of items in
each dimension/domain
 Classical psychometric criteria for the selection of items
 Expert opinion for the reduction of dimensions/domains,
items and response levels
Pulmonary hypertension CAMPHOR McKenna et al., 2008
Overactive bladder OAB-q (OAB-5D) Yang et al., 2009; Young et al., 2009
Asthma AQLQ (AQL-5D) Yang et al., 2011; Young et al., 2011
Cancer EORTC QLQ-C30
(EORTC-8D)
Rowen et al., 2011
QLQ-C30 (QLQ-PBM) Versteegh et al., 2012
Epilepsy NEWQOL
(NEWQOL-6D)
Mulhern et al., 2012a
Dementia DEMQOL, DEMQOL-
Proxy (DEMQOL-U,
DEMQOL-Proxy U)
Mulhern et al., 2012b; Rowen et al.,
2012)
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ii. Development of health state classifications that are unidimensional or have unidimensional components [method developed for this thesis]
Primary methodology used Condition Original measure
(new measure)
Relevant references
 ± PCA for exploration of the dimensionality of the
original measure
 Rasch analysis and classical psychometric criteria for
the construction of unidimensional health state
descriptions and the selection of items and response
levels
 Expert opinion for the reduction of dimensions/domains
and items
Common mental health
problems
CORE-OM (CORE-6D) Mavranezouli et al., 2011
Diabetes ADDQoL (DUI) Sundaram et al., 2009 & 2010
Flushing FSQ Young et al., 2010
Arthritis HAQ (HAQ-PBM) Versteegh et al., 2012
Multiple sclerosis MSIS-29 (MSIS-PBM) Versteegh et al., 2012
Vision loss NEI VFQ-25 (VFQ-UI) Kowalski et al., 2012
B. Identification of plausible health state descriptions
Primary methodology used Condition Original measure
(new measure)
Relevant references
Cluster analysis for the identification of distinct patient
severity groups
Depression SF-12 Lenert et al., 1999 & 2000a; Sugar et al.,
1998
Schizophrenia PANSS Lenert et al., 2004; Mohr et al., 2004
C. Hybrid approach: development of health state classifications and identification of plausible health state descriptions
Primary methodology used Condition Original measure
(new measure)
Relevant references
 Rasch analysis for the selection/exclusion of items in
each domain
 Classical psychometric criteria for the selection of items
 Expert opinion for the selection of the items
 Cluster analysis for the identification of distinct patient
severity groups
Rheumatoid arthritis HAQ McTaggart-Cowan et al., 2010
FA: Factor analysis; IRT: Item Response Theory; PCA: Principal Components Analysis
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Expert judgement is required at each stage to interpret the results of all
analyses undertaken and finalise decisions on the selection of the most
appropriate dimensions, items and response levels.
Stage 1. Assessment of the dimensionality of the original measure
Factor analysis and principal components analysis
Assessment of the dimensionality of a measure can be achieved by factor
analysis (FA) or principal components analysis (PCA). These are statistical
techniques that can assess whether variables (e.g. items of a measure) form
coherent subsets that are relatively independent from each other. Variables
that are correlated with one another but at the same time are largely
independent from other subsets of variables are combined into factors or
components, respectively (Tabachnick & Fidell, 1996). The difference between
FA and PCA is in the variance that is analysed. FA assumes that the variance
in the measured variables can be decomposed into that accounted for by
common factors, and that accounted for by unique factors. Subsequently, FA
analyses only shared variance (covariance), accounted for by the common
factors. PCA on the other hand analyses all the variance in the observed
variables, both common and unique. PCA is a unique mathematical solution
whereas most forms of FA are not unique (DeCoster, 1998; Tabachnick &
Fidell, 1996).
FA and PCA can identify the number of reliable and interpretable factors
(components) underlying the variables in a dataset. They can also estimate the
extent of variance in a dataset that is accounted for by these factors and
indicate the factors that account for the most variance within the dataset. A
factor is more easily interpreted when several observed variables correlate
highly with it and those variables do not correlate with other factors. Based on
their properties, FA and PCA can be used to assess the dimensional structure
of an instrument, to explore potential correlations between dimensions, and to
suggest appropriate reductions in dimensions (Chatfield & Collins, 1980). The
steps in both processes include selecting and measuring a set of items
(variables) forming an instrument, preparing the correlation matrix between
each pair of items, extracting a set of factors from the correlation matrix,
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determining the number of factors, rotating the factors to increase
interpretability, and interpreting the results (Tabachnick & Fidell, 1996).
Interpretation of results requires personal judgement, because it is possible
that the methods assign items belonging to the same conceptual dimension
into different components, based on their level of ‘difficulty’; this may occur
because ‘easy’ variables (for example items capturing milder levels of disease)
and ‘difficult’ variables (for example items with an ability to identify severe
levels of disease) have higher correlations amongst themselves (Bond, 1994).
Likewise, items belonging to different dimensions may be assigned to the
same component if they are phrased in a similar way that is distinct to phrasing
of other items (for example negatively versus positively worded items).
There are two major types of FA: exploratory and confirmatory. Exploratory FA
aims to describe and summarise data by grouping together variables that are
correlated. It examines whether there is an underlying pattern of scales
amongst a set of questionnaire items. It is a tool for consolidating variables
and for generating hypotheses about underlying processes. Confirmatory FA is
a more sophisticated technique used in advanced stages of the research
process to test a theory about latent processes (Tabachnick & Fidell, 1996).
More specifically, confirmatory FA tests whether a specified set of constructs is
influencing responses in a predicted way (DeCoster, 1998).
The number of factors (components) in a dataset can be estimated using
various criteria (DeCoster, 1998; Tabachnick & Fidell, 1996). The Kaiser
criterion relies on examination of the sizes of the eigenvalues in the correlation
matrix; eigenvalues express the amount of variance in the data that is
reproduced by a given factor. The number of significant factors equals the
number of the eigenvalues that are above 1 (Kaiser, 1960). Another criterion is
the scree test of eigenvalues plotted against factors (Cattell, 1966). Factors, in
descending order, are arranged along the abscissa with eigenvalues as the
ordinate. Usually the eigenvalue is highest for the first factor and moderate but
decreasing for the next few factors before reaching small values for the last
several factors. The last important factor lies at the point where the line drawn
through the points changes slope. The scree test involves judgement as to
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where discontinuity in eigenvalues occurs, especially when the sample size is
small, communalities are low, and each factor has few variables with not
particularly high loadings. A final method for identifying the number of
significant factors is based on Horn’s parallel analysis (Horn, 1965). This
procedure involves generation of random datasets of uncorrelated variables
that have the same number of cases and variables with the actual dataset.
Subsequently, eigenvalues are computed for the correlation matrices of the
original data and of each of the random datasets. Components whose
eigenvalues estimated from the original data are greater than eigenvalues
estimated from the random data should be retained. Horn’s parallel analysis
has been identified as the most accurate method for estimating the number of
significant factors (Zwick & Velicer, 1986).
Rotation of factors / components is a process by which the solution is made
more interpretable without changing its underlying mathematical properties.
There are two general classes of rotation. Orthogonal rotation assumes that all
factors are uncorrelated with each other; in this case, a loading matrix is
produced. This is a matrix of correlations between observed variables and
factors. The sizes of the loadings reflect the extent of the relationship between
each observed variable and each factor. Oblique rotation assumes that there is
correlation across the factors. In this case, several additional matrices are
produced: the factor correlation matrix provides the correlations among the
factors; the structure matrix presents the correlations between factors and
variables; and the pattern matrix shows the unique relationships between each
factor and each observed variable, uncontaminated by overlap among factors.
In oblique rotation the meaning of factors is ascertained from the pattern matrix
(Tabachnick & Fidell, 1996).
PCA played an important role in the identification and selection of dimensions
to be retained in the first derivation of a health state classification from an
existing measure, that is, the derivation of the SF-6D from the SF-36 health
survey (Brazier et al., 1998 & 2002). The SF-36 consists of 36 items that
belong to 8 different dimensions; the 36 items have different levels of response
that are not comparable across the items (Ware et al., 1993). Brazier and
97
colleagues (2002) derived the SF-6D from SF-36 by selecting appropriate
dimensions, items and levels from the initial instrument. This process was
based on the results of a PCA that had been previously undertaken at the
development of SF-12, a shorter form of SF-36 (Ware et al., 1995),
examination of the correlations between the SF-36 items and between each of
the SF-36 items and the whole measure, and expert judgement. The derived
SF-6D classification consists of 6 single-statement dimensions (physical
functioning, role limitations, social functioning, pain, mental health and vitality),
covering 11 of the SF-36 items (some items of SF-36 were combined into a
single item in SF-6D), with each statement having between 4 and 6 levels of
response, determined by expert judgement. The SF-6D can describe 18,000
different health states, 249 of which were selected for the valuation survey
using orthogonal arrays (Brazier et al., 2002). Similar work was undertaken to
derive a health state classification from the SF-12 (Brazier & Roberts, 2004).
Kok and colleagues (2002) derived a health state classification from the
International Prostate Symptom Score (IPSS) using PCA as the primary tool.
IPSS consists of 7 questions about symptoms and one question assessing the
impact of symptoms on patients’ HRQoL. Each of the 8 questions has 6 levels
of response. PCA undertaken on the 7 symptom items revealed that these
belonged to 2 components that could be interpreted as ‘obstructive symptoms’
and ‘irritative symptoms’. The 6 response categories of each component were
merged into 3 levels by expert judgement. Effectively, the authors constructed
a new 2-component measure consisting of two items (one capturing
obstructive and the other capturing irritative symptoms) with 3 levels of
response each that was possible to describe 32 = 9 distinct health states, all of
which were included in a valuation survey.
Kind and Macran (2005) and Lamers and colleagues (2007) derived a health
state classification system from the Functional Assessment of Cancer
Therapy-Lung (FACT-L) using the results of FA and a qualitative review of the
items. FA was carried out to determine the dimensional structure of the
measure and to identify the most representative items within each dimension.
The qualitative review of items aimed at determining each item’s importance
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and suitability for use in a PBM. This process resulted in a health state
classification with 6 dimensions (physical, emotional, functional, social/family,
general symptoms and specific symptoms). Four of the dimensions (physical,
emotional, functional and specific symptoms) contained 2 items each, so that
the new measure contained 10 items with 2 response levels (yes/no) each.
The health state descriptions that were used in valuation contained only one
item per dimension (i.e. 6 items in total), so that 2 different versions of the
health state classification were developed. In total, the system described 26 =
64 distinct health states. Two subsets of 10 health states using the 2 versions
of the health state classification were selected, using orthogonal arrays, for 2
valuation surveys that were conducted in the UK (Kind & Macran, 2005) and
Denmark (Lamers et al., 2007).
FA and PCA have comprised the first step in the process of deriving several
other health state classifications from existing measures, as described in the
sections that follow.
Stage 2. Selection of items and item response levels for inclusion in the
health state classification
Selection of items of a measure for inclusion in a health state classification can
be made using classical psychometric criteria. Item response theory (IRT) has
also been reported as a tool in the selection of items. Reduction in item
response levels can be made based on expert judgement. More recently,
selection of appropriate items and item response levels has been achieved
using Rasch analysis, a mathematical model that belongs in the family of the
IRT models.
Classical psychometric criteria
As discussed in Chapter 1 (section 1.2.4), classical psychometric criteria are
widely used for the assessment of outcome measures. These include the
appropriateness of a measure, its reliability (relating to the measure’s internal
consistency and reproducibility), validity (consisting of face validity, content
validity, construct validity, criterion validity and predictive validity),
responsiveness, precision, interpretability, acceptability and feasibility. In
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addition to the evaluation of whole measures, a number of these criteria have
also been used for the selection of ‘best-performing’ items for the derivation of
a scale from a larger questionnaire. The most commonly used classical
psychometric tests that have been used for the assessment of individual items
considered for inclusion in a new measure derived from an existing longer
scale are the following:
 internal consistency, expressed by the correlation of an item with the total
scale score, or the total score of the dimension it belongs to
 construct validity, as assessed by known groups validity (the item’s ability
to distinguish between groups with different levels of the severity of the
condition) and convergent validity (the item’s correlations with other
variables that have been designed to measure the same construct)
 responsiveness over time, usually assessed from the item’s ES (the item’s
change score divided by the standard deviation of the score at baseline),
or from the item’s SRM (the item’s change score divided by the standard
deviation of the change score)
 reproducibility, as assessed by the item’s test-retest reliability
 precision of an item, reflected in the distribution of responses across its
response levels, which can be assessed by the magnitude of ceiling or
floor effects
 acceptability of an item to respondents, reflected in the rate of missing
data.
A number of health state classifications have been successfully derived from
longer measures using primarily classical psychometric criteria supplemented
by expert judgment, including a menopause-specific health quality of life
questionnaire (Brazier et al., 2005b), the King’s Health Questionnaire (KHQ)
health state classification for urinary incontinence (Brazier et al., 2008), and a
health state classification derived from the Sexual Quality of Life questionnaire
(SQOL) (Ratcliffe et al., 2009). In all cases, a range of classical psychometric
criteria among those described above were used in combination with expert
judgement in order to initially exclude inappropriate items (for example items
that lacked face validity or items with relatively poor performance) and
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subsequently select best-performing items from the existing measures, so as
to develop concise health state classifications. In the case of the KHQ, expert
judgement was used prior to this process, to exclude dimensions that were not
appropriate for or directly relevant to a HRQoL measure.
The SQOL health state classification (SQOL-3D) consisted of 3 items, each
with 4 response levels, corresponding to the original 3 dimensions of the
SQOL (sexual performance, sexual relationship and sexual anxiety), and
therefore it described 43=64 possible health states (Ratcliffe et al., 2009). The
menopause health state classification comprised 7 single-item dimensions with
3 or 5 response levels each, defining 6,075 potential health states (Brazier et
al., 2005b). The KHQ health state classification consisted of 5 single-item
dimensions with 4 response levels each, describing 45=1,024 health states
(Brazier et al., 2008). Given the large number of potential health states
described by the menopause and the KHQ health state classifications, a
number of the health states were selected for the valuation survey using
orthogonal arrays.
Item response theory
IRT has been reported as a tool in the selection of items from a large
questionnaire for inclusion in a health state classification. IRT comprises a
family of mathematical models that are useful in the design and analysis of
psychological and educational measures (Weiss & Yoes, 1991). IRT models
assess how much of an attribute a person possesses, based on the person’s
responses to items of a scale designed to measure the attribute (Baker, 2001).
IRT models are designed to predict the probability of affirming an item,
depending on the person’s amount of the attribute and a number of item
parameters (Harvey & Hammer, 1999; Streiner & Norman, 1995). The simplest
IRT model is the one-parameter logistic model (Rasch model), which assumes
that only a single item parameter is required to predict a person’s response to
an item. This is the ‘difficulty’ of an item (that is, the amount of the attribute the
item is able to capture). The 2-parameter logistic model considers a second
item parameter, that of the ‘discriminative ability’ of an item, reflecting the fact
that some items on a scale have stronger or weaker relations than others to
the attribute being assessed. Finally, the 3-parameter logistic model takes into
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account that persons with a very low amount of the attribute may still affirm an
item due to pure chance or due to a ‘social desirability’ for a positive response
to the item.
Stevens and colleagues (2005) used IRT in addition to classical psychometric
tests in order to derive a health state classification for children with atopic
dermatitis from a larger questionnaire. IRT was used to select items that
represented different severities of impact on the child. The resulting health
state classification consisted of 4 items with 2 response levels each, and
therefore it formed 24=16 potential health states, all of which were included in
the valuation survey.
Rasch analysis
The Rasch model is by large the most commonly used IRT model for the
derivation of health state classifications from existing measures. Rasch
analysis has been used in combination with traditional psychometric criteria for
selection of items and item response levels. Rasch analysis is a statistical
measurement approach for examining the relationship between people’s
attributes, such as knowledge, quality of life or morbidity, and ordinal scales
designed to measure such attributes. It is based on the principles of the Rasch
model (Rasch, 1960) according to which the outcome of an encounter between
a person and an item is exclusively governed by the product of the person’s
‘ability’ (i.e. the person’s ‘amount’ of the attribute) and the item’s ‘difficulty’ (i.e.
how much ‘quantity’ of the attribute the item is able to capture) (Tennant &
Conaghan, 2007). The model is a probabilistic form of Guttman scaling, a
deterministic pattern that expects a strict hierarchical ordering of items (e.g.
from low to high difficulty) such that if a person has affirmed an item of a given
level of difficulty, then all easier items on the scale should also be affirmed
(Guttman, 1950). The Rasch model relaxes this proposition by stating that if a
more difficult item is affirmed, then there is a high probability that easier items
will also be affirmed (Tennant & Conaghan, 2007).
The Rasch model assumes that the probability of a given person affirming an
item is a logistic function of the relative distance between the item’s location
(determined by the item’s difficulty) and the person’s location (determined by
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the person’s ability) on a continuous scale with interval properties (Pallant &
Tennant, 2007). For dichotomous data, this can be mathematically expressed
as:
݌݊ ݅= (݁ఏ௡ି௕௜)1 + ݁ (ఏ௡ି௕௜)
where pni is the probability that person n will affirm item i, θ is the person’s
ability, and b is the item’s difficulty. Thus, the probability of a ‘correct’
(affirmed) response increases as the ability of a person increases, and the
difficulty of an item decreases (theory of conjoint measurement) (Bond & Fox,
2007).
Rasch analysis can convert ordinal scale scores into measurements of the
attribute on a continuous (latent) scale with interval properties, with the logit
(log odds unit) as the unit of measurement (Bond & Fox, 2007; Tennant &
Conaghan, 2007; Tennant et al., 2004). The logit is the distance along the line
of the scale that increases the odds of a person affirming an item of average
difficulty by a factor of 2.718. The Rasch model demonstrates what the
expected responses to items should be (according to each person’s ability and
each item’s difficulty), if interval scale measurement is to be achieved (Tennant
& Conaghan, 2007). Subsequently, the observed responses are compared
with the expected ones in order to assess whether the differences between
observed and expected scores (‘residuals’) are significant and whether the
examined dataset (in terms of both persons and items) fits the Rasch model
(Tesio, 2003). When a dataset fits the Rasch model, then Rasch analysis
allows prediction of a person’s responses to each item based exclusively on
the person’s ability and each item’s difficulty (Tennant et al., 2004).
Rasch analysis assigns individual persons and items on different points (or
‘locations’) along the Rasch model logit scale, according to each person’s
ability (reflected in the percentage of items affirmed by the person) and each
item’s difficulty (reflected in the percentage of persons affirming the item).
Assignment of persons and items across the scale presupposes that the ability
of a person and the difficulty of an item are independent from each other
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(‘separability theorem’) (Bond & Fox, 2007). Each location along the
continuous scale corresponds to a ‘Rasch model logit value’, with higher
values expressing more difficult items and more ‘able’ persons (i.e. persons
with higher amounts of the attribute). Respondents with the same ability on an
attribute (and therefore the same total score on the ordinal scale) are assigned
the same Rasch model logit value. The Rasch model logit scale is centred on
zero logit; the latter represents the item of average difficulty in the scale
(Tennant et al., 2004). Assignment of persons to different points along the
scale leads to generation of groups of respondents with different levels of
ability in the measured attribute (Bond & Fox, 2007).
The Rasch model is characterised by unidimensionality and local
independence of items. Unidimensionality means that all items of a scale fitting
the Rasch model capture a single attribute. Local independence of items
means that, once the ‘Rasch factor’ (i.e. the attribute) has been removed, there
should be no further associations (other than random associations) between
the items of the scale (Tennant & Conaghan, 2007; Tennant et al., 2004).
Local dependence may arise when the scale is multidimensional (and
therefore there are correlations between items beyond those that are
attributable to the Rasch factor) or when there is response dependency
between some items (i.e. when there is a logical relationship between the
items so that the response to one item determines the response to another
item).
Although originally Rasch analysis was developed for application in
dichotomous items, the theory has been extended for the analysis of
polytomous categorical items (Andrich, 1978). The rating scale Rasch model is
used when the polytomous items have the same response levels whereas the
partial credit Rasch model is used when polytomous items have different
response levels. Although these two models differ in the parameterisation and
the number of degrees of freedom, they do not differ in the structure and the
response process for a person responding to an item (Luo, 2005).
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Rasch analysis can be used to assess the following characteristics of an
instrument and its items (Pallant & Tennant, 2007; Tennant & Conaghan,
2007):
 Overall goodness of fit in the Rasch model: Rasch analysis assesses the
degree of the discrepancy between observed and expected responses.
Item-person interaction statistics are expressed by a Z score representing a
Z-standardised normal distribution. If items and persons fit the model, then
the mean of the distribution is expected to approximate zero and the
standard deviation to reach one. The item-trait interaction measures, by the
means of chi-squared statistics, whether data fit the Rasch model for
discrete groups of responders that represent different levels of ability (class
intervals) across the attribute. A significant chi square indicates that the
hierarchical ordering of the items varies across the attribute, thus
compromising the required property of invariance.
 Individual item and person fit: relevant chi-squared statistics demonstrate
whether distinct items and persons fit the Rasch model. Item and person fit
residuals examine the amount of variability between the expected and
observed responses for each item and each person separately.
 Threshold ordering of polytomous items: thresholds are the points
(locations) on the latent scale where the probability of response in adjacent
response levels is equally likely (50%). The Rasch model expects
thresholds to increase with increasing difficulty of adjacent response levels
(i.e. the threshold between adjacent response levels 2 and 3 should be
further on the scale from the threshold between adjacent response levels 1
and 2), so that the probability of obtaining a higher item score increases as
the ability of a respondent increases; this indicates that respondents are
able to distinguish between adjacent response levels (ordered thresholds).
Disordered thresholds are observed when an item score is likely to
decrease as respondent’s ability increases; this means that respondents
cannot distinguish between adjacent levels of response of this item. In
order to obtain items with ordered thresholds, adjacent response levels of
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items with disordered thresholds should be collapsed (merged) and
checked for threshold ordering in a subsequent Rasch analysis.
 Differential Item Functioning (DIF): this occurs when different sub-groups
within a study sample (discriminated by age, gender, or other socio-
demographic characteristics) behave differently and give persistently
different responses to one or more items, despite of having equal levels of
the attribute being measured. Uniform DIF exists when the sub-groups
show a consistent systematic difference in their responses to an item,
across the whole range of the attribute being measured. Non-uniform DIF
occurs when there is non-uniformity in the differences across sub-groups
(i.e. patterns of difference vary across different locations of the scale). DIF
can be a cause of misfit to the Rasch model. While non-uniform DIF cannot
be dealt with, uniform DIF can be resolved by splitting the item
demonstrating DIF and creating unique ‘sub-items’ corresponding to each
sub-group with different baseline characteristics for which DIF was
identified (Brodersen et al., 2007).
 Targeting of persons and items: Rasch analysis can assess whether an
instrument can capture the whole range of symptom severity observed in
the study population. In a well-targeted instrument, the average location of
the study population should coincide with the average location of items; in
addition, no floor or ceiling effects should be observed.
 Reliability: this is expressed by the person separation index (PSI), which
measures the discriminative ability of the instrument across different groups
of responders and is equivalent to Cronbach’s α in traditional test theory 
(Cronbach, 1951).
 Unidimensionality and local independence of items: these can be tested by
a variety of methods including independent t-tests (Smith, 2002) and PCA
of the fit residuals (Wright, 1996).
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A range of these criteria have been used in combination with standard
psychometric tests for the selection of items and the reduction of response
levels in a number of studies that derived health state classifications from
existing CSMs. McKenna and colleagues (2008) were the first to employ
Rasch analysis for this purpose. The authors reduced the 25-item Cambridge
Pulmonary Hypertension Outcome Review (CAMPHOR) into a health state
classification that consisted of 6 items, each with 2 or 3 response levels,
belonging to 4 domains. Selection of items was based on the following criteria:
 the item’s loading onto its domain as revealed by FA
 the logit location of each item in Rasch analysis that was conducted
separately on each domain of the CAMPHOR (items with extreme location
were candidates for exclusion)
 the percentage affirmation of each item (items affirmed by a very small or
very large percentage of respondents were excluded)
 the correlation of each item with a general health perception variable that
was predicted by the CAMPHOR responses by ordinal regression (items
with high correlation were candidates for inclusion)
 expert opinion, which was used to assess the face validity of items and the
coverage of relevant aspects of HRQoL in the new health state
classification
The methodology first described by McKenna and colleagues (2008) was
refined and standardised in a number of studies that used primarily Rasch
analysis supplemented by standard psychometric criteria to derive
multidimensional health state classifications from existing CSMs, including the
derivation of the OAB-5D from the Overactive Bladder Questionnaire (OAB-q)
(Yang et al., 2009; Young et al., 2009), the AQL-5D from the Asthma Quality of
Life Questionnaire (AQLQ) (Yang et al., 2011; Young et al., 2011), the
EORTC-8D from the European Organization for Research and Treatment of
Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) [in two separate
studies by Rowen and colleagues (2011) and Versteegh and colleagues
(2012)], the NEWQOL-6D from a quality of life measure for epilepsy
(NEWQOL) (Mulhern et al., 2012a), and the DEMQOL-U and DEMQOL-Proxy-
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U from 2 quality of life measures for dementia rated by patients (DEMQOL)
and carers (DEMQOL-Proxy), respectively (Mulhern et al., 2012b; Rowen et
al., 2012), All these studies used broadly the same methodology that can be
summarised as follows (Young et al., 2009):
Step I: PCA was used to establish the domain structure of the original
measure; eigenvalues, scree plots and the rotated component matrix were
examined for this purpose. PCA was also used to identify potential correlations
between items and domains, which informed the choice of domains for
inclusion in the health state classification. Moreover, items that loaded either
on no component or on more than one components were removed from
analysis.
Step II: Rasch analysis was undertaken separately in each domain to reduce
the number of items by excluding unsuitable items. The following criteria were
used:
 Threshold ordering: where items had disorder thresholds, ordering was
achieved by merging adjacent item levels using an item-by-item approach;
these items were not considered further for inclusion in the health state
classification, as it was deemed that they no longer captured the full-range
severity of the original measure; nevertheless, they were not removed from
subsequent Rasch analyses as threshold ordering might result in the item’s
fitting in the Rasch model.
 DIF: items demonstrating DIF were of limited value for making cross-
population comparisons and therefore were not considered for inclusion in
the health state classification; however, these items were separated into
different person factors (for which DIF was observed) and were retained in
subsequent Rasch analyses.
 Goodness of fit: the overall model fit was assessed by the item-trait
interaction statistics and the PSI; individual item fit statistics and fit
residuals were also examined. The item with the poorest individual fit
statistics was removed from the model and Rasch analysis was re-run. This
process was repeated until all non-fitting items were removed and the
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overall item-trait interaction showed a satisfactory model fit. All non-fitting
items were not considered for inclusion in the health state classification.
Step III: The results of the Rasch analysis undertaken in the previous step and
standard psychometric criteria were used to select one best-fitting item per
domain, aiming to select items capturing the full range of condition severity.
The following criteria were used:
 Rasch analysis criteria:
o the spread of item response levels across the logit scale, as depicted
in threshold probability curves which show the distribution of item
response levels across the logit scale (the wider the spread, the
easier for respondents to distinguish between adjacent response
levels)
o individual item fit statistics
 Classical psychometric criteria:
o acceptability (rate of missing data)
o internal consistency (correlation between item and domain scores)
o distribution of responses (e.g. magnitude of ceiling or floor effects)
o responsiveness to change over time (assessed using SRM)
Step IV: Following selection of one item per domain for inclusion in the health
state classification, the results of Rasch analysis undertaken in step II were
used in order to reduce the response levels of each item, so that health state
descriptions were more concise and easier to process in a valuation survey.
This was achieved by inspecting the threshold probability curves: response
levels with close thresholds were candidates for response level collapsing.
Moreover, response levels with low percentage of responses were candidates
for merging with an adjacent response level.
Step V: Validation of all the previous steps in a separate dataset.
In all steps expert opinion was used to assess the results of the statistical
analyses, evaluate qualitative features of the items and make final decisions
regarding the inclusion of items in the final health state classification.
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The 5-step methodology described above was first adopted by Young and
colleague (2009), for the derivation of the OAB-5D from OAB-q, a measure
specific to overactive bladder. OAB-5D consists of 5 single-item dimensions
with 5 response levels each that were established by PCA (urge, urine loss,
sleep, coping and concern). The OAB-5D can describe 55 = 3,125 potential
health states; of these, 98 were selected for valuation using a balanced
statistical design (Yang et al., 2009).
Similarly, Young and colleagues (2011) derived the AQL-5D from AQLQ.
AQLQ consists of 32 items with 7 response levels each, which form 4 distinct
domains (symptoms, activity limitations, emotional function and environmental
stimuli). Extra items not included in AQLQ and corresponding to a fifth domain
(sleep) were considered for inclusion in AQL-5D because sleep was deemed
to be an important aspect of HRQoL in patients with asthma. AQL-5D consists
of 5 single-item domains, each with 5 response levels. The system is possible
to describe 55 = 3,125 potential health states of which 99 were selected for
valuation using a balanced statistical design (Yang et al., 2011).
The same principles were adopted at the derivation of EORTC-8D from
EORTC QLQ-C30 (Rowen et al., 2011). EORT QLQ-30 is a cancer-specific
measure that contains 30 questions covering the most common cancer
symptoms (such as pain, fatigue, nausea and vomiting) and various aspects of
functioning (including physical, role, social, emotional and cognitive). The
QLQ-C30 is summarised using 14 2-item scales, each representing a
particular symptom or aspect of functioning, plus one 2-item global quality of
life scale. After initial exclusion of 3 items that related to global quality of life
and financial impact due to their inappropriateness for inclusion in a PBM, the
remaining 27 items were subject to the process described in Steps I-V. The
resulting EORT-8D comprised an 8-dimensional health state classification
(capturing physical functioning, role functioning, pain, emotional functioning,
social functioning, fatigue and sleep disturbance, constipation and diarrhoea,
and nausea) with each dimension being represented by one item; all items
have 4 response levels, except the physical functioning item which has 5
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response levels. The new measure can describe 81,920 health states, 85 of
which were selected for valuation using an orthogonal statistical design.
Mulhern and colleagues (2012b) used the process described in Steps I-V to
derive patient-reported and carer-reported health state classifications for
dementia from DEMQOL and DEMQOL-Proxy, respectively. DEMQOL
consists of 28 items with 4 response levels each, tapping health and well-
being, cognitive functioning, social relationships, daily activities and self-
concept. DEMQOL-Proxy, which was designed to enable measurement of
HRQoL in people with severe dementia, shares the same conceptual
framework with DEMQOL and contains 31 items with 4 response levels each.
Both measures include a global quality of life item that does not contribute to
the overall measure score. In step I of the process, PCA identified 5
dimensions in DEMQOL (positive emotion, memory, relationships, negative
emotion and loneliness) and 4 dimensions in DEMQOL-Proxy (all the above
except loneliness). Following application of Rasch analysis and psychometric
criteria, 2 health state classifications were derived, respectively: the 5-
dimensional DEMQOL-U with 4 response levels in each single-item dimension
that generate 45 = 1,024 possible health states and the 4-dimensional
DEMQOL-Proxy-U with 4 response levels in each single-item dimension that
describe 44 = 256 potential health states. A representative sample of states
was selected from each health state classification for valuation using a block
design, which led to the generation of combinations of states; each respondent
in the survey valued a block of seven mixed states plus the worst state (Rowen
et al., 2012).
Mulhern and colleagues (2012a) described the same 5-step process at the
derivation of NEWQOL-6D from NEWQOL. NEWQOL includes a range of
measures validated for general use across a range of conditions and
specifically for epilepsy; of these, a subset of 82 items was considered for the
derivation of the new health state classification. NEWQOL-6D has 6 single-
item dimensions with 4 response levels each, describing 46 = 4,096 distinct
health states. A sample of 50 health states was selected using an orthogonal
array for consideration in a valuation survey.
111
Finally, Versteegh and colleagues (2012) derived a health state classification
from the QLQ-C30 using PCA, Rasch analysis, classical psychometric criteria
and expert opinion. The resulting health state classification comprised 8 items
belonging to 5 dimensions (physical functioning, vitality, mental functioning,
discomfort, pain). Selection of health states for the valuation survey was based
on a level-balanced design, meaning that all response levels of each item were
seen with the same frequency within the selected health states; the latter
covered the entire spectrum of severity of symptoms.
Stage 3. Validation of the new health state classification
Validation of a newly developed health state classification is an essential step
that provides confirmation that the final set of dimensions, items and response
levels constitutes an optimal solution. This can be achieved by repeating the
process used for the derivation of the health state classification on a separate
study sample and/or on data from the same study sample collected at a
different time point. This method has been employed at the validation of OAB-
q (Young et al., 2009), AQL-5D (Young et al., 2011), EORTC-8D (Rowen et al.,
2011) and NEWQOL-6D (Mulhern et al., 2012a).
Discussion – strengths and limitations of the health state classification
approach
The health state classification approach comprises a useful method for
deriving health state descriptions from existing longer measures usually
consisting of multiple dimensions, items and response levels. Application of
statistical methods such as PCA, Rasch analysis and standard psychometric
criteria combined with expert judgement allows identification of the most
appropriate dimensions, items and response levels, so that the health state
classification is able to capture a variety of HRQoL aspects that are relevant to
the study population, across a range of HRQoL levels.
Health state classifications have been routinely derived from measures
consisting of multiple dimensions or domains with little or no correlation
between them. Ideally, health state classifications should retain this
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multidimensional structure and include items that behave independently. Apart
from the desired ability of health state classifications to tap as many relevant
HRQoL aspects as possible, this requirement results from the demands of the
valuation stage, where a sample of states is selected for valuation since it is
not practical to value all states described by a health state classification. As
described in Chapter 1 (section 1.3.1), the major approach for generating and
selecting health states from a health state classification for use in a valuation
survey relies on the use of conventional statistical approaches such as
orthogonal arrays and balanced designs; such techniques have been used in
order to select health states for valuation from the multidimensional EQ-5D
(Dolan et al., 1996) and SF-6D (Brazier et al., 2002). Alternatively, valuation of
HUI-3 was based on MAUT, which involved valuation of ‘corner’ states, where
one dimension is at the worst level and all others are at the best level (Feeny
et al., 2002). All these techniques employed for the generation of health states
treat items independently, as separate statements. If there is indeed no
correlation between the items of a health state classification, then any
combination of items will result in the description of a plausible health state.
A major problem arises when items in a health state classification tap the same
or highly correlated dimensions and therefore cannot be treated independently
when generating health states. In such cases, some of the health states
generated using standard approaches may include combinations of statements
that are not plausible (e.g. I feel happy most of the time and I often feel like
crying). This problem is most likely to arise when the original measure has
narrow scope and is characterised by high correlations between its dimensions
and items. Thus, derivation of health state classifications using the
methodology described earlier and subsequent use of standard approaches for
generating random health states (e.g. using orthogonal or block designs) or
‘corner’ states for valuation may not be appropriate if the original measure is
largely unidimensional or consists of highly correlated dimensions and items.
An alternative approach is therefore required for the derivation of health state
classifications from measures that are unidimensional or are characterised by
high correlations between their dimensions / domains and items.
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3.3.2 Derivation of health state descriptions in the form
of vignettes – the clustering-based approach
A different approach for deriving health state descriptions from existing
measures is to construct health states from item responses that are observable
in the study population by grouping (clustering) patients according to their level
of symptom severity.
Use of cluster analysis for the identification of distinct patient severity
groups that lead to the construction of plausible health states
The basic aim of cluster analysis is to reveal natural groupings (or clusters)
within a set of individuals (Chatfield & Collins, 1980). This is achieved by
allocating a set of individuals to a set of mutually exclusive groups based on
selected characteristics, such that individuals within a group are similar to one
another while individuals in different groups are dissimilar. An application of
cluster analysis is the grouping of patients in a dataset according to their
severity of symptoms. The resulting clusters are groups of patients with
different levels of symptom severity, which indicate distinct health states of a
condition / disease area.
This approach was first described by Sugar and colleagues (1998) who
conducted k-means cluster analysis using the mental and physical health
composite scores of SF-12 obtained from patients with depression, in order to
assign them into groups of different symptom severity. K-means cluster
analysis attempts to identify relatively homogeneous groups of cases based on
their characteristics, using an algorithm that can handle large numbers of
cases. The algorithm requires the researcher to specify the number of clusters;
once the number is selected, the algorithm specifies cluster membership. The
process resulted in specification of 6 distinct patient groups corresponding to 6
respective health states covering 2 dimensions, i.e. mental and physical health
(the 6 health states were ‘near normal health’, ‘mild mental and physical
impairment’, ‘severe physical impairment’, ‘severe mental impairment’, ‘severe
mental and moderate physical impairment’ and ‘severe mental and physical
impairment’). Subsequently, the authors examined the distribution of patients’
responses to SF-12 in each cluster and found that, for any item, one or two
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levels of response accounted for at least 50% of patient responses in a cluster.
By combining these ‘popular’ item responses, the authors developed 6 health
state descriptions for depression that were clinically meaningful; these health
state descriptions formed vignettes that were later valued by patients with
depression (Lenert et al., 1999 & 2000a).
A similar exercise was carried out to construct health states for schizophrenia
using clinicians’ ratings on the PANSS (Mohr et al., 2004). Previously
conducted FA had identified 5 domains within the scale (positive symptoms,
negative symptoms, cognitive impairment, mood disorder and
hostility/aggression). K-means cluster analysis was then conducted on the sum
of standardised PANSS scores within each domain to identify clusters of
patients with similar profiles of schizophrenic symptoms; results of cluster
analysis were compared with a conceptual framework of health states
developed by an expert panel. Final health states were determined by
combining profiles of schizophrenic symptoms from all PANSS domains, after
assessing the empirical results in conjunction with the conceptual framework.
This process resulted in the formation of 8 plausible health states with varying
levels of positive, negative and cognitive impairment, ranging from mild to
extremely severe symptoms, that are observable in the study population.
These health states were subsequently valued by a sample of the general
population in the US (Lenert et al., 2004).
Hybrid approach: derivation of a health state classification followed by
cluster analysis for the construction of health states within the
classification
McTaggart-Cowan and colleagues (2010) used a hybrid approach in order to
derive distinct health states from the Health Assessment Questionnaire (HAQ),
a measure for patients with rheumatoid arthritis. HAQ is an instrument with a
high number of components and items. The authors selected a 20-item
component of the instrument that was appropriate to form the basis of a PBM;
these 20 items have 4 response levels each and cover 8 domains relating to
patient’s ability to complete daily tasks, such as dressing and grooming,
arising, eating, walking, personal hygiene, reach, grip, and other activities.
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Before any analysis was conducted, it was proposed that the new health state
classification include 5 items, so as to be handled without difficulty by
respondents in a valuation survey. The choice of items was made based on
Rasch analysis and classical psychometric criteria following the approach
proposed by Young and colleagues (2009) that was described earlier. The
resulting instrument comprised 4 items with 4 response levels each.
Subsequently, the authors aimed to produce a low number of plausible health
states (3-4) that could cover a range of symptom severity in rheumatoid
arthritis but at the same time could be easily managed by respondents at a
valuation survey. For this reason k-means cluster analysis was conducted
using the approach suggested by Sugar and colleagues (1998) to group
respondents into distinct health states described by HAQ. Analysis indicated a
solution of 3 health state clusters of varying severity of rheumatoid arthritis,
ranging from very mild to severe. Further to this, the pain and discomfort
dimension of EQ-5D was incorporated into the 3 health state clusters resulting
in 3 health state descriptions (3 clusters) with 5 items each (4 HAQ items plus
the pain and discomfort EQ-5D item). The 3 health state descriptions of
rheumatoid arthritis were concise, plausible, and amenable to valuation.
Discussion – strengths and limitations of the clustering-based approach
The clustering-based approach for deriving health state descriptions from
existing measures results in the construction of health states that are made up
of frequent item responses that have been observed in the study population
and are therefore clinically meaningful.
The main advantage of the clustering-based approach is that, in contrast to the
health state classification approach, it does not require independence between
the dimensions of a health state classification; the clustering-based approach
allows construction of plausible health states and can therefore be employed
for the development of PBMs from measures with few and highly correlated
dimensions, where conventional approaches for generating health states are
not appropriate. A limitation of the approach is that k-means cluster analysis
uses arbitrary cut-off points for cluster identification and therefore it requires
substantial input from experts. Another limitation of the approach as employed
116
in the studies described above was that clustering was based on patients’
composite scores and not individual item responses. It is therefore possible
that each cluster included patients with a wide range of individual item
responses rather than a homogeneous patient group in terms of clinical
presentation. Moreover, health descriptions were constructed by combining the
most frequent scores/responses for every domain of the original measure in
each cluster. However, these descriptions did not necessarily reflect the most
frequent score / item response combinations in the study sample; what’s more,
it is possible that they did not form health states actually observed in the study
population. A final drawback of the approach is that it results in a limited
number of health states, thus potentially not covering all states that are
routinely observed in the study population Nevertheless, this approach
remains a strong alternative to the health state classification approach in
situations where items of a questionnaire do not behave independently and
therefore some of the potential health states derived from combinations of item
statements are not plausible.
3.4 Conclusion
This chapter presented the results of a systematic review on the methods
proposed in the literature for the derivation of health state descriptions that are
amenable to valuation from existing measures. The aim of the review was to
identify appropriate methods that can be used for the derivation of a health
state descriptive system from the CORE-OM. The review revealed that there
are two main approaches for this purpose:
The health state classification approach is the most widely reported in the
literature. The approach uses a range of statistical techniques such as PCA,
Rasch analysis and traditional psychometric tests to choose appropriate
dimensions, items and response levels from the original measure for inclusion
in a health state classification. The subsequent selection of health states for
valuation by standard statistical designs presupposes that the health state
classification is multidimensional with no correlations between its items. In
principle, this methodology cannot be used to derive health state
classifications from measures that are largely unidimensional or are
characterised by considerable correlations between their components,
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because it may result in the selection of health states that are implausible and
contain contradictory statements.
The alternative clustering-based approach groups patients according to their
symptom severity and uses these groupings to construct health state
descriptions of varying severity. Its advantage is that it creates plausible health
states by combining frequent responses of the patient population to the original
measure. Therefore, it is appropriate to use in unidimensional measures or
measures with high correlations between their items. However, the approach
only identifies elements of health states that subsequently need to be put
together to construct a full state and it cannot guarantee that the combinations
of these elements, i.e. the resulting health states, are actually observed in the
patient population. Moreover, this process results in a limited number of health
states.
The decision on the approach to adopt for the derivation of a health state
classification from the CORE-OM depends on the dimensionality of CORE-OM
and the presence or absence of correlations between its items. As discussed
in the next chapter, previous work has shown that CORE-OM does not have a
clear multidimensional structure, suggesting that the clustering-based
approach may be more appropriate to adopt. On the other hand, the review of
the properties of the Rasch model suggests that it may be possible to derive a
health state descriptive system by applying Rasch analysis on the entire
CORE-OM if this is unidimensional or has a strong unidimensional component;
following this process it is possible to generate plausible health states for the
valuation survey by identifying groups of respondents that have been assigned
to different points along the Rasch logit scale according to the severity of their
symptoms. These considerations led to the decision to use the mainstream
health state classification approach in order to derive health state descriptions
amenable to valuation from the CORE-OM, by employing PCA, Rasch analysis
and standard psychometric criteria.
Details on the methodology that was employed for the derivation of a health
state classification from the CORE-OM are provided in Chapter 4.
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Chapter 4. Methods used in this thesis
for the derivation of a health state
classification from the CORE-OM
4.1 Introduction
This chapter describes the methodology employed in this thesis in order to
derive a health state classification that is amenable to valuation from the
CORE-OM, which was the first stage in the development of a condition-specific
PBM for people with common mental health problems. Analysis of CORE-OM
data aimed at the selection of appropriate domains, items and response levels
from the CORE-OM, so as to construct a concise and, at the same time,
comprehensive health state descriptive system, able to capture a broad range
of elements and levels of HRQoL in people with common mental health
problems, and with minimum loss of information relative to the original 34-item
measure.
The CORE-OM has been shown to comprise a largely unidimensional
measure that is characterised by high correlation across its conceptual
domains and items. Previously undertaken exploratory FA indicated that the 34
items load on 3 components, one including mainly the negatively worded
items, one made up of the positively worded items, and one containing the risk
items (Evans et al., 2002). Examination of the correlation across the instrument
domains revealed that the domains of ‘subjective well-being’, ‘problems’, and
‘functioning’ were highly correlated with each other (in pairwise examinations
of the 3 domains the Spearman’s q value exceeded 0.70 in both clinical and
non-clinical populations); the ‘risk’ items also showed high though somewhat
lower correlation with the non-risk items. (Spearman’s q value = 0.64 in a
clinical sample; 0.44 in a non-clinical sample). These findings indicate that the
mainstream methodology used to develop typically multidimensional health
state classifications described in Chapter 3 may not be appropriate for the
derivation of a new health state descriptive system from the CORE-OM; this is
because a health state classification derived from the CORE-OM will also
contain highly correlated items, thus entailing the danger that some of the
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resulting health states generated using standard approaches may be
implausible. Nonetheless, in order to derive a health state classification from
the CORE-OM it was decided to use overall the same standard techniques that
have been previously described in the literature for this purpose, but in such a
way that the absence of clear multidimensionality of the CORE-OM is taken
into account and that despite of the (unavoidable) incorporation of potentially
highly correlated domains and items in the new measure, identification and
selection of plausible health states is ensured.
Rasch analysis had a central role in this process, which effectively utilised the
principle of unidimensionality underpinning the Rasch model (Tennant &
Conaghan, 2007; Tennant et al., 2004) and its ability to generate plausible
health states by identifying groups of respondents with distinct levels of
symptom severity that have been assigned to different points along the Rasch
logit scale. In summary, the process of deriving a new health state descriptive
measure from the CORE-OM involved 4 steps, similar to those that have been
described in the literature (Young et al., 2009):
1. Exploration of the dimensionality of the CORE-OM and correlations
between its domains. The dimensionality of the CORE-OM was explored
by undertaking PCA.
2. Investigation of the appropriateness and suitability of items and levels of
response for inclusion in a health state classification, using predominantly
a series of Rasch analyses and secondarily standard psychometric
methods. Items that were deemed unsuitable according to a number of set
criteria were excluded from further consideration.
3. Selection of items among those deemed suitable for inclusion in the final
measure, using primarily Rasch analysis, leading to the development of a
new health state classification.
4. Validation of the new health state descriptive system by repeating the
above process on a different dataset.
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In all steps of the process, an advisory group that was set up specifically for
this purpose provided expert advice on the overall appropriateness of the
methods employed, as well as on the interpretation and the clinical relevance
of the findings. A flow diagram of this process is presented in Figure 6.
Detailed description of the four steps of the process, an overview of the
membership and the role of the advisory group and details on the dataset used
in the analysis are provided in the remainder of the chapter.
Figure 6. Flow diagram of the process of deriving a new health state
classification from the CORE-OM
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4.2 Steps in the derivation of a health state
classification from the CORE-OM
This section provides details of the 4-step approach that was used to derive a
health state classification from the CORE-OM. The approach is similar to that
described by Young and colleagues (2009) and adopted by many other studies
with the same objective, as discussed in section 3.3.1 of Chapter 3.
4.2.1 Step 1. Exploration of the dimensionality of the
CORE-OM
Given the indications of previous research for high correlations between the
conceptual domains of the CORE-OM in clinical and non-clinical populations
(Evans et al., 2002), this step aimed at further exploring the dimensionality of
the CORE-OM and investigating potential strong correlations between its
domains. Investigation of correlation structures would then determine whether
the derivation of a health state classification system from the CORE-OM and
subsequent generation of health states using a standard statistical design
would be inappropriate, since this approach is likely to lead to generation of
implausible health states when used in measures with highly correlated
dimensions, as discussed in Chapter 3. Furthermore, this stage aimed to
identify major domains within CORE-OM that should be ideally represented in
the final instrument. Therefore, analysis undertaken at this stage intended to
 examine the correlation between underlying domains of CORE-OM and
 group the CORE-OM items into distinct domains so that, at next stages, the
most suitable items from each domain were candidates for inclusion in the
new health state classification.
The dimensionality of the CORE-OM was explored by undertaking PCA. PCA
has been suggested as a tool in the development of new polytomous scales in
order to provide early indications of dimensionality before Rasch analysis is
attempted (Tennant & Pallant, 2006).
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Principal components analysis
PCA was undertaken to identify major domains (components) within the
CORE-OM and to measure the correlations of each item with underlying
components. First, the Kaiser-Meyer-Olkin measure of sampling adequacy was
used to test whether correlations between CORE-OM items can be explained
by other underlying variables, and therefore to indicate whether PCA was
appropriate for the analysis of CORE-OM data. A value of the measure closer
to 1.0 indicates that PCA is an appropriate method of analysis (Cerny & Kaiser,
1977). In addition, Bartlett's test of sphericity was used to test the null
hypothesis that the CORE-OM items are uncorrelated. A significant test
confirms the appropriateness of PCA (Bartlett, 1950).
Significant components, i.e. components that mostly contribute to the
explanation of variance in the items, were identified using Horn’s parallel
analysis (Horn, 1965), as recommended in the literature (Zwick & Velicer,
1986), although eigenvalues with a value ≥ 1 and the screeplot of the analysis 
were also inspected. Subsequently, the rotated component matrices showing
the sizes of the loadings of each item to each extracted component were
examined to assess correlations of every item with each of the main
components of the instrument. Due to the indicated correlations between the
CORE-OM’s conceptual domains, two types of rotation were used: orthogonal
(Varimax method with Keiser normalisation), which assumes that all
components are uncorrelated to each other, and oblique (Promax method with
Keiser normalisation), which allows for correlations between components. Use
of both types of rotation and comparison of the results has been recommended
in the literature (Kieffer, 1998). It has been suggested that if the differences
between the results of the two types of rotation are negligible, then
interpretation of findings can be based on the orthogonal rotation. However, if
there are significant discrepancies between the results, then interpretation of
the oblique rotation should be preferred (Kieffer, 1998). In every rotated
solution, the correlation matrices between items and components were
inspected. For the oblique rotation, the pattern matrix of unique relationships
between items and components (uncontaminated by the overlap among
factors) as well as the component correlation matrix were assessed. In all
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matrices, loadings with coefficients  ≥ │0.40│were considered to reveal strong 
correlations between an item and a component, and between components
regarding the oblique rotation. Loading of items on the same component was
considered as a strong indication that these belonged to the same underlying
domain captured by the CORE-OM.
4.2.2 Step 2. Reduction of items and response levels from
the CORE-OM
The suitability and performance of the CORE-OM items were mainly assessed
by conducting Rasch analysis, supported by the results of classical
psychometric tests. These techniques examined the psychometric properties
of CORE-OM items and indicated which items should be considered for
exclusion. The decision for omission of items from the new measure was
determined by the interpretation of the results of the analyses conducted at
this stage, and further judgments on the content of the items in the context of
the eventual derivation of a PBM for common mental health problems. The
final decision for exclusion of items from the health state classification was
agreed with the thesis advisory group, which provided expert opinion. Further
to item reduction, Rasch analysis provided a guide for the reduction in the
response levels of the items included in the final measure.
Rasch analysis
Rasch analysis was used to assess the psychometric properties of the CORE-
OM items and the optimal levels of response, and ultimately assist in the
selection of best performing items for inclusion in the new PBM, in accordance
with the methodology employed in published literature (Young et al., 2009 &
2011). From early stages of data analysis it was decided that if initial analyses
of Step 1 provided further indications of high correlations between the CORE-
OM domains and items, then Rasch analysis would not be conducted
separately on each domain of CORE-OM, as described in relevant literature
(Young et al., 2009 & 2011), because this methodology entailed the danger of
generation of implausible health states, as already discussed. Instead, Rasch
analysis would be undertaken on the whole CORE-OM instrument, in order to
construct a unidimensional measure that fulfils the criteria of the Rasch model.
The justification for this type of analysis lies in the properties of the Rasch
124
model, which allow conversion of respondents’ ordinal scores into a
continuous scale, allocation of respondents along this scale based on their
symptom severity, and, consequently, identification of distinct groups of
respondents with various levels of symptom severity, which translate into
plausible health states, as discussed later in this chapter and reiterated in
Chapter 6.
Results of statistical tests employed at the first step of analysis revealed that,
indeed, CORE-OM does not have a clear multidimensional structure; the major
domains of the instrument are highly correlated. The findings of these analyses
are provided in detail in Chapter 5. These findings confirmed that the standard
approaches for developing a health state classification and for generating
health states for use in a valuation survey would not be appropriate in the case
of CORE-OM, since they were likely to eventually lead to the generation of
implausible health states. Based on these findings, it was decided to undertake
Rasch analysis on the whole CORE-OM instrument, aiming at discarding items
not fitting to the Rasch model and ultimately producing a unidimensional scale.
As it is discussed in Chapter 5, re-scoring of items was necessary due to
several items having disordered thresholds. Since no common re-scoring of all
34 items was possible to achieve, the partial credit Rasch model was used for
the analysis.
Items not fitting in the Rasch model were excluded one at a time, followed by
Rasch analysis on the remaining items and subsequent testing of fit statistics.
The order of exclusion of items was based on expert opinion after considering
the results of Rasch analyses and classical psychometric tests. This process
was repeated until all remaining items fit in the Rasch model. The PSI was
checked in each consecutive Rasch analysis to ensure that the model retained
good ability to discriminate amongst different respondent groups. In addition,
the class interval structure was inspected to confirm a homogeneous allocation
of respondents across class intervals, which would be an indication that
estimates of chi square statistics were reliable.
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The following Rasch analysis criteria were considered in Step 2, in order to
exclude non-fitting items and reduce response levels:
Item level (threshold) ordering and response level rescoring
Rasch item threshold maps were inspected to investigate whether the scoring
categories of each item progressed in a logical order, that is, whether
respondents were able to distinguish between adjacent response levels.
Normally, persons with higher symptom severity are expected to obtain higher
scores in each item, and this increase in scores alongside increases in
symptom severity should happen systematically in a logical progression. When
the probability of selecting higher (more difficult) response levels decreases
with respondents’ increased symptom severity, it is an indication that
respondents have difficulty in understanding the differences between item
response statements and are not able to discriminate between adjacent levels
of response.
When an item had disordered thresholds (i.e. when an item score was likely to
decrease as respondent’s severity increased), then item rescoring was
attempted, that is, adjacent response levels of this item were combined
(merged), in order to achieve ordered thresholds. Several ways of rescoring
were attempted. The following criteria were used in order to reduce response
levels of items with disordered thresholds and achieve threshold ordering:
 Visual inspection of category probability curves for each item: these curves
show the probability of a person selecting each response level of an item
depending on their ability across the Rasch model logit scale. Curves that
appeared to have considerable overlapping in the graph (in terms of the
area under the curve) indicated that respondents had difficulty in
distinguishing between respective (adjacent) response levels, and therefore
such response levels were candidates for merging.
 Examination of category response proportions: response levels with very
low proportion of responses were candidates for merging with an adjacent
response level, as they did not add much information about the
respondents’ severity of symptoms. Nevertheless, this criterion was not
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applied on the highest response levels of ‘difficult’ items (as indicated by
their location), as even low proportions of responses in these cases
indicated respondents with potentially very severe symptoms whom the
new health state classification should be able to identify, since the aim was
the development of a measure capturing the full range of symptom severity
of common mental health problems.
 Reduction in the number of scoring categories should be balanced between
developing a concise number of response levels and minimum loss of
information
 The new (merged) response categories should be clinically meaningful
without reducing significantly the information on the respondents’ symptom
severity. Clinically meaningful combinations of response levels were
considered to be:
 ‘never’ – ‘only occasionally’
 ‘only occasionally’ – ‘sometimes’
 ‘often’ – ‘most or all the time’
If the only way to order an item’s thresholds was by merging adjacent
responses that were judged to be not clinically meaningful (such as
‘sometimes’ and ‘often’), then this item was a candidate for exclusion from
the final measure. On the other hand, with regard to difficult items such as
the risk items, it was decided that merging the adjacent response levels
‘never’ and ‘only occasionally’ was not appropriate, as in this case these
indicated significantly different levels of symptom severity.
Following item rescoring attempts, subsequent Rasch analyses were
conducted to confirm that all items had ordered thresholds.
Goodness of fit with the Rasch model after threshold ordering
After item rescoring and threshold ordering, overall fit statistics (item-person
and item-trait interaction statistics) as well as individual item fit statistics were
measured to assess to what extent the measure fit in the Rasch model. The fit
of data into the model is indicated by a fit residual, which expresses the
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difference between the persons’ observed responses and those expected
according to the Rasch model, and approximates a Z-standardised normal
distribution. The item-trait interaction, which tests the overall fit between items
and persons across the scale, was determined by a chi-squared probability.
Regarding item-person interaction statistics, a fit residual of the mean of the
distributions around zero and a fit residual of the standard deviation close to
one indicated a good model fit. Regarding item fit residuals, those beyond ±
2.5 were considered to indicate a source of misfit in the model. Item fit
residuals with a value below -2.5 indicated that items over-discriminated
among respondents; such items were likely to summarise the rest of the items
and therefore were redundant (i.e. they did not provide any extra information
relative to the rest of the instrument); item fit residuals with values above +2.5
were signs of under-discrimination, and subsequently such items were also
candidates for exclusion. Misfit of an item could indicate that the item is badly
conceptualised, that it belongs to another domain and not to the underlying
unidimensional scale, or that it cannot target well the study population (for
example it is extremely easy or difficult). In addition to the fit residual, item fit
was indicated by a chi-squared probability. Person fit residuals were checked
in consecutive analyses to assess the level of outliers in the model. However,
persons with ‘extreme’ fit residuals were not excluded from analysis, with the
rationale that such persons are part of the study population, a realistic picture
of which should be reflected in the results of Rasch analysis. Significance
levels (probabilities) for the chi-square tests were calculated using Bonferroni
adjustments, based on the number of CORE-OM items, to account for multiple
testing (Bland & Altman, 1995).
Differential Item Functioning
All CORE-OM items were assessed for DIF. Items demonstrating significant
and persistent DIF in consecutive analyses (that is, item responses depended
on patients’ demographic characteristics) were strong candidates for exclusion
from the final PBM. This was decided for two reasons: first because DIF is a
source of misfit in the Rasch model; and second, because items included in a
PBM need ideally to constitute a universal measure, being perceived in a
similar (and not systematically different) way by the whole patient population,
as well as by the valuing population, regardless of their baseline
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characteristics. For the same reason, although uniform DIF of an item can be
dealt with by splitting the item for DIF and creating unique ‘sub-items’
corresponding to sub-groups differing in the baseline characteristic for which
DIF was identified (Brodersen et al., 2007), this was not attempted in this
analysis; therefore items demonstrating DIF were excluded from further
consideration.
Based on the availability of baseline demographic data included in the CORE-
OM dataset that was subject to Rasch analysis, items were examined for DIF
on three demographic characteristics: gender, age and ethnicity. Gender was
treated as a binary outcome. Regarding age, in order to create a categorical
outcome, persons in the dataset were divided into the following age groups:
 Age ≤ 25 years 
 Age between 26 and 40 years
 Age between 41 and 65 years
 Age > 65 years
Finally, in terms of their ethnicity, individuals in the dataset were categorised in
the following sub-groups, after taking into account the percentage of people
belonging to different ethnic groups that were included in the dataset (so that
some ethnic groups with very low percentage of respondents were merged
together):
 White
 Black
 Asian
 Other
 Mixed
Item location
Location of items was examined to assess their relative ‘difficulty’. In principle,
the new health state descriptive system should include a range of items of
varying difficulty, so that the respective PBM is able to target the study
population well, capturing the whole range of symptom severity and
distinguishing between different symptom severity levels.
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Classical psychometric tests
Standard psychometric tests were performed as an extra tool in the
assessment of psychometric properties of CORE-OM items. The results of
these tests indicated less suitable items for inclusion in the final measure and
were taken into account alongside the results of Rasch analysis when
considering potential candidates for exclusion from Rasch analysis (and
therefore from the final instrument). No strict thresholds were used to
determine the performance of CORE-OM items in psychometric testing. The
following psychometric criteria were considered:
Distribution of responses
Distribution of responses to each item was examined to explore the extent of
floor or ceiling effects. Such effects would imply that an item does not
efficiently target the severity of symptoms of the study population. In the
context of Rasch analysis, ceiling effects (i.e. a large proportion of responses
with a score 0 at baseline - for negatively worded outcomes) would indicate
that an item is rather ‘easy’ and cannot capture the severity of symptoms met
in the study population. Such an item is probably not appropriate for inclusion
in a PBM (and indeed in any outcome measure). In contrast, items with floor
effects (i.e. a large proportion of responses with a score 0 at baseline – for
negatively worded items) are likely to comprise ‘difficult’ items that can identify
more severe cases, the severity of which would not be possible to assess with
an item of ‘average difficulty’. Therefore, items with floor effects are not
considered to be unsuitable for inclusion in the final health state descriptive
system, as long as they can identify a minimum number of more severe cases
that is deemed to be significant.
Responsiveness
Responsiveness of each item was estimated by measuring the item change
score between baseline and end-of-therapy. The measure of responsiveness
was the SRM, defined as the change score of an item divided by the standard
deviation of the change score. Although no cut-off points were used in order to
judge the level of responsiveness, in general a SRM value of 0.2 to 0.3 was
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deemed to indicate a small effect, a value around 0.5 a medium effect, and a
value of 0.8 and above a large effect (Cohen, 1988).
In addition, because the responsiveness of an item can be affected by floor or
ceiling effects, it was decided to conduct a sub-analysis and measure
responsiveness for each item only for persons who had provided responses to
this particular item with scores ranging from 1 to 4 (“only occasionally” to “most
or all the time” for a negatively worded item) at baseline, thus excluding
respondents with a baseline score of 0 to this item. This was deemed useful
because some of the more difficult CORE-OM items (for example item 16, I
made plans to end my life) express more severe symptoms and are likely to
demonstrate floor effects, with the majority of the study population responding
“not at all” at baseline. Therefore, the average responsiveness for these items
is expected to be low, since in the majority of the study population there is no
scope for improvement. However, such items may be very useful in identifying
people with severe symptomatology and assessing their responsiveness to
treatment, and therefore should be still considered for inclusion in the final
PBM, despite of demonstrating low overall responsiveness due to floor effects
at baseline.
Correlation of each item score with the total CORE-OM score
This test was undertaken to explore the degree to which each item measures
the same attribute with that measured by the whole questionnaire. Items with
high correlation with the CORE-OM are judged to be good representatives of
the whole instrument and good candidates for a concise PBM that aims to
summarise information from a larger instrument with minimum information loss.
Correlation was expressed using Spearman’s non-parametric p values.
Percentage of missing data
The percentage of missing data for each item was measured as an estimate of
the item’s acceptability to the study population. High non-response rates imply
also a difficulty in understanding the item which reduces its usefulness as part
of a health state descriptive system.
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4.2.3 Step 3. Selection of CORE-OM items for inclusion in
the health state classification
After items that were judged to be inappropriate or less suitable for inclusion in
the final measure were excluded from further analysis and a unidimensional
scale fitting the Rasch model was constructed, further reduction of items was
attempted. This was essential as the purpose of this process was to develop a
concise PBM that is manageable in a valuation survey with, nonetheless,
minimum loss of information relative to the original measure; evidence has
shown that respondents can receive, process, and remember about 7 ± 2
pieces of information, depending on the complexity of the statements (Miller,
1956). In terms of statistical methods used, the final selection of items for
inclusion in the new PBM was based exclusively on Rasch analysis. In order to
make the final item selection, different combinations of the remaining (fitting)
items were tested against the following criteria:
 Wide coverage of CORE-OM domains
The final instrument should consist of items representing the various
domains of the CORE-OM, either expressed by the conceptual domains of
the CORE-OM or as indicated by PCA (if different). Items in the final health
state classification should express the maximum possible number of these
domains, so that the new PBM is able to tap a range of different aspects of
HRQoL that are relevant to people with common mental health problems,
as captured by the CORE-OM, with minimum loss of information.
 Best model and individual item fit
Overall model and individual item fit statistics should demonstrate best
possible fit of the measure into the Rasch model.
 Consistency in response levels across items
Response levels should ideally be the same for all items and reflect
clinically meaningful situations; consistency of scoring categories across
items included in the final instrument was attempted for practical purposes,
as it was considered that participants in a valuation survey were likely to
better understand and value items with the same response levels. This
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criterion meant that some items could potentially be rescored, despite
already having ordered thresholds, in order to achieve consistency
regarding response statements across all items in the final measure.
 Coverage of the full range of symptom severity
The final instrument should be well targeted and able to capture the whole
range of symptom severity observed in the study population; in order to
achieve this, items should cover different locations across the latent
variable. In a well-targeted instrument, the average location of the study
population is expected to coincide with the average location of the items.
Moreover, the extent of targeting can be assessed by inspection of the item
map, which displays the person-item targeting distributions.
 Reliability
The final measure should have acceptable reliability, expressed by the PSI,
having in mind that the ability of the measure to discriminate amongst
different respondent groups would likely need to be traded off with its
conciseness and convenience in using as a PBM. PSI is expected to be
greatly reduced with significant reduction in the number of items. Generally,
a PSI of 0.7 is regarded as the lowest acceptable level of reliability (Fisher,
1992).
 Unidimensionality
This property was tested using an extra post-hoc test (Smith, 2002) as
recommended in the literature (Tennant & Conaghan, 2007; Tennant &
Pallant, 2006). The first stage of this test was to undertake PCA on the item
fit residuals in order to identify the first residual factor that primarily
contributes to the variance of data after the ‘Rasch factor’ has been
accounted for. Subsequently, the nature of the correlation between the
items and the first residual factor was examined, in order to define two
subsets of items, those positively and those negatively correlated with the
first residual factor. These two ‘divergent’ sets of items, which were most
likely to breach the assumption of unidimensionality, were used to estimate
two separate scores for each respondent, respectively. If the content of the
133
whole scale was unidimensional, then each respondent should produce
similar scores in the two subsets. Thus, independent t-tests were
undertaken for each pair of scores on each respondent in order to estimate
the proportion of significant tests at the p=0.05 level in the study sample.
According to the post-hoc test, if the proportion of independent t-tests fell
outside the boundaries of acceptable significance, this would be an
indication that there might still be some degree of multidimensionality within
the whole construct, as respondents would be shown to behave differently
in each of the 2 (divergent) subsets of items. If the proportion of significant
independent t-tests was lower than 5%, this would confirm the
unidimensionality of the scale; if the proportion of significant independent
tests exceeded 5%, then a binomial confidence interval for proportions
would need to be estimated: a lower 95% confidence interval below 5%
would be an indication of unidimensionality.
 Local item independence
This was confirmed by checking the Varimax Rotation loadings produced
by the PCA on the item fit residuals: if local independence held, each item
of the final scale should load highly on separate residual components each,
indicating that no item is highly correlated with the others. Moreover, the
correlation of residuals between pairs of items was examined in the
residual correlation matrix: correlations between residuals within ± 0.40
were an indication of local item independence.
In addition to the above criteria, an extra criterion was set for the construction
of the final measure. This was directly related to the ability of the Rasch model
to assign persons on the Rasch model logit scale based on their responses,
thus generating groups of respondents of different symptom severity (Bond &
Fox, 2007) corresponding to plausible health states:
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 Increase in item threshold locations with increasing difficulty of the
item
Thresholds are the points on the logit scale where the probability of a
response to two adjacent response levels, like 0 and 1, or 1 and 2, etc. is
equally likely (50%). The difficulty of an item is expressed by its average
location on the scale. According to this criterion, for every item, the
threshold location of any two adjacent response levels (for example of
levels 0 and 1) should increase as the difficulty of the item increases. So
the threshold location of response levels 0 and 1 should be lower for an
easier item compared with a more difficult one; similarly, the threshold
location of response levels 1 and 2 should also be lower for the easier item.
This condition should apply across all thresholds and all items on the final
scale. Threshold locations for all adjacent response levels of all items were
compared by visual inspection of the item threshold map; this is an output
of Rasch analysis that depicts the most likely item response combinations
expected for each location across the Rasch model logit scale. Fulfilment of
this criterion ensured a ‘smooth’ transition of responses from milder to more
severe health states, allowing clear depicting of plausible health states on
the Rasch item threshold map. Identification and selection of plausible
health states was crucial for the valuation of the new instrument, as
illustrated in Chapter 6 (section 6.2.1).
The combination of items that met as many of the above set criteria as
possible formed the final health state classification that led, following valuation,
to the development of a decision-specific PBM for people with common mental
health problems.
4.2.4 Step 4. Validation of the new health state
classification
The new health state classification was validated by repeating the above
process on three different samples of respondents. In both of those samples,
the final measure was tested for overall and item fit statistics, DIF, reliability,
targeting of study population and local independence of items. The post hoc
unidimensionality test was repeated and the Rasch item threshold map was
inspected to confirm the smooth transition of responses from milder to more
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severe health states and that the same plausible health states were identified
in all samples.
PCA and classical psychometric tests were conducted in SPSS 19 (IBM Corp.,
2010). Monte Carlo PCA for Parallel Analysis software was used to identify
significant eigenvalues for PCA according to Horn’s parallel analysis (Watkins,
2008). Rasch analysis was undertaken in RUMM2020 (Andrich et al., 2003).
4.2.5 Expert opinion – other considerations
A thesis advisory group was set up at the start of the development of the new
PBM in order to advise on the appropriateness and suitability of each of the
CORE-OM items for inclusion in a PBM for common mental health problems,
following interpretation of the results of the statistical analyses and further
considerations regarding the relevance of some of the items. Interpretation of
the findings relied on many occasions on the group’s judgment rather than pre-
determined psychometric cut-off points, as these might have statistical but not
necessarily clinical relevance.
The group met at regular intervals to review the results of the analyses
undertaken up to that point and subsequently advise on further steps.
Alongside the results of the statistical analyses, the group’s judgments
contributed significantly to the final decisions regarding the inclusion or
exclusion of certain CORE-OM items and the construction of the final PBM.
The thesis advisory group consisted of the following members:
 Professor John Brazier, who provided expert opinion on the overall
methodology to be used for the derivation of a health state classification
from the CORE-OM, the interpretation of the results of statistical analyses
and the suitability of items for inclusion in the new PBM, given his
involvement in the derivation of numerous PBMs from existing generic and
condition-specific non-PBMs, including the derivation of the SF-6D from the
SF-36 (Brazier et al., 2002).
 Professor Michael Barkham, one of the developers of the CORE-OM and a
CORE System Trustee, who provided background information on the
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original instrument and advised at various stages of the development of the
new measure regarding the structure and the conceptual domains of
CORE-OM, the appropriateness and relevance of each of the CORE-OM
items for inclusion in a PBM, as well as the interpretation of the findings of
the statistical analyses, given his involvement in both the development and
the application of the CORE-OM in clinical practice and research (Barkham
et al., 2001; Evans et al., 2000; Stiles et al., 2008).
 Dr Tracey Young, who advised on the methods to be adopted for the
development of the new measure, the interpretation of the findings of the
statistical analyses and the suitability of items for inclusion in the new PBM,
as she has been involved in the derivation of several PBMs from existing
CSMs, using mainly Rasch analysis and classical psychometric tests
(Young et al., 2009 & 2011).
4.3 CORE-OM datasets used in the analyses
Data analysed in order to construct a health state classification from the
CORE-OM were derived from a database service containing information on
6,610 clients from 33 NHS primary care counselling services. The database
was created through the accumulation of data from a data mounting, analysis
and reporting service based at the Psychological Therapies Research Centre
(PTRC), University of Leeds. Counselling services sent completed batches of
CORE system forms to PTRC for analysis and reporting. Data mounting was
automated by the FormicTM system which exports the data in SPSS data files
which are then checked thoroughly for scanning and data entry errors.
Services agreed to the accumulation of anonymous data into a cumulative
database. Each service was given a 3-hour training session which included an
introduction to the system, its rationale and advice on completion of the forms.
In addition, each participating practitioner was provided with a comprehensive
user manual that contained scoring information and guidelines for completion
of the CORE system measures (CORE System Group, 1999). Services also
had telephone support from the CORE team to deal with specific queries if
required. Details on the full dataset and data collection procedures are
available in Evans and colleagues (2003). A random sample of 1,500 primary
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care clients from this database formed the dataset analysed for the purposes
of this thesis [N1500].
The dataset included data on clients’ demographic parameters, information on
client history and assessment outcome, service parameters relating to therapy,
as well as clients’ scores on each of the 34 CORE-OM items at baseline and
end of therapy. All variables contained in the dataset are provided in Table 9.
PCA was undertaken on the baseline data of the whole CORE-OM dataset
[N1500] and repeated on each of two random sub-sets [N750a] and [N750b]
which the whole dataset [N1500] was split into, in order to test the
reproducibility of the PCA findings on [N1500].
Regarding Rasch analysis, it has been shown that a number of statistics for
polytomous scales (such as chi square statistics) are highly dependent on the
sample size used (Smith et al., 2008). It has been argued that analyses of
large sample sizes can demonstrate misfit even if data actually fit the model;
this occurs because fit statistics become more powerful as the sample size
increases, and with large sample sizes, even the slightest misfit will be
exposed, translating into a higher probability for type I errors with increased
sample size (Linacre, 2003). Rasch analysis was thus performed on a sub-
sample of 400 randomly selected respondents [N400a] out of the [N1500]
dataset.
Standard psychometric tests contributing to the assessment of psychometric
properties of CORE-OM items were also performed on the sample [N400a],
which was used in Rasch analysis. This was decided because results of
psychometric tests supplemented the results of Rasch analysis and it was
deemed more appropriate for results of both types of analysis to refer to the
same study sample.
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Table 9. Demographic, history, assessment and other types of data
contained in the dataset [N1500] analysed in this thesis in order to derive
a health state classification from the CORE-OM
 Demographic parameters
 Gender
 Ethnicity
 Age
 Employment status
 Place of residence, relationships and support
 History
 Previously seen for therapy
 First or follow-up assessment
 Number of previous episodes
 Months since last episode
 Concurrent or previous primary, secondary and specialist care
 Prescribed medication
 Problem mix (severity and duration) assessed by the practitioner
 Depression  Living/welfare problems
 Anxiety/stress  Eating disorder
 Trauma/abuse  Work/academic problems
 Bereavement/loss  Physical problems
 Psychosis  Addictions
 Self esteem  Suicide risk
 Personality problems  Self harm risk
 Interpersonal/relationship problems  Harm to others risk
 Cognitive/learning problems  Legal/forensic problems
 ICD-10 diagnosis
 Negative and positive actions to cope with problems
 Baseline scores on 34 CORE-OM items
 Assessment outcome
 Problem resolved
 Accepted for further sessions
 Referred back to referrer or to other service
 Therapy declined by the client
 Service parameters
 Mean waiting time to first appointment (days)
 Mean number of sessions offered / attended
 Type of therapy
 Frequency of therapy
 Discontinuation and reasons
 Therapy outcome
 Problem mix (severity and duration) assessed by the practitioner
 End-of-therapy scores on 34 CORE-OM items
 Other benefits
 Coping
 Subjective well-being
 Day-to-day functioning
 Personal relationships
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The final measure was validated on three separate study samples:
a. another random sub-sample of 400 respondents [N400b] out of the
[N1500]
b. the whole initial sample [N1500] after adjusting the sample size for use in
the test-of-fit statistics
c. because the [N1500] dataset consisted of patients presenting to primary
care services and there were concerns that the newly developed
instrument might not be representative of the intended study population
(that is, the whole population of people with common mental health
problems irrespective of their level of severity or their site of access), the
results of the final solution of Rasch analysis were also validated on a
separate ‘mixed’ sample of 1,500 patients attending either primary or
secondary care [N1500v]. This sample was randomly selected from a
dataset of 7,651 people with common mental health problems; data were
collected from 49 NHS sites routinely using the CORE-OM to monitor
patients at intake. These sites comprised counselling or psychology
services within primary care groups or Trusts, or secondary care settings
providing clinical psychology and psychotherapy services. The dataset,
which is described by Barkham and colleagues (2005b), was available
from the same data mounting, analysis and reporting service based at the
PTRC, University of Leeds, that provided the [N1500] dataset. Baseline
demographic, history and CORE-OM data were available for 1,390
persons in the [N1500v] dataset. Rasch analysis on the [N1500v] was also
adjusted for sample size for use in the test-of-fit statistics, to avoid the risk
for type I errors due to large sample size. Further to the validation of the
final solution of Rasch analysis, [N1500v] was used to explore potential
presence of DIF in the final solution regarding the site of patient access.
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4.4 Summary
This chapter presented the methods that were employed in order to derive a
health state classification from the CORE-OM. The methodology adopted
included techniques such as PCA, Rasch analysis and classical psychometric
tests, which have been widely used for the derivation of multidimensional
health state classifications from existing measures in the literature. The
methodology that was followed in the case of CORE-OM was different from
that reported in the relevant literature, dictated by the measure’s lack of clear
multidimensionality and the danger of generating implausible health states if
the ‘standard’ health state classification approach and statistical techniques for
generation of health states were to be followed. Chapter 5 presents the results
of the analyses of all methodological steps proposed in this chapter that led to
the development of a new health state classification for people with common
mental health problems.
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Chapter 5. Results on the derivation of a
health state classification from the CORE-
OM
5.1 Introduction
This chapter presents the results of all the analyses undertaken on the CORE-
OM including PCA, Rasch analysis and classical psychometric tests, together
with the considerations and expert advice of the thesis advisory group, that led
to the derivation of a new health state classification system for people with
common mental health problems that is amenable to valuation. It follows from
the 4-step proposed methodology outlined in the previous chapter. The results
presented here have also been reported in a paper publication (Mavranezouli
et al., 2011).
5.2 Characteristics of the study sample
The [N1500] CORE-OM dataset that was used for PCA included 1500 people
with common mental health problems presenting to NHS primary care
counselling services; baseline demographic, history and CORE-OM data were
available for 1320 persons. A random sub-sample of 400 cases out of the
[N1500] was used in Rasch analysis and classical psychometric testing
[N400a]. A summary of the baseline demographic and history characteristics of
the study sample [N1500] as well as of the sub-sample [N400a] are shown in
Table 10.
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Table 10. Demographic and history characteristics of the study
sample [N1500] and the random sub-sample [N400a] analysed in
this thesis in order to derive a new health state classification from
the CORE-OM
Parameter [N1500] [N400a]
Mean age (standard deviation)
Age distribution
  ≤ 25  
26 - 40
41 - 65
> 65
Gender - female
Ethnicity
Asian
Black
White
Other - Mixed
Employment
Full-time paid employment
Part-time paid employment
Receiving sickness benefit
Unemployed
Full-time student
Part-time student
Retired
House person
Other
Place of residence/relationships/support
Living alone (not including dependents)
Living with partner
Living with parents/guardian
Living with other relatives/friends
Living in shared accommodation
Living in temporary accommodation
Living in institution/hospital
Caring for a child
Full time carer
Other service use for psychological problems
Primary care
Concurrent - Previous
Secondary care (any setting)
Concurrent - Previous
Specialist care (any setting)
Concurrent – Previous
Mean CORE-OM score at intake (standard deviation)
38.4 (13.3)
16.4%
46.3%
32.9%
4.4%
72.0%
4.2%
1.9%
92.2%
1.7%
39.8%
14.4%
7.7%
13.1%
2.5%
1.8%
5.8%
13.5%
1.4%
29.8%
50.7%
9.4%
6.7%
2.5%
0.8%
0.1%
37.8%
1.0%
41.7% - 15.1%
2.7% - 7.9%
0.9% - 5.7%
18.17 (6.75)
38.2 (13.4)
16.4%
43.6%
36.2%
3.8%
71.5%
3.2%
1.8%
92.6%
2.4%
40.1%
12.5%
7.1%
10.9%
2.7%
1.8%
6.1%
17.3%
1.5%
30.2%
51.1%
9.6%
5.6%
2.7%
0.7%
0.0%
39.0%
1.4%
40.3% - 14.5%
3.0% - 5.6%
0.8% - 4.3%
18.11 (6.50)
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The [N1500] consisted mainly of women (72.0%) and white population
(92.2%). The mean age of the sample was 38.4 years (range 12 to 88 years,
standard deviation 13.3 years). The majority was in full-time (39.8%) or part-
time (14.4%) paid employment, while 13.1% were unemployed and 13.5%
considered themselves as house persons. A small proportion (5.8%) of the
sample was retired, and another 4.3% was full- or part-time students. Just over
50% of the sample lived with a partner, 29.8% lived alone, and 37.8% looked
after at least one child. A large proportion of the sample stated they received
other services for a psychological problem at the time of presentation: 41.7%
in a primary care setting, 2.7% in secondary care and 0.9% in specialist care.
Moreover, a proportion of the sample stated they had received services for a
psychological problem in the past (15.1%, 7.9% and 5.7% in primary,
secondary and specialist care, respectively). The average CORE-OM score
was 18.17 (standard deviation 6.75) on a scale 0-40. The demographic and
history characteristics were very similar for the sub-sample [N400a].
5.3 Results of Step 1: exploration of the
dimensionality of the CORE-OM
5.3.1 Principal Component Analysis
PCA was undertaken on [N1500], as well as on two random subsets [N750a]
and [N750b] the study sample was split into. Analysis of the CORE-OM data in
[N1500] showed that the Kaiser-Meyer-Olkin measure of sampling adequacy
reached 0.95, meaning that factoring of data was appropriate and meaningful.
Bartlett’s test of sphericity demonstrated the significance of the findings
(p<0.001). Although the analysis identified 7 components with eigenvalues
above 1, Horn’s parallel analysis indicated 5 significant components (Table
11). The latter finding is in agreement with the screeplot of the analysis, which
is provided in Figure 7: the slope of the line appears to change after the 5th
component, suggesting that only the first 5 components are significant.
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Table 11. Significant components of CORE-OM identified by Principal
Components Analysis in [N1500] - Comparison of components with
eigenvalues >1 with significant components identified by Horn’s parallel analysis
Component
PCA: Initial Eigenvalues Horn’s parallel analysis:
Significant mean
eigenvalues (SD)Total % of Variance Cumulative %
1 11.15 32.8 32.8 1.29 (0.02)
2 2.08 6.1 38.9 1.26 (0.02)
3 1.75 5.2 44.1 1.23 (0.01)
4 1.48 4.3 48.4 1.21 (0.01)
5 1.23 3.6 52.0 1.19 (0.01)
6 1.07 3.2 55.2 1.17 (0.01)
7 1.02 3.0 58.2 1.15 (0.01)
Significant eigenvalue levels identified using each approach are provided in bold; SD =
standard deviation
Figure 7. Screeplot of Principal Component Analysis in [N1500]
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Loadings of the CORE-OM items on the identified significant components in
the whole dataset [N1500] are presented in Table 12, which depicts the rotated
component matrix resulting from orthogonal rotation, and in Table 13, which
provides the pattern matrix of oblique rotation, that is, the matrix that allows
identification of the unique relationships between items and components,
uncontaminated by the overlap across components. Strong loadings were
considered those with a correlation coefficient ≥ │0.40│. Results were very 
similar between the two methods of rotation. The majority of CORE-OM items
loaded on the same component(s) regardless of the method of rotation; the
exception to this pattern were 5 items (items 2, 15, 17, 23, 27) that were shown
to load on component 1 and/or component 2 in orthogonal rotation but not in
oblique, as well as item 31 that was shown to load on components 2 and 5 in
orthogonal rotation but only on component 1 in oblique.
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Table 12. Findings of Principal Components Analysis on CORE-OM data
in [N1500]. Orthogonal rotation – rotated component matrix
CORE-OM items
Components
1 2 3 4 5 6 7
1. [terribly alone and isolated] .50 .39 .28 .18 .20 -.07 .11
2. [tense, anxious or nervous] .42 .46 .22 -.00 -.12 .02 .38
3. [somebody to turn to for support] .16 .09 .22 .04 .71 .04 .07
4. [felt ok about myself] .32 .56 .17 .14 .30 -.01 -.02
5. [totally lacking in energy and enthusiasm] .40 .46 .06 .06 .06 .05 .29
6. [physically violent to others] .03 .12 .02 .18 -.03 .80 .02
7. [able to cope when things go wrong] .29 .65 .06 .15 .08 .10 -.08
8. [aches, pains, physical problems] .13 -.00 -.01 .05 .11 -.01 .81
9. [thought of hurting myself] .18 .17 .11 .83 .06 .08 .02
10. [talking to people has felt too much] .30 .27 .22 .07 .27 .07 .33
11. [tension/anxiety prevented doing things] .22 .60 .23 .11 -.10 .10 .41
12. [happy with the things I’ve done] .22 .65 .18 .07 .29 .08 -.09
13. [disturbed by unwanted thoughts/feelings] .61 .09 .16 .22 -.01 -.03 .22
14. [felt like crying] .70 .27 .13 .12 .03 .05 -.06
15. [felt panic or terror] .37 .40 .16 .21 -.22 -.03 .36
16. [made plans to end my life] .11 .13 .10 .82 .01 .02 .06
17. [overwhelmed by my problems] .58 .48 .23 .12 -.01 .06 .10
18. [difficulty of getting to sleep/staying asleep] .60 .13 -.08 .07 .20 .10 .21
19. [felt warmth or affection for someone] -.05 .24 .02 .12 .64 .05 .02
20. [problems impossible to put to one side] .61 .37 .20 .03 -.01 .09 .06
21. [able to do most things I needed to] .08 .72 .10 .11 .07 .14 .12
22. [threatened or intimidated another person] .07 .04 .24 .07 .05 .75 -.01
23. [felt despairing or hopeless] .48 .48 .34 .21 .09 .04 .12
24. [thought it would be better if I were dead] .28 .22 .29 .69 .10 .04 .01
25. [felt criticised by other people] .19 .16 .76 .06 .08 .17 .06
26. [thought I have no friends] .20 .15 .61 .17 .31 .07 .08
27. [felt unhappy] .64 .42 .22 .10 .18 .02 -.03
28. [unwanted images/memories distressing] .68 .02 .20 .22 .02 .05 .07
29. [irritable when with other people] .46 .14 .30 .00 .17 .39 .04
30. [I am to blame for problems & difficulties] .28 .24 .47 .18 .14 -.00 -.13
31. [felt optimistic about my future] .15 .50 .01 .05 .41 -.12 .05
32. [achieved the things I wanted to] .14 .61 .17 .13 .31 .05 .01
33. [felt humiliated or shamed by other people] .17 .16 .74 .17 -.03 .15 .09
34. [hurt myself physically/risks with health] .10 .02 .04 .59 .15 .33 .06
Rotation method Varimax with Kaiser normalisation. Loadings ≥ │0.40│are shown in bold; 
loadings on the 2 components that were found to be non-significant by Horn’s analysis have
been shaded in grey.
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Table 13. Findings of Principal Components Analysis on CORE-OM data in
[N1500]. Oblique rotation - pattern matrix
CORE-OM items
Components
1 2 3 4 5 6 7
1. [terribly alone and isolated] .42 .22 .15 .06 .12 -.14 .03
2. [tense, anxious or nervous] .26 .37 .11 -.13 -.17 -.02 .29
3. [somebody to turn to for support] .09 -.05 .18 -.04 .72 -.01 .15
4. [felt ok about myself] .16 .57 .01 .03 .21 -.06 -.09
5. [totally lacking in energy and enthusiasm] .30 .42 -.13 -.05 .01 .02 .22
6. [physically violent to others] -.02 .18 -.10 .12 -.05 .81 -.01
7. [able to cope when things go wrong] .13 .75 -.14 .05 -.03 .07 -.20
8. [aches, pains, physical problems] .01 -.16 -.05 .02 .21 -.03 .90
9. [thought of hurting myself] .04 .06 -.04 .85 -.00 .02 -.02
10. [talking to people has felt too much] .17 .14 .13 -.04 .25 .02 .33
11. [tension/anxiety prevented doing things] -.12 .63 .14 .00 -.15 .06 .31
12. [happy with the things I’ve done] .01 .75 .03 -.05 .19 .04 -.18
13. [disturbed by unwanted thoughts/feelings] .71 -.20 .01 .13 -.06 -.08 .15
14. [felt like crying] .85 .06 -.09 -.01 -.08 .01 -.18
15. [felt panic or terror] .21 .32 .04 .13 -.28 -.07 .25
16. [made plans to end my life] -.05 .02 -.00 .86 -.04 -.04 .03
17. [overwhelmed by my problems] .52 .35 .05 -.02 -.12 .00 -.04
18. [difficulty of getting to sleep/staying asleep] .79 -.08 -.32 -.02 .17 .08 .19
19. [felt warmth or affection for someone] -.19 .30 -.08 .08 .64 .03 .10
20. [problems impossible to put to one side] .64 .22 .02 -.11 -.11 .05 -.06
21. [able to do most things I needed to] -.25 .91 -.05 .02 -.01 .12 .02
22. [threatened or intimidated another person] .02 -.00 .21 -.02 .02 .73 -.04
23. [felt despairing or hopeless] .32 .35 .21 .07 -.01 -.03 .01
24. [thought it would be better if I were dead] .13 .04 .19 .66 .02 -.05 -.05
25. [felt criticised by other people] -.08 -.05 .91 -.09 .01 .07 -.01
26. [thought I have no friends] -.02 -.06 .69 .04 .26 -.03 .06
27. [felt unhappy] .66 .26 .02 -.04 .06 -.04 -.14
28. [unwanted images/memories distressing] .86 -.31 .04 .12 -.05 -.00 -.01
29. [irritable when with other people] .50 -.06 .20 -.15 .11 .35 -.01
30. [I am to blame for problems & difficulties] .14 .10 .48 .08 .04 -.08 -.21
31. [felt optimistic about my future] -.01 .59 -.14 -.02 .37 -.15 .04
32. [achieved the things I wanted to] -.13 .71 .04 .03 .23 .01 -.05
33. [felt humiliated or shamed by other people] -.13 -.04 .89 .05 -.10 .05 .01
34. [hurt myself physically/risks with health] .05 -.08 -.09 .59 .13 .30 .07
Rotation method Promax with Kaiser normalisation. Loadings ≥ │0.40│are shown in bold; 
loadings on the 2 components that were found to be non-significant by Horn’s analysis have
been shaded in grey.
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Table 14 provides a summary of the findings, showing the CORE-OM items
that load on each of the underlying components (determined using a cut-off
point of ≥ │0.40│for ‘strong’ loadings), and the conceptual domain of CORE-
OM they belong to. Overall, the majority of the items loaded on the first two
components (11 and 13 on each component, respectively, and 20 in total,
using orthogonal rotation; 9 and 8 on each component, respectively, and 17 in
total, using oblique rotation). Some items (2, 17, 23 and 27) loaded on both
components under orthogonal rotation, but this finding was not supported in
oblique rotation. It must be noted that items loading on the first 2 components
cover 3 out of the 4 conceptual domains of CORE-OM, including
symptoms/problems, functioning and subjective well-being. This implies that
the conceptual domains of CORE-OM are not consistent with the components
identified in this analysis. The results of PCA suggest that, in general,
component 1 includes a number of items that belong to the conceptual
domains of subjective well-being, symptoms and functioning, while component
2 covers positively worded items, together with some items representing
subjective well-being, symptoms and functioning. Component 3 included the
same 4 items in both rotations, mostly expressing functioning – close and
social relationships, although one item (item 30) reflected symptoms -
depression. Component 4, in both rotations, included the 4 items that comprise
the risk/harm-to-self conceptual domain of CORE-OM. Component 5 included
3 items only, 2 items on functioning - close relationships (items 3 and 19) and
item 31 on subjective well-being – the latter did not load on component 5 under
oblique rotation. Component 6, which was non-significant according to Horn’s
analysis, included the 2 risk/harm-to-others items. Finally, the non-significant
component 7 included item 8 (I have been troubled by aches, pains or other
physical problems), which expresses physical health.
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Table 14. Summary of findings of Principal Components Analysis in
[N1500]. CORE-OM items with significant loadings (coefficients ≥ │0.40│) 
on underlying components – results of both orthogonal and oblique
rotations
Component CORE-OM item Conceptual domain of item
1
1. [terribly alone and isolated] Functioning - close relationships
2. [tense, anxious or nervous]* Symptoms – anxiety
13. [disturbed by unwanted thoughts/feelings] Symptoms – trauma
14. [felt like crying] Subjective well-being
17. [overwhelmed by my problems] Subjective well-being
18. [difficulty of getting to sleep/staying asleep] Symptoms – physical
20. [problems impossible to put to one side] Symptoms – anxiety
23. [felt despairing or hopeless]* Symptoms - depression
27. [felt unhappy] Symptoms - depression
28. [unwanted images/memories distressing] Symptoms – trauma
29. [irritable when with other people] Functioning - social relationships
2
2. [tense, anxious or nervous]* Symptoms – anxiety
4. [felt ok about myself] Subjective well-being
5. [totally lacking in energy and enthusiasm] Symptoms - depression
7. [able to cope when things go wrong] Functioning – general
11. [tension/anxiety prevented doing things] Symptoms – anxiety
12. [happy with the things I’ve done] Functioning – general
15. [felt panic or terror]* Symptoms – anxiety
17. [overwhelmed by my problems]* Subjective well-being
21. [able to do most things I needed to] Functioning – general
23. [felt despairing or hopeless]* Symptoms - depression
27. [felt unhappy]* Symptoms - depression
31. [felt optimistic about my future] Subjective well-being
32. [achieved the things I wanted to] Functioning – general
3
25. [felt criticised by other people] Functioning - social relationships
26. [thought I have no friends] Functioning - close relationships
30. [I am to blame for problems & difficulties] Symptoms - depression
33. [felt humiliated or shamed by other people] Functioning - social relationships
4
9. [thought of hurting myself] Risk/harm to self
16. [made plans to end my life] Risk/harm to self
24. [thought it would be better if I were dead] Risk/harm to self
34. [hurt myself physically/risks with health] Risk/harm to self
5
3. [somebody to turn to for support] Functioning - close relationships
19. [felt warmth or affection for someone] Functioning - close relationships
31. [felt optimistic about my future]* Subjective well-being
6
6. [physically violent to others] Risk/harm to others
22. [threatened or intimidated another person] Risk/harm to others
7 8. [aches, pains, physical problems] Symptoms – physical
Items marked with asterisk (*) loaded strongly on the respective component only in orthogonal
rotation; grey-shaded components are those found non-significant according to Horn’s parallel
analysis
150
The component correlation matrix in Table 15 shows the correlations between
significant components, as indicated by oblique rotation. Loadings
demonstrate a strong correlation between components 1, 2 and 3, and a
moderate to strong correlation of component 4 with components 1 and 3.
Table 15. Findings of Principal Components Analysis of CORE-OM data
in [N1500]. Oblique rotation – component correlation matrix
Component 1 2 3 4 5 6 7
1 1.00 0.69 0.65 0.40 0.15 0.10 0.36
2 0.69 1.00 0.58 0.36 0.17 0.06 0.35
3 0.65 0.58 1.00 0.40 0.18 0.20 0.25
4 0.40 0.36 0.40 1.00 0.12 0.16 0.15
5 0.15 0.17 0.18 0.12 1.00 0.06 -0.20
6 0.10 0.06 0.20 0.16 0.06 1.00 0.04
7 0.36 0.35 0.25 0.15 -0.20 0.04 1.00
Rotation method Promax with Kaiser normalisation. Correlation coefficients ≥ │0.40│are 
shown in bold; correlations of the 2 components that were found to be non-significant by
Horn’s analysis have been shaded in grey.
Results of PCA on the two random sub-samples [N750a] and [N750b] are
presented in Appendix 5. Findings were overall quite similar to those derived
from analysis on the whole sample [N1500], in terms of the large number of
items loading on the first two components and the correlations between
domains identified by oblique rotation. More specifically, PCA on [N750a]
identified 5 significant components according to Horn’s parallel analysis (6 with
eigenvalues above 1), which did not substantially differ between orthogonal
and oblique rotation. The first two components included the majority of CORE-
OM items (20 in total under orthogonal rotation and 19 under oblique rotation),
with component 1 capturing mainly items relating to symptoms of emotional
distress and component 2 containing the vast majority of the positively worded
items. Component 3 appeared to cover items relating to functioning – close
and social relationships, while components 4 and 5 covered risk/harm-to-self
items and risk/harm-to-others items, respectively. Non-significant component 6
according to Horn’s parallel analysis covered the physical item 8 (I have been
troubled by aches, pains or other physical problems). The component
correlation matrix produced by oblique rotation showed that component 1
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correlated with all other significant components; however, no strong
correlations between the other components were identified.
PCA on [N750b] revealed only 4 significant components based on Horn’s
parallel analysis (7 with eigenvalues above 1). There were more differences
between the findings of orthogonal and oblique rotation than those observed
between the two types of rotation in PCA in samples [N1500] and [N750a].
Under orthogonal rotation, 18 items loaded on the first two components, while
under oblique rotation the respective number was 15 items. Component 1, as
with other analyses, included items relating to symptoms of emotional distress,
and component 2 included most of the positively worded items. However,
some items relating to symptoms of emotional distress, which had been found
to load on component 1 in previous analyses, were now found to load on
component 3, together with item 8 (I have been troubled by aches, pains or
other physical problems). Component 4 included all risk/harm-to-self items
under both types of rotation. The last 3 components that were found to be non-
significant according to Horn’s parallel analysis included items on functioning –
close and social relationships (component 5), items 3 and 19 on close
relationships (component 6) and the two items expressing risk/harm-to-others
(component 7). The component correlation matrix resulting from oblique
rotation showed that the first 3 components were strongly correlated. In
addition, non-significant component 5 was also strongly correlated with the first
3 components.
5.3.2 Summary and interpretation of findings – advisory
group’s views and decision on the approach to be
adopted
The findings of PCA indicated that the CORE-OM consists of a large pool of
items that belong to domains that are highly correlated; few items appear to
belong to independent domains. The first 2 components identified in PCA
contained the majority of CORE-OM items, with one component including
mainly items expressing various symptoms of emotional distress and the other
component made up mostly of positively worded items. A small number of
items (items 25, 26, 29, 30 and 33) appeared to form a rather distinct group;
with the exception of item 30, which conceptually belongs to the domain
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symptoms – depression, the rest of these items conceptually express
functioning – close or social relationships. Risk/harm-to-self and risk/harm-to-
others items appeared to form two separate components, respectively. Items 3
and 19, which conceptually belong to functioning – close relationships, also
formed a separate component. Finally, item 8 appeared to behave
independently from the other CORE-OM items.
The loadings of the items on the identified components in the rotated matrices
showed a similar pattern in both orthogonal and oblique rotations of PCA,
indicating that orthogonal rotation might be an acceptable solution. On the
other hand, oblique rotation revealed strong correlations between underlying
domains identified by PCA. It is noticeable that the domains identified in PCA
were overall not consistent with the conceptual structure of CORE-OM, as the
first two components included items from all conceptual domains of CORE-
OM, with the exception of risk items.
The findings of PCA performed in Step 1 suggest that the CORE-OM
comprises a measure with no clear multidimensionality, since its domains (as
identified by PCA) are highly correlated, perhaps with the exception of the risk
items and items 8, 3 and 19, which overall appear to belong to separate,
independent domains. It has to be noted, though, that literature suggests that it
is possible that items with different levels of difficulty (e.g. items that capture
different severity levels of mental symptoms) may form separate components
in PCA, even though they may capture the same dimension; this may occur
because ‘easy’ items (i.e. items capturing milder levels of disease) and
‘difficult’ items (i.e. items with an ability to identify severe levels of disease)
have higher correlations amongst themselves (Bond, 1994). This means that
the risk items may potentially belong to the same broad domain with the other
items of CORE-OM, but load on different components due to their higher level
of ‘difficulty’. Moreover, the finding of most positively worded items loading on
the same component may be attributable to the common way of phrasing
these items rather than their belonging to a domain that expresses a distinct
attribute.
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The advisory group considered the findings of PCA together with the issues
raised above regarding the possibility of parameters other than the
dimensionality of CORE-OM affecting the results of PCA. It was therefore
agreed to attempt Rasch analysis on the whole CORE-OM, and not to carry
out separate Rasch analyses on each domain identified in PCA, which is the
approach that has been previously reported in the literature for the derivation
of PBMs from existing CSMs (Young et al., 2009 & 2011). Such a decision was
dictated by the lack of an explicit multidimensional structure of the CORE-OM,
as PCA showed that the majority of CORE-OM items formed a large item pool
belonging to 2 domains only, despite the multidimensional conceptual structure
of the measure. Moreover, the results were not entirely consistent in the
analyses performed across the total sample [N1500] and the two random sub-
samples [N750a] and [N750b], so that underlying domains were not clearly
and undoubtedly defined. Finally, and more importantly, PCA identified strong
correlations between the different domains of the instrument. If such
correlations were not taken into consideration during the development of the
new health state classification, there was the danger of formation of
implausible health states if standard techniques used for the generation of
health states, such as orthogonal block designs, were applied. This issue was
raised in Chapter 4 (section 4.1), and will be revisited in Chapter 6 (section
6.2.1), where a new approach for the identification of plausible health states,
based on Rasch analysis, is described.
In conclusion, Rasch analysis was decided to be undertaken on the whole
instrument at the next step of the process, in an attempt to exclude unsuitable
items and ultimately develop a unidimensional scale that fits into the Rasch
model.
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5.4 Results of Step 2: reduction of items and
response levels from the CORE-OM
5.4.1 Rasch analysis
Investigation of threshold ordering and item rescoring
The first stage of Rasch analysis undertaken in [N400a] was to explore
whether the CORE-OM items had ordered thresholds, i.e. whether
respondents could discriminate between adjacent response levels. Items with
disordered thresholds are demonstrated on the item threshold map, an output
of RUMM2020 that provides the most likely responses to each item with
ordered thresholds that are expected for each respondent, depending on the
respondents’ level of symptom severity as determined by their location on the
Rasch logit scale. For items with disordered thresholds it is not possible to
predict the most likely responses since respondents cannot differentiate across
adjacent response levels; therefore the most likely responses for these items
are not depicted on the Rasch item threshold map. As shown in Figure 8,
which presents the item threshold map of Rasch analysis in [N400a], the
majority of the CORE-OM items (24 out of the 34) had disordered thresholds.
Only 8 items had ordered thresholds and were therefore depicted on the map,
meaning that respondents could perceive the differences between the 5-level
response statements relating to each of these items.
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Figure 8. Rasch item threshold map of initial analysis of the CORE-OM –
[N400a]
Item 1
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Item 22
Item 23
Item 24
Item 25
Item 26
Item 27
Item 28
Item 29
Item 30
Item 31
Item 32
Item 33
Item 34
Rasch logit scale
Response levels 0-4 correspond to response statements as follows: 0: not at all; 1: only
occasionally; 2: sometimes; 3: often; 4: most or all the time, with the exception of positively
worded items in which response statements are reversed.
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The ‘threshold structure’ of each item can be visualised in a category
probability curve, which shows the probability of every respondent obtaining
each response level depending on respondents’ symptom severity expressed
by their location on the Rasch logit scale.
Figure 9 shows the category probability curve for item 27 (I have felt unhappy),
which is an item with ordered thresholds. It can be seen that as the location
across the Rasch logit scale increases, the probability of moving from
response level 0 (not at all) to response level 4 (most or all the time) through
intermediate levels 1 (only occasionally), 2 (sometimes) and 3 (often) also
increases; each response level receives its ‘peak’ probability at some location
across the Rasch logit scale, with this location increasing as the response level
increases. When a response level acquires its ‘peak’ probability, all other
response levels have lower probabilities of being chosen by respondents,
meaning respondents at this location are more likely to select the response
level in question and less likely to select any other response level. In contrast,
Figure 10 shows the category probability curve for item 22 (I have threatened
or intimidated another person), which was found to have disordered
thresholds. In this case the probability of obtaining consecutive levels of
response does not increase with increasing person location; rather, persons
seem to be able to distinguish only between response levels 0 (not at all) and
4 (most or all the time), with levels 1, 2 and 3 never becoming the most likely
responses at any location across the scale. The category probability curves for
all CORE-OM items as produced by initial Rasch analysis on [N400a] are
illustrated in Appendix 6.
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Figure 9. Example of category probability curve for an item with ordered
thresholds [item 27 – I have felt unhappy]
Figure 10. Example of category probability curve for an item with
disordered thresholds [item 22 – I have threatened or intimidated another
person]
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The next stage before attempting to do any further Rasch analysis was to
order the thresholds of all items. As described in section 4.2.2 of Chapter 4, at
this stage the criteria for collapsing response levels in order to create new
response categories were:
 visual inspection of category probability curves for each item: response
levels with substantial overlapping in the areas under the curve were
candidates for merging
 examination of category response proportions: response levels selected by
very few respondents were generally candidates for merging with adjacent
response levels
 minimum loss of information - thus the minimum possible merging of
response categories was attempted
 clinically meaningful response statements.
Table 16 shows the category response proportions for each item, together with
its status of threshold ordering. Items in the table have been ordered from the
easiest to the most difficult one, according to their average location on the
Rasch logit scale. It can be seen that, overall, easier items tend to have
ordered thresholds. As difficulty increases, practically all items have disordered
thresholds. Another point for observation is that difficult items (at the bottom of
the table), especially risk items (which are the most difficult ones as they
capture high symptom severity), have very low response proportions in their
higher response levels. In contrast, easier items (on top of the table) tend to
have low response proportions in their lower response levels (notably for
response level 0 – “not at all”), although this finding does not seem to affect
threshold ordering.
159
Table 16. Category response proportions for the 34 CORE-OM items
before threshold ordering was attempted – [N400a]
Item Location Threshold
Proportion of responses in each
response category
0 1 2 3 4
27 -1.196 Ordered 0.03 0.10 0.23 0.37 0.28
2 -1.188 Ordered 0.02 0.09 0.20 0.38 0.31
20 -0.877 Ordered 0.06 0.13 0.20 0.27 0.33
5 -0.790 Ordered 0.05 0.15 0.25 0.30 0.26
14 -0.745 Ordered 0.08 0.11 0.19 0.30 0.32
18 -0.606 Disordered 0.11 0.08 0.23 0.25 0.33
32 -0.573 Disordered 0.10 0.10 0.33 0.21 0.26
30 -0.478 Ordered 0.11 0.15 0.22 0.28 0.24
31 -0.468 Disordered 0.09 0.13 0.29 0.29 0.20
4 -0.464 Disordered 0.09 0.08 0.40 0.26 0.17
17 -0.379 Ordered 0.12 0.17 0.26 0.26 0.19
13 -0.347 Disordered 0.13 0.12 0.29 0.28 0.18
28 -0.316 Disordered 0.17 0.10 0.26 0.23 0.23
12 -0.232 Disordered 0.11 0.14 0.38 0.25 0.11
7 -0.212 Disordered 0.14 0.11 0.38 0.22 0.14
29 -0.177 Ordered 0.12 0.18 0.32 0.26 0.11
1 -0.142 Disordered 0.16 0.14 0.33 0.23 0.13
23 -0.141 Disordered 0.19 0.17 0.25 0.23 0.16
11 -0.111 Disordered 0.19 0.16 0.28 0.21 0.15
8 -0.067 Disordered 0.24 0.19 0.23 0.16 0.17
3 0.014 Disordered 0.23 0.12 0.28 0.25 0.12
25 0.056 Disordered 0.21 0.16 0.28 0.24 0.10
10 0.148 Disordered 0.22 0.21 0.34 0.14 0.08
15 0.196 Disordered 0.26 0.20 0.26 0.19 0.09
19 0.282 Disordered 0.34 0.26 0.24 0.08 0.08
21 0.349 Disordered 0.26 0.22 0.30 0.16 0.06
33 0.448 Disordered 0.42 0.15 0.27 0.09 0.08
26 0.509 Disordered 0.43 0.19 0.18 0.14 0.06
24 0.628 Disordered 0.53 0.20 0.10 0.10 0.07
22 0.927 Disordered 0.74 0.11 0.08 0.03 0.03
9 1.344 Disordered 0.69 0.14 0.11 0.04 0.01
16 1.464 Disordered 0.83 0.09 0.06 0.01 0.01
6 1.544 Disordered 0.88 0.07 0.04 0.01 0.01
34 1.598 Disordered 0.84 0.09 0.05 0.01 0.01
Response levels 0-4 correspond to response statements as follows: 0: not at all; 1: only
occasionally; 2: sometimes; 3: often; 4: most or all the time, with the exception of positively
worded items in which response statements are reversed. Proportions <0.10 are shown in
bold.
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Various ways of merging response levels and rescoring items with disordered
thresholds were attempted using the set criteria, until all items demonstrated
ordered thresholds in the item threshold map of Rasch analysis. Since no
common re-scoring to all 34 CORE-OM items was possible to apply at this
stage, the partial-credit Rasch model was selected for analysis of the data.
Figure 11 shows the new response levels of CORE-OM items following
merging of response statements, where required, so as to achieve threshold
ordering. In the case of some items, for example item 34 (I have hurt myself
physically or taken risks with my health), more than two adjacent response
levels needed to be merged in order to acquire ordered thresholds.
Figure 12 shows the Rasch item threshold map following threshold ordering of
all CORE-OM items. The category probability curves of the 34 CORE-OM
items following merging of response levels and threshold ordering are provided
in Appendix 7.
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Figure 11. New response levels of the CORE-OM items following merging
of original response levels and subsequent threshold ordering – [N400a]
ITEM 0 1 2 3 4
1. [terribly alone and isolated]
2. [tense, anxious or nervous]
3. [somebody to turn to for support]
4. [felt ok about myself]
5. [totally lacking in energy and enthusiasm]
6. [physically violent to others]
7. [able to cope when things go wrong]
8. [aches, pains, physical problems]
9. [thought of hurting myself]
10. [talking to people has felt too much]
11. [tension/anxiety prevented doing things]
12. [happy with the things I’ve done]
13. [disturbed by unwanted thoughts/feelings]
14. [felt like crying]
15. [felt panic or terror]
16. [made plans to end my life]
17. [overwhelmed by my problems]
18. [difficulty of getting to sleep/staying asleep]
19. [felt warmth or affection for someone]
20. [problems impossible to put to one side]
21. [able to do most things I needed to]
22. [threatened or intimidated another person]
23. [felt despairing or hopeless]
24. [thought it would be better if I were dead]
25. [felt criticised by other people]
26. [thought I have no friends]
27. [felt unhappy]
28. [unwanted images/memories distressing]
29. [irritable when with other people]
30. [I am to blame for problems & difficulties]
31. [felt optimistic about my future]
32. [achieved the things I wanted to]
33. [felt humiliated or shamed by other people]
34. [hurt myself physically/risks with health]
Response levels 0-4 correspond to response statements as follows: 0: not at all; 1: only
occasionally; 2: sometimes; 3: often; 4: most or all the time, with the exception of positively
worded items in which response statements are reversed.
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Figure 12. Rasch item threshold map of the CORE-OM after item
rescoring (leading to ordered thresholds for all items) – [N400a]
Item 1
Item 2
Item 3
Item 4
Item 5
Item 6
Item 7
Item 8
Item 9
Item 10
Item 11
Item 12
Item 13
Item 14
Item 15
Item 16
Item 17
Item 18
Item 19
Item 20
Item 21
Item 22
Item 23
Item 24
Item 25
Item 26
Item 27
Item 28
Item 29
Item 30
Item 31
Item 32
Item 33
Item 34
Rasch logit scale
Response levels 0-4 correspond to different response statements, depending on the
merging of response levels – this map needs to be interpreted in connection with
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Analysis after threshold ordering
Rasch analysis was undertaken on the CORE-OM following threshold
ordering. According to the summary statistics shown in Table 17, the CORE-
OM was somewhat ‘difficult’ for the study sample: its mean location on the
Rasch logit scale was zero (set by default), while the mean location of the
respondents was lower, at -0.328. The fit residual of the standard deviation of
the mean location of items was high, at 2.283, implying some misfit in the
model, while the respective parameter of persons equalled 1.496. The total
chi-square probability for the model’s degrees of freedom was <0.001,
indicating that the CORE-OM did not fit in the Rasch model. The PSI, which
expresses the reliability of a measure, was estimated at 0.93, indicating that
the measure had excellent ability to discriminate amongst different respondent
groups.
Table 17. Rasch analysis of CORE-OM data following threshold ordering:
item-person and item-trait interaction summary statistics– [N400a]
Items Persons
Location Fit residual Location Fit residual
Mean 0.000 0.098 -0.328 -0.207
Standard deviation 0.865 2.283 0.964 1.496
Item-trait interaction Reliability indices
Total Item chi-square 460.314 PSI 0.93104
Total degrees of freedom 170.000 Cronbach Alpha N/A (missing data)
Total chi-square probability 0.00000 Power of test-of-fit Excellent
Individual item statistics and indications for DIF are shown in Table 18. It can
be seen that a number of items (items 1, 3, 8, 17, 19, 23, 27, 30 and 31) did
not fit in the Rasch model as they demonstrated fit residuals beyond ± 2.5.
Moreover, a number of items (items 3, 8, 9, 19, 23, 24, 27, and 30) showed
significant chi-squared probabilities following Bonferroni adjustment, indicating
their misfit in the Rasch model. Five items showed DIF: item 14 was
characterised by uniform DIF by gender, while items 6, 8, 24 and 29 were
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characterised by uniform DIF caused by age. In terms of location, items
belonging to the conceptual domains of ‘symptoms’ and ‘subjective well-being’
tended to be easier than items belonging to ‘functioning’. Risk items appeared
to be the most difficult ones. These results indicate that people with mild
common mental health problems first experience a reduction in their subjective
well-being, along with symptoms relating to emotional distress. As symptom
severity increases, people experience problems relating to their functioning,
both general and within their relationships. At the most severe level of common
mental health problems, people seem to take risks with themselves and with
other people. This finding on the relative ‘difficulty’ of the conceptual domains
corroborates the suggested 3-phase model of psychotherapy outcome that
entails projective improvement of subjective well-being, which is prerequisite
for the (subsequent) reduction in emotional distress, which, in turn, is
necessary before improvement in functioning is achieved (Howard et al.,
1993). It also supports the concern that the PCA may ascribe dimensionality
based on item difficulty.
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Table 18. Rasch analysis of CORE-OM data following threshold ordering:
individual item statistics and indications of differential item functioning –
[N400a]
Item CD Location Residual Chi-square P-value DIF
1. [terribly alone and isolated] FC -0.430 -2.904 14.998 0.010 No
2. [tense, anxious or nervous] SA -1.430 -0.616 6.866 0.231 No
3. [somebody to turn to for support] FC 0.364 3.134 20.166 0.001 No
4. [felt ok about myself] SW -0.296 -1.278 11.010 0.051 No
5. [totally lacking in energy and enthusiasm] SD -0.986 1.630 9.731 0.083 No
6. [physically violent to others] RO 2.182 -0.394 13.651 0.018 Yes
7. [able to cope when things go wrong] FG 0.003 0.619 4.722 0.451 No
8. [aches, pains, physical problems] SP -0.092 3.547 23.140 0.000 Yes
9. [thought of hurting myself] RS 0.612 -1.516 21.974 0.001 No
10. [talking to people has felt too much] FS 0.125 -0.296 0.794 0.977 No
11. [tension/anxiety prevented doing things] SA 0.127 0.045 1.383 0.926 No
12. [happy with the things I’ve done] FG 0.086 0.177 1.706 0.888 No
13. [disturbed by unwanted thoughts/feelings] ST -0.452 1.416 11.120 0.049 No
14. [felt like crying] SW -0.958 -1.024 1.940 0.857 Yes
15. [felt panic or terror] SA 0.760 -0.083 3.304 0.653 No
16. [made plans to end my life] RS 1.520 -1.168 14.745 0.012 No
17. [overwhelmed by my problems] SW -0.542 -2.647 13.309 0.021 No
18. [difficulty of getting to sleep/staying asleep] SP -0.669 0.637 5.091 0.405 No
19. [felt warmth or affection for someone] FC 0.530 4.642 53.685 0.000 No
20. [problems impossible to put to one side] SA -1.090 0.276 1.258 0.999 No
21. [able to do most things I needed to] FG 0.753 -0.591 10.146 0.071 No
22. [threatened or intimidated another person] RO 0.847 1.259 8.202 0.145 No
23. [felt despairing or hopeless] SD -0.186 -4.230 39.698 0.000 No
24. [thought it would be better if I were dead] RS 1.098 -1.926 20.214 0.001 Yes
25. [felt criticised by other people] FS 0.087 -0.445 5.269 0.384 No
26. [thought I have no friends] FC 0.660 -0.238 5.567 0.350 No
27. [felt unhappy] SD -1.476 -4.086 29.228 0.000 No
28. [unwanted images/memories distressing] ST -0.472 -0.582 13.432 0.020 No
29. [irritable when with other people] FS -0.307 2.491 9.778 0.082 Yes
30. [I am to blame for problems & difficulties] SD -0.636 6.074 44.289 0.000 No
31. [felt optimistic about my future] SW -0.640 3.613 19.361 0.002 No
32. [achieved the things I wanted to] FG -0.987 0.158 4.119 0.532 No
33. [felt humiliated or shamed by other people] FS 0.308 -1.724 12.224 0.032 No
34. [hurt myself physically/risks with health] RS 1.585 -0.643 4.195 0.522 No
Residuals ≥ │2.5│are considered high; chi-squared probabilities have been assessed using 
Bonferroni adjustment. DIF was determined by chi-square statistics following Bonferroni
adjustment. All statistics showing item misfit in the Rasch model are illustrated in bold. CD =
conceptual domain; FC = functioning-close relationships; FG = functioning-general; FS =
functioning-social relationships; SA = symptoms-anxiety; SD = symptoms-depression; SP =
symptoms-physical; ST = symptoms-trauma; SW = subjective well-being; RO = risk/harm-to-
others; RS = risk/harm-to-self.
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5.4.2 Classical psychometric tests
The results of classical psychometric tests regarding responsiveness, floor or
ceiling effects, correlation with the total CORE-OM score and percentage of
missing data are shown in Table 19, while the full distribution of responses
(indicating floor or ceiling effects) is shown in Table 16. Risk items had rather
low responsiveness (<0.50), which, however, improved substantially once
respondents with a baseline response of ‘not at all’ were removed from
analysis. This finding was not unexpected, given that risk items are the most
difficult ones, and therefore a high proportion of respondents were at the
lowest response level at baseline with no scope for improvement. Item 19 had
also low responsiveness (SRM 0.33), which did not improve much after
exclusion of respondents with a zero response level at baseline. A number of
items demonstrated floor effects (proportion of the respondents at the lower
response level ≥ 0.30). These included all risk items, a finding that was 
anticipated given the difficulty of these items, which meant that a large
proportion of participants gave a negative response (‘not at all’) at baseline.
Another 3 items (19, 26 and 33) that were among the most difficult according
to their mean location also showed floor effects. On the other hand, items 2,
14, 18 and 20 demonstrated ceiling effects (proportion of responders at the
highest response level ≥ 0.30). Regarding correlation with the total CORE-OM 
score, items 34, 19, 8 and the two risk/harm-to-others items 6 and 22 showed
rather low correlation as expressed by the Spearman’s ρ value. The 
percentage of missing data was low for all items, with only item 19 showing
somewhat higher percentage compared with the other CORE-OM items (2.4%
vs. ≤ 1.5%). 
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Table 19. Results of standard psychometric tests on CORE-OM items:
responsiveness, floor and ceiling effects, correlation with total CORE-OM
score and percentage of missing data – [N400a]
Item SRM (sub-analysis)
Pr of response
at level 0 / 4*
Spearman’s
ρ value 
Missing
data
1. [terribly alone and isolated] 0.99 (1.31) 0.16 / 0.13 0.71 0.4%
2. [tense, anxious or nervous] 1.18 (1.25) 0.02 / 0.31 0.60 0.3%
3. [somebody to turn to for support] 0.65 (0.97) 0.23 / 0.12 0.42 0.7%
4. [felt ok about myself] 1.00 (1.19) 0.09 / 0.17 0.65 0.6%
5. [totally lacking in energy and enthusiasm] 0.96 (1.13) 0.05 / 0.26 0.59 0.4%
6. [physically violent to others] 0.24 (1.54) 0.88 / 0.01 0.28 0.5%
7. [able to cope when things go wrong] 0.78 (1.05) 0.14 / 0.14 0.59 0.6%
8. [aches, pains, physical problems] 0.61 (0.92) 0.24 / 0.17 0.28 0.7%
9. [thought of hurting myself] 0.46 (1.58) 0.69 / 0.01 0.53 0.4%
10. [talking to people has felt too much] 0.81 (1.13) 0.22 / 0.08 0.55 0.7%
11. [tension/anxiety prevented doing things] 0.89 (1.23) 0.19 / 0.15 0.64 0.8%
12. [happy with the things I’ve done] 0.85 (1.11) 0.11 / 0.11 0.62 0.8%
13. [disturbed by unwanted thoughts/feelings] 0.95 (1.23) 0.13 / 0.18 0.56 0.5%
14. [felt like crying] 1.19 (1.40) 0.08 / 0.32 0.63 0.3%
15. [felt panic or terror] 0.84 (1.36) 0.26 / 0.09 0.58 0.4%
16. [made plans to end my life] 0.29 (1.54) 0.83 / 0.01 0.44 1.0%
17. [overwhelmed by my problems] 1.09 (1.32) 0.12 / 0.19 0.74 1.0%
18. [difficulty of getting to sleep/staying asleep] 0.93 (1.09) 0.11 / 0.33 0.52 0.6%
19. [felt warmth or affection for someone] 0.33 (0.66) 0.34 / 0.08 0.30 2.4%
20. [problems impossible to put to one side] 1.04 (1.16) 0.06 / 0.33 0.63 0.9%
21. [able to do most things I needed to] 0.69 (1.05) 0.26 / 0.06 0.57 0.8%
22. [threatened or intimidated another person] 0.32 (1.15) 0.74 / 0.03 0.27 1.0%
23. [felt despairing or hopeless] 1.09 (1.43) 0.19 / 0.16 0.79 0.8%
24. [thought it would be better if I were dead] 0.58 (1.39) 0.53 / 0.07 0.65 0.7%
25. [felt criticised by other people] 0.70 (1.07) 0.21 / 0.10 0.56 0.8%
26. [thought I have no friends] 0.65 (1.25) 0.43 / 0.06 0.60 0.9%
27. [felt unhappy] 1.26 (1.32) 0.03 / 0.28 0.73 0.5%
28. [unwanted images/memories distressing] 0.89 (1.17) 0.17 / 0.23 0.58 0.6%
29. [irritable when with other people] 0.86 (1.07) 0.12 / 0.11 0.55 0.9%
30. [I am to blame for problems & difficulties] 0.80 (0.99) 0.11 / 0.24 0.53 0.5%
31. [felt optimistic about my future] 0.81 (0.96) 0.09 / 0.20 0.47 1.0%
32. [achieved the things I wanted to] 0.86 (1.07) 0.10 / 0.26 0.59 1.5%
33. [felt humiliated or shamed by other people] 0.61 (1.31) 0.42 / 0.08 0.56 1.1%
34. [hurt myself physically/risks with health] 0.27 (1.25) 0.84 / 0.01 0.35 0.9%
SRM = standardised response mean; in parenthesis results for each item after including only
respondents who had a baseline value of at least 1 in the particular item (or at maximum 3 in
positively worded items). Pr = proportion of respondents; Spearman’s ρ value expresses 
correlation with total CORE-OM score. In bold: SRM values <0.50; proportion of respondents
at level 0 or 4 ≥ 30%; Spearman’s ρ values < 0.40; and % of missing data ≥ 1.0% 
*levels have been reversed for positively worded items.
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5.4.3 Interpretation of the findings – advisory group’s
opinion on candidate items for exclusion from the new
health state classification
The thesis advisory group considered the findings of Rasch analysis on the 34
CORE-OM items following threshold ordering, the results of the standard
psychometric tests and other issues on the appropriateness and relevance of
the items for inclusion in a PBM, in order to identify candidate items for
exclusion from the new measure. The following views were expressed:
The two risk/harm-to-others items 6 (I have been physically violent to others)
and 22 (I have threatened or intimidated another person) should be prioritised
for deletion. Both items had very low correlation with the total CORE-OM score
and demonstrated low responsiveness to treatment and floor effects (although
these findings were partially justified by the high difficulty of these items).
Moreover, item 6 showed DIF. Most importantly, the advisory group expressed
the view that these items were not relevant to a PBM, as they expressed
external behaviour affecting society rather than people’s perceptions of their
own HRQoL.
Item 34 (I have hurt myself physically or taken risks with my health) was
characterised by low responsiveness, low correlation with the total CORE-OM
score and floor effects. Moreover, the advisory group judged its wording to be
ambiguous. Therefore, this item was also prioritised for exclusion.
Item 8 (I have been troubled by aches, pains, physical problems) was also
decided to be excluded due to significant item misfit into the Rasch model,
which had been anticipated, since the item expressed physical symptoms and
therefore clearly belonged to a different dimension from items measuring, in
their majority, emotional symptoms. In addition, item 8 demonstrated DIF and,
not surprisingly, low correlation with the total CORE-OM score. Nevertheless,
physical symptoms were judged to constitute an important dimension in its own
right that should be captured by the final PBM; hence, although item 8 was
excluded from Rasch analysis, it was decided to be combined, at a later stage,
with the final (unidimensional) product of Rasch analysis.
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Other items that demonstrated misfit to the model as indicated by either their fit
residuals or their chi-squared probability (that is, items 1, 3, 9, 17, 19, 23, 24,
27, 30 and 31) were considered for exclusion from the final measure. Items 3,
19 and 31 also showed relatively low correlation with the total CORE-OM
score. Moreover, items 19, 26 and 33 demonstrated floor effects, and item 19
had the highest percentage of missing data.
Items 14 and 29 were potential candidates for exclusion as they demonstrated
DIF in the initial analysis. DIF was considered non-acceptable in a PBM that
should capture HRQoL of all respondents in a similar way, without
systematically discriminating according to demographic characteristics.
It should be noted that the initial misfit of items into the Rasch model was only
an indication for exclusion from the final instrument, and did not determine
exclusion at this stage. This was decided because item fit in the Rasch model
depends to a large extent on the behaviour of the other items comprising the
scale, and therefore exclusion of other items might alter item fit statistics at
later stages of analysis. Therefore, items were excluded one at a time followed
by Rasch analysis on the remaining items and subsequent testing of fit
statistics. The order of exclusion of items was agreed with the advisory group,
based on the group’s considerations as previously described. This process
was repeated until all remaining items fit in the Rasch model.
5.4.4 Exclusion of unsuitable CORE-OM items -
construction of a scale fitting the Rasch model
Items 6, 22, 34 and 8 were the first items that were excluded from further
consideration, based on the findings of the analyses and the advisory group’s
views. Successive Rasch analyses led to the exclusion of items 3, 9, 19, 23,
24, 27, 30 and 31 that persistently (in the initial and all consecutive analyses)
misfit into the Rasch model. Items 14 and 29 were excluded because they
demonstrated persistently significant DIF. Items 5, 18 and 28, although did fit
in the Rasch model in the initial analysis, showed high fit residuals (≥ │2.5│) at 
later stages and were eventually excluded from further consideration. On the
other hand, items 1 and 17, which showed misfit in the model at initial stages
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of analysis, appeared to fit in the model at later stages following deletion of
other items, and were thus retained in the analysis. All item exclusions were
agreed with the advisory group.
The 17 remaining items of the CORE-OM that fit in the Rasch model and their
respective item fit statistics are presented in Table 20. The overall Rasch
statistics of this 17-item measure are provided in Table 21. It can be seen that,
according to the conceptual framework of CORE-OM, 9 of the 17 items reflect
functioning; 5 items express symptoms; 2 items represent subjective well-
being; and one item expresses risk/harm-to-self. Data on both tables indicate
that the scale and all individual items fit the Rasch model (total chi-squared
probability 0.17). No item was associated with DIF. The scale had an excellent
ability to discriminate amongst different groups of respondents (PSI 0.90). The
Rasch item threshold map of the 17-item scale illustrating the ordered
thresholds of all items is shown in Figure 13.
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Table 20. Results of Rasch analysis of the 17 CORE-OM items fitting the
Rasch model: individual item statistics and indications of differential
item functioning – [N400a]
Item CD Location Residual Chi-square
P-
value DIF
1. [terribly alone and isolated] FC -0.392 -1.393 8.602 0.126 No
2. [tense, anxious or nervous] SA -1.502 -0.326 3.543 0.617 No
4. [felt ok about myself] SW -0.270 0.053 1.902 0.863 No
7. [able to cope when things go wrong] FG 0.068 0.631 7.073 0.215 No
10. [talking to people has felt too much] FS 0.193 0.628 4.120 0.532 No
11. [tension/anxiety prevented doing things] SA 0.218 0.008 6.176 0.289 No
12. [happy with the things I’ve done] FG 0.147 0.925 1.141 0.950 No
13. [disturbed by unwanted thoughts/feelings] ST -0.405 2.379 11.933 0.036 No
15. [felt panic or terror] SA 0.858 0.203 5.160 0.397 No
16. [made plans to end my life] RS 1.579 -0.463 4.754 0.447 No
17. [overwhelmed by my problems] SW -0.525 -2.058 12.036 0.034 No
20. [problems impossible to put to one side] SA -1.109 0.275 3.177 0.673 No
21. [able to do most things I needed to] FG 0.873 -0.454 5.300 0.380 No
25. [felt criticised by other people] FS 0.140 0.996 3.811 0.577 No
26. [thought I have no friends] FC 0.731 0.873 9.621 0.087 No
32. [achieved the things I wanted to] FG -0.987 0.918 1.139 0.951 No
33. [felt humiliated or shamed by other people] FS 0.384 -0.897 7.631 0.178 No
Residuals beyond ≥ │2.5│ are considered high; chi-square probabilities have been assessed 
using Bonferroni adjustment. DIF was determined by chi-square statistics following
Bonferroni adjustment. CD = conceptual domain; FC = functioning-close relationships; FG =
functioning-general; FS = functioning-social relationships; RS = risk/harm-to-self; SA =
symptoms-anxiety
Table 21. Rasch analysis of the 17 CORE-OM items fitting the Rasch
model: item-person and item-trait interaction statistics – [N400a]
Items Persons
Location Fit residual Location Fit residual
Mean 0.000 0.135 -0.304 -0.220
Standard deviation 0.788 1.037 1.143 1.223
Item-trait interaction Reliability indices
Total Item chi-square 97.117 PSI 0.90087
Total degrees of freedom 85 Cronbach Alpha N/A (missing data)
Total chi-square probability 0.1737 Power of test-of-fit Excellent
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Figure 13. Rasch item threshold map of the 17-CORE-OM item scale
fitting the Rasch model – [N400a]
5.5 Results of Step 3: selection of CORE-OM items
for inclusion in the new health state classification
Although the 17-item scale derived from the CORE-OM fit the Rasch model,
further reduction was required in order to construct a concise measure
amenable to valuation. Further exclusion of items was thus undertaken, after
testing different item combinations and applying the set criteria reported in
section 4.2.3 of Chapter 4.
Coverage of CORE-OM domains
The advisory group expressed the view that the items in the final instrument
should capture as many domains of the CORE-OM as possible, as
represented in the measure’s conceptual domains but also as indicated by
PCA. This would ensure that the new PBM is able to tap a range of different
aspects of HRQoL that are relevant to people with common mental health
problems, as captured by the CORE-OM, with minimum loss of information. In
Item 1
Item 2
Item 4
Item 7
Item 10
Item 11
Item 12
Item 13
Item 15
Item 16
Item 17
Item 20
Item 21
Item 25
Item 26
Item 32
Item 33
Rasch logit scale
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addition, the new measure should include at least one positively worded item
to retain the ‘character’ of the original measure. However, it was acknowledged
that, since the measure needed to fit in the Rasch model and fulfil a number of
other criteria, representation of all domains might not be possible.
Of the 10 conceptual sub-domains of the CORE-OM, 3 were not represented
in the 17-item scale developed in the previous step, as their items had been
excluded in previous stages of analysis: ‘symptoms - depression’, ‘symptoms -
physical’, and ‘risk/harm to others’. It has to be noted, though, that item 8 was
initially removed with the intension to be combined with the unidimensional
final output of Rasch analysis at a later stage.
The ‘subjective well-being’ domain (items 4 and 17 in the 17-item scale) was
also deemed as an important aspect of the measure; however, it was
recognised that this domain covered the overall perception of persons’ HRQoL
rather than distinct symptoms / problems of people with mental disorders.
Moreover, in the PCA undertaken in Step 1 of the process, items belonging to
‘subjective well-being’ loaded on the same components with items expressing
symptoms (components 1 and 2). Indeed, this domain has been previously
found to highly correlate with items in the overall ‘problems’ domain (Evans et
al., 2002). It was therefore accepted that it was less crucial for this domain to
be included in the final measure. Regarding the ‘symptoms - trauma’ sub-
domain (item 13 in the 17-item scale), this was considered less relevant for
inclusion in a HRQoL measure for people with common mental health
problems. Importantly, attempts to include items of ‘subjective well-being’ and
‘symptoms - trauma’ in the final measure resulted in a scale not satisfying the
final criterion of increase in item threshold locations with increasing difficulty of
the items. Consequently, these two sub-domains were not represented in the
final measure.
The advisory group concluded that the remaining conceptual sub-domains
‘symptoms - anxiety’ (represented by items 2, 11, 15, 20 in the 17-item scale),
‘functioning - general’ (items 7, 12, 21, 32 in the 17-item scale), ‘functioning -
close relationships’ (items 1, 26 in 17-item scale), ‘functioning - social
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relationships’ (items 10, 25, 33 in the 17-item scale) and ‘risk/harm to self’
(item 16 in the 17-item scale) reflected conceptual major domains in people
with common mental health problems and should be represented in the final
construct.
Furthermore, it was agreed that the new measure should ideally include one
item per domain as identified in PCA undertaken on the CORE-OM. According
to the results of this analysis, the vast majority of the items comprising the 17-
item scale loaded on PCA components 1 [items 1, 2, 13, 17 and 20] and 2
[items 2, 4, 7, 11, 12, 15, 17, 21 and 32] with items 2 and 17 loading on both
components. These two components included the majority of CORE-OM items,
which belonged to various conceptual domains of CORE-OM. Three items [25,
26 and 33] loaded on component 3, which appeared to capture mostly items
on functioning – relationships, and item 16 loaded on component 4, which
contained all the risk-to-self items. Item 10 did not load on any of the
components identified in PCA. On the other hand, the 5th significant
component of PCA was the only one not represented in the 17-item scale.
Ensuring consistency in response levels across items of the new
measure
Items were excluded one at a time and Rasch statistics as well as the PSI
were constantly checked. In addition, during this process, a number of items
were re-scored, while the impact of re-scoring on their threshold ordering as
well as on the overall model and individual item fit was constantly checked.
Rescoring of some items was attempted so that the final measure had
homogeneous response levels across all its items (the items comprising the
17-item scale had different response levels). When item re-scoring aiming at
consistency of response levels across all items of the final measure was not
possible without negatively affecting overall model and individual item
statistics, then the item was excluded from further analysis.
Constructing the emotional component of the new health state
classification
Following exclusion of a number of items, various combinations of 5 items (of
those included in the 17-item scale), corresponding to the 5 conceptual
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domains considered crucial for representation in the new measure, were
tested against the set criteria for this step, in order to construct the emotional
component of the final health state classification. Testing of various item
combinations resulted in a scale consisting of 5 items (1, 15, 16, 21 and 33),
each with 3 levels of response, common to all items (‘not at all’, ‘only
occasionally or sometimes’, and ‘often, most or all the time’). The 5 items
belonged to 5 major CORE-OM conceptual sub-domains, respectively, and
included one positively worded item. Moreover, the 5 items represented 4 out
of the 5 significant components that were identified in PCA, with component 2
being represented by 2 items, one of which was positively worded.
Model and individual item fit – reliability of the emotional component
The overall model statistics of the 5-item emotional component of the new
measure are shown in Table 22. The scale demonstrated good model fit (chi-
square probability 0.69). The measure appeared to be somehow ‘difficult’ for
the study population, given the lower mean location of persons compared with
the mean location of the items. However, this was attributed to the inclusion of
one risk item (16), which was deemed necessary in order to capture more
severe cases. The PSI index reached 0.66, which is somewhat lower than the
0.70 value that is generally considered acceptable for group comparison
(Fisher, 1992). Nevertheless, the figure of 0.66 was deemed adequate for the
purpose of the development of a new PBM by the advisory group, considering
that the ability of the scale to discriminate amongst different respondent groups
needed to be traded off with its conciseness and convenience in a valuation
survey, where respondents need to process a combination of individual
statements rather than a summated scale score. All items fit in the model, as
indicated by the statistics shown in Table 23; no DIF was observed in any of
the items. The class interval structure, demonstrated in Table 24, showed a
homogeneous allocation of respondents across class intervals.
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Table 22. Rasch analysis of the final 5-item emotional component of the
new measure: item-person and item-trait interaction statistics – [N400a]
Items Persons
Location Fit residual Location Fit residual
Mean 0.000 0.072 -0.818 -0.254
Standard deviation 1.293 0.404 1.425 0.791
Item-trait interaction Reliability indices
Total Item chi-square 20.970 PSI 0.65929
Total degrees of freedom 25 Cronbach Alpha N/A (missing data)
Total chi-square probability 0.6943 Power of test-of-fit Good
Table 23. Results of Rasch analysis of the 5-item emotional component
of the new measure: individual item statistics – [N400a]
Item CD Location Residual Chi-square
P-
value
1. [terribly alone and isolated] FC -1.468 -0.099 2.044 0.843
15. [felt panic or terror] SA -0.881 -0.058 3.403 0.638
16. [made plans to end my life] RS 1.801 -0.358 5.812 0.325
21. [able to do most things I needed to] FG 0.702 0.717 6.520 0.259
33. [felt humiliated or shamed by other people] FS -0.154 0.156 3.191 0.671
Residuals ≥ │2.5│are considered high; chi-square probabilities have been assessed using 
Bonferroni adjustment. CD = conceptual domain; FC = functioning-close relationships; FG =
functioning-general; FS = functioning-social relationships; RS = risk/harm-to-self; SA =
symptoms-anxiety
Table 24. Class interval distribution of the emotional component of the
new measure – [N400a]
ITEM CI1 CI2 CI3 CI4 CI5 CI6 CI7
1 42 46 56 63 46 37 35
15 41 46 56 64 46 37 35
16 42 46 56 63 47 37 35
21 41 46 54 63 46 37 35
33 42 46 56 62 46 37 35
CI: Class interval
Coverage of the full range of emotional symptom severity
The item map depicted in Figure 14 demonstrates that the instrument is well
targeted to the study population as it is able to practically capture the full range
of severity of emotional symptoms, with minimal floor or ceiling effects and
good spread of items across the full range of respondents’ scores.
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Figure 14. Item map of the emotional component of the new measure
Increase in item threshold locations with increasing difficulty of the item
in the emotional component
The Rasch item threshold map of the emotional component of the new
measure is shown in Figure 15. Items have been ordered from the easiest to
the most difficult one according to their location on the Rasch model logit
scale. Threshold locations between response levels 0-1 and 1-2 increase (that
is, they move from the left to the right) with increasing difficulty of the item, thus
ensuring a smooth transition of responses from milder to more severe
symptoms.
Figure 15. Rasch item threshold map of the emotional component of the
new health state classification system that was derived from the CORE-
OM
Rasch logit scale
Item 1
Item 15
Item 33
Item 21
Item 16
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Local item independence in the emotional component
PCA on the item fit residuals was undertaken to explore potential item
correlations and therefore to test the local independence of the items.
According to the Varimax Rotation loadings shown in Table 25, each item
loaded highly on each of the 5 residual components identified, indicating that
none is highly correlated with the others. This indication was confirmed in the
residual correlation matrix, in Table 26, which showed low correlations in pair-
wise comparisons between the 5 items.
Table 25. Principal Component Analysis on the item fit residuals:
loadings of the 5 items of the emotional component of the new measure -
[N400a]
Item Component
1
Component
2
Component
3
Component
4
Component
5
1 0.20 0.93 -0.18 -0.13 -0.22
15 0.26 -0.23 -0.21 -0.11 0.91
16 0.13 -0.11 -0.14 0.97 -0.08
21 0.15 -0.17 0.95 -0.15 -0.18
33 -0.91 -0.22 -0.17 -0.16 -0.26
Varimax rotation; loadings ≥ │0.40│are shown in bold 
Table 26. Residual correlation matrix of the 5 items of the emotional
component of the new measure – [N400a]
Item 1 15 16 21 33
1 1.00
15 -0.31 1.00
16 -0.16 -0.09 1.00
21 -0.24 -0.26 -0.22 1.00
33 -0.28 -0.37 -0.20 -0.19 1.00
None of the correlation coefficients between different items is ≥ │0.40│ 
Unidimensionality of the emotional component
The post-hoc test of unidimensionality (Smith, 2002) established the
unidimensionality of the scale: items were divided between those positively
and those negatively correlated with the first residual component, and
subsequently, for each subset, two scores were estimated for each
respondent. Independent t-tests between the two scores were undertaken for
each respondent; the proportion of independent t-tests that were significant at
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the 0.05 level was 1.34% (well below 5%), thus confirming the
unidimensionality of the emotional component of the new measure.
5.6 Results of Step 4: validation of the emotional
component of the new health state classification
The emotional component of CORE-6D was validated by undertaking Rasch
analysis on the random sample [N400b]. Validation was also achieved in an
analysis adjusted for sample size (so as to avoid Type I error) on the whole
initial sample [N1500]. Finally, the emotional component of CORE-6D was
validated on the ‘mixed’ random sample [N1500v] that consisted of people with
mental disorders presenting to either primary or secondary care, adjusted for
sample size as well. In all 3 analyses the 5-item scale had satisfactory overall
and item fit statistics and showed no DIF. Moreover, no DIF was observed for
access site (primary or secondary care setting) in the analysis of [N1500v].
The post-hoc unidimensionality test verified the scale’s unidimensionality in all
3 validation datasets; the item threshold map produced in the 3 validation
analyses confirmed a smooth transition of responses from milder to more
severe symptoms, the same with that demonstrated by the analysis on sample
[N400a]. Results of the validation of the emotional component of CORE-6D are
provided in Appendix 8.
5.7 Constructing a 2-dimensional health state
classification: the development of CORE-6D
The 5-item emotional component derived from Rasch analysis was combined
with the physical item 8, thus producing a new health classification tapping 5
emotional domains and one physical domain, named CORE-6D (Clinical
Outcomes in Routine Evaluation – 6-dimensional health state classification).
The response statements were slightly reworded in present tense, since
statements referring to the present were deemed to be more appropriate for
the respondents in a valuation survey to comprehend and value. Moreover, the
response level ‘not at all’ of CORE-OM was replaced by ‘never’ in CORE-6D,
as the latter was deemed to be more suitable for inclusion in a full statement
expressing a HRQoL state.
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The CORE-6D is a 6-item health descriptive system consisting of a 5-item
unidimensional emotional component and a physical item. Each item has 3
response levels: ‘never’, ‘only occasionally or sometimes’ and ‘often, most or
all the time’. Each response level gets an individual score (0-1-2). One item is
positively worded and therefore its response levels are reversed. The total
score of the emotional component is the sum of individual scores (ranging from
0 to 10), with higher scores indicating higher levels of emotional distress. This
ordinal score can be converted into an interval score on the Rasch model logit
scale, which is important for the modelling approach that was used to predict
utility values for all states of the CORE-6D following the valuation survey, as it
will be discussed in Chapter 6. The unidimensional emotional component
combined with the physical item creates a 2-dimensional scale, tapping
emotional and physical symptoms in people with common mental health
problems. The system describes 36 = 729 unique health states. The 6 CORE-
OM items that formed the CORE-6D were slightly altered (mainly changed
from past perfect to present tense) so as to construct response statements that
are meaningful to respondents in a valuation survey. Other than that, it was
intended that the response statements were kept as similar as possible (in
terms of structure and phrasing) to the items of the original instrument, so that
the new utility index can be unambiguously applied/ mapped on datasets
containing the CORE-OM.
The CORE-6D health state descriptive system is shown in Table 27.
5.8 Discussion and conclusion
This chapter describes the development of CORE-6D, a 2-dimensional health
state classification for common mental health problems that consists of an
emotional component and a physical item. CORE-6D was derived from the
CORE-OM using predominantly Rasch analysis. Due to the large dependence
across the domains of CORE-OM, the methodology employed was different
from that described in section 3.3.1 of Chapter 3, where Rasch analysis was
used to derive health state classifications from CSMs with clear
multidimensional structure. In the studies reviewed in that section, Rasch
analysis was performed separately on each dimension of a multidimensional
CSM, to identify the best performing item within each dimension; subsequently,
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these items were combined in a multidimensional health state classification. In
contrast, in the study carried out for this thesis, Rasch analysis was
undertaken on the full measure (CORE-OM), aiming to identify, and eventually
discard, items that differentiated from the largely unidimensional behaviour of
the measure. Use of Rasch analysis in this case led to the development of the
emotional component of CORE-6D and confirmed its unidimensional
character.
Table 27. The CORE-6D health state classification
Emotional component
1 I never feel terribly alone and isolated
I feel terribly alone and isolated only occasionally or sometimes
I feel terribly alone and isolated often, most or all the time
0
1
2
2 I never feel panic or terror
I feel panic or terror only occasionally or sometimes
I feel panic or terror often, most or all the time
0
1
2
3 I never feel humiliated or shamed by other people
I feel humiliated or shamed by other people only occasionally or sometimes
I feel humiliated or shamed by other people often, most or all the time
0
1
2
4 I am able to do most things I need to often, most or all the time
I am able to do most things I need to only occasionally or sometimes
I am not able to do the things I need to
0
1
2
5 I never make plans to end my life
I make plans to end my life only occasionally or sometimes
I make plans to end my life often, most or all the time
0
1
2
Physical health item
6 I am never troubled by aches, pains or other physical problems
I am troubled by aches, pains or other physical problems only occasionally or sometimes
I am troubled by aches, pains or other physical problems often, most or all the time
0
1
2
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CORE-6D was derived from the CORE-OM by applying Rasch analysis on
data from a sample of people with common mental health problems presenting
to NHS primary care counselling services in the UK. The new measure was
validated on a large mixed sample of people with common mental health
problems presenting to either primary or secondary care. Rasch analysis on
this mixed sample illustrated that there was no DIF regarding the access site,
thus confirming that the measure is applicable to (and does not differentiate
between) people with common mental health problems treated in primary and
secondary care settings. It should be noted, though, that primary care is
currently the dominant service provider for people with common mental health
problems in the UK, and the choice between primary and secondary care is
more related to access issues determining the pathway into the service rather
than to the patients’ level of symptom severity. In any case, the 5-item
unidimensional emotional component of CORE-6D is able to capture a broad
range of severity of emotional symptoms in people with common mental health
problems.
Further to the elimination of items and the development of a health state
classification, the great advantage of the use of Rasch analysis in the case of
the CORE-OM (and other measures with no clear multidimensional structure)
is that it enables the identification of plausible health states amenable to
valuation, thus preventing the generation of implausible health states that
might occur following use of standard techniques (e.g. orthogonal block
designs) usually employed for the generation of health states from
multidimensional health state classifications. This issue is illustrated and
further discussed in Chapter 6.
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Chapter 6. Development of a preference-
based index: valuation of CORE-6D
6.1 Introduction
This chapter reports on the methods and the results of the valuation survey
that was undertaken in order to attach utility values to selected health states of
the CORE-6D and describes the modelling techniques that were subsequently
employed in order to develop an algorithm that links all the health states
described by the new measure with appropriate utility values. This process led
to the construction of a preference-based index that can be used for the
estimation of QALYs in economic evaluation of interventions for common
mental health problems. The analyses and findings presented in this chapter
have also been reported in a publication by Mavranezouli and colleagues
(2012).
6.2 Methods
The methods adopted for the valuation of CORE-6D, including the generation
and selection of health states for use in the valuation survey and the modelling
methods employed for the valuation of all health states described by the new
measure, were dictated by the unidimensionality of the emotional component
of CORE-6D, which did not allow use of conventional statistical techniques that
have been previously undertaken for the development of other PBMs.
6.2.1 Generating plausible health states for the valuation
survey using Rasch analysis
As already described in Chapter 1 (section 1.3.1), the method for the selection
of health states for consideration in the valuation survey depends on the
modelling approach that is used to predict utility values for all states of the
health state classification following the valuation survey. In the composite
modelling approach, which uses statistical modelling, the selection of health
states for valuation can be made using a statistical design such as an
orthogonal array or a balanced methodology. In the decomposed modelling
approach, which is based on MAUT, every dimension of a measure is valued
separately, followed by valuation of ‘corner’ multidimensional (‘full’) states,
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which consist of one dimension at one extreme (usually the worst response
level) and the rest dimensions at the other extreme (usually the best response
level). As argued in Chapter 3 (section 3.3.1), both approaches require that
dimensions be structurally independent from each other in order to create
meaningful health states. Use of these conventional approaches for generating
health states from a measure with high correlation between its items (such as
a unidimensional measure or a measure with large unidimensional
components) is not appropriate because it is likely to generate implausible
health states that cannot be processed and valued by participants in a
valuation survey.
CORE-6D consists of a 5-item emotional component and a physical item. The
emotional component of CORE-6D is, by construction, unidimensional,
meaning that its items are not independent from each other, resulting in some
item response combinations being implausible; e.g. “I make plans to end my
life often, most or all the time” and “I never feel terribly alone and isolated”.
Therefore, conventional methods for generating health states were not
appropriate in the case of CORE-6D. Instead, identification of plausible health
states described by the emotional component of CORE-6D was based on the
results of Rasch analysis and was achieved by a novel method developed for
this thesis, named the ‘Rasch vignette approach’.
The Rasch vignette approach relies on the inspection of the Rasch item
threshold map, an output of Rasch analysis that depicts the most likely item
response combinations expected for each location across the Rasch model
logit scale; this means that the map can help identify the most likely response
combination at each level of emotional distress captured by the emotional
component of CORE-6D, from the mildest to the most severe. These unique
response combinations represent ‘emotional’ health states that have been
observed in people with common mental health problems across the
continuum of severity of emotional distress, and therefore they describe actual
and, very importantly, plausible health states that are amenable to valuation. It
should be clarified that the Rasch item threshold map allows identification of
the one most likely (and thus plausible) health state at each location across the
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continuous Rasch model scale; it does not depict every plausible health state
described by a unidimensional scale. For each level of symptom severity there
may be several other plausible health states (which have the same total
ordinal scale score and Rasch model logit value) that are not depicted on the
map, as they are less likely to be observed in the study population in
comparison with the depicted state of that particular severity level.
Following identification of plausible health states in the Rasch item threshold
map produced by Rasch analysis on the dataset [N400a], the ‘emotional’
health states of CORE-6D were combined with different response levels of the
physical item, so as to produce ‘full’ CORE-6D health states, as described in
section 6.3.1 later in this chapter. Given the way these states were generated,
there were important implications for the design of the valuation survey, which
are described below.
6.2.2 Valuation survey
A valuation survey using face-to-face interviews was carried out in South
Yorkshire, aiming at determining public preferences for a number of health
states derived from CORE-6D. Selected health states were valued using the
TTO technique, which has been described in Chapter 1 (section 1.3.1). More
specifically, the version of TTO developed by the MVH group was used,
including the visual props designed by this group, i.e. a set of health state
cards (including a ‘full health’ card and a ‘death’ card) and a double-sided time
board, with one side used for states considered better than death and the
other one for states rated as worse than death, that contains a sliding scale
that can move across the board (in a range between 0 and 10 years) to show
the number of years to be spent in each alternative option assessed (Dolan et
al., 1996; Gudex, 1994).
According to the MVH protocol, respondents were first asked whether they
preferred to live in a specified health state hi for t = 10 years after which they
died, or to die immediately. This question determined whether respondents
valued the health state as better, worse, or equal to being dead. For health
states considered better than death, respondents were asked to choose either
life in the health state hi for 10 years followed by death or life in full health for x
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years where x < 10. The number of x years in full health was varied by units of
one year, starting from x = 5, until the point where the respondent was
indifferent or switched preferences between the two alternatives. The utility
value given to the state hi was x/10. For health states considered worse than
being dead, respondents were asked to choose either life in the health state hi
for y years followed by full health for x years after which they would die (with y
+ x = 10), or immediate death. Years in full health (x) were varied by one year,
starting from x = 5, by concurrently varying years in the health state (y) so that
y + x always equalled 10, until the point where respondents were indifferent or
switched preferences between the two options. Valuations in the case of states
considered worse than death were estimated using the formula -x/10, following
the same process with that reported at the TTO valuation of UK EQ-5D (Dolan
et al., 1996), so that TTO values for states worse than dead were bounded by -
1. The interviewer booklet, which shows the details of the protocol used in the
valuation survey of CORE-6D health states, is provided in Appendix 9.
Use of the TTO method and the MVH protocol in particular was dictated by
NICE guidance on the methodology that should be adopted for the evaluation
of technologies in its appraisal programme. According to this guidance, “when
EQ-5D data are not available or are inappropriate for the condition or effects of
treatment, the valuation methods should be fully described and comparable to
those used for the EQ-5D”. More specifically, “the valuation of descriptions
should use the time trade-off method in a representative sample of the UK
population, with ‘full health’ as the upper anchor, to retain methodological
consistency with the methods used to value the EQ-5D” (National Institute for
Health and Clinical Excellence, 2008). The rationale behind this guidance was
to ensure comparability across the Institute’s Appraisal programme. Additional
guidance from the NICE Decision Support Unit specified that “comparability
with EQ-5D is enhanced by using the same valuation technique [i.e. TTO], the
same variant of the technique [i.e. use of visual props] and by the same mode
[i.e. interviewer-administered] (Brazier & Rowen, 2011). Therefore, the protocol
used for the valuation of CORE-6D was fully consistent with NICE guidance.
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Interviews were conducted by trained and experienced interviewers from the
Centre for Health and Social Care Research at Sheffield Hallam University.
Valuations were elicited from members of the UK general public, as
recommended by NICE (National Institute for Health and Clinical Excellence,
2008). Respondents were selected using sampling from streets in both urban
and rural areas with a mix of socio-demographic characteristics in the North of
England using a comprehensive contact management system for names and
addresses in the UK (AFD Names and Numbers version 3.1.25 database, AFD
Software Limited, Ramsey, UK). Households in these areas received letters
informing them that interviewers would be in their area and interviewers then
visited houses. Subsequently, all eligible and willing participants were
interviewed in the respondent’s own home. Eligible population consisted of
adults aged over 18 years, who were considered by the interviewers to be
cognitively able to participate in an interview. Addresses were visited up to four
times on different days and times of the day before an address was considered
a non-responder. No financial reward was offered for participation in the
survey.
Ethical approval for the survey was received by the School of Health and
Related Research (ScHARR) Research Ethics Committee at the University of
Sheffield, as part of a wider MRC-NIHR funded methodology project
(Condition-Specific Methodology for estimating QALYs: Developing and testing
methods for deriving preference-based measures of health from condition
specific measures - CoSMeQ) (Brazier et al., 2012). The letter from the
ScHARR Research Ethics Committee confirming ethical approval for this
project is provided in Appendix 10.
Funding for the valuation survey was provided by the MRC-NIHR Methodology
Research Programme (project number 06/97/04). The funding received for the
valuation survey was sufficient for 225 interviews. Previous valuation exercises
have shown that respondents cannot value more than 13 health states during
an interview (Dolan et al., 1996), and typically they are asked to value between
6 and 8 health states (Brazier et al., 2002, 2005b & 2008; Dolan et al., 1996;
Yang et al., 2011). In order to increase the number of health states valued in a
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survey, respondents can be divided into smaller sub-groups, each valuing
different health states. One health state needs to be valued by all respondents,
to allow comparison of mean values elicited from different sub-groups. For the
valuation of CORE-6D, the 225 respondents were divided into 3 sub-groups,
each provided with a card block of 8 health state cards; every card described a
different health state, with the exception of the state that was valued by all
respondents, which was shown on 3 cards distributed across the 3 card
blocks, respectively. This arrangement allowed valuation of 22 health states,
including the health state valued by all sub-groups.
Respondents were first asked to self-complete EQ-5D and CORE-6D for their
own health, so as to become familiarised with the idea of describing health
states, as well as with the items and response levels of CORE-6D.
Subsequently, each respondent was given one of the three card blocks and
undertook warm-up ranking and TTO tasks. This task, which allowed
respondents to become familiarised with the cards and with the notion of
having preferences for one health state over another, was followed by TTO
valuations of 8 CORE-6D health states. If, during the TTO valuations, it was
made clear that a respondent did not understand the TTO task, the interview
was terminated by the interviewer and these partially completed interviews
were not included in the dataset for analysis. The following exclusion criteria
were applied: respondents with two or fewer responses; respondents who
valued the worst state higher than all other states; respondents who valued all
states worse than being dead; and respondents who valued all states
identically but lower than 1.
Each interviewer started with a different card block with their first respondent,
and moved on systematically alternating card blocks in the same order in
successive interviews, e.g. the interviewer starting with card block 1 for the first
respondent moved to card block 2 with the second respondent, then used card
block 3 for the third respondent, then back to 1 with the fourth respondent, and
so on. Because of the nature of some item responses (e.g. I make plans to
end my life), respondents were informed in the cover letter and information
sheet that the interview was about common mental and physical health
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problems. In the information sheet and in a ‘thank you note’ left at the end of
the interview all respondents were strongly recommended that they seek
appropriate professional support either from their general practitioner (GP) or
from a professional agency such as the Samaritans (their contact details being
provided) if the interview raised personal issues for them. Finally, respondents
were asked a number of background questions covering health, demographic
and socio-demographic characteristics and how difficult they found the
valuation tasks. The self-completion booklet provided to participants in the
survey is presented in Appendix 11.
6.2.3 Modelling health state values using Rasch analysis
The standard approach for modelling utility values for health states described
by a health state classification has been by creating dummy variables for each
level of every dimension of an instrument (Brazier et al., 2002; Dolan, 1997)
and regressing these onto the health state values (obtained using TTO or SG).
However, this approach was not appropriate in the case of CORE-6D, since
the highly correlated items of its emotional component were expected to
produce significant, multiple interaction effects, and consideration of all
possible interactions across different response levels of different items would
require complex regression models as well as valuation of a large number of
health states in order to predict utility values for all health states of the
instrument (Brazier et al., 2007). An alternative method for modelling utility
values derived from unidimensional PBMs has been described by Young and
colleagues (2010): this method, which is based on Rasch analysis, employs a
series of regression analyses in order to explore the relationship between the
utility values derived from a valuation survey and the respective Rasch model
logit values of the health states included in the survey. The selected regression
model that best defines this relationship is then used to predict utility values for
all potential states of the unidimensional PBM.
Nevertheless, this new method alone was not adequate for the estimation of
utility values for CORE-6D; this is because CORE-6D is a 2-dimensional scale,
consisting of a unidimensional emotional component and a physical item.
Thus, in order to predict utility values for all health states described by CORE-
6D taking into account the effect of the physical item, a hybrid approach was
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adopted: the methodology described by Young and colleagues (2010), which
can be used for the prediction of utility values in the case of unidimensional
measures such as the emotional component of CORE-6D, was combined with
the standard approach used for the prediction of utility values that relies on the
use of dummy variables to reflect all the different levels of each dimension; in
the case of CORE-6D, the dummy variables represented the different severity
levels of the physical item.
More specifically, a series of regression analyses were undertaken to explore
the relationship between the utility value of each health state of CORE-6D that
was considered in the valuation survey and
a. the respective Rasch model logit value corresponding to the emotional
component of the health state, as calculated by previously undertaken
Rasch analysis of CORE-6D data on [N400a]
b. the response level (0, 1 or 2) of the physical item of the health state,
modelled in the form of 2 dummy dichotomous variables, one for response
level 1 and one for response level 2.
OLS models were used to analyse the valuation data at an aggregate (mean)
level first, i.e. regression analyses were carried out on the mean utility values
obtained for each of the 18 health states included in the valuation survey,
without taking into account individual respondent characteristics (such as age,
gender, ethnicity, etc.), since aggregate utility data (i.e. data at the population
level) are typically those that are used in cost-utility analyses of healthcare
technologies. Previous research has shown that, despite having fewer degrees
of freedom available for analysis, aggregate models may perform equally or
even better than individual-level ones in predicting mean health state utility
values (Brazier et al., 2002 & 2008; McKenna et al., 2008; Yang et al., 2009 &
2011).
Various regression models were fitted on the data, including simple linear,
quadratic and cubic forms, to reflect potential non-linearities in the relationship
between the utility values (dependent variable) and the Rasch model logit
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scale. These ‘base-case’ models assumed an additive relationship between
the emotional component of CORE-6D and the physical item of the measure.
Moreover, models that took into account the potential (multiplicative)
interaction between the emotional component of CORE-6D and the physical
item (also considering linear, quadratic and cubic relationship) were tested to
explore whether considering multiplicative interactions between the two
dimensions of CORE-6D improved the overall model fit; for this purpose,
interaction variables were added to the best solution identified among the
base-case models. The model fit and predictive ability was assessed using the
coefficient of determination (adjusted R-Squared), the root mean squared error
(RMSE), the mean absolute error (MAE) [i.e. the mean absolute difference
between the predicted and the observed utility value across all health states],
and the number of health states with absolute error above 0.01, 0.05 and 0.10
(Brazier et al., 2007). The model with the best fit at the mean level was
selected in order to predict mean TTO values for all health states described by
CORE-6D based on their respective Rasch model logit value and the response
level of the physical item. In order to test the fit of the selected model, residuals
of all health states (i.e. differences between predicted and observed utility
values) were plotted against each of the independent variables of the model,
as well as against the predicted utility values, to confirm lack of any systematic
relationship (Altman, 1991). The predictive ability of the selected model was
also assessed by visually inspecting the plot of the predicted utility values
against the observed utility values that were obtained in the valuation survey.
In addition, OLS regression analyses at the individual level were carried out, to
explore the impact of respondents’ personal characteristics including age,
gender, ethnicity, marital status, home ownership, level of education and
employment status, on the elicited utility values. An important limitation of the
OLS model is that it assumes a continuous variable without censoring; in this
case, it does not allow for the dependent variable (utility value) to be bounded
by a maximum value of +1 and a minimum value of -1. Therefore, Tobit models
were estimated, which allowed censoring at both the top and bottom ends of
the relationship (Tobin, 1958). The general Tobit model with upper and lower
censoring limit of +1 and -1, respectively, is defined as:
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y*ij = βxi + θri + δzij + εij
where y*i the unobservable latent variable. The censored observed outcome yi
is:
-1 if y*i ≤ -1 
yi = y*i if -1 < y*i < 1
1 if y*i  ≥ 1     (Long, 1997) 
The fit of individual OLS models was assessed using the adjusted R-Squared
and the RMSE. Tobit models were assessed using the estimated standard
error of the regression, which is analogous to the RMSE in OLS regression.
OLS mean-level analyses were performed on SPSS version 19 (IBM Corp.,
2010); all individual-level analyses (OLS and Tobit models) were run on
STATA version 10 (Stata Corp., 2007).
6.3 Results
6.3.1 Generation of plausible health states using Rasch
analysis
Identification of plausible health states from the emotional component of
CORE-6D
Identification of plausible health states from the emotional component of
CORE-6D was achieved by inspection of the Rasch item threshold map that
was produced at the development of the emotional component of CORE-6D,
as reported in Chapter 5 (section 5.5). The item threshold map of the
emotional component of CORE-6D is illustrated in Figure 16.
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Figure 16. Rasch item threshold map of the emotional component
of CORE-6D
0 = never; 1 = only occasionally or sometimes; 2 = often, most or all the time; note that the fourth item is
positively worded and therefore response levels are reversed
The map depicts the most likely combinations of responses to the 5 items of
the emotional component of CORE-6D across the continuum of the emotional
symptom severity. Items of the emotional component have been ordered from
the easiest to the most difficult one as indicated by their mean location on the
Rasch logit scale. Coloured areas 0 (light blue), 1 (yellow) and 2 (purple)
correspond to the 3 response levels of the measure, that is, ‘never’, ‘only
occasionally or sometimes’, and ‘often, most or all the time’, respectively, with
the exception of the positively worded item (I am able to do most things I need
to), the response levels of which are reversed. The map allows prediction of
the most likely responses at each level of emotional symptom severity
captured by the interval Rasch scale. For example, a person whose level of
emotional distress corresponds to a Rasch logit value of +1 is expected to
most likely respond 22210 to the 5 items of the emotional component of
CORE-6D, ordered from the easiest to the most difficult one, respectively.
Each combination of item responses represents a plausible health state, likely
to be observed in people with common mental health problems. As illustrated
in Table 28, 11 distinct emotional health states were identified along the Rasch
model logit scale, each reflecting the most likely emotional state to be
observed in a person with common mental health problems at a specific level
of emotional symptom severity. Detailed descriptions of these 11 health states
depicted in the Rasch item threshold map are provided in Appendix 12.
Rasch model logit scale
[terribly alone and isolated]
[panic or terror]
[humiliated or shamed by people]
[able to do most things I need to]
[make plans to end my life]
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Table 28. Plausible health states of the emotional component of CORE-
6D as identified by the Rasch item threshold map and frequency of each
health state in the study sample [N400a]
N = never; S = only occasionally or sometimes; O = often, most or all the time; note that the 4th item
is positively worded and therefore response levels are reversed
The emotional component of CORE-6D can describe 35 = 243 emotional
health states. The 11 emotional states identified by inspection of the Rasch
item threshold map represent only 4.5% of the health states that can be
described by the emotional component. However, these 11 states covered
37.1% of the response combinations obtained from the study sample [N400a],
that is, from the random study sample used in Rasch analysis of CORE-OM
data, and 33.7% of the response combinations observed in [N1500], which is
the original dataset the [N400a] was derived from, after excluding cases with
one or more responses missing. The frequency and percentage of individuals
in [N400a] and [N1500] that experienced each of the 11 emotional health
states among those that provided complete responses to the emotional
component of CORE-6D are shown in Table 29.
In contrast, as it can be seen in Table 30, the coverage of the 15 health states
derived using an orthogonal block design (generated on IBM SPSS Statistics
19) on the full range of emotional health states described by CORE-6D was
only 14.5% in [N400a] and 14.1% in [N1500]. Moreover, some of the states
generated using the latter approach were not plausible, as, for example, they
described a situation where a person ‘never felt alone and isolated’ and at the
same time ‘made plans to end their life often, most or all the time’.
Item
Health states
1 2 3 4 5 6 7 8 9 10 11
[terribly alone and isolated] N S S S S O O O O O O
[panic or terror] N N S S S S O O O O O
[humiliated or shamed by people] N N N S S S S O O O O
[able to do most things I need to] O O O O S S S S S N N
[make plans to end my life] N N N N N N N N S S O
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Table 29. Frequency and percentage of observations of the 11 emotional
health states of CORE-6D that were identified by inspection of the Rasch
item threshold map in datasets [N400a] and [N1500]
Emotional
state Classification
[N400a] [N1500]
Frequency % Frequency %
State 1 00000 18 5.3 73 5.6
State 2 10000 20 5.9 82 6.3
State 3 11000 21 6.2 60 4.6
State 4 11100 17 5.0 54 4.1
State 5 11110 19 5.6 69 5.3
State 6 21110 9 2.7 29 2.2
State 7 22110 9 2.7 29 2.2
State 8 22210 5 1.5 24 1.8
State 9 22211 5 1.5 14 1.1
State 10 22221 0 0.0 3 0.2
State 11 22222 2 0.6 5 0.4
Total in the 11 health states 125 37.1 442 33.7
Total number of complete
observations 337 1310
Each emotional state is represented by a five digit code (‘classification’) that indicates the response
level of each of the 5 emotional items, from left to right: I feel terribly alone and isolated; I feel panic
or terror; I feel humiliated or shamed by other people; I am able to do most things I need to; I make
plans to end my life.
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Table 30. Frequency and percentage of observations of the 15 emotional
health states of CORE-6D that were identified using an orthogonal
design, in datasets [N400a] and [N1500]
Emotional
state Classification
[N400a] [N1500]
Frequency % Frequency %
State 1 00000 18 5.3 73 5.6
State 2 00120 0 0.0 0 0.0
State 3 00210 0 0.0 0 0.0
State 4 01022 0 0.0 0 0.0
State 5 01201 0 0.0 0 0.0
State 6 02012 0 0.0 0 0.0
State 7 02101 0 0.0 0 0.0
State 8 10021 0 0.0 0 0.0
State 9 10202 0 0.0 0 0.0
State 10 11110 19 5.6 69 5.3
State 11 12000 2 0.6 12 0.9
State 12 20011 0 0.0 0 0.0
State 13 20102 0 0.0 0 0.0
State 14 21000 5 1.5 19 1.5
State 15 22220 5 1.5 12 0.9
Total in the 15 health states 49 14.5 185 14.1
Total number of complete
observations 337 1310
Each emotional state is represented by a five digit code (‘classification’) that indicates the
response level of each of the 5 emotional items, from left to right: I feel terribly alone and
isolated; I feel panic or terror; I feel humiliated or shamed by other people; I am able to do
most things I need to; I make plans to end my life.
In order to obtain full CORE-6D health states, each emotional health state
needs to be combined with different response levels of the physical item. The
11 emotional health states selected by inspection of the Rasch item threshold
map combined with the 3 response levels of the physical item of CORE-6D
produce a 2-dimensional set of 11 x 3 = 33 health states that are overall
frequently observed in the study population and, as such, are plausible.
Selection of plausible health states for the valuation survey
As reported in section 6.2.2, the number of respondents and their arrangement
in 3 sub-groups allowed the valuation of 22 health states (with 1 health state
being valued by all 3 sub-groups). Selection of the 22 health states of CORE-
6D for consideration in the valuation survey was made in collaboration with Dr
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Donna Rowen, research fellow at ScHARR, University of Sheffield, who has
expertise in this field. As described earlier, 33 full CORE-6D health states were
constructed by combining the 11 emotional health states identified by
inspection of the Rasch item threshold map with the 3 response levels of the
physical item. However, the emotional health state 10 (22221) was not
represented in the study sample [N400a] (as shown in Table 29), had a very
narrow logit range (as shown on the item threshold map in Figure 16) and was
therefore excluded from further consideration, leaving 30 full CORE-6D health
states as candidates for inclusion in the valuation survey. In addition, as part of
the CoSMeQ study (Brazier et al., 2012) a number of emotional health states
without any reference to the physical component were also selected for
valuation, so as to assess the impact of the addition of the physical component
on valuations of the emotional states of CORE-6D, and this allowed fewer full
health states to be valued (since the limit was the valuation of 22 health states
in total).
Selection of the 22 health states for the valuation survey was made as follows:
First, the 10 emotional health states chosen using the Rasch vignette
approach were combined with the physical item at response level zero (never
troubled by aches, pains, or other physical problems) and were included in the
valuation survey. In addition, and in order to assess the impact of physical
functioning on utility values, 4 of these emotional states (including best state
00000, worst state 22222 and two intermediate states) were combined with
levels 1 and 2 of the physical item, so as to cover the full severity range
captured by CORE-6D, thus producing another 8 CORE-6D health states. The
criteria for selecting the two intermediate emotional states for valuation were
as follows:
 relative frequency of the state in the study samples [N400a] and
[N1500] (as shown in Table 29) – states with high frequency were
preferred
 location coverage (range) of the state on the item threshold map (shown
in Figure 16) – states with wider location coverage were favoured
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 relative distance between the 4 states (best, worse and the 2
intermediate) – ideally the selected states should be of variant symptom
severity
Based on the above criteria, intermediate emotional states 3 (11000) and 7
(22110) were selected for combination with response levels 1 and 2 of the
physical item and inclusion in the valuation survey. In addition to the 18 full
health states, 4 emotional health states (best 00000, worst 22222 and
intermediate states 11000 and 22110 as chosen already) with no reference to
the physical item were also selected for use in the related CoSMeQ study
(Brazier et al., 2012). Responses to the states describing only the emotional
component of CORE-6D were analysed separately and are available in the
study by Brazier and colleagues (2012). A sample of a health state card used
in the valuation survey is presented in Table 31.
Table 31. Sample of a health state card used in the valuation survey –
card describing CORE-6D state 221101
The 22 health states were distributed across the 3 card blocks used in the
valuation survey so that each person was asked to value a variety of health
states across the range of symptom severity captured by CORE-6D. The
health states contained in each of the card blocks are presented in Table 32.
Two of the card blocks contained 8 full CORE-6D health states each. The
 You feel terribly alone and isolated often, most or all the time
 You feel panic or terror often, most or all the time
 You feel humiliated or shamed by other people only occasionally or
sometimes
 You are able to do most things you need to only occasionally or
sometimes
 You never make plans to end your life
 You are troubled by aches, pains or other physical problems only
occasionally or sometimes
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other card block contained 4 full CORE-6D health states, and 4 emotional
health states (identical with the emotional components of the 4 full CORE-6D
states already included in this card block, but without any reference to the
physical item). CORE-6D state 222220 was included in all 3 card blocks. All
respondents first ranked and valued 4 states and subsequently ranked and
valued the remaining 4 states in the card block. In the card block that
contained 4 emotional health states without reference to the physical item and
4 full CORE-6D states, the emotional states were ranked and valued first,
followed by ranking and valuation of the full CORE-6D states, so that
responders were not aware of the presence of the physical item when valuing
the 4 emotional states; in the other two card blocks, the 4 full CORE-6D states
that were ranked and valued first were chosen at random.
Table 32. Health states included in each of the 3 cardblocks used in the
valuation survey of CORE-6D
Card block 1 Card block 2 Card block 3
00000N 000000 100000
11000N 000001 111000
22110N 110000 111100
22222N 110002 221101
000002 211100 221102
110001 222110 222100
221100 222222 222221
222220 222220 222220
Each health state is represented by a six digit code that indicates the response level of
each of the 5 emotional items plus the physical item, from left to right: I feel terribly alone
and isolated; I feel panic or terror; I feel humiliated or shamed by other people; I am able to
do most things I need to; I make plans to end my life; I feel aches, pains, or other physical
problems. Response levels for the positively worded item are reversed. ‘N’ signifies that the
physical item was not included in these states and therefore was not mentioned in the card.
Similarly, Figure 17 shows the allocation of states in each card bloc: states in
card block 1 [B1] are coloured yellow; states in card block 2 [B2] are coloured
blue; states in card block 3 [B3] are coloured red; the state coloured green was
included in all 3 card blocks. The figure helps identify states that share the
same level of emotional component but differ in the response level of the
physical item and vice versa, thus allowing exploration of the impact of the
level of physical functioning on the health state utility value.
Figure 17. Health states included in each of the three card blocks used in the valuation survey of CORE-6D
PF = physical functioning; card bloc 1 includes the states highlighted in yellow, card bloc 2 includes the states highlighted in blue and card bloc 3 includes the
states highlighted in red. State highlighted in green was valued by all respondents in the survey. Each health state box includes the bloc (B1, B2, B3 or ALL), the
mental health state number and the level of severity of the physical functioning dimension. For example, x1a indicates mental health state 1 and no mention of
physical functioning, x3b indicates mental health state 3 with physical functioning at level 0, x5c indicates mental health state 5 with physical functioning at level 1
and x7d indicates mental health state 7 with physical functioning at level 2. The arrows indicate how the states can be used to estimate the relationship between
utility and physical functioning severity.
Mental health only Mental health,
PF at level 1
Mental health,
PF at level 2
Mental health,
PF at level 3
Health state
State 1
State 2
State 3
State 4
State 5
State 6
State 7
State 8
State 9
State 10
State 11
B1 X1a
B1 X3a
B1 X7a
B1 X11a
B2 X1b
B3 X2b
B2 X3b
B3 X4b
B3 X5b
B2 X6b
B1 X7b
B3 X8b
B2 X9b
X10b
ALL X11b
B2 X1c
B1 X3c
B3 X7c
B3 X11c
B1 X1d
B2 X3d
B3 X7d
B2 X11d
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6.3.2 Valuation survey
Respondents’ characteristics
The valuation survey, which was conducted on 225 respondents, achieved a
response rate of 45.7% for respondents answering their door at the time of
interview. The study achieved a completion rate of 99.7% for all 18 health
states included in the valuations of full CORE-6D states that were considered
in this thesis (only 4 utility values were missing). Characteristics of all
respondents included in the analysis are presented in Table 33, which allows
comparison of the valuation study sample to the general population in South
Yorkshire and England (Kind et al., 1999). The study sample had a higher
mean age, a higher proportion of females, home owners and retired
individuals, and a lower proportion of employed/self-employed individuals.
A large proportion of respondents reported that they found the rank (35.1% of
respondents) and TTO (40.9% of respondents) tasks either ‘very difficult’ or
‘rather difficult’, and this likely includes both respondents who found
completion of the task complex and respondents who found the decisions
involved challenging. Finding a task difficult does not convey a lack of
understanding, as no respondents met the set exclusion criteria (i.e. providing
≤ 2 responses; valuing the worst state higher than all other states; valuing all 
states worse than being dead; or valuing all states identically but lower than 1)
that indicated no understanding of the TTO task. Moreover, interviewers
reported that it was doubtful (according to their expert judgment) whether the
respondent understood the rank and TTO tasks in just 5.8% and 4.9% of the
interviews, respectively.
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Table 33. Characteristics of respondents in the valuation survey and
comparison with population characteristics for South Yorkshire and
England
Variable Respondents(n=225)
South
Yorkshire1 England
1
Mean age (SD) 48.9 (17.2) - -
Age distribution
18-40 32.7% 41.2% 41.6%
41-65 48.0% 39.1% 39.1%
Over 65 19.3% 19.7% 19.3%
Female 58.7% 51.2% 51.3%
Married/Partner 69.8% - -
Employed or self-employed 51.3% 56.1% 60.9%
Unemployed 3.1% 4.1% 3.4%
Long-term sick 5.4% 7.7% 5.3%
Full-time student 5.4% 7.5% 7.3%
Retired 22.3% 14.4% 13.5%
Own home outright or with a mortgage 80.0% 64.0% 68.7%
Renting property 20.0% 36.0% 31.3%
Secondary school is highest level of
education
37.9% - -
Average EQ-5D score (SD) 0.83 (0.28) - 0.86 (0.23)2
TTO completion rate 99.7% - -
Respondent found 1st rank valuation
task very or rather difficult 35.1% - -
Respondent found 1st TTO valuation
task very or rather difficult 40.9% - -
Interviewer doubted whether respondent
understood 1st rank task 5.8% - -
Interviewer doubted whether respondent
understood 1st TTO task 4.9% - -
1. Statistics for South Yorkshire Health Authority and for England in the Census 2001.
Questions used in this study and the census are not identical. The census includes
persons aged 16 and above whereas this study surveyed persons aged 18 and above
only. Age distribution is here reported as the percentage of all adults aged 18 and over.
2. Interviews conducted in the Measurement and Valuation of Health (MVH) study (Kind
et al., 1999).
SD = standard deviation
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Health state utility values
The descriptive statistics for the utility values obtained for each health state
valued in the survey are reported in Table 34. The mean utility values range
from 0.96 (best state 000000) to 0.10 (worst state 222222) and have large
standard deviations. Median values are consistently higher than mean ones
(with the exception of worst state 222222 where the median and mean utility
value are equal), indicating a negative skewness of the data. This skewness is
most apparent in the histogram created from the utility values obtained in the
survey, which is illustrated in Figure 18. The histogram reveals that a
substantial proportion of responses (466/1492, i.e. 31.2%) corresponded to a
utility value of 1.0, illustrating that on many occasions respondents were not
prepared to sacrifice time for quality of life. Overall, the results of the survey
indicate 3 types of respondents: a. a small proportion of respondents (14/225,
i.e. 6.2%) who never trade time for quality (and thus attach a utility value of 1.0
to any state); b. a significant proportion of respondents (70/225, i.e. 31.1%)
who always trade time for quality (and thus never attach a utility value of 1.0 to
any state) and c. the largest proportion of respondents (141/225, i.e. 62.7%)
who do both, depending on the state valued (so that they attach a utility value
of 1.0 to some states and a utility value less than 1.0 to other states).
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Table 34. Utility values by CORE-6D health state obtained in the valuation
survey
CORE-
6D health
state
Utility value
N Mean SD Minimum 25
th
percentile
Median 75
th
percentile
Maximum Mode
000000 74 0.96 0.13 0.08 0.99 1.00 1.00 1.00 1.00
000001 75 0.93 0.14 0.33 0.93 1.00 1.00 1.00 1.00
000002 76 0.82 0.32 -0.93 0.78 0.93 1.00 1.00 1.00
100000 74 0.87 0.22 0.08 0.84 1.00 1.00 1.00 1.00
110000 75 0.88 0.25 -0.73 0.85 1.00 1.00 1.00 1.00
110001 76 0.86 0.27 -0.93 0.80 0.96 1.00 1.00 1.00
110002 75 0.74 0.31 -0.83 0.57 0.83 1.00 1.00 1.00
111000 74 0.79 0.29 -0.23 0.69 0.93 1.00 1.00 1.00
111100 74 0.76 0.33 -0.40 0.53 0.93 1.00 1.00 1.00
211100 75 0.66 0.35 -0.63 0.50 0.73 1.00 1.00 1.00
221100 75 0.57 0.44 -0.93 0.45 0.63 0.93 1.00 1.00
221101 73 0.49 0.47 -0.88 0.30 0.50 0.88 1.00 1.00
221102 74 0.40 0.49 -0.93 0.14 0.44 0.83 1.00 1.00
222100 74 0.47 0.43 -0.93 0.20 0.50 0.84 1.00 1.00
222110 74 0.38 0.45 -0.98 0.08 0.44 0.70 1.00 1.00
222220 225 0.23 0.52 -0.98 0.00 0.30 0.53 1.00 1.00
222221 74 0.21 0.50 -0.93 -0.08 0.23 0.50 1.00 1.00
222222 75 0.10 0.53 -0.93 -0.33 0.10 0.48 1.00 1.00
SD = standard deviation
Figure 18. Histogram of the utility values obtained in the valuation survey
of CORE-6D health states
Utility value
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Table 35, which shows responses by card block, demonstrates the changes in
obtained mean utility values with increasing severity of physical and emotional
symptoms: moving to states with more severe physical symptoms (i.e.
increasing the response level of the physical item), while keeping the
emotional health state unchanged, results in a decrease in the mean utility
value; similarly, moving to states with more severe emotional symptoms (i.e.
moving from emotional state 00000 to emotional state 22222), while keeping
the response level of the physical item intact, also results in a decrease in the
mean utility value. There is only one inconsistency to this pattern, observed for
states 100000 and 110000; in this case the mean utility value increased by a
small and non-significant amount (from 0.87 to 0.88, respectively) despite of
the increase in the emotional symptom severity. This inconsistency can be
explained by the fact that these health states were included in different card
blocs and hence were valued by different respondents.
Table 35. Mean utility values for each CORE-6D health state included in
valuation survey by severity of emotional and physical symptoms
CORE-6D Response levels of the physical item
Emotional
component 0 1 2
00000 0.96 (0.13) 0.93 (0.14) 0.82 (0.32)
10000 0.87 (0.22)
11000 0.88 (0.25) 0.86 (0.27) 0.74 (0.31)
11100 0.79 (0.29)
11110 0.76 (0.33)
21110 0.66 (0.35)
22110 0.57 (0.44) 0.49 (0.47) 0.40 (0.49)
22210 0.47 (0.43)
22211 0.37 (0.45)
22221
22222 0.23 (0.52) 0.21 (0.50) 0.10 (0.53)
Health states included in each card bloc are highlighted in a different colour: states in card
bloc 1 are highlighted in yellow, states in card bloc 2 are highlighted in blue and states in card
bloc 3 are highlighted in red; all respondents valued state 222220, highlighted in green;
standard deviation is provided in parenthesis.
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6.3.3 Modelling health state values using Rasch analysis
Mean-level models
A number of OLS models at the mean level were explored using as
independent (explanatory) variables the Rasch model logit value (assuming
simple linear, quadratic and cubic relationships) as suggested by Young and
colleagues (2010) and 2 dummy variables accounting for the response level of
the physical item. The models aimed to predict utility values for the 33 CORE-
6D health states that are formed by combining the emotional states depicted in
the Rasch item threshold map with the 3 response levels of the physical item.
However, given that emotional health states with the same total (ordinal) score
correspond to the same Rasch logit value, it is possible to predict utility values
for all CORE-6D health states, based on their total emotional component score
and the response level of the physical item.
The Rasch model logit values for each emotional state identified on the Rasch
item threshold map were rescaled and anchored at 0.96 and 0.23, which were
the observed mean utility values obtained in the valuation survey for the best
state 00000 and worst state 22222, respectively. Rescaling was achieved
using the formula:
zi = maxnew + r * (minRasch * xi)
where zi is the Rasch model rescaled logit value of emotional state i, xi is the
Rasch model original logit value of the emotional state i, maxnew is the
maximum value of the new scale, minRasch is the minimum value of the Rasch
original logit scale, and r is the range of the new scale divided by the range of
the Rasch original logit scale. This process did not alter the interval scale
properties of the Rasch model logit values, but converted the original Rasch
scale (which ranged from -3.748 to +3.562) into a more easily interpretable
scale (ranging from 0.23 to 0.96).
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The following model specifications were tested:
Model m1 – simple linear relationship: y = α + β1R + γ1P1 + γ2P2
Model m2 – quadratic relationship: y = α + β2R2 + γ1P1 + γ2P2
Model m3 – cubic relationship: y = α + β3R3 + γ1P1 + γ2P2
Model m4 – quadratic relationship: y = α + β1R + β2R2 + γ1P1 + γ2P2
Model m5 – cubic relationship: y = α + β1R + β3R3 + γ1P1 + γ2P2
Model m6 – cubic relationship: y = α + β2R2 + β3R3 + γ1P1 + γ2P2
Model m7 – cubic relationship: y = α + β1R + β2R2 + β3R3 + γ1P1 + γ2P2
where y is the mean predicted utility value, R is the Rasch model rescaled logit
value, P1 is a dummy variable for response level 1 of the physical item (I have
been troubled by aches, pains, physical problems only occasionally or
sometimes), P2 is a dummy variable for response level 2 of the physical item (I
have been troubled by aches, pains, physical problems often, most or all the
time), α is the constant, and βi and γi are regression coefficients.
The regression coefficients and goodness of fit statistics for all 7 base-case
models are shown in Table 36. The adjusted R-squared statistics varied from
0.773 (model m3) to 0.990 (model m7); these high values may be an artefact
of the the relatively large number of independent variables (ranging from 3 to
5) compared with the number of mean obsservations (n=18). It needs to be
noted that the adjusted R-squared increased with increase of independent
variables (from 3 to 5), indicating that the addition of extra variables improved
the regression model more than what would be expected by chance. The
RMSE ranged from 0.0275 to 0.1292, while the MAE ranged from 0.014
(standard deviation 0.019) to 0.102 (standard deviation 0.052). In two models
(m2 and m3) a number of states demonstrated absolute errors higher than
0.10 (5 and 9 states, respectively); in no model were absolute errors for all
states lower than 0.05, but in model m7 the absolute error of 17 out of the 18
health states was lower than 0.05 (one state had an absolute error between
0.05 and 0.10). The regression coefficients of all independent variables were
overall statistically significant at the 0.05 level across the models; only dummy
variable P1 was non-significant in any of the models, although in model m7 the
level of significance was only moderately above 0.05 (0.07).
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The largest mean-level model with linear, quadratic and cubic terms for the
Rasch logit value and 2 physical dummy variables (model m7) had the highest
R-squared (0.990), the lowest RMSE (0.0275), the lowest MAE (0.014) and the
best predictive ability (14 out of the 18 health states showed absolute error no
more than 0.01, 3 health states had absolute error above 0.01 and up to 0.05,
and only one state had an absolute error of 0.07). The constant and the
regression coefficients of all independent variables were statistically significant,
with the exception of P1, the level of significance of which reached 0.07. Based
on these findings, model m7 was the preferred solution among the base-case
models for the prediction of utility values of the 33 CORE-6D health states.
Additional models that considered multiplicative interaction terms3 between the
emotional component and the physical item of CORE-6D did not appear to
offer any improvement in the model fit compared with the selected model m7.
As it can be seen in Table 37, in none of these additional models were the
interaction terms significant. Moreover, consideration of interaction terms did
not offer any improvement in the model fit and its predictive ability, as
suggested by the RMSE and MAE statistics and the adjusted R-Squared
values, which were, at best, equivalent to those of the selected mean-level
additive OLS model m7. These findings suggest that a simple additive model
was adequate to capture the relationship between the utility values on the one
side of the equation, and the Rasch model logit value of the emotional
component as well as the physical dummy variables on the other.
3 In order to estimate multiplicative interaction terms between the emotional
component and the physical item of each health state, the response levels of each of the
6 items were rescored on a scale from 1-3 (instead of the original 0-2 scale). The total
new score of the emotional component, as obtained by summing the individual
emotional item scores, was multiplied by the new score of the physical item at the state
level to give the multiplicative interaction term.
Table 36. Results of base-case mean-level ordinary least squares regression models for the prediction of CORE-6D utility
values [analysis on N = 18 mean utility values]
Model Cons
(p val)
R
(p val)
R2
(p val)
R3
(p val)
P1
(p val)
P2
(p val)
Adj
R-sq RMSE
MAE
(SD)
No.
>|0.01|
No.
>|0.05|
No.
>|0.10|
m1 y = α + β1R + γ1P1 + γ2P2
0.008
(0.833)
1.057
(0.000)
-0.044
(0.189)
-0.151
(0.000) 0.961 0.0533
0.040
(0.029) 12 5 0
m2 y = α + β2R2 + γ1P1 + γ2P2
0.302
(0.000)
0.844
(0.000)
-0.070
(0.219)
-0.177
(0.006) 0.886 0.0916
0.073
(0.036) 17 13 5
m3 y = α + β3R3 + γ1P1 + γ2P2
0.416
(0.000)
0.779
(0.000)
-0.085
(0.284)
-0.193
(0.025) 0.773 0.1292
0.102
(0.052) 18 14 9
m4 y = α + β1R + β2R2 + γ1P1 + γ2P2
-0.130
(0.100)
1.585
(0.000)
-0.443
(0.056)
-0.029
(0.329)
-0.137
(0.000) 0.969 0.0478
0.037
(0.019) 16 3 0
m5 y = α + β1R + β3R3 + γ1P1 + γ2P2
-0.108
(0.072)
1.388
(0.000)
-0.282
(0.025)
-0.028
(0.329)
-0.135
(0.000) 0.972 0.0452
0.034
(0.020) 17 3 0
m6 y = α + β2R2 + β3R3 + γ1P1 + γ2P2
0.099
(0.002)
2.624
(0.000)
-1.758
(0.000)
-0.029
(0.170)
-0.137
(0.000) 0.985 0.0331
0.024
(0.016) 13 2 0
m7 y = α + β1R + β2R2 + β3R3 + γ1P1 + γ2P2
0.366
(0.004)
-1.695
(0.022)
5.712
(0.000)
-3.446
(0.000)
-0.033
(0.069)
-0.141
(0.000) 0.990 0.0275
0.014
(0.019) 4 1 0
Notes: Adj R-sq = adjusted R-squared; Cons = constant; R: Rasch model rescaled logit values; P1 and P2: dummy variables accounting for response levels 1 and
2, respectively, of the physical item of CORE-6D; MAE = mean absolute error; RMSE = root mean squared error; sd = standard deviation; p val: p value
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Table 37. Results of mean-level ordinary least squares regression models considering potential multiplicative interactions
between the emotional component and the physical item of CORE-6D – additional independent variables added to the best-
performing additive model among the base-case mean-level model specifications (Model m7)
[analysis on N = 18 mean utility values]
Base-case model m7 plus… Cons
R
(p val)
R2
(p val)
R3
(p val)
P1
(p val)
P2
(p val)
I
(p val)
I2
(p val)
I3
(p val)
Adj
R-Sq RMSE
MAE
(SD)
No.
>|0.01|
No.
>|0.05|
No.
>|0.10|
…linear multiplicative interaction
y = α + β1R + β2R2 + β3R3 + γ1P1 + γ2P2 + δ1Ι
0.415
(0.009)
-1.790
(0.023)
5.803
(0.001)
-3.493
(0.000)
-0.018
(0.531)
-0.111
(0.044)
-0.002
(0.528)
0.989 0.0281
0.018
(0.015) 9 1 0
…quadratic multiplicative interaction
y = α + β1R + β2R2 + β3R3 + γ1P1 + γ2P2 + δ2Ι2
0.386
(0.008)
-1.766
(0.027)
5.804
(0.001)
-3.491
(0.000)
-0.030
(0.155)
-0.131
(0.001)
-0.000
(0.701)
0.989 0.0285
0.017
(0.017) 5 1 0
…cubic multiplicative interaction
y = α + β1R + β2R2 + β3R3 + γ1P1 + γ2P2 + δ3Ι3
0.375
(0.009)
-1.730
(0.031)
5.760
(0.001)
-3.470
(0.000)
-0.033
(0.096)
-0.137
(0.000)
-0.000
(0.855)
0.989 0.0286
0.016
(0.017) 5 1 0
…quadratic multiplicative interaction
y = α + β1R + β2R2 + β3R3 + γ1P1 + γ2P2 + δ1Ι + δ2Ι2
0.557
(0.009)
-1.582
(0.044)
5.250
(0.002)
-3.244
(0.001)
0.060
(0.416)
0.006
(0.955)
-0.015
(0.217)
0.000
(0.255)
0.990 0.0276
0.064
(0.084) 14 4 3
…cubic multiplicative interaction
y = α + β1R + β2R2 + β3R3 + γ1P1 + γ2P2 + δ1Ι + δ3Ι3
0.493
(0.007)
-1.633
(0.037)
5.415
(0.001)
-3.321
(0.001)
0.035
(0.535)
-0.034
(0.688)
-0.009
(0.218)
0.000
(0.276)
0.990 0.0277
0.034
(0.043) 9 3 1
…cubic multiplicative interaction
y = α + β1R + β2R2 + β3R3 + γ1P1 + γ2P2 + δ2Ι2 + δ3Ι3
0.411
(0.006)
-1.694
(0.033)
5.622
(0.001)
-3.416
(0.001)
0.002
(0.955)
-0.086
(0.104)
0.000
(0.246)
0.000
(0.265)
0.989 0.0280
0.041
(0.031) 15 5 0
…cubic multiplicative interaction
y = α + β1R + β2R2 + β3R3 + γ1P1 + γ2P2 + δ1Ι + δ2Ι2 + δ3Ι3
0.493
(0.007)
-1.633
(0.037)
5.415
(0.001)
-3.321
(0.001)
0.035
(0.535)
-0.034
(0.688)
-0.009
(0.218)
I2 term
REM
0.000
(0.276)
0.990 0.0277
0.034
(0.043) 9 3 1
Notes: Adj R-Sq = adjusted R-squared; Cons = constant; R: Rasch model rescaled logit values; P1 and P2: dummy variables accounting for response levels 1 and
2, respectively, of the physical item of CORE-6D; I = multiplicative interaction term; δi = additional regression coefficients; REM = removed from regression due to
multi-collinearity (i.e. strong correlation with other independent variables, which increases the standard errors of the coefficients); MAE = mean absolute error;
RMSE = root mean squared error; sd = standard deviation; p val: p value
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Figure 19 shows the plotting of residuals obtained from model m7 against each
of the independent variables of the model, as well as against the predicted
utility values. Despite the small number of data points, the plots suggest that
the points are randomly scattered across x values indicating a good model fit.
Figure 19. Plots of residuals against (a) each of the five independent
variables of selected model m7 and (b) predicted utility values
a a
a a
a b
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Figure 20 allows the comparison between actual mean utility values obtained
from the valuation survey for the selected CORE-6D health states, and
predicted utility values for all potential health states described by CORE-6D,
derived from the mean-level base-case regression model m7. The x axis of the
graph represents Rasch rescaled logit values that cover the full severity range
of all potential emotional health states described by CORE-6D. The y axis
depicts respective utility values. There are three lines on the graph, one for
each level of the physical item. The 3 lines have an s-shape reflecting the
cubic relationship between the Rasch logit scale and the health state utility
value. Visual inspection of the plot of the observed and predicted utility data
alongside the statistical performance of the base-case model m7 confirms that
the model performs well.
Figure 20. Mean observed (from the valuation survey) and modelled
(based on regression model m7) utility values by Rasch rescaled logit
value
Note: Modelled utility values are predicted using the Rasch rescaled logit value of the
emotional health state and the response level of the physical item ‘I am troubled by aches,
pains, physical problems’ (level 0 = never; level 1 = only occasionally or sometimes; level 2 =
often, most or all the time)
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As already noted, the regression models described above can be used to
estimate a utility value for every CORE-6D health state, based on the total
(ordinal) score of its emotional component and the response level of the
physical item. Table 38 reports the total (ordinal) emotional state score, the
corresponding Rasch logit value (both original and rescaled), and the modelled
utility values for all potential CORE-6D health states as estimated using the
selected base-case regression model m7. It can be seen that the utility values
of the CORE-6D index range from 0.10 (worst emotional and physical state) to
0.95 (best emotional and physical state). Utility values appear to be only mildly
affected by moderate physical symptoms (i.e. response level 1), while severe
physical symptoms (response level 2) seem to affect more substantially the
estimated utility values. A syntax that allows calculation of CORE-6D utility
values from CORE-OM data in SPSS is provided in Appendix 13.
Table 38. Modelled mean utility values for all CORE-6D health states,
based on the total ordinal score of the emotional component of the state
and the response level of the physical item, using the base-case
regression model m7
CORE-6D Response levels of the physical
item
Total
emotional
state score
Corresponding
original Rasch
logit value
Corresponding
rescaled Rasch
logit value
0 1 2
0 -3.748 0.96 0.95 0.92 0.81
1 -2.681 0.85 0.94 0.90 0.80
2 -1.836 0.77 0.87 0.84 0.73
3 -1.168 0.70 0.80 0.77 0.66
4 -0.573 0.64 0.72 0.69 0.58
5 0.002 0.59 0.64 0.61 0.50
6 0.594 0.53 0.55 0.52 0.41
7 1.217 0.46 0.47 0.43 0.32
8 1.878 0.40 0.38 0.35 0.24
9 2.652 0.32 0.30 0.26 0.16
10 3.562 0.23 0.24 0.20 0.10
214
Individual-level models
Individual-level regression analysis considered 4 different models:
Model i1 was an OLS model that used as explanatory variables the Rasch
model rescaled logit value (linear, quadratic and cubic form) and 2 dummy
variables for response levels 1 and 2 of the physical item of CORE-6D, that is,
it used the same explanatory variables considered in the best-performing
mean-level OLS base-case model m7 (‘health state variables’). Model i1 did
not take into account any socio-demographic characteristics.
Model i2 was an OLS model, which, in addition to the above explanatory
health state variables, considered also socio-demographic variables with
significant coefficients at the p=0.05 level, that is, age, gender and ethnicity. A
preliminary OLS analysis that included a wider range of socio-demographic
characteristics as explanatory variables revealed that a number of other
variables, such as relationship status, home ownership, level of academic
degree and employment status had non-significant coefficients; these
variables were thus excluded from consideration in model i2. Age was entered
in the regression as a continuous variable in linear and quadratic form (i.e.
age-squared); gender and ethnicity were entered by introducing 2 dummy
binary variables, female vs. male and white British background vs. any other
ethnic background, respectively.
Model i3 was a Tobit model that considered the same explanatory variables
with model i1 (that is, it included exclusively health state variables).
Model i4 was a Tobit model that contained the same explanatory variables with
model i2 (that is, it considered both health state variables and significant socio-
demographic variables).
Results of individual-level models are provided in Table 39. For each Tobit
model, two pairs of results are provided: the regression coefficients which
reflect how the unobserved, latent variable y*i changes with respect to
changes in the independent variables, and the mean marginal effects of the
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independent variables on the censored observed utility value yi. It can be seen
that the response level 1 of the physical item was non-significant in any of the
models; the Rasch logit model value had significant regression coefficients at
the 0.05 level only in Tobit models, whereas the quadradic and cubic forms of
the Rasch logit model value as well as the response level 2 of the physical
item had significant regression coefficients in all individual-level models. Both
OLS and Tobit analyses indicated a statistically significant relationship
between the observed utility values and age, gender and ethnicity (Table 39).
Consideration of these variables improved to a small extent the model fit in
both types of models (RMSE of individual-level OLS regression improved from
0.39 when no socio-demographic characteristics were considered, to 0.38,
when socio-demographics were considered; the estimated standard error of
the Tobit regression without socio-demographic characteristics was 0.51 and
was reduced at 0.49, when socio-demographic variables were added).
Overall, inclusion of significant socio-demographic variables improved only
marginally the fit of the models. More importantly, the model fit of the
individual-level models was much lower than that observed for the mean-level
models (Table 36), which reflects the large random variability at the individual
level that is not needed for policy purposes, where mean-level models are
more suitable to use.
An interesting finding of the individual-level analyses that included socio-
demographic variables is the quadratic relationship between utility values and
age, which represents an inverted U-shaped function. According to the
marginal effects of the Tobit model (model i4), ceteris paribus, the preferences
of a 24-year old person are likely to be the same with those of a 85-year old
person; similarly, the utility values obtained by a 38-year old person should be
the same with those elicited from a 71-year old person. The maximum utility
value is obtained at 54 years of age.
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Table 39. Results of individual-level least ordinal squares and Tobit
regression models for the prediction of CORE-6D utility values
[analysis on N = 1,492 individual utility values]
Model (i1) (i2) (i3) (i4)
Variable RC RC RC ME RC ME
Constant 0.375
(0.035)
-0.177
(0.351)
0.639
(0.009)
NA -0.159
(0.533)
NA
Rasch model logit value of the emotional component (linear, quadratic and cubic form)
R -1.788
(0.125)
-1.904
(0.095)
-3.354
(0.036)
-2.399
(0.036)
-3.516
(0.024)
-2.546
(0.023)
R2 5.994
(0.006)
6.234
(0.004)
9.010
(0.003)
6.445
(0.003)
9.360
(0.002)
6.778
(0.002)
R3 -3.662
(0.003)
-3.819
(0.002)
-5.011
(0.004)
-3.584
(0.004)
-5.249
(0.002)
-3.801
(0.002)
Dummy variables for response levels of the physical item other than zero
P1 -0.0232
(0.391)
-0.0161
(0.542)
-0.0383
(0.309)
-0.0277
(0.314)
-0.0285
(0.436)
-0.021
(0.439)
P2 -0.1281
(0.000)
-0.1264
(0.000)
-0.2032
(0.000)
-0.1529
(0.000)
-0.2010
(0.000)
-0.1531
(0.000)
Dummy variables accounting for personal characteristics
Age 0.0263
(0.000)
0.0379
(0.000)
0.0274
(0.000)
Age squared -0.0002
(0.000)
-0.0003
(0.000)
-0.0003
(0.000)
Gender (female) 0.0651
(0.002)
0.0884
(0.002)
0.0645
(0.002)
Ethnicity (white British) -0.1188
(0.002)
-0.1612
(0.002)
-0.1088
(0.001)
Overall model stats
Adjusted R-Squared 0.3249 0.3636 - -
RMSE/mean standard error 0.3949 0.3824 0.5131 0.4916
Notes:
Model i1 – OLS regression, no socio-demographic characteristics considered
Model i2 – OLS regression including significant socio-demographic characteristics (p≤0.05) 
Model i3 – Tobit regression, no socio-demographic characteristics considered
Model i4 – Tobit regression including significant socio-demographic characteristics (p≤0.05) 
ME: mean marginal effects
RC: regression coefficients
RMSE: Root mean squared error
p values in parenthesis
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The impact of age is also shown in Figure 21. The graph presents the
predicted utility values against age, for men of white origin and for 3 different
emotional health states, each combined with the physical item at response
level 0: a. the mildest emotional state 00000 (producing the full state 000000);
b. the intermediate emotional state 22110 (leading to full state 221100); and c.
the worst emotional state 22222 (resulting in full state 222220). For all states,
the relationship between utility values and age follows an inverted U-shaped
function, with maximum utility value reached at 54 years of age. The shape
becomes sharper as the emotional health states become more severe,
indicating that the impact of age becomes more prominent as the emotional
symptom severity increases.
Figure 21. Effect of age on predicted utility value (Model i4)
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6.4 Discussion
This chapter describes the development of a utility index for the CORE-6D
classification system, following a novel methodology that uses mainly the
results of Rasch analysis. Rasch analysis was employed at the development of
the unidimensional emotional component of CORE-6D, as described in detail
in Chapter 5. Subsequently, it was employed for the identification and selection
of plausible emotional health states that were considered in the valuation
survey. Finally, Rasch analysis enabled prediction of utility values for all health
states of CORE-6D by estimating the relationship between the Rasch model
logit values and the mean observed utility values obtained from the valuation
survey using regression analysis. This novel approach based on Rasch
analysis was adopted because of the high correlations between the CORE-6D
items that did not allow use of standard methods for generating and modelling
health states.
Conventional approaches for generating health states, such as orthogonal
block designs, treat items as independent (uncorrelated) statements (e.g.
Brazier et al., 2002; Dolan et al., 1996). Therefore, such approaches are not
appropriate for use in measures that have no clear multidimensional structure
(that is, measures that consist of highly correlated items), such as the
emotional component of CORE-6D, because they entail the danger of
generating implausible health states (an example is a state that includes the
statement “I have felt optimistic about my future” at the same time with the
statement “I have made plans to end my life”). In contrast, consideration of the
Rasch item threshold map for the identification of health states from CORE-6D
helped to avoid generation of such implausible health states and, instead,
create credible health states that comprised combinations of item responses
observed in a real population.
An advantage of the ‘Rasch vignette approach’ is that it leads to the
development of health states that represent not only plausible, but also the
most likely combinations of responses over a continuum of symptom severity,
thus allowing prediction of a person’s symptom severity based on his/her
responses and vice versa. Indeed, the 11 emotional health states of CORE-6D
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that were identified by inspection of the Rasch item threshold map were
among the most frequently observed emotional health states in the study
population: although these states represent only 4.5% of the potential 243
health states described by the emotional component of CORE-6D, they
covered approximately 35% of the responses obtained from a large CORE-OM
dataset that was analysed in this thesis [N1500]. In contrast, the coverage of
the 15 health states generated from the emotional component of CORE-6D
using an orthogonal block design reached only 14% in the same dataset;
furthermore, use of an orthogonal block design generated a number of
implausible health states.
The Rasch vignette approach for the identification of plausible health states
can be compared with the clustering-based approach developed by Sugar and
colleagues (1998), who, as described in Chapter 3 (section 3.3.2), used
predominantly cluster analysis to group item responses and subsequently
combined the most frequent individual item responses within each cluster in
order to develop health state descriptions. However, in contrast to the Rasch
vignette approach, the item response combinations derived from the
clustering-based approach were not necessarily the most frequently observed
in the study sample; what’s more, it is possible that they had not been
observed at all in the study sample.
One limitation of the Rasch vignette approach, similar to the methodology
proposed by Sugar and colleagues (1998), is that the number of generated
health states is limited and does not capture the whole range of plausible
combinations of responses. In the case of CORE-6D, the Rasch vignette
approach led to identification of 11 plausible emotional health states, which,
combined with 3 response levels of the ‘physical’ item of the original CORE-
OM (I have been troubled by aches, pains, or physical problems), produce a 2-
dimensional set of 33 plausible health states that were used as the basis for
the valuation of the CORE-6D.
Nonetheless, despite generating a limited number of health states, the major
advantage of the Rasch vignette approach over the clustering-based approach
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is that it allows the valuation of all potential health states described by a
unidimensional measure (such as the emotional component of CORE-6D) by
assigning all potential health states (i.e. all combinations of item responses
including those not illustrated in the Rasch item threshold maps) to different
locations along the latent scale according to their level of severity. The
relationship between the Rasch model logit values of the health states and the
corresponding mean observed utility values obtained from a valuation survey
can be then established using regression analysis and subsequently used to
generate utility values for all people completing CORE-OM.
In the case of CORE-6D, the standard approach for modelling utility values, by
creating dummy variables in regression analysis for each level of every item of
the measure (Brazier et al., 2002; Dolan, 1997), would have required far more
states to be valued, due to the high correlation between the items of the
emotional component of CORE-6D. In contrast, Rasch analysis has proved to
be a more efficient solution for modelling utility values in such cases. For this
thesis, a mixed approach for modelling utility values was successfully
developed, by combining the Rasch-based approach reported by Young and
colleagues (2010) with the standard approach used to account for the different
severity levels of the physical item of CORE-6D (Brazier et al., 2002; Dolan,
1997). A number of additive mean-level regression models were tested, which
assumed that there is no utility interaction between the response level of the
physical item and the severity level of the emotional component of CORE-6D.
The selected cubic model was characterised by a high adjusted R-Squared
(0.990), low RMSE (0.0275), low MAE (0.014) and good predictive ability as
indicated by low observed residuals [78% (14/18) of health states had a
residual ≤ 0.01, 17% (3/18) had a residual higher than 0.01 but ≤ 0.05 and 6% 
(1/18) of the states had a residual ≤ 0.10]. Inspection of residual plots indicated 
no bias in the distribution of residuals around independent variables and
around predicted utility values, suggesting a good model fit. Visual inspection
of the plot of observed utility values against the predicted ones confirmed the
good predictive ability of the model. These results compare favourably with
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regression models described in similar modelling studies (Brazier et al., 2002 &
2008; Dolan, 1997; Yang et al., 2009 & 2011).
It needs to be noted that the number of independent variables fitted in the
model (5) was relatively high compared with the small number of data points
(18 mean-level utility values obtained in the valuation survey). The latter
reflected the small number of health states that were included in the valuation
survey, owing to funding restrictions. Although this is acknowledged as a
limitation of the analysis, on the other hand, modelling at the mean rather the
individual level of utility values was preferred, as prediction of mean utility
values is more relevant in cost-utility analysis where the preferences of the
population need to be taken into account (Brazier et al., 2007; Feeny et al.,
2002). However, in cases where the number of independent variables is large
relative to the number of data points, there is danger that the model is
overfitting the data and the value of R-squared statistics is limited (Harrell,
2001). In such cases it is advised that only variables that are expected to be
good predictors of the dependent variable (utility value) be included in OLS
regression analysis (Harrell, 2001). The selected model m7 included 5
independent variables; 3 were forms of the Rasch logit model value (linear,
quadratic and cubic) reflecting the level of emotional distress while 2 dummy
variables expressed the level of physical impairment. Both emotional distress
and physical impairment are conceptually expected to be good predictors of
perceived HRQoL and hence of utility values. Four of the variables (all forms of
Rasch logit model value and response level 2 of physical item) had statistically
significant regression coefficients in the selected model, and one variable
(response level 1 of the physical item) had a regression coefficient that was
slightly above the 0.05 level of significance (p=0.07). Individual-level models
showed that the quadratic and cubic forms of the Rasch logit model value and
the response level 2 of the physical item had statistically significant regression
coefficients in all respective analyses (both OLS and Tobit), while the linear
form of the Rasch logit model value was significant in Tobit models. The
response level 1 of the physical item was non-significant in any of the analyses
either at the mean or the individual level; nevertheless, this variable was
deemed to conceptually be affecting HRQoL and was thus retained in the
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analysis. Other statistics indicated that the selected model m7 had good model
fit and predictive ability. Therefore, this model was finally selected for the
prediction of mean utility values from CORE-6D, although the limitations of this
analysis are acknowledged.
Extra mean-level regression models that considered multiplicative interaction
between the physical item and the emotional component of CORE-6D did not
offer any improvement in the model fit compared with the selected model, thus
suggesting that a simple additive model was adequate. This latter finding
supports an assumption that the impact of different dimensions on preferences
is additive. If the assumption holds, inclusion or exclusion of a dimension
should lead to no significant change in the coefficients of the other dimensions
in the classification. However, this was not found in another study where a pain
dimension was added to an asthma-specific utility measure, the AQL-5D
(Brazier et al., 2011). This resulted in the coefficients of 2 of the other
dimensions being significantly changed. However, the case of AQL-5D is
different from that of CORE-6D because the other dimensions of AQL-5D were
primarily concerned with physical health and so were less independent from a
pain dimension than the emotional component of CORE-6D from the
measure’s physical item.
Analysis of valuation data at an individual level showed that there was a small
but significant relationship between the utility values obtained in the valuation
survey and some of the socio-demographic characteristics of the respondents,
including age, gender and ethnicity. This finding is broadly consistent with the
results reported in the valuation of EQ-5D, where age, gender and marital
status were found to significantly affect the utility values elicited in the
valuation survey (Dolan, 2000; Dolan & Roberts, 2002). The influence of these
variables on the utility values was weak to moderate, with marginal effects in
the Tobit model ranging in magnitude from 0.03 (age) to 0.11 (ethnicity).
Interestingly, individual-level analysis revealed an inverted U-shaped function
between utility values and age (fitted with age and age-squared terms), which
is comparable with the relationship between these two variables found at the
valuation of EQ-5D (Dolan & Roberts, 2002) and SF-6D (Kharroubi et al.,
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2007). These findings highlight the importance of eliciting preferences from a
representative sample of the general population in terms of age, gender and
ethnicity, since valuations elicited from non-representative samples may not
reflect the general population’s preferences.
Nevertheless, the analysis demonstrated that the Rasch model logit value of
the emotional component of CORE-6D, which expresses the level of severity
of emotional symptoms, was by far the most substantial determinant of utility
values. In any event, analysis of valuation data at an aggregate (mean) level
offered a better solution for prediction of utility values compared with individual
level models. This is consistent with findings of previous research, according to
which aggregate models may perform equally to or even better than individual-
level ones, regardless of the presence of some significant socio-demographic
factors, because they eliminate unhelpful individual-level variation (Brazier et
al., 2002 & 2008; McKenna et al., 2008; Yang et al., 2009 & 2011).
The valuation of CORE-6D followed the MVH group TTO protocol that was
developed for the valuation of EQ-5D (Dolan, 1997; Dolan et al., 1996).
Adoption of this protocol including its visual props permitted comparability of
CORE-6D with the EQ-5D and met previous NICE requirements according to
which, when an alternative to EQ-5D is used, the same methods of valuation
should be adopted (National Institute for Health and Clinical Excellence, 2008).
However, the MVH group TTO protocol suffers from a number of limitations. A
major criticism involves the effect of respondents’ age on valuations (Dolan,
2000; Dolan et al., 1996). It could be argued that framing the valuation
statements using a 10-year time horizon, as in the MVH protocol, may feel too
generous for older respondents and yet too short for younger ones. The time
horizon used to frame the statements has indeed been shown to affect TTO
valuations, with TTO utility values decreasing as the time horizon of the
valuation statement increases (Lin et al., 2012; Stiggelbout et al., 1995).
Further exploration of the impact of age on health state valuations suggests
that differences in valuations between young and old respondents would have
still been observed if respondents’ life expectancy had been used rather than a
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fixed time horizon of the valuation statements (Dolan & Roberts, 2002;
Robinson et al., 1997).
A second major criticism of the MVH group TTO protocol relates to the
procedure for the valuation of states that are worse than death. One problem
of the procedure is that it includes the apparently unrealistic scenario of
moving from poor health to full health. On the other hand, reversing the
ordering of the states so that the move is from full health to poor health entails
the danger that respondents may believe that they can commit suicide
following the end of the period they spend in full health (Rowen & Brazier,
2011). Another problem of the TTO procedure for valuation of states worse
than death is that it is different from the procedure for valuation of states better
than death: the procedure for valuation of states worse than death assumes a
total fixed duration of the time spent in full health plus the time spent in the
health state subject to valuation, and varies the duration of the time spent in
full health concurrently with the time in the health state subject to valuation, so
that the total duration remains intact; in contrast, the procedure for the
valuation of states better than death assumes a fixed duration for the period of
time spent in the health state subject to valuation, and varies only the period
spent in full health. Further to the confusion caused to the respondents, use of
different procedures for valuation of states worse versus better than death
creates a gap effect in the utility values for states around death (Tilling et al.,
2010).
Finally the MVH protocol has been criticised for the monotonic transformation
of values of states considered worse than death so that values are bounded by
-1. As described in section 1.3.1 of Chapter 1, the need for this transformation
was dictated by the very low values that were possible to obtain when the
formula –x/y was used, with implications at the modelling of valuation data.
However, the transformation of values for states considered worse than death
by using the formula –x/10 means that these values can no longer be
interpreted as utility scores, and therefore are not comparable to utility values
elicited for states better than death; consequently, aggregation of these two
sets of values in econometric modelling becomes problematic (Patrick et al.,
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1994). Possible resolutions to this problem comprise an alteration in the TTO
protocol used to elicit values by introducing a ‘lead time’ in full health for both
types of states (better and worse than death), and an alternative methodology
in the modelling techniques used for the prediction of utility values, with both
approaches being under on-going research (Rowen & Brazier, 2011).
It is acknowledged that the valuation of the CORE-6D suffers from the same
limitations characterising the MVH protocol. As stated earlier, adoption of the
same protocol was deemed necessary to ensure comparability of CORE-6D
with EQ-5D, which was prerequisite for the use of CORE-6D in the NICE
decision-making context. At the same time researchers have highlighted the
importance of balancing between compliance with requirements of regulatory
bodies and the use of currently best available methods (Feeny, 2013); any
limitations in methodology advocated by such bodies should be identified,
leading to prioritisation of areas for further research (Sculpher, 2013). It should
be noted, though, that the most recently published NICE methods guidance no
longer requires, at least explicitly, the same valuation method with that
adopted for EQ-5D when alternative PBMs are used for the estimation of
QALYs (National Institute for Health and Care Excellence, 2013).
6.5 Conclusion
The use of the novel methodology described in this chapter, based primarily on
Rasch analysis, enabled the development of a utility index for CORE-6D, a 2-
dimensional PBM that can be used for the estimation of QALYs in economic
evaluations of interventions for common mental health problems. The resulting
algorithm can be applied to any CORE-OM dataset prospectively or
retrospectively. Application of the CORE-6D algorithm on existing CORE-OM
datasets has been used to examine the performance of the new PBM. The
results of this exercise are described in Chapter 7.
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Chapter 7. Performance of CORE-6D:
comparison with generic preference-
based measures and the CORE-OM
7.1 Introduction
The purpose of developing CORE-6D was the formation of a new PBM that is
specific to common mental health problems, an area where the use of generic
PBMs appears to be rather limited, less acceptable and less responsive to
HRQoL changes compared with other disease areas where physical symptoms
prevail. However, before CORE-6D is widely used in economic evaluations for
the estimation of QALYs, its psychometric properties and content need to be
assessed in order to confirm that the new measure can capture appropriately
any changes in the HRQoL of people with common mental health problems.
This chapter presents the methodology and the results of a series of analyses
that aimed to compare the CORE-OM with generic PBMs in terms of their
psychometric properties, and also to explore the degree of loss of information
resulting from the derivation of CORE-6D from the original CORE-OM. The
methods adopted and the generic PBMs used as comparators for this purpose
were dictated by the availability of relevant data in the area of common mental
health problems.
7.2 Methods
7.2.1 Overview of compared measures
CORE-6D
The CORE-6D consists of an emotional component with 5 conceptual domains
(symptoms - anxiety, functioning - general, functioning - close relationships,
functioning - social relationships, risk /harm to self) and a physical health item.
Each item has 3 levels of severity, which, combined, can produce 729 distinct
health states; utility values range from 0.10 to 0.95.
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SF-6D
The SF-6D can be derived from SF-36 (Brazier et al., 2002) as well as from its
shortened version SF-12 (Brazier & Roberts, 2004). The SF-6D has 6
dimensions (physical functioning, role limitations, social functioning, bodily
pain, mental health and vitality). When derived from SF-36, physical
functioning and bodily pain have 6 levels of severity, role limitations 4 and the
rest 3 dimensions have 5 levels of severity each; this form of SF-6D can
describe approximately 18,000 unique health states and the resulting utility
values range from 0.301 to 1. When derived from SF-12, SF-6D includes 3
levels of response for physical functioning, 4 levels of response for role
limitations, and 5 levels of response for each of the remaining dimensions,
resulting in the formation of roughly 7,500 unique health states. This version of
SF-6D corresponds to utility values that range from 0.35 to 1.
EQ-5D
The EQ-5D has 5 dimensions (mobility, self-care, usual activities,
pain/discomfort, anxiety /depression). The version of EQ-5D used in the
comparisons has 3 levels of severity ranging from ‘no problems’ to ‘severe
problems’ (Brooks, 1996). The health state classification system therefore
describes 243 unique health states; utility values for the UK population range
from -0.59 to 1 (Dolan, 1997).
EQ-5D data were not available in 2 of the 3 datasets that were analysed. In
these 2 datasets available SF-12 data were mapped onto EQ-5D utility values.
As discussed in Chapter 1 (section 1.3.3), mapping refers to the estimation of
a statistical relationship between two measures that allows prediction of values
of one measure, which is not available in a dataset, using data from another
measure that is included in the dataset. The relationship is determined by
undertaking regression analysis on a separate dataset that has similar patient
characteristics to the dataset of interest and contains both measures (Brazier
et al., 2010).
Two studies reporting mapping algorithms between SF-12 and EQ-5D utility
values were reviewed for this purpose; both used data from 12,967 adults
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participating in a national US survey on medical expenditure in 2000 (details of
which are available from http://www.meps.ahrq.gov/mepsweb/). The first
algorithm was developed by Franks and colleagues (2004), who used OLS
regression methods to map the physical and mental component summary
scores of the SF-12 (PCS-12 and MCS-12, respectively) onto EQ-5D utility
values for the UK population (Dolan, 1997). The methodology used in this
study was rather crude, as it ignored individual responses to each of the items
of SF-12. Moreover, use of OLS has theoretical limitations, given the skewed
and bounded nature of the utility data.
The second published algorithm was developed by Gray and colleagues
(2006), who applied multinomial logit regression and Monte Carlo simulation
methods to generate predictions of EQ-5D responses using individual item
responses and summary scores from the SF-12 as explanatory variables. The
predicted EQ-5D responses were then linked to the UK EQ-5D tariff (Dolan,
1997). The approach was validated on data from 13,304 people aged above
16 years who participated in a national health survey conducted in England in
1996 (Department of Health et al., 1998). This more sophisticated approach
made better use of the available SF-12 data and overcame some of the
problems characterising the algorithm developed by Franks and colleagues
(2004). Therefore it was chosen for the prediction of EQ-5D utility values from
available SF-12 data. In order to obtain mapped utility values using this
algorithm, 1,000 iterations of the probabilistic algorithm were run and the
median values of the predicted 1,000 EQ-5D utility values were used in the
analyses described in this chapter.
CORE-OM
The CORE-OM consists of 34 items, each with 5 levels of response, capturing
4 conceptual domains: subjective well-being, problems (depression, anxiety,
physical symptoms, and trauma), functioning (general functioning, close
relationships, social relationships), and risk (risk-to-self and risk-to-others).
Depending on the level of response, each item is scored from 0 to 4. The
CORE-OM clinical score is then calculated by adding all 34-item scores,
multiplying by 10 and dividing by 34. The CORE-OM clinical score can get
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values between 0-40, with 10 being considered the cut-off point between
clinical and non-clinical cases. A clinical score 10 to <15 indicates mild
psychological distress, 15 to <20 moderate distress, 20 to <25 moderate to
severe distress, and 25 to 40 severe psychological distress (Barkham et al.,
2006). A completed CORE-OM questionnaire is considered ‘valid’ if responses
to no more than 3 items are missing (that is, at least 31 items have been
completed). When up to 3 item scores are missing, the CORE-OM clinical
score is calculated by adding the scores of all completed items, multiplying by
10 and dividing by the number of completed items (Evans et al., 2002).
7.2.2 Quantitative and qualitative analyses performed
A number of psychometric and statistical tests (described in detail in section
1.2.4 of Chapter 1) were undertaken to compare CORE-6D with generic PBMs
and the CORE-OM; all statistical analyses were performed on SPSS 19 (IBM
Corp., 2010). In addition, the content validity of CORE-6D was explored using
qualitative assessment.
Acceptability
Acceptability of the measures to respondents was indirectly assessed by the
percentage of missing data across all available observations.
Floor and ceiling effects
Floor and ceiling effects are observed when a large percentage of people in
the sample are in the worst and best health state, respectively. The presence
of such effects indicates that the instrument is not well targeted to the study
population, as it cannot measure the whole range of health; consequently the
instrument is unable to capture improvement (where there are ceiling effects)
or deterioration (where there are floor effects) in health. Such effects have an
impact on a measure’s responsiveness to change over time. Floor and ceiling
effects were estimated and reported across all available observations in each
of the datasets used.
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Responsiveness to change over time
Responsiveness expresses the ability of an instrument to capture known and
important changes in the health of individuals, which may reflect therapeutic
effects (Kirshner & Guyatt, 1985). To ensure comparability of the results,
responsiveness of the measures was examined using SRM and ES. SRM is
the mean change score of a measure between two different time points divided
by the standard deviation of the change score; the ES is the mean change
score of a measure between two time points divided by the standard deviation
of the score at baseline. A value of SRM or ES around 0.2 to 0.3 has been
deemed to indicate a small effect, a value around 0.5 a medium effect, and a
value of 0.8 and above a large effect (Cohen, 1988). Statistical significance of
differences was assessed using paired t-tests.
It should be noted that assessment of a measure’s responsiveness with these
criteria implies that there is a real improvement in health over time following
treatment, which the measure is able to capture. However, treatment may in
fact not be effective, at least not for all people in the study population, so a
finding of low responsiveness of a measure does not necessarily mean that
the measure cannot capture real changes in health over time – it may simply
reflect the fact that no real health improvement occurred following treatment. In
the datasets and mental health populations used in the analyses reported in
this chapter there was no ‘gold standard’ measure that could verify that
people’s health indeed changed over time, but rather an expectation that
health improved following treatment, which the PBMs attempted to capture.
Therefore, the results of these analyses should be interpreted with caution.
Statistics based on SRM and ES were reported for observations containing
available data for every measure of interest.
Prior to examination of SRM and ES, utility values generated from all PBMs
were plotted by period to determine whether they showed comparable
movements in HRQoL at different time points, thus indicating that the PBMs
capture changes in HRQoL over time in a similar way.
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Construct validity
Construct validity refers to the extent to which an instrument can measure an
underlying ‘construct’ (Fitzpatrick et al., 1998 & 2007). It can be assessed by
the ability of the measure to distinguish among groups that are known to differ
in the underlying construct (‘known groups validity’), or by quantitatively
examining the correlations of the instrument with a set of other variables that
have been designed to measure the same construct (‘convergent validity’).
The known groups validity of the measures was assessed by their ability to
distinguish among groups that are known to differ in mental symptom severity
and overall health. To allow comparison across measures, this was
standardised by estimating the ES, which was calculated as the difference in
mean scores between two adjacent groups of study participants with different
levels of mental symptom severity or overall health, divided by the standard
deviation of the scores obtained from the mildest of the two sub-groups.
Magnitude of the ES was judged as previously described, with a value
approximately 0.2 to 0.3 considered to indicate a small effect, a value around
0.5 a medium effect, and a value of 0.8 and above a large effect (Cohen,
1988). The statistical significance of differences in values between sub-groups
(pairwise comparisons) was assessed using t-tests. The significance of the
ability of the measures to distinguish across multiple distinct levels of mental
symptom severity and overall health was assessed by analysis of variance
(ANOVA), after applying a post-hoc F-test. Statistics were reported for
observations containing available data for every measure of interest.
Prior to the assessment of known groups validity, utility values generated from
all PBMs were plotted across sub-groups of study participants with different
levels of mental symptom severity as well as different levels of overall health.
Such plots allowed assessing whether utility values can measure an
improvement in perceived HRQoL resulting from a clinical improvement in the
condition of interest.
The convergence of PBMs with CSMs that capture changes in mental
symptom severity was explored as an indicator of the convergent validity of
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the PBMs. The extent of convergence was assessed by estimation of the
Pearson correlation coefficients between each PBM and the relevant CSMs
that were available in the datasets. Coefficients above 0.8 were considered
strong; those around 0.5 were deemed moderate, and up to 0.3 were thought
to be rather weak. The level of statistical significance of correlations was also
estimated. Statistical tests were performed by making pairwise comparisons
across all available observations.
Agreement between preference-based measures
PBMs could be seen as variables of the same class sharing the same metric
and variance (i.e. they all generate utility values on the same 1-0 full health-
death scale) but there are reasons for supposing they may be different, as they
capture different dimensions of HRQoL. Therefore, the level of agreement
across PBMs was assessed by estimating intraclass correlation coefficients
(ICC) (McGraw & Wong, 1996). Strong agreements were deemed those with
coefficients above 0.8; coefficients around 0.5 indicated moderate agreements;
and agreements with coefficients up to 0.3 were deemed rather weak. The
level of statistical significance of agreement was also estimated. Tests were
undertaken by making pairwise comparisons across all available observations.
Differences in the content between CORE-6D items and items of generic
preference-based measures
CORE-6D is by purpose more focused on mental health problems compared
with generic PBMs. Nevertheless, despite the difference in focus, a number of
CORE-6D items appear to be similar to generic PBM items. For example, the
physical item of CORE-6D appears to be directly related to the ‘bodily pain’
item of SF-6D, and also to the ‘pain/discomfort’ item of EQ-5D. Both CORE-6D
and SF-6D include a social functioning item. Also, SF-6D and EQ-5D have an
explicit mental health item each. Such similar items across different PBMs are
normally expected to capture the same underlying HRQoL dimension. In order
to explore the extent of similarities (or differences) in the content of the
different dimensions captured by CORE-6D and generic PBMs, Spearman
rank correlations were estimated between each of the CORE-6D items, and
each of the items of generic PBMs. Coefficients ≥ │0.40│, which showed a 
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moderate to strong correlation, indicated that the items of CORE-6D and the
generic PBM captured dimensions with similar aspects. The level of statistical
significance of the correlation was also of interest. Correlations between items
of CORE-6D and generic PBMs were examined in pairwise comparisons using
all available observations.
Content validity
Qualitative assessment of the content validity of CORE-6D was attempted by
comparing the content of the CORE-6D items with the content of the 7 major
themes of HRQoL that were identified as most relevant to people with mental
disorders by Brazier and colleagues (2014) and Connell and colleagues
(2012), as described in section 2.3.3 of Chapter 2. The 7 major themes of
HRQoL in people with mental disorders that were identified by the above
studies are subjective well-being & ill-being; activity & functioning; social well-
being, belonging & relationships; self-perception; control, autonomy & choice;
hope & hopelessness; and physical health. For comparison, the assessment of
the content validity of generic PBMs against these 7 themes of HRQoL, which
was reported in section 2.3.3 of Chapter 2, is presented later in this chapter as
well.
7.2.3 Datasets analysed
Data derived from three different UK studies were analysed: the first dataset
included a sub-sample of participants in the adult psychiatric morbidity survey
(PMS) conducted in Great Britain in 2000 (Singleton et al., 2001); the second
dataset included people with mild to moderate anxiety and/or depression
participating in a RCT of supervised self-help cognitive behavioural therapy
(psychological health by assessing self-help education – PHASE programme)
(Richards et al., 2003); and the third dataset consisted of data obtained from
postnatal women recruited for a multicentre RCT assessing psychological
interventions for postnatal depression (postnatal depression effectiveness
randomised controlled trial - PoNDER) (Morrell et al., 2009a & 2009b).
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PMS dataset
The PMS dataset contains data from a sub-sample of a much larger sample
included in a national psychiatric morbidity survey that was conducted in the
UK in 2000 (Singleton et al., 2001). All participants in this survey (8,580 adults)
had completed the CIS-R, an interviewer-administered questionnaire that
covers 14 non-psychotic symptoms. Total CIS-R score is an indication of the
overall symptom severity: a score of ≥6 suggests symptoms of a mental 
disorder, a score of ≥12 indicates a significant level of symptoms, and a score 
of ≥18 denotes symptoms of a level likely to require treatment (Lewis et al., 
1992). From the original survey sample, 3,536 respondents were selected for
follow-up interviews approximately 18 months later (Singleton & Lewis, 2003).
This follow-up sample included all participants in the initial survey who had
scored ≥6 on the CIS-R, indicating some symptoms or the presence of a 
mental disorder, as well as a random sample of 20% of the survey
respondents who had scored 0–5 on the CIS-R, indicating no mental disorder.
After a second follow-up interview, participants were randomly allocated to
complete one of three self-report paper measures of psychological wellbeing,
with 682 individuals being allocated to complete the CORE–OM. Of these, 558
returned questionnaires, with 553 providing valid CORE-OM questionnaires
(that is, questionnaires with at least 31 completed items). Data on these 553
respondents comprised the dataset used in this analysis. More details on the
process of the selection of the 553 adults included in the PMS dataset
analysed here are provided in Connell and colleagues (2007).
The dataset included responses to CORE-OM and SF-12, which allowed
estimation of CORE-6D and SF-6D utility scores, respectively. SF-12 was also
used in order to obtain mapped EQ-5D utility values. All data in the PMS
dataset were collected at a single time point; no follow-up data were available.
PHASE dataset
The PHASE dataset consisted of adults participating in a RCT evaluating self-
help cognitive behavioural therapy (CBT) facilitated by practice nurses against
ordinary GP care (control group) for mild to moderate anxiety and/or
depression, which was conducted in 17 general practices in north-east
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England. The dataset included 112 study participants that had completed
consent forms and the General Health Questionnaire-12 (GHQ-12), which was
used to detect clinical cases (a mean score of 3 and above indicated a clinical
case). Details on the selection of patients included in the dataset are reported
in Richards and colleagues (2003).
The dataset included responses to CORE-OM and EQ-5D, which allowed
estimation of CORE-6D and EQ-5D utility scores, respectively. Data were
available at baseline, end of treatment, 1-month follow-up and 3-month follow-
up (although there was no demarcated end of treatment for the control group,
assessment occurred at the same time as end of treatment for the self-help
CBT group to provide a 'matched' point of assessment). Due to large attrition
rates, the 112 participants provided in total 214 observations across the 4 time
points.
PoNDER dataset
The PoNDER dataset consisted of postnatal women recruited for a RCT
assessing psychological interventions for postnatal depression, conducted in
101 general practices in Trent, England, between 2003 and 2006. The dataset
included 3,689 women, of whom 3,437 provided data at baseline. Details on
the selection of women for the study are reported in two publications (Morrell et
al., 2009a & 2009b). Women diagnosed with postnatal depression according to
an Edinburgh postnatal depression scale (EPDS) score ≥ 12 were offered 
treatment (either by trained health visitors or standard care).
The dataset included responses to CORE-OM and SF-36, which allowed
estimation of CORE-6D and SF-6D utility scores, respectively. SF-36 was also
used to derive SF-12 data and subsequently mapped EQ-5D utility values.
Data were available at baseline (6 weeks postnatally) as well as at 6-month,
12-month, and 18-month follow-up. Analyses were undertaken on the whole
sample of 3,689 participants, who provided 9,439 observations across the 4
time points. In addition to these analyses, estimation of SRM and ES were also
performed on a sub-sample of women that were diagnosed with postnatal
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depression at baseline and had no missing data of interest at any time point in
the study.
7.2.4 Determining known groups of different mental
symptom severity and overall health in the datasets
The CORE-OM clinical score was used to determine different levels of mental
symptom severity across observations in all datasets, according to the severity
categories described earlier, due to lack of availability of other relevant
measures in the datasets. In the PMS dataset, CIS-R data were also used to
stratify respondents to different mental symptom severity levels: a score of 0-5
indicates little evidence of a mental disorder; 6-11 suggests some symptoms of
mental disorder; ≥12 indicates symptoms at a clinical level; and a score of 18-
63 denotes symptoms of a level likely to require treatment (Lewis et al., 1992).
The level of overall health of each respondent in the PMS and PoNDER
datasets was determined using their responses to the general health item 1 of
the SF-12 (“in general, would you say your health is 1. excellent 2. very good
3. good 4. fair 5. poor”). The latter allowed assessment of the ability of CORE-
6D to distinguish across different levels of overall (physical and mental) health,
which is nonetheless relevant to a population with mental health problems and
thus a desirable property for a mental health-specific PBM.
7.3 Results
7.3.1 Study sample characteristics and descriptive
statistics
Sample characteristics
The PMS study sample had a mean age of 44.3 years (standard deviation
14.4); 43% of the sample were male. The mean CORE-OM clinical score in the
study sample was 6.36 (standard deviation 5.19). Of the 553 respondents, 115
comprised clinical cases according to a CORE-OM clinical score ≥10 (20.8% of 
the sample). The mean CIS-R score was 7.40 (standard deviation 7.86); 122
respondents comprised clinical cases according to a CIS-R score ≥12 (22.1% 
of the sample). In the PHASE dataset, the mean age of the 112 participants in
the trial was 39.3 years (standard deviation 12.7); 23.3% of the participants
were male. The mean CORE-OM clinical score at baseline was 19.55
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(standard deviation 5.22). Of the 106 participants who provided CORE-OM
clinical scores at baseline, 103 (97.2%) scored at or above the clinical cut-off
level of 10. Data were available for 109 people at baseline and 54 people at
the end of treatment, while at the 1-month and 3-month follow-ups only 33 and
18 observations, respectively, were available. Finally, the mean age of the
PoNDER sample was 31.1 years (standard deviation 5.4). Of the 3,437 women
that provided responses at baseline (out of the 3,689 that were included in the
dataset), 595 (17.3%) were diagnosed with postnatal depression according to
an EPDS score ≥ 12, and 602 (17.5%) had a CORE-OM clinical score ≥ 10. 
Descriptive statistics
As illustrated in Table 40, all PBMs generated a wide range of utility values in
all 3 datasets, approximating each measure’s utility range, with the exception
of CORE-6D in the PMS dataset, where the range of its values was somewhat
narrower compared with the other two datasets (range 0.71 in the PMS
dataset vs. 0.85 in the PHASE and PoNDER datasets). The range of SF-6D
values was the narrowest, approximately 0.65 in both PMS and PoNDER
datasets, while EQ-5D (both direct and mapped) covered the widest range of
values (range ≥1 in all datasets), reflecting the (inherent) wider utility range of 
EQ-5D compared with the other two PBMs.
Overall, the mean value of CORE-6D was higher than that of the generic
PBMs, while its standard deviation was lower; the measure with the next
highest mean value was the mapped EQ-5D. Mean utility values of all PBMs
were higher in the PMS and PoNDER datasets compared with the PHASE
dataset, likely reflecting the high percentage of non-clinical cases in the PMS
and PoNDER study samples (approximately 80% in each dataset at baseline).
Table 40. Descriptive statistics, acceptability and floor and ceiling effects of all measures across the 3 datasets examined
Dataset Measure % missingdata Mean (SD) Minimum Maximum
% at floor
(worst state)
% at ceiling
(best state)
% at ceiling (best
state) in clinical cases
(CORE-OM ≥10) 
PMS
(n=553)
CORE-6D 2.0 0.86 (0.11) 0.24 0.95 0.0 22.3 3.5
(n=115)
SF-6D 0.9 0.77 (0.14) 0.37 1.00 0.0 1.5 0.0
Mapped EQ-5D 0.0 0.80 (0.23) -0.14 1.00 0.0 36.0 5.2
CORE-OM 0.0 6.36 (5.19) 0.00 30.00 0.0 8.6 NA
PHASE - all
observations
(n=214)
CORE-6D 9.7 0.70 (0.18) 0.10 0.95 0.5 4.6 0.0
(n=161)EQ-5D 6.9 0.60 (0.32) -0.18 1.00 0.0 9.4 1.3
CORE-OM 5.5 16.27 (7.73) 0.00 37.65 0.0 1.0 NA
PoNDER - all
observations
(n=9,439)
CORE-6D 1.1 0.89 (0.09) 0.10 0.95 0.0 34.6 0.4
(n=1,391)
SF-6D 3.1 0.77 (0.12) 0.34 1.00 0.0 1.4 0.1
Mapped EQ-5D 0.0 0.86 (0.16) -0.18 1.00 0.0 43.6 3.5
CORE-OM 0.6 5.04 (5.10) 0.00 36.47 0.0 19.0 NA
CORE-OM scores were considered to correspond to full health if they had a value between 0-0.99; SD = standard deviation
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7.3.2 Results of the psychometric analyses and statistical
tests
Acceptability
The percentage of missing values for CORE-6D were within the range of 1-2%
in the PMS and PoNDER datasets, which overall compared favourably with the
respective figures of the other PBMs (Table 40); no missing values were
recorded for mapped EQ-5D due to the probabilistic nature of the algorithm –
so this result does not reflect the measure’s acceptability. The CORE-OM
demonstrated lower percentages of missing data, as CORE-OM scores can be
estimated even when up to 3 item responses are missing. In the PHASE
dataset the percentage of missing values was higher for CORE-6D (9.7%)
compared with EQ-5D (6.9%), and both values were higher than the respective
figure for CORE-OM (4.2%).
Floor and ceiling effects
No PBM showed floor effects (Table 40); yet mapped EQ-5D and, in a
somewhat lesser degree, CORE-6D suffered from ceiling effects in the PMS
(36.0% and 22.3%, respectively) and the PoNDER (43.6% and 34.6%,
respectively) datasets, providing a first indication that they may not be able to
cover the whole severity range in the study population. However, the majority
of cases included in both these datasets (roughly 80% in each dataset) were
non-clinical cases according to their CORE-OM clinical score, and therefore
the high proportion of responses stating full health is not surprising. The
presence of ceiling effects in these datasets was subsequently investigated
following exclusion of all non-clinical cases, as defined by a CORE-OM clinical
score <10, from analysis. Ceiling effects were reduced to a large extent, falling
at 3.5% for CORE-6D and 5.2% for mapped EQ-5D in the PMS dataset, and
0.4% for CORE-6D and 3.5% for mapped EQ-5D in the PoNDER dataset. SF-
6D showed a minimal ceiling effect in both PMS and PoNDER full datasets
(around 1.4%). In the PHASE dataset, the percentage of ceiling effects for EQ-
5D and CORE-6D was 9.4% and 4.6%, respectively, and were eliminated
when only clinical observations (CORE-OM clinical score ≥10) were 
considered.
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Responsiveness to change over time
Changes in the values of all PBMs over time in the PoNDER dataset are
shown in Figure 22. Figure 22a shows data for cases with full utility data
available across all time points (n=716), while Figure 22b shows cases with a
diagnosis of postnatal depression (based on EPDS ≥12) at baseline and with
full utility data available across all time points (n=103). All 3 measures detected
comparable changes in HRQoL over time, indicating that the measures
capture changes over time in a similar way. CORE-6D utility values were
always higher than those generated using generic PBMs; SF-6D had the
lowest values at each time point. Changes in utility values beyond the time
point of 6 months were very small for all PBMs, both in the whole study sample
and in the sub-sample of women with postnatal depression at baseline. Utility
values generated from PBMs included in the PHASE dataset were not plotted
by period, due to the small number of observations with data on both CORE-
6D and EQ-5D (n=28 at 1-month follow-up and n=14 at 3-month follow-up).
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Figure 22. Utility values plotted by period, PoNDER dataset
a
b
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Table 41 provides findings on the mean change (and standard deviation), SRM
and ES of each measure between baseline and different time points of
analysis in the PHASE and PoNDER datasets. The table also presents the p-
values of the paired t-tests that assessed the significance of change over time
for each measure. In the PHASE dataset, CORE-6D showed a higher SRM
and ES than EQ-5D between baseline and each time point examined (i.e. end
of treatment, 1-month follow-up, and 3-month follow-up). CORE-6D
demonstrated a moderate to large SRM and ES across different time periods,
whereas the EQ-5D was characterised by negligible to moderate SRM and ES.
The CORE-OM showed consistently higher responsiveness than CORE-6D,
with values of SRM and ES exceeding 0.8 over any time period examined.
Paired t-tests verified the significance of the results at the 0.05 level, with the
exception of results obtained for the two PBMs between baseline and 3-month
follow-up, which lacked statistical significance, possibly due to the very low
number of observations (n=10). The number of observations used to compare
responsiveness of the measures in the PHASE dataset was in general very
small, and therefore the results should be interpreted with caution.
Results in the PoNDER dataset indicate that CORE-6D and CORE-OM had
minimal (but statistically significant) responsiveness to change over time, with
SRM and ES for both measures lying below 0.2 between baseline and the 3
time points examined (i.e. 6 months, 12 months, and 18 months). In contrast,
SF-6D and mapped-EQ-5D showed a moderate to large (and significant)
effect, with respective values of SRM and ES ranging from 0.51 to 0.75. In the
sub-analysis that included only women diagnosed with postnatal depression at
baseline, generic PBMs and the CORE-OM reflected a large, significant effect
across all time points (all SRM and ES were above 0.75). CORE-6D showed a
somewhat smaller but also significant responsiveness, with SRM and ES
values ranging from 0.54 to 0.66, probably due to some loss of information
relative to the CORE-OM.
Table 41. Responsiveness to change over time: standardised response mean and effect size
PHASE dataset – only participants with data available for all 3 measures
Measure
Baseline to end of treatment [N=39] Baseline to 1-month follow-up [N=21] Baseline to 3-month follow-up [N=10]
Mean change
(SD) SRM ES
t-test
p value
Mean change
(SD) SRM ES
t-test
p value
Mean change
(SD) SRM ES
t-test
p value
CORE-6D 0.09 (0.19) 0.45 0.49 0.008 0.16 (0.21) 0.78 0.85 0.002 0.12 (0.23) 0.52 0.54 0.134
EQ-5D 0.10 (0.27) 0.38 0.35 0.021 0.12 (0.18) 0.68 0.44 0.005 0.00 (0.27) 0.01 0.01 0.973
CORE-OM -6.27 (7.48) -0.84 -1.04 <0.001 -7.77 (7.99) -0.97 -1.19 <0.001 -7.32 (8.90) -0.82 -0.90 0.029
PoNDER dataset – only women with data available across all time points [N=716]
Measure
Baseline to 6 months Baseline to 12 months Baseline to 18 months
Mean change
(SD) SRM ES
t-test
p value
Mean change
(SD) SRM ES
t-test
p value
Mean change
(SD) SRM ES
t-test
p value
CORE-6D 0.02 (0.08) 0.19 0.18 <0.001 0.02 (0.09) 0.18 0.20 <0.001 0.02 (0.08) 0.19 0.20 <0.001
SF-6D 0.08 (0.12) 0.63 0.65 <0.001 0.08 (0.13) 0.58 0.66 <0.001 0.09 (0.13) 0.65 0.75 <0.001
Mapped EQ-5D 0.09 (0.17) 0.52 0.53 <0.001 0.10 (0.18) 0.53 0.58 <0.001 0.10 (0.19) 0.53 0.59 <0.001
CORE-OM -0.70 (4.27) -0.16 -0.14 <0.001 -0.65 (4.59) -0.14 -0.14 0.001 -0.46 (4.67) -0.10 -0.10 0.009
PoNDER dataset – only women with postnatal depression at baseline, with data available across all time points [N=103]
Measure
Baseline to 6 months Baseline to 12 months Baseline to 18 months
Mean change
(SD) SRM ES
t-test
p value
Mean change
(SD) SRM ES
t-test
p value
Mean change
(SD) SRM ES
t-test
p value
CORE-6D 0.07 (0.13) 0.57 0.61 <0.001 0.07 (0.14) 0.54 0.61 <0.001 0.08 (0.13) 0.64 0.66 <0.001
SF-6D 0.11 (0.12) 0.87 1.48 <0.001 0.12 (0.12) 1.01 1.62 <0.001 0.14 (0.14) 1.03 1.93 <0.001
Mapped EQ-5D 0.17 (0.21) 0.81 0.93 <0.001 0.18 (0.24) 0.77 0.99 <0.001 0.20 (0.24) 0.82 1.08 <0.001
CORE-OM -5.45 (6.08) -0.90 -1.10 <0.001 -5.65 (6.74) -0.84 -1.14 <0.001 -5.45 (7.06) -0.77 -1.10 <0.001
ES = effect size; SD = standard deviation; SRM = Standardised Response Mean; t-test = paired t-test
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Construct validity
Known groups validity
Utility values were first plotted across groups of different symptom severity
(Figure 23) and different levels of overall health (Figure 24) in the PHASE and
PoNDER datasets. Utility values across different CORE-OM clinical scores
were not plotted for the PMS dataset, due to the very low number of people
assigned to the more severe categories (n=38 in the 3 more severe categories
combined). The graphs demonstrated that utility values increased in a
consistent way as mental symptom severity decreased and general health
increased. Overall, CORE-6D demonstrated the highest utility values among
all PBMs and a shallower gradient compared with direct and mapped EQ-5D
utility values. SF-6D had the narrowest range of values among PBMs between
the worst and the mildest mental symptom severity groups as determined by
the CORE-OM clinical score. When symptom severity was determined by CIS-
R (PMS dataset), the range of values of all PBMs was narrower compared with
the utility range under CORE-OM-defined symptom severity. CORE-6D had
consistently the narrowest range of utility values between the worst and best
general health level, as defined by responses to question 1 of the SF-12.
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Figure 23. Utility values plotted by level of symptom severity
a
b
c
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Figure 24. Utility values plotted by level of general health
a
b
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CORE-6D and CORE-OM demonstrated the highest ES across different
mental symptom severity groups, defined by either CORE-OM (Table 42) or
CIS-R scores (Table 43). The ES values of CORE-6D exceeded 1 across all
adjacent CORE-OM symptom severity groups in all datasets, and reached 1
when symptom severity was determined by CIS-R. The ES values observed
for CORE-OM were substantially higher when known groups were defined by
CORE-OM scores, ranging from 2.67 to 4.38 (Table 42). When known groups
were defined by CIS-R, the CORE-OM ES was within the range of 1.0-1.5
(Table 43). T-tests confirmed the statistical significance of differences in the
CORE-6D values and CORE-OM scores in pairwise comparisons between all
different symptom severity groups (p<0.01).
In contrast, generic PBMs failed to discriminate between some levels of
adjacent symptom severity determined by the CORE-OM clinical score,
especially in the more severe end of symptoms, in the PMS and PHASE
datasets. However, lack of statistical significance is possibly attributable to the
small numbers of observations in the more severe end of symptoms in both
PMS and PHASE datasets. In the PoNDER dataset, mapped EQ-5D was able
to distinguish across adjacent levels of symptom severity, while SF-6D failed to
distinguish between more severe symptom levels. Both SF-6D and mapped
EQ-5D were able to distinguish across different CIS-R severity groups in the
PMS dataset. The ES values of generic PBMs were in most cases
considerably lower than those of CORE-6D (the ES of which was in the range
of 0.79-1.92), and varied between 0.36-1.22 for the SF-6D (except between
the two most severe CORE-OM levels in PMS where SF-6D moved in the
opposite direction from that expected), 0.39-0.60 for EQ-5D and 0.06-1.22 for
mapped EQ-5D, with higher ES values found in milder levels of symptom
severity (Table 42 and Table 43). The ES values of all PBMs were comparable
in the adjacent milder levels of symptom severity in the PoNDER dataset.
ANOVA confirmed the statistical significance of differences of all measures
across all groups of different symptom severity, determined by either the
CORE-OM or the CIS-R clinical score.
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Table 42. Known groups validity for different levels of mental symptom
severity determined by the CORE-OM clinical score
Severe Moderateto severe Moderate Mild
Non-
clinical
ANOVA:
<0.0011
PMS dataset [N=11] 2 [N=27] [N=71] [N=425] T-tests3
CORE-6D
Mean
(SD)
0.52
(0.16)
0.65
(0.10)
0.79
(0.09)
0.90
(0.06) <0.001
ES 1.30 1.46 1.92
SF-6D
Mean
(SD)
0.56
(1.12)
0.55
(0.09)
0.66
(0.12)
0.80
(0.12)
<0.001 to 0.055
1.0004ES -0.11 0.93 1.15
Mapped
EQ-5D
Mean
(SD)
0.45
(0.33)
0.47
(0.31)
0.70
(0.23)
0.86
(0.18)
<0.001 to 0.001
1.0004ES 0.06 1.04 0.89
CORE-OM
Mean
(SD)
24.16
(3.20)
17.42
(1.54)
11.75
(1.35)
4.19
(2.58) <0.001
ES -4.38 -4.20 -2.93
PHASE dataset [N=26] [N=47] [N=49] [N=39] [N=44]
CORE-6D
Mean
(SD)
0.39
(0.14)
0.58
(0.12)
0.71
(0.10)
0.80
(0.08)
0.87
(0.07) <0.001 to 0.008
ES 1.57 1.30 1.08 1.06
EQ-5D
Mean
(SD)
0.28
(0.29)
0.44
(0.31)
0.63
(0.31)
0.73
(0.17)
0.82
(0.23) <0.001 to 0.015
>0.055ES 0.53 0.60 0.59 0.39
CORE-OM
Mean
(SD)
27.88
(2.75)
22.41
(1.58)
17.14
(1.38)
12.77
(1.32)
5.00
(2.91) <0.001
ES -3.46 -3.82 -3.31 -2.67
PoNDER dataset [N=39] [N=124] [N=385] [N=799] [N=7,577]
CORE-6D
Mean
(SD)
0.42
(0.14)
0.59
(0.11)
0.71
(0.10)
0.80
(0.09)
0.92
(0.05) <0.001
ES 1.61 1.22 1.10 1.29
SF-6D
Mean
(SD)
0.53
(0.08)
0.58
(0.08)
0.61
(0.07)
0.66
(0.09)
0.79
(0.11) <0.001
>0.1006ES 0.61 0.36 0.58 1.22
Mapped
EQ-5D
Mean
(SD)
0.36
(0.22)
0.53
(0.24)
0.65
(0.18)
0.74
(0.16)
0.89
(0.13) <0.001
ES 0.70 0.63 0.56 1.22
CORE-OM
Mean
(SD)
27.79
(2.77)
22.00
(1.44)
17.02
(1.43)
12.03
(1.45)
3.23
(2.58) <0.001
ES -4.02 -3.48 -3.44 -3.41
ANOVA = analysis of variance; ES = effect size; SD = standard deviation
1. Significant for all measures in all datasets across different levels of symptom severity
defined by CORE-OM
2. Severe & moderate to severe levels were merged due to small number of observations
3. Level of significance in pairwise comparisons between different severity levels
4. Between ‘moderate’ and the merged level ‘moderate to severe and severe’
5. Between all adjacent symptom severity levels except between ‘moderate’ and ‘moderate to
severe’
6. Between ‘moderate’ and ‘moderate to severe’ as well as between ‘moderate to severe’ and
‘severe’
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Table 43. Known groups validity for different levels of symptom severity
determined by the CIS-R score - PMS dataset
Symptom severity level – by CIS-R score
ANOVA:
<0.0011
Measure 18+ [N=58] 12-17 [N=62] 6-11 [N=122] 0-5 [N=292] T-tests2
CORE-
6D
Mean (SD) 0.70 (0.16) 0.79 (0.10) 0.86 (0.09) 0.91 (0.05)
<0.001
ES 0.94 0.79 1.00
SF-6D
Mean (SD) 0.59 (0.11) 0.66 (0.13) 0.74 (0.12) 0.83 (0.11) <0.001
to 0.009ES 0.52 0.67 0.87
Mapped
EQ-5D
Mean (SD) 0.54 (0.31) 0.69 (0.26) 0.80 (0.18) 0.89 (0.15) <0.001
to 0.003ES 0.60 0.60 0.60
CORE-
OM
Mean (SD) 15.34 (5.94) 10.24 (3.47) 6.34 (3.26) 3.61 (2.69)
<0.001
ES -1.47 -1.20 -1.01
ANOVA = analysis of variance; ES = effect size; SD = standard deviation
1. Significant for all measures across different levels of symptom severity defined by CIS-R
2. Level of significance in pairwise comparisons between different severity levels
As shown in Table 44, both CORE-6D and CORE-OM were able to distinguish
between all adjacent general health levels, determined by responses to
question 1 of SF-12, in both PMS and PoNDER datasets, with the exception of
‘excellent’ and ‘very good’ general health in the PMS dataset (pairwise t-tests
non-significant). The ES of CORE-6D was higher than that of CORE-OM at the
worst end of health. The ES of CORE-6D ranged between 0.31 and 0.91. The
ES of CORE-OM had a narrower range, from 0.45 to 0.80. Generic PBMs were
also able to distinguish across different levels of general health and overall
demonstrated higher ES compared with the CSMs (especially the EQ-5D), a
finding that was expected given the nature of question 1 of SF-12 as a general
health item that can be deemed to mostly represent physical health. The
overall range of ES values in both PMS and PoNDER datasets was 0.56-0.96
for SF-6D and 0.61-1.57 for mapped EQ-5D. ANOVA established the statistical
significance of differences of all measures across all groups of different levels
of general health, as determined by responses to question 1 of SF-12.
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Table 44. Known groups validity for different levels of general health
determined by responses to question 1 of the SF-12
Poor Fair Good Very good Excellent ANOVA:
<0.0011
PMS dataset [N=46] [N=100] [N=172] [N=148] [N=68] T-tests2
CORE-
6D
Mean
(SD)
0.71
(0.15)
0.81
(0.11)
0.87
(0.09)
0.91
(0.06)
0.92
(0.05)
<0.001
to 0.009
1.0003ES 0.91 0.70 0.57 0.31
SF-6D
Mean
(SD)
0.55
(0.107)
0.67
(0.14)
0.78
(0.11)
0.83
(0.09)
0.88
(0.06) <0.001
to 0.013
ES 0.86 0.96 0.65 0.86
Mapped
EQ-5D
Mean
(SD)
0.36
(0.29)
0.69
(0.21)
0.84
(0.13)
0.90
(0.10)
0.98
(0.06) <0.001
to 0.007
ES 1.57 1.17 0.61 1.38
CORE-
OM
Mean
(SD)
12.54
(6.59)
8.72
(5.33)
5.98
(4.49)
4.44
(3.46)
3.21
(2.50)
<0.001
to 0.020
0.5853ES -0.72 -0.61 -0.45 -0.49
PoNDER dataset [N=46] [N=525] [N=2808] [N=4192] [N=1353]
CORE-
6D
Mean
(SD)
0.68
(0.16)
0.78
(0.13)
0.87
(0.10)
0.91
(0.06)
0.93
(0.05) <0.001
ES 0.78 0.83 0.71 0.36
SF-6D
Mean
(SD)
0.55
(0.11)
0.63
(0.10)
0.72
(0.11)
0.79
(0.11)
0.85
(0.10) <0.001
ES 0.84 0.83 0.67 0.56
Mapped
EQ-5D
Mean
(SD)
0.33
(0.29)
0.65
(0.20)
0.81
(0.15)
0.90
(0.12)
0.96
(0.09) <0.001
ES 1.53 1.08 0.75 0.67
CORE-
OM
Mean
(SD)
14.41
(7.41)
10.83
(6.49)
6.80
(5.47)
3.76
(3.81)
2.39
(3.03) <0.001
ES -0.55 -0.74 -0.80 -0.45
ANOVA = analysis of variance; ES = effect size; SD = standard deviation
1. Significant for all measures in both PMS and PoNDER datasets across different levels of
general health defined by question 1 of SF-12.
2. Level of significance in pairwise comparisons between different severity levels
3. Between ‘excellent’ and ‘very good’ response levels
Convergence
According to the results in Table 45, CORE-6D was strongly correlated with
CORE-OM, with Pearson correlation coefficients exceeding 0.80 in all
datasets, which was not an unexpected finding, given that CORE-6D is derived
from CORE-OM. The generic PBMs were moderately correlated with CORE-
OM, with all coefficients being within the range of 0.55-0.65. All PBMs showed
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moderate to strong correlations to CIS-R, which tended to be higher for CORE-
6D, with coefficients ranging from 0.53 (mapped EQ-5D) to 0.69 (CORE-6D).
All correlations were significant at the 0.01 level.
Table 45. Convergence: Pearson correlation coefficients of preference-
based measures with CORE-OM and CIS-R
CORE-OM CIS-R
PMS dataset PHASE dataset PoNDER dataset PMS dataset
CORE-6D -0.83 -0.84 -0.81 -0.69
SF-6D -0.64 NA -0.64 -0.62
EQ-5D NA -0.57 NA NA
Mapped EQ-5D -0.55 NA -0.61 -0.53
All correlations are significant at the 0.01 level (2-tailed); correlations are negative because
CORE-OM and CIS-R clinical scores increase with increased symptom severity
Agreement between preference-based measures
As shown in Table 46, CORE-6D demonstrated rather moderate to strong
agreement with generic PBMs, with ICCs ranging from 0.48 (agreement with
mapped EQ-5D, PMS dataset) to 0.71 (agreement with SF-6D, PoNDER
dataset). ICCs between SF-6D and mapped EQ-5D ranged from 0.73 to 0.88,
indicating strong agreement that is not surprising given that both generic PBMs
were derived / mapped from SF-36 or SF-12. All correlations were significant
at the 0.01 level.
Table 46. Agreement: Intraclass correlation coefficients between
preference-based measures
PMS dataset PHASE dataset PoNDER dataset
CORE-6D SF-6D CORE-6D CORE-6D SF-6D
SF-6D 0.62 1 NA 0.71 1
EQ-5D NA 0.67 NA
Mapped EQ-5D 0.48 0.73 NA 0.68 0.88
All correlations are significant at the 0.01 level (2-tailed)
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Differences in the content between CORE-6D and generic preference-
based measures
Correlations between the CORE-6D and the generic PBM items were rather
weak although significant in most cases (Table 47), indicating that CORE-6D
may capture different aspects of HRQoL from those tapped by generic PBMs.
Moderate to strong correlations (Spearman coefficients around 0.42-0.68)
were found:
a. between 4 of the CORE-6D items (all except the ‘risk-to-self’ item and
the physical item) and the ‘anxiety/depression’ item of EQ-5D
b. between the CORE-6D item “I feel terribly alone and isolated” and the
SF-6D items on ‘role limitations’, ‘social functioning’ and ‘mental health’
c. between the CORE-6D item “I am able to do most things I need to” and
SF-6D items on ‘role limitations’ and ‘social functioning’
d. between the CORE-6D physical item and
i. all SF-6D items except the ‘mental health’ one;
ii. the EQ-5D items on ‘pain/discomfort’ and ‘mobility’
Correlations between the CORE-6D physical item and the pain items of the
two generic PBMs were not as strong as it might have been expected
considering the overlapping content of these items (maximum correlation
coefficient observed in the datasets 0.68)
All other correlations between CORE-6D items and the items of generic PBMs
were weak or non-existent. In general, all CORE-6D items correlated weakly or
moderately (but in all cases significantly) with each of the 6 SF-6D items. On
the other hand, CORE-6D items correlated significantly (weakly or moderately)
only with some of the EQ-5D items.
Surprisingly, the CORE-6D items correlated rather weakly with the mental
health item of SF-6D (except the moderate correlation between the latter and
the CORE-6D item ‘I feel terribly alone and isolated’ - correlation coefficient
0.49), despite the focus of CORE-6D on mental health aspects of HRQoL.
Table 47. Correlations of CORE-6D items with SF-6D and EQ-5D dimensions: Spearman’s rank correlations
SF-6D dimensions: PMS datasetPoNDER dataset EQ-5D dimensions: PHASE dataset
CORE-6D items Physicalfunctioning
Role
limitations
Social
functioning
Bodily
pain
Mental
health Vitality Mobility
Self
care
Usual
activities
Pain /
discomfort
Anxiety /
depression
alone and isolated
0.17**
0.19**
0.37**
0.43**
0.32**
0.44**
0.21**
0.22**
0.38**
0.49**
0.24**
0.37**
0.10 -0.06 0.26** 0.13 0.50**
panic or terror
0.10*
0.14**
0.39**
0.30**
0.32**
0.33**
0.23**
0.16**
0.31**
0.36**
0.20**
0.25**
0.08 -0.03 0.25** 0.17* 0.48**
felt humiliated
0.03
0.11**
0.17**
0.27**
0.17**
0.27**
0.06
0.14**
0.22**
0.32**
0.09*
0.20*
0.13 0.02 0.19** 0.07 0.43**
able to do things
0.33**
0.17**
0.43**
0.30**
0.42**
0.34**
0.28**
0.18**
0.19**
0.32**
0.33**
0.32** 0.18* 0.16* 0.36**
0.11 0.48**
plans to end life
0.10*
0.05**
0.17**
0.10**
0.16**
0.11**
0.14**
0.06**
0.14**
0.12**
0.13**
0.08**
0.09 0.00 0.09 -0.02 0.17*
aches, pains
0.51**
0.42**
0.47**
0.32**
0.51**
0.33**
0.56**
0.63**
0.24**
0.21**
0.48**
0.32** 0.50** 0.38** 0.33** 0.68** 0.16*
Notes: *=correlation is significant at the 0.05 level (2-tailed); ** = correlation is significant at the 0.01 level (2-tailed). All coefficients ≥ 0.40 are shown in bold.
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Content validity
As illustrated in Table 48, the 6 items of CORE-6D capture, even if partially in
some cases, all 7 major domains of HRQoL that are important to people with
mental health problems, as identified by Brazier and colleagues (2014) and
Connell and colleagues (2012). Some items have been assigned to more than
one theme, with the secondary themes being indicated by items shown in
square brackets. The theme of subjective well-being & ill-being is only partly
covered by item “I feel panic or terror”, which does not cover depression and
focuses on ill-being caused by panic and anxiety symptoms rather than
positive well-being. More implicitly, it could be argued that the item “I feel
terribly alone and isolated” indicates depressive symptoms, and can also be
considered to reflect subjective ill-being. Positive aspects of activities and
functioning are captured, to some extent, by the item “I am able to do most
things I need to”. Close and social relationships are reflected in items “I feel
terribly alone and isolated” and “I feel humiliated or shamed by other people”,
respectively. The latter also reflects aspects of self-perception through the
eyes of others. The item “I am able to do most things I need to” suggests
autonomy and control over life. Hopelessness is captured by the item “I make
plans to end my life”. Finally, the physical item of CORE-6D (“I am troubled by
aches, pains, physical problems”) captures the theme of physical health.
As reported in section 2.3.3 of Chapter 2, Brazier and colleagues (2014)
assessed the content validity of EQ-5D against the 7 domains of HRQoL that
were identified as important to people with mental disorders. Of the 7 HRQoL
domains, EQ-5D captures well the one on physical health (by items on
mobility, self-care, usual activities and pain). Activity and functioning is vaguely
covered by the EQ-5D item on usual activities. Social well-being, belonging
and relationships is only partially captured by the EQ-5D item on usual
activities. Subjective ill-being (but, like CORE-6D, not well-being) is broadly
reflected in the EQ-5D item on depression and anxiety. EQ-5D is not able to
represent the remaining 3 domains of HRQoL that are important to people with
mental disorders, that is, control, autonomy and choice; self-perception; and
hope and hopelessness.
255
In the same section of Chapter 2 there is also an assessment of the content
validity of SF-6D against the 7 HRQoL domains that are important to
populations with mental health problems, as reported by Brazier and
colleagues (2014). Compared with EQ-5D, SF-6D covers a wider range of the
7 HRQoL domains that are relevant to mental health, as it is more balanced in
taping both physical and mental health aspects. SF-6D captures the domain of
physical health through its questions on physical functioning, vitality, and
bodily pain and its sub-question on role limitations due to physical problems.
Activity and functioning is covered by SF-6D items on physical functioning and
role limitations. Social well-being, belonging and relationships is broadly
captured by the social functioning item of SF-6D. Subjective well-being and ill-
being is covered by the mental health and the vitality SF-6D items and, partly,
by the sub-question on role limitations due to emotional problems. Similarly to
EQ-5D, SF-6D is unable to capture the remaining 3 domains of HRQoL that
are important to people with mental disorders, that is, control, autonomy and
choice; self-perception; and hope and hopelessness.
In summary, the qualitative assessment of the content validity of CORE-6D,
EQ-5D and SF-6D indicated that CORE-6D is more appropriate than generic
PBMs in capturing aspects of HRQoL that are important to people with mental
health problems.
Table 48. Content validation of CORE-6D against the main domains of health-related quality of life that are important to
people with mental health problems [as identified by Brazier and colleagues (2014) and Connell and colleagues (2012)]
Domain Sub-theme and summary description CORE-6D item
Subjective
well-being & ill-
being
Distress; associated with depression, experience of psychosis and mania and anxiety
Depressive mood; is associated with poor concentration, low energy and poor motivation
Fear or panic and anxiety; can be caused by stressful social situations
Psychosis-related: distress caused by critical voices, difficult to differentiate from reality
Positive well-being: happiness and enjoyment; feeling peaceful, calm, relaxed and safe
Energy and motivation (lack of both often caused by lack of sleep)
[I feel terribly alone and isolated]
I feel panic or terror
Activity &
functioning
Positive: work, hobbies or social interaction
Negative: stressful if too demanding; fear of stress may result in avoiding enjoyable activities
[I am able to do most things I need to]
Social well-
being,
belonging &
relationships
Relationships: close friends and family
Social relationships
Reactions of others – understanding, acceptance and stigma
Sense of belonging
I feel terribly alone and isolated
I feel humiliated or shamed by other people
Self-perception Self-identity
Self-efficacy, self-esteem and self-acceptance
Self-stigma
[I feel humiliated or shamed by other people]
Control,
autonomy &
choice
Dependence and independence – relating to support
Self-control: mainly related to relief / management of symptoms, usually through medication
Choice: money and access to resources
I am able to do most things I need to
Hope &
hopelessness
Dreams and goals, involvement in activities that give meaning and purpose
Hopelessness; lowering of aspirations I make plans to end my life
Physical health Physical comorbidity or experience associated with mental health problem I am troubled by aches, pains, physical problems
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7.4 Discussion
This chapter evaluated the psychometric properties and content of CORE-6D,
a PBM aimed at capturing HRQoL changes relating to common mental health
problems, relative to those of the generic PBMs EQ-5D and SF-6D, using 3
different datasets. Where EQ-5D utility values were not directly available, they
were obtained via mapping using SF-36 or SF-12 data. CORE-6D was also
compared with the CORE-OM (the measure that CORE-6D was derived from)
to assess the degree of the loss of information arising from moving from a 34-
item instrument to a 6-item measure. Finally, CORE-6D was assessed for its
content validity against the 7 areas of HRQoL that have been found to be most
relevant to people with mental health problems.
Summary of findings
Comparisons between preference-based measures
CORE-6D appeared to have comparable acceptability to generic PBMs
(reflected in small percentage of missing data), and showed no floor or any
significant ceiling effects in populations with common mental health problems.
The responsiveness of CORE-6D was better than that of EQ-5D in the PHASE
dataset, although this finding must be interpreted with caution due to small
numbers of pairwise observations across different time points. In the PoNDER
dataset, CORE-6D showed negligible responsiveness in the whole sample of
postnatal women, but this reflected the poor performance of CORE-OM in this
sample. The responsiveness of both CORE-6D and CORE-OM was much
improved when data exclusively from women diagnosed with postnatal
depression at baseline were analysed. Generic measures showed persistently
moderate to high responsiveness in the PoNDER dataset, regardless of the
sample used in the analysis.
CORE-6D demonstrated a substantially better ability to distinguish across
different symptom severity groups defined by either the CORE-OM or the CIS-
R score compared with generic PBMs. However, with respect to CORE-OM
defined severity groups, this may be expected as CORE-6D is derived from the
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CORE-OM and is made up of a subset of CORE-OM items. On the other hand,
generic PBMs showed somewhat better (and, in contrast to CORE-6D, always
significant) ability to distinguish across groups with different levels of general
health as determined by responses to question 1 of the SF-12.
CORE-6D utility values showed better correlation with CORE-OM than any
other generic PBM did, but this was anticipated, considering its derivation from
CORE-OM and its sharing of common items. On the other hand, the
correlation of all PBMs with CIS-R, which was used as an indicator of
convergent validity, was comparable. Agreement between CORE-6D and the
generic PBMs was moderate to strong. Regarding the correlations between
individual items of CORE-6D and items of generic PBMs, all CORE-6D items
correlated weakly to moderately with each of the SF-6D items; on the other
hand, the only correlations between CORE-6D and EQ-5D items were
moderate and were observed between the CORE-6D emotional items and the
depression/ anxiety item of EQ-5D, and also between the CORE-6D physical
item and the EQ-5D items on mobility and pain/discomfort.
In contrast to generic PBMs, CORE-6D appeared to broadly cover all 7 major
themes of HRQoL that have been found to be important to people with mental
disorders, although some important sub-themes, such as subjective well-being,
were not captured by any of the CORE-6D items.
Extent of loss of information relative to the CORE-OM
As anticipated, CORE-6D correlated strongly with the CORE-OM;
nevertheless, there was a modest reduction in the responsiveness of CORE-
6D relative to that of the CORE-OM, suggesting some loss of sensitivity.
Perhaps not surprisingly, CORE-OM showed a substantially higher ability than
CORE-6D in distinguishing across different symptom severity groups when
symptom severity was determined using the CORE-OM clinical score.
However, the two measures were more comparable in distinguishing across
different symptom severity groups determined by CIS-R. The ability of the two
measures in distinguishing across different levels of general health was similar,
with CORE-6D showing better ability at the lower levels of health, while both
measures seemed unable to capture small differences between adjacent high
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levels of general health (as measured by responses to question 1 of the SF-
12). These results overall suggest a rather small loss of information at the
derivation of CORE-6D from CORE-OM.
Interpretation of the results
The results indicate that the performance of CORE-6D overall compares to
that of generic PBMs. CORE-6D showed, as expected, higher ability to
distinguish across groups with different levels of mental symptom severity, and
lower ability to distinguish across groups with different levels of overall health.
It also showed higher responsiveness that EQ-5D in the PHASE dataset. The
low responsiveness of CORE-6D and CORE-OM that was observed in the
PoNDER dataset can be possibly explained by the fact that the majority of
women in the sample (about 83%) did not have postnatal depression at
baseline and therefore had little scope for improvement in mental health
symptoms which are the focus of CORE-6D and CORE-OM. On the other
hand, the moderate responsiveness of the generic PBMs in the whole sample
can be justified on the basis of evidence that childbirth is associated with
numerous physical problems, accompanied by extreme tiredness and
exhaustion due to the demands of parenting, which naturally resolve over time
(Bick & MacArthur, 1995; Brown & Lumley, 1998; Thompson et al., 2002); such
problems most likely reduce the baseline HRQoL in terms of physical and
social functioning, usual activities, self-care and vitality, i.e. dimensions that
are the main focus of generic PBMs. It therefore appears that SF-6D and
mapped-EQ-5D apparently captured the scope for natural improvement in the
physical health of all postnatal women over the time period following childbirth.
The increased responsiveness of all measures (in particular of the condition-
specific ones) in the sub-sample of women with postnatal depression may
suggest that the condition-specific measures captured the improvement in
mental health symptoms of the depressed women following treatment,
whereas the changes in the generic PBMs over time reflected the
improvements in overall health experienced by the women in this sub-group.
The lack of strong correlations between individual items of CORE-6D and
items of generic PBMs suggests that CORE-6D may capture different aspects
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of HRQoL from those reflected in items of generic PBMs, even though the
content of some CORE-6D items appears to overlap with the content of some
of the items of the generic PBMs. The lack of strong correlations between
seemingly similar items of CORE-6D and generic PBMs may be attributable to
i. differences in the context, as items are answered within a different set
of questions, with CORE-6D items being embedded in a large, mental
health-specific questionnaire and SF-6D items being embedded in a 12-
item or a 36-item generic HRQoL instrument (while EQ-5D forms a
distinct questionnaire)
ii. differences in the wording of the items
iii. differences in the recall period related to each measure: CORE-6D
measures health over the past week, SF-6D asks questions mostly over
the past 4 weeks, whereas EQ-5D measures health today.
Nevertheless, the most important differences between CORE-6D and generic
PBMs lie in the actual content of their items, as revealed by qualitative
assessment of their content against the 7 themes identified as relevant to
people with mental health problems, with CORE-6D covering fully or partially
all 7 areas, while generic PBMs were able to represent only 4; this is in line
with the conclusion of Brazier and colleagues (2014), who noted that the
factors that determine the HRQoL in people with mental health problems are
quite complex and generic measures are not able to capture the aspects of
HRQoL that matter most to this population due to their focus on physical
aspects of health.
Limitations of the analyses
Analyses described in this chapter were conducted on 3 separate datasets.
This increased the number of analyses that could be performed and allowed
checking of the reproducibility of results in different populations. The selection
of these 3 datasets was dictated by the need for concurrent availability of
CORE-OM and generic PBM data in the same dataset. However, of the 3
datasets, only the PHASE dataset included a ‘clinical’ population seeking
treatment for common mental health problems. The PMS dataset included
participants in a survey, a considerable proportion of whom had no indication
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for or symptoms of a mental health problem; in the PoNDER dataset only a
minority of women were diagnosed with postnatal depression at baseline.
Consequently, with the exception of the PHASE dataset, the dataset
populations are not fully representative of people with common mental health
problems, which is the target patient population of the CORE-6D. A further
limitation was that, with the exception of CIS-R in the PMS dataset, the
different severity sub-groups used to test the known groups validity of PBMs
were determined by CORE-OM clinical scores, due to unavailability of
alternative mental health-specific instruments in the datasets. This is likely to
have introduced bias in the analyses, as CORE-6D is directly related to the
CORE-OM; therefore its superior performance in terms of known groups
validity across symptom severity groups relative to generic PBMs is not
surprising. On the other hand, it should be noted that CORE-6D demonstrated
a higher known groups validity relative to EQ-5D and SF-6D even when CIS-R
was used to form different symptom severity groups.
Another limitation of the analyses was that responsiveness to change over
time was assumed to reflect underlying important changes in health and
HRQoL following treatment. However, it is not known whether treatment was
effective in the study samples and, if it was, to what extent, and therefore
responsiveness has been measured on the assumption and expectation
(rather than real observation) that people’s health and HRQoL did change
overtime following treatment. This assumption was necessary due to lack of a
gold standard measure that could confirm underlying differences in health and
HRQoL overtime.
Finally, validation of CORE-6D was attempted by comparing its performance to
that of generic PBMs. However, since the use of generic PBMs in mental
health population is, as already discussed in Chapter 2, problematic,
comparison of CORE-6D with generic PBMs is not ideal. On the other hand,
quality of life is a subjective as well as complex concept, for the measurement
of which no acceptable gold standard is available at the moment (Brazier et al.,
2014). Since a more relevant and reliable comparison was not possible,
assessment of the properties of CORE-6D relative to those of generic PBMs
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was considered acceptable. It is acknowledged, though, that, although such
comparisons may provide some indications on the psychometric performance
of CORE-6D, they cannot lead to unambiguous results that prove or discard
the measure’s value as a mental health-specific PBM.
7.5 Conclusion
The analyses presented in this chapter show promising results regarding the
acceptability, validity and responsiveness of CORE-6D as a condition-specific
PBM, although no firm conclusions on the psychometric properties of CORE-
6D can be drawn at this stage. CORE-6D shows acceptable agreement with
generic PBMs and suffers from relatively small loss of information compared
with the CORE-OM. Its items can broadly capture all HRQoL aspects that are
important to people with mental health problems, although it is acknowledged
that each aspect covers a broad area of HRQoL and includes several sub-
themes, the majority of which are not reflected in CORE-6D items. However,
any limitations regarding loss of information and inability to capture a number
of HRQoL sub-themes that are relevant to people with mental disorders might
be deemed to be acceptable, considering that CORE-6D is by intension a
brief, concise 6-item measure. The findings on the psychometric properties of
CORE-6D are constrained by a number of limitations. Nevertheless, the
properties of CORE-6D suggest that it may be appropriate to use as a utility
measure in economic evaluations of interventions for common mental health
problems. Further research should explore the psychometric properties of
CORE-6D in more depth and establish its value as a PBM for people with
common mental health problems.
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Chapter 8. Discussion and conclusion
8.1 Introduction
The subject of this thesis was the development of CORE-6D, a PBM that is
relevant to common mental health problems, derived from a large CSM, the
CORE-OM. Due to the high correlation between the domains and items of
CORE-OM, a novel methodology was developed and applied for the derivation
of CORE-6D, rather than standard methods described in the literature previous
to this research, which have been employed for the development of typically
multidimensional PBMs.
The methodology adopted in the development of CORE-6D as well as its
strengths and limitations have been described in previous chapters. The
purpose of this final chapter is to evaluate the contribution of this thesis to the
broader methodology described in the literature for the derivation of PBMs
from existing measures, discuss the implications for policy resulting from the
output of this thesis, point to some broader issues on the role of condition-
specific PBMs in the wider healthcare resource allocation environment and the
potential role of patients’ preferences in the economic assessment of
healthcare interventions, and propose areas for further research.
8.2 Contribution of this thesis to the methodology
for deriving preference-based measures from
existing instruments
The standard methodology that is described in the literature for the derivation
of health state classifications from existing, longer measures, the subsequent
selection of health states for valuation and the modelling techniques used to
attach appropriate utility values to all health states described by the health
state classification presupposes independence between the dimensions of the
original measure. In summary, the standard methodology for the derivation of
health state classifications comprises identification and/or establishment of the
dimensions of the original measure using FA or PCA, followed by selection of
the most suitable item(s) of each dimension based on psychometric criteria,
judgement and, more recently, Rasch analysis. This process typically results in
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the development of a health state classification where each item represents
one dimension and items are not considerably correlated to each other. For
the selection of the health states to be valued and for the modelling of
valuation data in order to produce an algorithm linking all possible health
states to a utility value, the two main approaches proposed in the literature are
the composite, which uses statistical designs for the selection of a sample of
health states for valuation, followed by regression modelling techniques for the
prediction of utility values for all health states described by the health state
descriptive system; and the decomposed, based on MAUT, which involves
valuation of individual dimensions and of a number of multidimensional states
followed by the development of a system of equations that allow attaching
utility values to every multidimensional health state. Both approaches require
dimensions to be independent and not highly correlated at the descriptive
level.
The novel methods proposed in this thesis for the derivation of new PBMs from
existing instruments are appropriate to apply to unidimensional measures or
measures with highly correlated dimensions, in order to overcome problems
that would arise from employment of conventional techniques: one such
problem could be the generation of implausible health states when using
statistical designs; another implication from the use of standard techniques
could be the need for complex econometric modelling to take account of
multiple interaction effects between highly correlated items when modelling
utility values. The proposed methodology, which avoids this kind of problems,
is likely most applicable to CSMs that have a narrow scope, for example by
focusing mainly on symptoms or one aspect of patients’ HRQoL. In all cases,
the dimensionality of the existing measure should be examined at an initial
stage of the process; exploratory FA can be used for this purpose, to give an
indication of the extent of unidimensionality and the number of dimensions
covered by the original instrument (Tennant & Pallant, 2006).
If the original instrument is clearly multidimensional, then standard
methodology is appropriate to use, as described in the relevant literature (for
example, Brazier et al., 2002 & 2008; Young et al., 2009 & 2011). If, on the
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other hand, the original instrument is found to have a largely unidimensional
component or highly correlated dimensions, then Rasch analysis can be used
to select items in order to construct a unidimensional health state classification
(or a health state classification with a large unidimensional component) and to
select plausible health states for valuation by inspection of the Rasch item
threshold map. Subsequently, if the new health state classification comprises a
unidimensional scale, then the approach described by Young and colleagues
(2010) can be adopted in order to predict utility values for all potential health
states using the results of Rasch analysis. If, on the other hand, the new health
state classification has more dimensions but with a prevailing unidimensional
component, then the hybrid approach developed for this thesis can be used for
modelling utility values following the valuation of plausible health states.
The methodology developed for this thesis regarding the derivation of health
state classifications from instruments without clear multidimensional structure
has already been adopted by a number of studies that were undertaken after
the work conducted for this thesis was reported. The earliest of these studies
was carried out by Young and colleagues (2010), who used Rasch analysis in
order to derive a health state descriptive system from the Flushing Symptoms
Questionnaire (FSQ), a unidimensional scale measuring symptoms associated
with flushing as a side effect of taking niacin medications. Following
construction of a unidimensional health state classification based primarily on
Rasch analysis, the authors identified plausible health states by inspection of
the Rasch item threshold map and undertook a valuation survey. Up to this
point, the study adopted the approach proposed in this thesis. The authors
developed this approach further, as their study was the first to examine the
relationship between the utility values obtained from the valuation survey and
the respective Rasch logit values of the health states valued, and to use this
relationship in order to model utility values for all health states described by the
PBM.
Kowalski and colleagues (2012) adopted the methodology developed for this
thesis to derive a unidimensional health state classification from the National
Eye Institute Visual-Function Questionnaire-25 (NEI VFQ-25). A number of
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health states were subsequently included in a valuation survey, followed by
regression modelling in order to attach utility values to all health states
described by the classification (Rentz et al., 2014). The method for selection of
health states for the valuation survey was not reported, but it was likely based
on the methodology proposed in this thesis, as subsequent modelling of utility
data followed the method developed by Young and colleagues (2010). The
authors justified adopting this modelling approach “because the dimensions of
the health state descriptions [were] not independent” and therefore
“conventional methods [for modelling valuation data] could not be used”.
Versteegh and colleagues (2012) also used Rasch analysis as proposed in
this thesis to derive a unidimensional health state classification from the Health
Assessment Questionnaire (HAQ), a measure widely used in rheumatology to
assess functional abilities. Selection of health states for valuation was made
using an orthogonal block design combined with a selection of the most
observed health states and modelling of valuation data followed standard
statistical methodology, without inclusion of any interaction terms. The authors
reported that “the unidimensionality of the HAQ caused some problems in the
valuation task” because items of the classification were highly correlated
resulting in one of the health states selected for valuation being implausible
and causing “confusion with some of the respondents”. Use of the Rasch item
threshold map for the selection of health states would have prevented this
situation, as it would have led to the identification of plausible health states for
inclusion in the valuation survey.
In the same publication (Versteegh et al, 2012), the authors reported that they
derived a 2-dimensional health state classification from the Multiple Sclerosis
Impact Scale 29 (MSIS-29), an instrument assessing the physical and
psychological impact of multiple sclerosis. MSIS-29 consists of a physical and
a psychological scale and Rasch analysis was undertaken separately on each
scale, to create a 2-dimensional health state classification consisting of two
unidimensional components. The authors employed standard techniques for
the selection of health states (combined with a selection of the most observied
health states) and for modelling utility values for all states described by the
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health state classification, without reporting any problems regarding the
plausibility of the health states selected for the valuation survey or the need for
complex modelling to account for interaction between items within each of the
2 unidimensional components of the new measure.
In addition to those studies, Sundaram and colleagues (2009) developed in
parallel similar methodology with that proposed in this thesis in order to derive
a health state classification from the Audit of Diabetes-Dependent Quality-of-
Life (ADDQoL), a 18-item instrument measuring HRQoL in patients with
diabetes. As part of the process, Rasch analysis was undertaken on the whole
measure aiming to develop a unidimensional instrument amenable to
valuation. The resulting health state classification, the Diabetes Utility Index
(DUI) was reported to be unidimensional and, at the same time, to consist of 5
distinct attributes (physical ability and energy level, relationships, mood and
feelings, enjoyment of diet and satisfaction with managing diabetes). Valuation
of DUI was achieved following application of MAUT using a multiplicative
model that took account of the preference interactions between the attributes
(Sundaram et al., 2010).
Overall, the literature suggests that the methodology developed for this thesis
can be useful (and has already been used) in the development of PBMs that
are derived from instruments with high correlations between their items, both in
the construction of the health state classification and in the selection of
plausible health states for valuation.
8.3 A new preference-based measure for cost-
utility analysis of mental health interventions –
implications for mental health policy and practice
The output of this thesis, CORE-6D, is a 2-dimensional PBM, consisting of a 5-
item emotional component and a physical item. It has been developed
following Rasch analysis and psychometric testing on CORE-OM data from
people with common mental health problems presenting to NHS primary care
services, and has been validated on a large mixed sample of people
presenting to either primary or secondary services in the UK. Therefore, it is
suitable for use in a wide range of services and settings, and can capture the
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full spectrum and range of symptom severity of common mental health
problems, as ensured by the Rasch analysis criteria used at its development.
8.3.1 Comparison of the psychometric properties of
CORE-6D with those of generic preference-based
measures
By design, CORE-6D appears to be more suitable than generic PBMs such as
EQ-5D, SF-6D and HUI-3 for the estimation of QALYs in cost-utility analyses
undertaken in the area of mental health. With 5 out of its 6 items representing
emotional aspects of HRQoL, CORE-6D appears to be more relevant to
people with mental disorders, compared with EQ-5D, which consists of 4 items
on physical health (mobility, self-care, usual activities and pain/discomfort) and
one mental health item (anxiety/depression). Similarly, HUI-3 contains 6
‘physical health’ attributes (vision, hearing, speech, ambulation, dexterity and
pain), one attribute on cognition, and only one on emotion. SF-6D on the other
hand, although generic, is somewhat more balanced between physical and
emotional aspects of HRQoL, with 3 exclusively ‘physical health’ dimensions
(physical functioning, bodily pain and vitality), one pure ‘mental health’
dimension, and 2 dimensions relating to both physical and mental health (role
limitations and social functioning).
Indeed, as discussed in Chapter 2, the report by Brazier and colleagues
(2014), which attempted to validate generic PBMs in a range of mental
disorders, described a mixed picture of the performance of EQ-5D and SF-6D
regarding their psychometric properties, which depended also on the type of
mental disorder assessed. Overall, EQ-5D and SF-6D showed good construct
validity and responsiveness in the area of common mental health problems,
which is the focus of CORE-6D. Generic PBMs appeared to perform
satisfactorily in depression, but less so in anxiety and personality disorders.
Results were mixed in schizophrenia and bipolar disorder. The authors
suggested that generic PBMs may be picking depressive symptoms (or
comorbid depression) rather than core symptoms associated with a range of
conditions, including anxiety and schizophrenia. In dementia, self-reported EQ-
5D had questionable validity and poor agreement with proxy EQ-5D ratings;
the later appeared to have higher validity (Hounsome et al., 2011).
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The review of qualitative evidence on aspects of HRQoL that are important to
people with mental health problems suggested that generic PBMs fail to
address the complexity of quality of life measurement and the broad range of
domains that are important to people with mental health problems. Based on
their findings, the authors concluded that none of the existing generic
measures can adequately capture the aspects of HRQoL that are important to
people with mental health problems and proposed the development of a new
mental health-specific PBM that is relevant across all populations with mental
health problems. The authors acknowledged that it may not be possible to
capture all dimensions of physical and mental health with the same detail in
the new measure, but the latter would need to incorporate the impact of both
physical and mental health problems.
As reported in Chapter 7, psychometric analyses of CORE-6D data showed
promising results regarding the measure’s responsiveness and construct
validity in populations with common mental health problems, although these
analyses had a number of limitations and further research needs to validate
the findings. In contrast to generic PBMs, CORE-6D is able to broadly tap the
7 major themes of HRQoL that were found to be most relevant to people with
mental disorders, namely, subjective well-being & ill-being; activity &
functioning; social well-being, belonging & relationships; self-perception;
control, autonomy & choice; hope & hopelessness; and physical health
(Brazier et al., 2014; Connell et al., 2012). It is true that CORE-6D focuses
largely on emotional symptoms, captured by its 5 emotional items, but it also
incorporates the impact of physical problems on HRQoL, as it includes a
physical item. The composition of CORE-6D reflects the structure of the
original measure CORE-OM, which has been designed primarily for the
monitoring of emotional, rather than physical, symptoms. Inclusion of one
physical item in CORE-6D allows a rather crude representation of physical
symptoms, which, nevertheless, enables the assessment and valuation of both
emotional and physical dimensions of HRQoL in people with common mental
health problems.
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8.3.2Use of CORE-6D in cost-utility analysis of mental
health interventions – advantages, limitations and
implications
Cost-utility analysis has proved to be problematic in the area of mental health.
Generic PBMs that would allow estimation of QALYs are not routinely used in
mental health clinical practice or in the design of clinical and/or economic
studies, possibly revealing unacceptability of such measures among mental
health practitioners, patients and researchers (Crawford et al., 2010; Gilbody
et al., 2003). A review of relatively recent NICE guidelines in the area of mental
health, which included systematic reviews of economic evaluations of
pharmacological and psychosocial mental health interventions, suggests that
less than 50% of the economic evaluations in this area are in the form of cost-
utility analysis. More specifically, in the area of depression, only 13 out of the
29 economic evaluations published between 1998-2008 that were included in
the respective NICE guideline were cost-utility analyses and only 9 of them
reported use of a generic PBM (National Collaborating Centre for Mental
Health, 2010a). In the area of GAD, 2 of the 5 economic analyses published
between 1997-2009 that were included in the NICE guideline were cost-utility
analyses (National Collaborating Centre for Mental Health, 2011), while in the
area of social anxiety only one out of the 4 economic evaluations that were
included in the NICE guideline used the QALY as the measure of outcome
(National Collaborating Centre for Mental Health, 2013). In more severe mental
disorders such as bipolar disorder and schizophrenia the proportion of cost-
utility analyses in economic evaluations considered alongside NICE guideline
development was 6/14 (National Collaborating Centre for Mental Health, 2014)
and 10/35 (National Collaborating Centre for Mental Health, 2010b),
respectively. In particular in the area of schizophrenia only 3 out of the 10 cost-
utility analyses utilised a generic PBM, with the remaining 7 using utility values
estimated based on vignettes or a CSM. This latter finding may reflect the
perceived unsuitability of using generic PBMs in the area of schizophrenia. It
should be noted that a number of the NICE guidelines reviewed above were
published a few years ago, and the proportion of economic studies in the form
of cost-utility analysis as well as the use of generic PBMS for estimation of
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QALYs in the areas covered by the guidelines is likely to have increased in
more recent years.
The majority of economic studies identified in the review of NICE clinical
guidelines were cost effectiveness or cost consequence analyses, where the
outcome measure was often expressed as ‘proportion of people responding to
treatment’, ‘number of relapses avoided’, ‘number of depression-free days’,
and so on. Use of such measures in economic evaluation may reflect
unacceptability or perceived inappropriateness of generic PBMs in the area of
mental health, or even lack of a more appropriate condition-specific PBM.
However, use of natural units as outcome measures in economic studies limits
comparability across disease areas (even within mental health) and requires
outcome-specific judgements when determining cost effectiveness. A more
characteristic example is when the measure of outcome is expressed as a
change score on a continuous scale, so that the ICER is estimated as cost per
change in score, making judgements on cost effectiveness dubious or even
impossible (for example McCrone et al., 2009, who evaluated the cost
effectiveness of computerised self-help in people with agoraphobia/panic
disorder). The limitations arising from use of outcome measures other than the
QALY highlight the need for use of a valid, responsive and acceptable PBM
that can be used for estimation of QALYs in the area of mental health.
In this context and given the lack of contect validity of generic PBMs in mental
health, CORE-6D can be used to conduct cost-utility analyses for the
assessment of interventions and programmes for common mental health
problems. Results of such analyses will be more readily interpretable
compared with economic analyses that use a natural unit as the measure of
outcome; moreover, they allow comparisons with results of cost-utility analyses
in other areas of mental health. The value of CORE-6D as a PBM is increased
considering the wide use of CORE-OM (and, consequently, CORE-6D) for the
clinical monitoring of people with common mental health problems in the UK
practice setting. CORE-OM is an acceptable measure to both patients and
healthcare professionals; moreover it is freely available to users (Barkham et
al., 2001). Derivation of utility values from CORE-6D does not place any
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burden on patients in terms of answering extra questionnaires when CORE-
OM data are being recorded. Relevant syntax can be read by SPSS data files
to estimate utilities directly, when CORE-OM data are available, so there is no
extra burden to researchers or clinicians either.
One limitation of CORE-6D in the wider mental health services context is that it
is probably not suitable to use as a universal PBM across all mental health
conditions. This is because the original instrument, CORE-OM, has been
designed for the measurement of psychological distress primarily associated
with common mental health problems; these include various forms of unipolar
depression and anxiety disorders such as GAD, panic disorder, phobias, and
OCD. CORE-OM covers aspects of severe mental illness, as it includes items
capturing suicidal thinking, self-harm, threatening behaviour and other severe
distress. However, CORE-OM was not specifically designed for people with a
psychotic element, and therefore may not be valid for outcome measurement
in people with psychosis, including people with schizophrenia, bipolar disorder
and personality disorders. Consequently, CORE-6D may not be appropriate for
the estimation of QALYs in the evaluation of interventions targeted at psychotic
disorders and therefore cannot be used as a generic mental health PBM.
Nevertheless, common mental health problems constitute the most prevalent
group of mental disorders, experienced by 17.6% of people aged 16 to 64
years in England; for comparison, the prevalence of psychotic disorders in this
population is 0.4% (McManus et al., 2009). It can be thus concluded that
CORE-6D is suitable for the estimation of QALYs in the large majority of
people with mental disorders, including those with common mental health
problems and, potentially, those with more severe mental illness, such as, for
example, people self-harming. It is acknowledged that the purpose of this
thesis was to develop a generic mental health PBM that can be used across all
mental health areas. However, currently, an outcome measure that is valid and
responsive in capturing symptoms and aspects of HRQoL that are relevant
across all mental disorders, which could be used to derive a generic mental
health PBM, does not seem to exist. Therefore, a generic mental health PBM
would need to be developed de novo, and this is proposed in section 8.6.7.
273
One point worth noting is that CORE-6D is not an autonomous measure; its 6
items are embedded in the 34-item CORE-OM. Reading the 6 items of CORE-
6D within the context of the CORE-OM questionnaire may effect the meaning,
intensity and relative importance of each of the 6 items, which, in turn, may
have an impact on the responses obtained. Although there is evidence that the
response rates and quality of responses to instruments embedded in longer
questionnaires are not affected by the length of the questionnaire (Jenkinson
et al., 2003), it is not known whether and how the context of the longer
questionnaire affects responders, and whether isolation of a small number of
items (such as the items of CORE-6D) out of the context of a longer
questionnaire (such as the CORE-OM), has any effect on rates and levels of
responses. Use of CORE-6D as an independent measure in a study that does
not use CORE-OM may be appealing, given the measure’s brevity and
function as a utility measure, but may in theory elicit different responses from
those obtained when all 34 items of CORE-OM are included in the
questionnaire.
Indeed, a study that compared SF-6D utility values generated from responses
to the SF-36 with utility values obtained from the SF-6D administered as an
independent instrument demonstrated that there were significant differences
between the two sets of values (Ferreira et al., 2013). The authors concluded
that since the SF-6D was originally designed to derive utilities from the SF-36,
it should be used in this context and not as an independent measure. Further
research should address the same issue for CORE-6D, as proposed in section
8.6.5. It should be noted, though, that the SF-6D utility values generated from
the SF-36 are by design determined by responses to 11 SF-36 items, as some
SF-6D items are scored by combining responses to 2-3 SF-36 items (Brazier
et al., 2002), whereas SF-6D utility values obtained from the ‘independent’ SF-
6D were generated using direct responses to the 6 SF-6D items (Ferreira et
al., 2013). This difference in the number/content of items expressed in the two
SF-6D versions might be responsible, at least to some degree, for the
discrepancy in the 2 sets of utility values obtained. In contrast, the scoring of
the 6 CORE-6D items depends exclusively on the scoring of these particular
items within the CORE-OM, so, apart from differences in response levels and
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small changes in wording, the 6 items of an ‘independent’ CORE-6D are
directly comparable to the respective 6 items within the CORE-OM; therefore,
the possibility that CORE-6D can stand as an independent PBM is likely higher
compared with that of SF-6D.
Given the routine use of CORE-OM in the clinical monitoring of people with
common mental health problems in the UK, CORE-6D is expected to
contribute to the wider assessment of healthcare interventions for the
management of common mental health problems in the form of cost-utility
analysis in the UK, using existing and prospective CORE-OM datasets, in
particular those that include the CORE-OM but no generic PBMs. Beyond the
UK, CORE-OM can be routinely used in many other countries, as validated
translations are now available in about 20 other languages, including Welsh,
Norwegian, Spanish, Portuguese, German, Dutch, Greek, Italian, Danish,
Icelandic, Swedish, Polish, Finnish, Lithuanian, Slovak, Turkish, Croatian,
Albanian and Gujarati4. Use of CORE-6D as a PBM in settings that use a
translated version of CORE-OM is a possibility, although further work is
needed, as discussed in section 8.6.6.
The usefulness and anticipated contribution of CORE-6D in the economic
assessment of mental health interventions and programmes is evident.
However, when decisions accruing from economic evaluations in the area of
mental health have a knock-on effect on other areas of healthcare, for example
in the wider health policy-making context such as that of NICE, the
appropriateness of using CORE-6D may be questioned, due to expressed
concerns about the limitations of condition-specific PBMs and doubts
regarding their comparability with generic PBMs. These issues are discussed
in the next section.
4 http://www.coreims.co.uk/About_Core_Translations.html [Accessed 25 April 2013].
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8.4 Comparison of condition-specific preference-
based measures with generic ones
Is there a place for CORE-6D in the current UK healthcare decision-
making context?
The usefulness of CORE-6D, as well as of any other condition-specific PBM, in
the wider NICE decision-making context is more controversial. As discussed in
Chapter 1, the necessity for the development of condition-specific PBMs
derives from the inappropriateness or insensitivity of generic PBMs in
capturing relevant HRQoL aspects in various medical conditions and patient
populations – and this was the rationale for the development of CORE-6D as
well. In addition to being more relevant and sensitive, condition-specific PBMs
are more likely to be acceptable to patients and clinicians, and, if derived from
an existing measure that is being routinely used, they do not require extra time
for their completion. Condition-specific PBMs can be used in prospective but
also retrospective analyses when data on generic measures are lacking
(Brazier et al., 2007).
8.4.1 Limitations of condition-specific preference-based
measures
Apart from their apparent advantages, condition-specific PBMs are
characterised by a number of limitations, which may considerably reduce their
comparability with generic PBMs. An important flaw of the condition-specific
PBMs is that they normally have a narrow scope and thus capture a limited
number of HRQoL dimensions. For example, they normally do not consider
side-effects of treatment or comorbidities. Omission of comorbidities from the
health state descriptive system is likely to distort the results of a valuation
survey when there is preference interaction, that is, when the impact of
comorbidities (or, indeed, of any other dimensions) on preferences is not
simply additive (Brazier & Tsuchiya, 2010; Rowen & Brazier, 2011). It is true
that some degree of interaction has been shown to exist for generic PBMs
(Brazier et al., 2002; Dolan, 1997; Feeny et al., 2002). But for condition-
specific PBMs, the impact of such an interaction may be even more significant,
given their narrower scope, which entails omission of a wider range of
dimensions from their descriptive system.
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Indeed, there is evidence that addition of extra dimensions to condition-specific
PBMs has had a significant impact on mean utility values, although not always
in the expected direction; the impact of adding an extra dimension may not be
additive and may not be consistent across existing dimensions, resulting to the
need for re-valuation when addition of an extra dimension to a condition-
specific CSM is decided in order to capture side effects or comorbidities
(Brazier et al., 2011 & 2012). Inclusion of extra dimensions on PBMs derived
from CSMs limits the value of deriving the PBM from an existing, readily
available measure, as it requires collection of additional data relating to the
extra dimension. Furthermore, extra dimensions may miss unknown side
effects or less frequent comorbidities. For this reason, researchers have
proposed the addition of extra dimensions to generic PBMs to make them
more relevant to specific conditions, as an alternative to use of condition-
specific PBMs (Rowen & Brazier, 2011). Examples of such add-ons include the
addition of a sleep dimension to EQ-5D (Yang et al., 2013a) as well as the
addition of a cognitive dimension to the same measure (Krabbe et al., 1999).
However, this solution has also limitations as it requires inclusion of the extra
questions in prospective studies, and does not allow estimation of utilities (and
QALYs) from existing datasets. Furthermore, there is only scope for bolting-in
one or two extra dimensions before the instrument becomes too large for
valuation (Brazier et al., 2007).
Another flaw of condition-specific PBMs relative to generic ones relates to the
distortions created in the valuation process by focusing effects, i.e. when
respondents overrate the importance of the symptoms associated with the
condition being described because they are provided with a narrow
perspective of HRQoL. Such effects may potentially generate a larger
decrement than a generic PBM because the respondent is not being given the
broader HRQoL context, and may have important implications for omitted
comorbidities (Brazier & Tsuchiya, 2010). However, it is possible that
respondents do implicitly consider other dimensions of HRQoL when valuing
narrow health states described by condition-specific PBMs, and therefore the
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impact of focusing effects may be less substantial than initially thought (Brazier
et al., 2012).
Similar to focusing effects is the impact of naming the condition, which is
usually inherent in condition-specific PBMs; explicitly stating the condition that
is being valued may potentially distort respondents’ preferences on HRQoL
due to their preconceptions about the condition or their experience of the
condition as patients or carers (Brazier & Tsuchiya, 2010; Brazier et al., 2012).
Here, research findings are mixed, as the effect on utility values appears to
depend on the label used and the severity of the health state being valued
(Brazier et al., 2012). One way to limit this effect would be to remove the label
from the PBM, but in the case of PBMs derived from existing CSMs this would
result in discrepancies between the PBM and the original CSM. Alternatively, a
de novo condition-specific PBM that does not name the condition could be
developed. A final solution would be to retain the label and accept distortions
in valuation, a solution that may actually lead to higher accuracy in the health
state description and thus in the resulting utility values, although this issue
warrants further research (Brazier et al., 2012).
A final issue relating to the comparability across PBMs (either generic or
condition-specific) is the upper anchor used in valuation. If this upper anchor is
the instrument-specific best state (which was the case in the valuation of
generic PBMs), then respondents may not necessarily assume that other,
omitted dimensions are at their optimum level and instead they may imagine
other health problems, perhaps their own health, which could potentially affect
their preferences. In order to ensure comparability across PBMs, it has been
recommended that a generic ‘full health’ upper anchor be used across
valuations of PBMs (Brazier et al., 2012).
8.4.2NICE position on the use of condition-specific
preference-based measures
Comparability across different PBMs is crucial when economic evaluations
using a variety of PBMs are undertaken to inform decisions within the same
resource allocation context. To enhance comparability and consistency across
its appraisal programme, NICE has explicitly expressed a preference for the
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EQ-5D for use in cost-utility analyses of interventions for adults (National
Institute for Health and Care Excellence, 2013). Nonetheless, NICE recognises
that EQ-5D data may not be available or may be inappropriate for the condition
or effects of treatment. When EQ-5D data are not available, NICE
recommends mapping of other available measures on EQ-5D. In situations
where the use of EQ-5D is considered to be inappropriate, NICE requires
reporting of quantitative and qualitative empirical evidence on the lack of
responsiveness, construct and content validity of the EQ-5D in the particular
patient population. Where mapping onto EQ-5D is not possible or the use of
EQ-5D is inappropriate, alternative PBMs may be used, accompanied by a
detailed reporting of the methods used for their development, evidence of their
validity, and description of the impact of methods on the resulting utility values.
Moreover, NICE requests information on the extent of the impact of the use of
the alternative measure on the value of the QALYs gained. For any PBM used
to inform the Institute’s decisions, NICE requires that the measurement of
changes in HRQoL be reported directly from patients (or, if this is not possible,
by persons acting as their carers in preference to healthcare professionals),
and the respective utility values be based on public preferences, elicited from a
representative sample of the UK general population using a choice-based
method (i.e. TTO or SG) (National Institute for Health and Care Excellence,
2013). These rules for the valuation of newly developed PBMs aim to ensure a
better degree of comparability with EQ-5D, and, thus, consistency across the
Institute’s appraisal programme.
8.4.3 The place of CORE-6D in the NICE decision-making
context
Existing psychometric evidence indicates that EQ-5D may be appropriate to
use in some mental health conditions, mainly depression and, to some extent,
anxiety and personality disorders, but its use is problematic in more severe
mental disorders such as schizophrenia and bipolar disorder. The performance
of EQ-5D in some common mental health problems such as OCD, panic
disorder, generalised and specific phobias has not been assessed due to lack
of relevant evidence. Qualitative evidence suggests that EQ-5D lacks
important content validity in people with mental disorders (Brazier et al., 2014).
EQ-5D is quite often absent from clinical evaluations carried out in mental
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health. Attempted mapping of a number of widely used CSMs (including
routinely used measures of common mental health problems such as the
Hospital Anxiety and Depression Scale [HADS], PHQ-9, GAD-7, GHQ-12 and
CORE-OM) onto generic measures (mainly SF-6D but also EQ-5D in lesser
extent) using datasets of populations with depression and/or anxiety revealed
weaknesses in the mapping functions (Brazier et al., 2014), which may indicate
that generic PBMs are unable to fully capture the range of symptoms
experienced by people with mental health problems. Overall, this evidence
suggests that EQ-5D may not be appropriate to use in some populations with
mental health problems, and points to the direction of the development and
use of an alternative PBM in such populations.
The analyses presented in Chapter 7 showed promising results regarding the
validity and responsiveness of CORE-6D in populations with depression and/or
anxiety, although further research needs to validate these findings and expand
analyses to a wider range of populations with common mental disorders, which
are the focus of CORE-6D; moreover, qualitative analysis indicated that
CORE-6D has higher content validity compared with generic PBMs in
populations with common mental health problems. The methods used for the
valuation of CORE-6D are comparable to those used at the development of
the EQ-5D utility index, i.e. utility values were elicited from a random sample of
the UK population using the MVH group TTO protocol (Dolan et al., 1996; MVH
Group, 1995). Consideration of the issues relating to the performance and
availability of EQ-5D in populations with mental health problems and the
promising properties of CORE-6D appear to support the use of CORE-6D in
the NICE policy context for the evaluation of interventions and programmes for
people with common mental health problems, in situations where EQ-5D is
shown not to perform satisfactorily or is not available. The results presented in
Chapter 7 also provide some information on the potential impact of the use of
CORE-6D instead of EQ-5D regarding the expected mean change in utility
values and standard deviation over time and across different symptom severity
groups, which is required by NICE before a new PBM can be used in a cost-
utility analysis conducted as part of the Institute’s appraisal programme.
According to these results, CORE-6D showed smaller mean changes in utility
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values over time and across different severity groups compared with EQ-5D
and SF-6D, but overall larger values of SRM and ES (due to smaller standard
deviation), which is important for the power of a study as it indicates that
CORE-6D may be able to detect significant differences with a smaller sample
size. Moreover, this may lead to reduced uncertainty and affect the output of
probabilistic sensitivity analysis in economic evaluation (Brazier et al., 2012). It
needs to be emphasised, though, that before CORE-6D is used in this context,
it is advisable that its psychometric properties are validated in larger datasets
and other populations with common mental health problems.
As a condition-specific PBM, CORE-6D suffers from the limitations described
in section 8.4.1, including omission of side effects and comorbidities, focusing
effects and naming the condition. Nevertheless, CORE-6D does contain a
physical dimension that to some extent picks up comorbidities and perhaps
reduces the impact of focusing effects. CORE-6D health state descriptions do
not explicitly name the underlying condition, although it is apparent that this
involves the presence of mental health symptoms. The analysis of valuation
data for CORE-6D presented in Chapter 6 indicated that there was no
preference interaction between its emotional and physical components.
The role of generic and condition-specific PBMs has been (and still is) an
important subject of debate (Dowie, 2002a & 2002b; Brazier & Tsuchiya, 2010;
Brazier & Fitzpatrick, 2002; Feeny, 2002; Guyatt, 2002). Ultimately, the choice
between a generic and a condition-specific PBM, such as CORE-6D, in a wider
healthcare decision-making context is a trade-off between cross-programme
comparability and relevance and sensitivity of the selected PBM in capturing
HRQoL changes that are important to patients with the specific condition
examined. This remains a controversial issue as well as an area for further
research that extends beyond the scope of this thesis.
8.5 The role of patients’ preferences in the
economic assessment of healthcare interventions
Utility values may be elicited from various groups of stakeholders, including
patients, their carers, health professionals and the general public. Selection of
one stakeholder group over another may have significant implications in the
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estimation of cost-utility of healthcare interventions, as evidence suggests that
there are considerable discrepancies in the values obtained from different
stakeholders. The current trend, in line with recommendations by advisory and
regulatory bodies such as the US Panel on Cost-Effectiveness in Health and
Medicine (Russell et al., 1996) and NICE (National Institute for Health and
Care Excellence, 2013), is to elicit utility values from a random sample of the
general public. This has been the approach at the valuation of the generic
PBMs EQ-5D (Dolan et al., 1996), SF-6D (Brazier et al., 2002), and HUI-3
(Feeny et al., 2002), and several condition-specific ones (for example Brazier
et al., 2005b & 2008; Yang et al., 2009 & 2011) including the CORE-6D. The
main argument for elicitation of preferences from members of the general
public is that since health care programmes are funded using society’s
resources (e.g. through taxation), it is society’s preferences that should be
taken into account when allocating resources (Gold et al., 1996).
On the other hand, it could be argued that members of the general public have
not personally experienced the HRQoL of the health states being valued and
therefore they may be lacking the ability to imagine hypothetical health states
and to take into account future adaptation to ill health (Brazier et al., 2007;
Rowen & Brazier, 2011; Torrance, 1986). A proposed solution to this problem
is to provide more information on respondents about the health states being
valued, including future adaptation to impaired health, with preliminary
evidence indicating that members of the public may change their values in the
light of such information (McTaggart-Cowan, 2011; McTaggart-Cowan et al.,
2011 & 2012).
In contrast to members of the general public, patients (or carers, when patients
are too unwell to provide their own valuations or when the patient population
consists of children who do not understand the valuation tasks) can better
appreciate the true implications of living in a particular health state and
therefore they may be a more appropriate population for eliciting preferences.
Moreover, patients may be better suited to be consulted since it is they who
are going to be affected by resource allocation decisions. However, one of the
dangers in this case is that patients may intentionally or unintentionally
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overstate a reduction in the HRQoL relating to their condition, in an effort to
ensure access to new treatments that are expected to improve health, as in
this case the scope for improvement will look broader. Another problem when
eliciting preferences from patients is that they do not have the experience of
living under other conditions of health except theirs, so they cannot make
judgements across different disease areas (Brazier et al., 2007; Torrance,
1986). Less often, health professionals’ values have been used based on their
knowledge and expertise in managing the disease area in question. The
downside of using this population group is the potential bias that may be
introduced due to conflicts of interest and also due to this group’s special age,
sex, and socio-economic status (Torrance, 1986).
Overall, current evidence indicates that patients value health states more
highly than members of the general public (Brazier et al., 2009). This
phenomenon has been observed in several disease areas and suggests that
either the public does not understand how valuable life can be for patients (or,
as argued above, it cannot consider mechanisms of future adaptation), or that
patients consciously or subconsciously overstate their HRQoL (Ubel et al.,
2003). Another explanation for the discrepancy in values obtained from
different stakeholders is that different stakeholder groups have diverse
preferences for various types of clinical outcomes. For example, research in
the area of schizophrenia has shown that patients rate the importance of
extrapyramidal syndrome, a neurological side effect of antipsychotics, more
highly than the rest of the stakeholder groups do; clinicians rate social
functioning as more important than patients or family members do; clinicians
and family members give higher ratings for vocational functioning compared
with patients and the general public (Shumway et al., 2003). Such
discrepancies in preferences for types of clinical outcomes provide an
alternative explanation for the differences in utility values obtained by different
stakeholder groups in schizophrenia (Briggs et al., 2008; Lee et al., 2000;
Lenert et al., 2000b).
Ultimately, the selection of the valuing population should be determined by the
purpose of the study. For comparisons of alternative treatment options in one
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patient population, patients with the condition are probably best judges of their
HRQoL and it is their preferences that should count. However, for cost-utility
analyses undertaken to inform public-funded health service decisions, the
appropriate population is probably members of the general public, who are
taxpayers and, therefore, funders of the service (Torrance, 1986).
Nevertheless, the discrepancy in utility values obtained from different
population groups and the importance of considering patients’ views and
preferences have been the basis for proposals for further research into an
approach that directly integrates patients’ values into assessments of clinical
and cost effectiveness (Brazier et al., 2005a). Direct valuation of CORE-6D by
people with common mental health problems is one of the topics
recommended for future research in section 8.6.2.
8.6 Recommendations for future research
The discussion of the methods employed in this thesis for the development of
CORE-6D, their advantages and limitations, the applicability of the new PBM
and the implications for mental health policy brought up a number of issues
that warrant further research.
8.6.1 Further use of Rasch analysis in the derivation of
preference-based measures from existing measures
The derivation of CORE-6D from CORE-OM was based mainly on Rasch
analysis regarding the development of the health state classification, the
selection of plausible health states for valuation and the modelling of utility
values for all health states described by the new PBM. The latter relied heavily
on the relationship between the Rasch logit values of the health states
selected for valuation and the corresponding utility values obtained in the
valuation survey. Further research into this relationship would allow more
vigorous use of Rasch analysis for the derivation of PBMs from existing
measures, either unidimensional or with strong unidimensional components,
not only regarding the construction of the health state classification (which
appears to be its main use so far), but also in the selection of health states for
valuation and the subsequent prediction of utility values for all states described
by the PBM.
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8.6.2 Larger valuation survey and exploration of the
preferences of people with common mental health
problems
CORE-6D was valued by a random sample of 225 people living in South
Yorkshire. Some of the sample’s socio-economic characteristics differed from
those of the general UK population. Compared with the participants in the
valuation of EQ-5D (3,337 respondents) and, to lesser extent, of SF-6D (611
respondents), valuation of CORE-6D used a smaller number of respondents
due to funding constraints. In the future it may be worth undertaking re-
valuation of the measure with a larger, more representative sample of the
general UK population, in order to refine the existing valuation results. Also, a
valuation survey of people with common mental health problems will add
insight on how this population experiences and values their symptoms and
explore discrepancies between the preferences of this patient group and the
general population. Ultimately, preferences of people with common mental
health problems on HRQoL aspects captured by CORE-6D may play a more
active role in the economic assessment of mental health services.
8.6.3 Further validation and testing of the applicability
and performance of CORE-6D in a wide range of mental
health conditions
As described in Chapter 7, testing of the psychometric properties of CORE-6D
and comparison to generic PBMs was characterised by several limitations:
analyses were confined to 3 datasets, due to unavailability of other datasets
that contained both CORE-OM and other generic measures. Only one of these
datasets included a purely ‘clinical’ population. The known groups validity of
CORE-6D and generic PBMs for different levels of mental symptom severity
was primarily tested using CORE-OM severity levels, due to lack of another
available CSM in the datasets. Similarly, the convergent validity of CORE-6D
and generic PBMs was mainly tested against CORE-OM due to lack of other
available CSMs. Comparison of CORE-6D with direct (rather than mapped)
values of EQ-5D was limited to one small dataset. Comparisons of CORE-6D
with mapped EQ-5D values have been likely affected by the applied mapping
function and the applicability of this function to populations with common
mental health problems. Considering these limitations, future research needs
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to validate the results on the psychometric properties of CORE-6D in larger
datasets; compare CORE-6D with EQ-5D values that were obtained directly
and not by mapping; test the known groups validity of CORE-6D and generic
PBMs against a CSM other than CORE-OM that will serve as an independent
indicator of symptom severity; assess the convergent validity of CORE-6D and
generic PBMs using an alternative CSM and not CORE-OM; and, most
importantly, explore the suitability of CORE-6D in a wide range of common
mental health problems, including unipolar depression, GAD, panic disorder,
OCD, and various types of phobias.
8.6.4 Mapping CORE-10 and CORE-5 onto CORE-6D
The CORE system includes a number of shorter forms of CORE-OM, among
which the brief forms CORE-10 and CORE-5 are quite widely used in routine
practice for session-by-session monitoring. CORE-6D shares two items with
each of the two brief CORE system forms, so it is not possible to obtain
CORE-6D values from responses to CORE-10 or CORE-5. Nevertheless, the
statistical relationship between each of the two CORE brief forms and CORE-
6D can be established by mapping; the resulting algorithms will enable
estimation of CORE-6D-based QALYs in datasets that include CORE-10 or
CORE-5, but not the full 34-item CORE-OM.
8.6.5 Potential use of CORE-6D as an independent
measure
The current proposed use of CORE-6D in a study presupposes use of the
CORE-OM, given that CORE-6D items are embedded in the longer 34-item
measure. This means that if CORE-OM is not used in a study for outcome
measurement, it is not possible to estimate QALYs from CORE-6D.
Independent use of CORE-6D has theoretically the advantage that it allows
estimation of QALYs with lower burden. However, before CORE-6D is
proposed as an independent measure, future research should ensure that the
rate and level of responses to the 6 CORE-6D items are not affected by the
presence of the rest 28 CORE-OM items, i.e. responses would be the same
regardless of whether CORE-6D is embedded in CORE-OM or forms an
independent measure.
286
8.6.6 Use of CORE-6D outside the UK
The translation and validation of CORE-OM in several other languages and
countries enables the use of CORE-6D as a PBM in economic evaluations
undertaken in mental health settings outside the UK. However, before CORE-
6D can be used in other counties, and since its development was based on
analysis of UK datasets, the health state descriptive system of CORE-6D (i.e.
its items and response levels) needs to be validated by Rasch analysis in other
non-UK mental health populations. There is a possibility that different items
and health state profiles emerge from such an exercise depending on patients’
experiences of mental disease in each particular country, which may indicate
the need to derive different health state classifications from CORE-OM for
different countries. In any case, whether CORE-6D is validated or a new health
state descriptive system is derived as a result of this process, separate
valuation surveys need to be conducted in each country, to reflect the
preferences of the country’s general population.
8.6.7 Development of a ‘generic’ preference-based
measure for all mental disorders
CORE-6D is a PBM relevant to people with common mental health problems
as the original CORE-OM has been designed with a focus on this patient
population. CORE-6D is probably not appropriate for use in severe, psychotic
disorders, as it lacks items that can capture psychotic symptoms. This means
that CORE-6D cannot be used as a generic mental health PBM. However,
development and use of a generic PBM that is relevant to the full spectrum of
mental disorders, covering both common mental health problems and
psychotic disorders such as schizophrenia, bipolar disorder and personality
disorders would allow wider cost effectiveness comparisons in the area of
mental health. De novo development of such a measure seems to be the only
option, as no generic mental health CSM that is relevant across all areas of
mental illness and appropriate for the derivation of a generic mental health
PBM is currently available. The new PBM can be developed using as the basis
the 7 HRQoL themes that were identified to be most relevant to people with
mental disorders (Brazier et al., 2014; Connell et al., 2012).
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8.7 Conclusion
Despite the preference of advisory bodies worldwide on the use of generic
PBMs for the estimation of QALYs in economic evaluation of healthcare
technologies and programmes, these may not be available or appropriate in
some conditions and patient populations. In such instances, condition-specific
PBMs may prove to be more relevant and sensitive to HRQoL changes. One
disease area where generic measures seem to be inappropriate to use is
mental health, where the generic measures’ inability to capture important
qualitative aspects of HRQoL combined with their non-acceptability by patients
and healthcare professionals pointed to the need for the construction of a new
condition-specific PBM. This need was partly fulfilled with the development of
CORE-6D, a PBM derived from the CORE-OM; the latter is a measure
routinely used in the NHS that has been designed for the evaluation of
psychological services for people with common mental health problems.
CORE-6D is a 2-dimensional PBM, capturing emotional and physical
symptoms, that has been validated for use in primary and secondary mental
healthcare settings. Analyses of its validity and responsiveness in populations
with depression and/or anxiety indicated a promising psychometric
performance and demonstrated little loss of information compared with the
CORE-OM, although further research needs to validate these results and
expand analyses to other populations with common mental health problems.
Following validation, CORE-6D may be appropriate to use in cost-utility
analyses of interventions for common mental health problems, in situations
where EQ-5D is not available or has been shown to be inappropriate. The
advantages of the use of CORE-6D (and any other condition-specific PBM)
over generic PBMs need to be traded-off against compromises in cross-
programme comparability, when decisions affecting the wider allocation of
healthcare resources are involved, though CORE-6D is less focused on
condition-specific problems than many CSMs. The new methods developed for
the derivation of CORE-6D from CORE-OM are appropriate for the derivation
of new PBMs from instruments with no clear multidimensional structure and/or
high correlations across their items, and contribute to the pool of existing
methodologies for the derivation of health state classifications from longer
measures. These need further exploration, but provide a useful development.
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Appendix 1. The structure of the generic
preference-based measures EQ-5D, SF-6D and
HUI-3
Table A1. The structure of the 3-level response version of EQ-5D
[available on www.euroqol.org (Accessed 23 April 2010)]
Dimension Level Statement
Mobility 1 I have no problems in walking about
2 I have some problems in walking about
3 I am confined to bed
Self-care 1 I have no problems with self-care
2 I have some problems washing or dressing myself
3 I am unable to wash or dress myself
Usual activities
(e.g. work, study,
housework, family or
leisure activities)
1 I have no problems with performing my usual activities
2 I have some problems with performing my usual activities
3 I am unable to perform my usual activities
Pain/Discomfort 1 I have no pain or discomfort
2 I have moderate pain or discomfort
3 I have extreme pain or discomfort
Anxiety/Depression 1 I am not anxious or depressed
2 I am moderately anxious or depressed
3 I am extremely anxious or depressed
Table A2. The structure of SF-6D (Brazier et al., 2002)
Dimension Level Statement
Physical functioning 1 Your health does not limit you in vigorous activities
2 Your health limits you a little in vigorous activities
3 Your health limits you a little in moderate activities
4 Your health limits you a lot in moderate activities
5 Your health limits you a little in bathing and dressing
6 Your health limits you a lot in bathing and dressing
Role limitations 1 You have no problems with your work or other regular daily activities as a result of your physical health or any emotional problems
2 You are limited in the kind of work or other activities as a result of your physical health
3 You accomplish less than you would like as a result of emotional problems
4 You are limited in the kind of work or other activities as a result of your physical health and accomplish less than you would like as
a result of emotional problems
Social functioning 1 Your health limits your social activities none of the time
2 Your health limits your social activities a little of the time
3 Your health limits your social activities some of the time
4 Your health limits your social activities most of the time
5 Your health limits your social activities all of the time
Bodily pain 1 You have no pain
2 You have pain but it does not interfere with your normal work (both outside the home and housework)
3 You have pain that interferes with your normal work (both outside the home and housework) a little bit
4 You have pain that interferes with your normal work (both outside the home and housework) moderately
5 You have pain that interferes with your normal work (both outside the home and housework) quite a bit
6 You have pain that interferes with your normal work (both outside the home and housework) extremely
Mental health 1 You feel tense or downhearted and low none of the time
2 You feel tense or downhearted and low a little of the time
3 You feel tense or downhearted and low some of the time
4 You feel tense or downhearted and low most of the time
5 You feel tense or downhearted and low all of the time
Vitality 1 You have a lot of energy all of the time
2 You have a lot of energy most of the time
3 You have a lot of energy some of the time
4 You have a lot of energy a little of the time
5 You have a lot of energy none of the time
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Table A3. The structure of HUI-3 (Feeny et al., 2002)
Attribute Level Statement
Vision 1 Able to see well enough to read ordinary newsprint and recognize a friend on the other side of the street without glasses or contactlenses
2 Able to see well enough to read ordinary newsprint and recognize a friend on the other side of the street, but with glasses or contact
lenses
3 Able to read ordinary newsprint with or without glasses but unable to recognize a friend on the other side of the street, even with glasses
or contact lenses
4 Able to recognize a friend on the other side of the street with or without glasses but unable to read ordinary newsprint, even with glasses
5 Unable to read ordinary newsprint and unable to recognize a friend on the other side of the street, even with glasses or contact lenses
6 Unable to see at all
Hearing 1 Able to hear what is said in a group conversation with at least three other people, without a hearing aid
2 Able to hear what is said in a conversation with one other person in a quiet room without a hearing aid, but requires a hearing aid to hear
what is said in a group conversation with at least three other people
3 Able to hear what is said in a conversation with one other person in a quiet room with a hearing aid, and able to hear what is said in a
group conversation with at least three other people, with a hearing aid
4 Able to hear what is said in a conversation with one other person in a quiet room, without a hearing aid, but unable to hear what is said in
a group conversation with at least three other people even with a hearing aid
5 Able to hear what is said in a conversation with one other person in a quiet room with a hearing aid, but unable to hear what is said in a
group conversation with at least three other people even with a hearing aid
6 Unable to hear at all
Speech 1 Able to be understood completely when speaking with strangers or friends
2 Able to be understood partially when speaking with strangers but able to be understood completely when speaking with people whoknow me well
3 Able to be understood partially when speaking with strangers or people who know me well
4 Unable to be understood when speaking with strangers but able to be understood partially by people who know me well
5 Unable to be understood when speaking to other people (or unable to speak at all)
Ambulation 1 Able to walk around the neighbourhood without difficulty, and without walking equipment
2 Able to walk around the neighbourhood with difficulty, but does not require walking equipment or the help of another person
3 Able to walk around the neighbourhood with walking equipment, but without the help of another person
4 Able to walk only short distances with walking equipment, and requires a wheelchair to get around the neighbourhood
5 Unable to walk alone, even with walking equipment. Able to walk short distances with the help of another person, and requires a
wheelchair to get around the neighbourhood
6 Cannot walk at all
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Dexterity 1 Full use of two hands and ten fingers
2 Limitations in the use of hands or fingers, but does not require special tools or help of another person
3 Limitations in the use of hands or fingers, is independent with use of special tools (does not require the help of another person)
4 Limitations in the use of hands or fingers, requires the help of another person for some tasks (not independent even with use of specialtools)
5 Limitations in the use of hands or fingers, requires the help of another person for most tasks (not independent even with use of specialtools)
6 Limitations in the use of hands or fingers, requires the help of another person for all tasks (not independent even with use of specialtools)
Emotion 1 Happy and interested in life
2 Somewhat happy
3 Somewhat unhappy
4 Very unhappy
5 So unhappy that life is not worthwhile
Cognition 1 Able to remember most things, think clearly and solve day to day problems
2 Able to remember most things, but have a little difficulty when trying to think and solve day to day problems
3 Somewhat forgetful but able to think clearly and solve day to day problems
4 Somewhat forgetful, and have a little difficulty when trying to think or solve day to day problems
5 Very forgetful, and have great difficulty when trying to think or solve day to day problems
6 Unable to remember anything at all, and unable to think or solve day to day problems
Pain 1 Free of pain and discomfort
2 Mild to moderate pain that prevents no activities
3 Moderate pain that prevents a few activities
4 Moderate to severe pain that prevents some activities
5 Severe pain that prevents most activities
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Appendix 2. Search strategy used for the
identification of reviews assessing the use of
generic preference-based measures and
condition-specific outcome measures in mental
health research and practice
Databases Embase <1980 to 2012 Week 50>, Ovid MEDLINE(R) <1946
to November Week 3 2012>, PsycINFO <1806 to December
Week 2 2012>
Interface OvidSP
Date of search 20 December 2012
Search Strategy:
No Search terms Hits
1 exp mental health/ or exp psychiatry/ or exp mental disease/ 1,695,768
2 1 use emez 1,524,932
3 exp Mental Health/ or exp Psychiatry/ or exp Mental Disorders/ 2,935,053
4 3 use mesz 959,496
5 3 use psyh 450,625
6 2 or 4 or 5 2,935,053
7 mental health.ti,ab. 249,188
8 mental* ill*.ti,ab. 77,699
9 mental* ill-health.ti,ab. 1,090
10 psychiatr*.ti,ab. 549,795
11 mental* disorder*.ti,ab. 79,590
12 or/6-11 3,180,951
13
exp "quality of life"/ or exp treatment outcome/ or exp
psychologic assessment/ or exp health survey/ or exp
psychotherapy/ or exp outcomes research/ or exp outcome
assessment/
2,684,683
14 13 use emez 1,341,205
15
exp "Quality of Life"/ or exp Treatment Outcome/ or exp Health
Surveys/ or exp Psychotherapy/ or exp "Outcome Assessment
(Health Care)"/
2,672,645
16 15 use mesz 1,137,873
17 exp "Quality of Life"/ or exp Treatment Outcomes/ or expPsychological Assessment/ or Surveys/ or exp Psychotherapy/ 955,084
18 17 use psyh 239,680
19 or/14,16,18 2,718,758
20 treatment effectiveness evaluation.mp. 14,102
21 health status indicator*.ti,ab 696
22 health outcome*.ti,ab 45,694
23 ((quality adj1 life) or qol or hrqol or hrql or hql or hqol or qaly orquality adjusted life or qwb).ti,ab. 88,307
24 (quality adj1 (wellbeing or well being)).ti,ab. 348
25 ((measur* or assess* or scor* or index* or indices or scal* or 383,540
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monitor*) adj2 outcome*).ti,ab.
26 ((improv* or measur*) adj1 (productivity or performance)).ti,ab. 47,943
27 ((output or price) adj (index* or indices)).ti,ab. 1,375
28 outcome measure*.ti,ab. 296,694
29 ((utilit* or preference) adj1 (based or index* or indices ormeasure* or valu* or scor* or weigh*)).ti,ab. 9,897
30 (euroqol* or euro qol* or eq5d* or eq 5d*).ti,ab. 8,845
31 (hui or hui1 or hui2 or hui3).ti,ab. 2,088
32
(sf36 or sf 36 or short form 36 or shortform 36 or sf thirtysix or
sf thirty six or shortform thirtysix or shortform thirty six or short
form thirtysix or short form thirty six).ti,ab.
35,459
33 (sf6 or sf 6 or short form 6 or shortform 6 or sf six or sfsix orshortform six or short form six).ti,ab. 2,288
34 (sf12 or sf 12 or short form 12 or shortform 12 or sf twelve orsftwelve or shortform twelve or short form twelve).ti,ab. 5,911
35 (sf16 or sf 16 or short form 16 or shortform 16 or sf sixteen orsfsixteen or shortform sixteen or short form sixteen).ti,ab. 46
36 (sf20 or sf 20 or short form 20 or shortform 20 or sf twenty orsftwenty or shortform twenty or short form twenty).ti,ab. 661
37 or/19-36 3,054,371
38 12 and 37 532,216
39 limit 38 to (human and english language and "reviews(maximizes specificity)" and yr="2002 -Current") 8,658
Database HMIC Health Management Information Consortium <1979 to
November 2012>
Interface OvidSP
Date of search 20 December 2012
Search Strategy:
No Search terms Hits
1 exp Mental health/ or exp Psychiatry/ or exp Mental illness/ 11,660
2 mental health.ti,ab. 15,532
3 mental* ill*.ti,ab. 4,335
4 mental* ill-health.ti,ab. 174
5 psychiatr*.ti,ab. 8,130
6 mental* disorder*.ti,ab. 1,378
7 or/1-6 26,474
8 exp "Quality of life"/ or exp Patient outcome/ or exp Healthsurveys/ or exp Psychotherapy/ or exp Outcome measurement/ 9,297
9 treatment outcome.mp. 114
10 outcome research.mp. 51
11 health status indicator*.ti,ab. 13
12 health outcome*.ti,ab. 1,973
13 ((quality adj1 life) or qol or hrqol or hrql or hql or hqol or qaly orquality adjusted life or qwb).ti,ab. 1,115
14 (quality adj1 (wellbeing or well being)).ti,ab. 8
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15 ((measur* or assess* or scor* or index* or indices or scal* ormonitor*) adj2 outcome*).ti,ab. 7,475
16 ((improv* or measur*) adj1 (productivity or performance)).ti,ab. 1,159
17 ((output or price) adj (index* or indices)).ti,ab. 68
18 outcome measure*.ti,ab. 6,119
19 ((utilit* or preference) adj1 (based or index* or indices ormeasure* or valu* or scor* or weigh*)).ti,ab. 176
20 (euroqol* or euro qol* or eq5d* or eq 5d*).ti,ab. 250
21 (hui or hui1 or hui2 or hui3).ti,ab. 20
22
(sf36 or sf 36 or short form 36 or shortform 36 or sf thirtysix or
sf thirty six or shortform thirtysix or shortform thirty six or short
form thirtysix or short form thirty six).ti,ab.
376
23 (sf6 or sf 6 or short form 6 or shortform 6 or sf six or sfsix orshortform six or short form six).ti,ab. 2
24 (sf12 or sf 12 or short form 12 or shortform 12 or sf twelve orsftwelve or shortform twelve or short form twelve).ti,ab. 68
25 (sf16 or sf 16 or short form 16 or shortform 16 or sf sixteen orsfsixteen or shortform sixteen or short form sixteen).ti,ab. 0
26 (sf20 or sf 20 or short form 20 or shortform 20 or sf twenty orsftwenty or shortform twenty or short form twenty).ti,ab. 2
27 or/8-26 18,837
28 7 and 27 2,222
29 limit 28 to (yr="2002 -Current" and english) 1,306
Databases Cochrane Database of Systematic Reviews (CDSR),
Cochrane Methodology Register, Health Technology
Assessment (HTA) database, Database of Abstracts of
Reviews of Effects (DARE)
Interface Wiley
Date of search 20 December 2012
Search Strategy:
No Search terms Hits
1 MeSH descriptor: [Mental Health] explode all trees 487
2 MeSH descriptor: [Psychiatry] explode all trees 399
3 MeSH descriptor: [Mental Disorders] explode all trees 37,889
4 "mental health":ti,ab 3,123
5 mental* next ill*:ti,ab 1,030
6 mental* next ill-health:ti,ab 4
7 psychiatr*:ti,ab 6,321
8 mental* next disorder*:ti,ab 1,965
9 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 43,485
10 MeSH descriptor: [Quality of Life] explode all trees 12,121
11 MeSH descriptor: [Health Surveys] explode all trees 20,840
12 MeSH descriptor: [Psychotherapy] explode all trees 13,097
13 MeSH descriptor: [Outcome Assessment (Health Care)]explode all trees 82,442
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14 treatment next outcome*:ti,ab 29,647
15 "outcome research":ti,ab 64
16 health next status next indicator*:ti,ab 44
17 health next outcome*:ti,ab 1,909
18 ((quality near/2 life) or qol or hrqol or hrql or hql or hqol or qalyor (quality next adjusted next life) or qwb):ti,ab 19,089
19 (quality near/2 (wellbeing or well next being)):ti,ab 146
20 ((measur* or assess* or scor* or index* or indices or scal* ormonitor*) near/3 outcome*):ti,ab 36,554
21 ((improv* or measur*) near/2 (productivity or performance)):ti,ab 3,707
22 ((output or price) next (index* or indices)):ti,ab 14
23 outcome next measure*:ti,ab 28,517
24 ((utilit* or preference) next (based or index* or indices ormeasure* or valu* or scor* or weigh*)):ti,ab 401
25 (euroqol* or euro qol* or eq5d* or eq 5d*):ti,ab 710
26 (hui or hui1 or hui2 or hui3):ti,ab 71
27
(sf36 or sf 36 or "short form 36" or "shortform 36" or "sf thirtysix"
or "sf thirty six" or "shortform thirtysix" or "shortform thirty six" or
"short form thirtysix" or "short form thirty six"):ti,ab
2,744
28 (sf6 or "sf 6" or "short form 6" or "shortform 6" or "sf six" or sfsixor "shortform six" or "short form six"):ti,ab 73
29
(sf12 or "sf 12" or "short form 12" or "shortform 12" or "sf
twelve" or sftwelve or "shortform twelve" or "short form
twelve"):ti,ab
557
30
(sf16 or "sf 16" or "short form 16" or "shortform 16" or "sf
sixteen" or sfsixteen or "shortform sixteen" or "short form
sixteen"):ti,ab
5
31
(sf20 or "sf 20" or "short form 20" or "shortform 20" or "sf
twenty" or sftwenty or "shortform twenty" or "short form
twenty"):ti,ab
56
32
#10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or
#19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or
#28 or #29 or #30 or #31
143,558
33 #9 and #32 20,231
34
#34 from 2002, in Cochrane Reviews (Reviews only), Other
Reviews, Methods Studies, Technology Assessments and
Cochrane Groups
1,651
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Appendix 3. The CORE Outcome Measure form
Reproduced with kind permission of the CORE System Trust
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Appendix 4. Search strategy used for the
identification of studies reporting methods for the
derivation of health state descriptions from
existing non-preference-based measures
Databases Embase <1980 to 2012 Week 50>, HMIC Health Management
Information Consortium <1979 to November 2012>, Ovid
MEDLINE(R) <1946 to November Week 3 2012>, PsycINFO
<1806 to December Week 3 2012
Interface OvidSP
Date of search 21 December 2012
Search Strategy:
No Search terms Hits
1 exp "quality of life"/ 353,400
2 ((quality adj1 life) or qol or hrqol or hrql or hql or hqol or qaly orquality adjusted life or quality-adjusted life or qwb).ti,ab. 89,440
3 (quality adj1 (wellbeing or well being)).ti,ab. 356
4 1 or 2 or 3 369,409
5 ((utilit* or preference) adj1 (based or index* or indices ormeasure* or valu* or scor* or weigh*)).ti,ab. 10,075
6 ((health state* or health-state*) adj1 (descri* or classification* orvalu*)).ti,ab. 1,103
7 (condition-specific or condition specific).ti,ab. 2,432
8 5 or 6 or 7 12,969
9 (transform* or translat* or transfer* or develop* or conver* ormap* or deriv*).ti,ab. 9,836,495
10 4 and 8 and 9 2,607
11 limit 10 to english language [Limit not valid in HMIC; recordswere retained] 2,564
12 limit 11 to human [Limit not valid in HMIC; records wereretained] 2,341
13 remove duplicates from 12 1,397
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Databases Cochrane Database of Systematic Reviews (CDSR),
Cochrane Methodology Register, Health Technology
Assessment (HTA) database, Database of Abstracts of
Reviews of Effects (DARE)
Interface Wiley
Date of search 21 December 2012
Search Strategy:
No Search terms Hits
1 MeSH descriptor: [Quality of Life] explode all trees 12,121
2
((quality near/2 life) or qol or hrqol or hrql or hql or hqol or qaly
or (quality next adjusted next life) or (quality-adjusted next life)
or qwb):ti,ab
19,089
3 (quality near/2 (wellbeing or well next being)):ti,ab 146
4 #1 or #2 or #3 22,596
5 ((utilit* or preference) next (based or index* or indices ormeasure* or valu* or scor* or weigh*)):ti,ab 401
6 ((health next state* or “health-state”) next (descri* orclassification* or valu*)):ti,ab 25
7 (“condition-specific” or “condition specific”):ti,ab 2,827
8 #5 or #6 or #7 3,233
9 (transform* or translat* or develop* or transfer* or conver* ormap* or deriv*):ti,ab 81,349
10 #4 and #8 and #9 136
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Appendix 5. Results of Principal Components
Analysis on CORE-OM data in study samples
[N750a] and [N750b]
PCA analysis in [N750a]
Table A4. Significant components of CORE-OM identified by Principal
Components Analysis in study sample [N750a]
Component
PCA: Initial Eigenvalues Horn’s parallel analysis:
Significant mean
eigenvalues (SD)Total % of Variance Cumulative %
1 11.26 33.2 33.2 1.42 (0.03)
2 2.14 6.3 39.5 1.37 (0.02)
3 1.83 5.4 44.9 1.33 (0.02)
4 1.48 4.3 49.2 1.30 (0.02)
5 1.30 3.8 53.0 1.27 (0.02)
6 1.08 3.2 56.2 1.24 (0.02)
Significant eigenvalue levels identified using each approach are provided in bold; SD =
standard deviation
Figure A1. Screeplot of Principal Components Analysis in [N750a]
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Table A5. Findings of Principal Components Analysis on CORE-OM
data in study sample [N750a]. Orthogonal rotation - rotated
component matrix
CORE-OM items Components1 2 3 4 5 6
1. [terribly alone and isolated] .60 .29 .30 .19 -.02 .08
2. [tense, anxious or nervous] .61 .23 .08 .00 .16 .34
3. [somebody to turn to for support] -.01 .33 .64 .02 -.10 .12
4. [felt ok about myself] .40 .59 .25 .14 .01 .03
5. [totally lacking in energy and enthusiasm] .46 .36 .11 .03 .12 .33
6. [physically violent to others] .06 .02 -.05 .18 .78 .04
7. [able to cope when things go wrong] .40 .55 .07 .13 .16 -.08
8. [aches, pains, physical problems] .11 -.01 .03 .04 .02 .82
9. [thought of hurting myself] .23 .12 .09 .84 .07 .03
10. [talking to people has felt too much] .25 .24 .42 .13 .02 .33
11. [tension/anxiety prevented doing things] .52 .37 -.04 .08 .20 .35
12. [happy with the things I’ve done] .31 .66 .21 .06 .12 -.06
13. [disturbed by unwanted thoughts/feelings] .65 .02 .16 .18 .01 .12
14. [felt like crying] .62 .14 .25 .15 .03 -.06
15. [felt panic or terror] .66 .12 -.11 .19 .08 .27
16. [made plans to end my life] .16 .12 .05 .82 .03 .07
17. [overwhelmed by my problems] .70 .33 .16 .11 .15 .07
18. [difficulty of getting to sleep/staying asleep] .47 .07 .26 .04 -.03 .38
19. [felt warmth or affection for someone] -.09 .60 .18 .08 -.11 -.03
20. [problems impossible to put to one side] .69 .23 .16 .03 .13 .02
21. [able to do most things I needed to] .35 .62 -.05 .03 .18 .08
22. [threatened or intimidated another person] .06 .04 .26 .06 .73 .01
23. [felt despairing or hopeless] .60 .38 .25 .23 .12 .10
24. [thought it would be better if I were dead] .28 .22 .25 .71 .10 -.01
25. [felt criticised by other people] .32 .13 .57 .10 .34 .04
26. [thought I have no friends] .28 .22 .60 .19 .07 .03
27. [felt unhappy] .64 .35 .31 .13 -.01 -.03
28. [unwanted images/memories distressing] .68 -.06 .28 .18 .00 -.05
29. [irritable when with other people] .35 .08 .49 .06 .36 .10
30. [I am to blame for problems & difficulties] .31 .19 .43 .15 .10 -.15
31. [felt optimistic about my future] .05 .65 .15 .10 -.10 .14
32. [achieved the things I wanted to] .30 .64 .16 .14 .11 .10
33. [felt humiliated or shamed by other people] .36 .04 .50 .21 .33 -.00
34. [hurt myself physically/risks with health] .02 .07 .15 .57 .39 .04
Rotation method Varimax with Kaiser normalisation. Loadings ≥ │0.40│are shown in bold; 
loadings on the component that was found to be non-significant by Horn’s analysis have been
shaded in grey.
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Table A6. Findings of Principal Components Analysis on CORE-OM data
in study sample [N750a]. Oblique rotation - pattern matrix
CORE-OM items
Components
1 2 3 4 5 6
1. [terribly alone and isolated] .61 .11 .17 .07 -.14 -.00
2. [tense, anxious or nervous] .63 .06 -.04 -.11 .08 .26
3. [somebody to turn to for support] -.26 .30 .73 -.07 -.15 .14
4. [felt ok about myself] .26 .54 .14 .03 -.07 -.06
5. [totally lacking in energy and enthusiasm] .39 .25 .02 -.07 .05 .25
6. [physically violent to others] -.13 -.02 -.12 .12 .84 -.00
7. [able to cope when things go wrong] .29 .53 -.08 .02 .10 -.18
8. [aches, pains, physical problems] -.02 -.11 .10 .05 .00 .85
9. [thought of hurting myself] .10 -.00 -.06 .87 -.01 .01
10. [talking to people has felt too much] .08 .12 .43 .05 -.06 .32
11. [tension/anxiety prevented doing things] .46 .26 -.18 -.01 .13 .26
12. [happy with the things I’ve done] .13 .67 .10 -.06 .06 -.15
13. [disturbed by unwanted thoughts/feelings] .78 -.21 .03 .08 -.11 .05
14. [felt like crying] .71 -.05 .10 .02 -.09 -.15
15. [felt panic or terror] .78 -.07 -.29 .12 -.02 .18
16. [made plans to end my life] .01 .02 -.08 .87 -.04 .06
17. [overwhelmed by my problems] .73 .15 -.02 -.04 .05 -.04
18. [difficulty of getting to sleep/staying asleep] .48 -.12 .22 -.05 -.13 .34
19. [felt warmth or affection for someone] -.36 .72 .17 .06 -.12 -.05
20. [problems impossible to put to one side] .79 .04 -.01 -.12 .03 -.09
21. [able to do most things I needed to] .21 .64 -.20 -.07 .14 -.03
22. [threatened or intimidated another person] -.16 -.03 .25 -.06 .77 -.01
23. [felt despairing or hopeless] .55 .22 .09 .11 .01 .01
24. [thought it would be better if I were dead] .12 .10 .12 .68 .01 -.05
25. [felt criticised by other people] .16 -.04 .56 -.06 .29 .01
26. [thought I have no friends] .12 .07 .59 .07 -.02 .01
27. [felt unhappy] .67 .17 .16 -.02 -.13 -.12
28. [unwanted images/memories distressing] .86 -.32 .15 .05 -.13 -.12
29. [irritable when with other people] .23 -.10 .48 -.10 .31 .07
30. [I am to blame for problems & difficulties] .25 .07 .37 .03 .03 -.19
31. [felt optimistic about my future] -.21 .73 .12 .06 -.13 .10
32. [achieved the things I wanted to] .08 .63 .06 .05 .06 .02
33. [felt humiliated or shamed by other people] .25 -.15 .46 .07 .27 -.03
34. [hurt myself physically/risks with health] -.21 .00 .09 .56 .38 .04
Rotation method Promax with Kaiser normalisation. Loadings ≥ │0.40│are shown in bold; 
loadings on the component that was found to be non-significant by Horn’s analysis have
been shaded in grey.
305
Table A7. Findings of Principal Components Analysis of CORE-OM data
in study random sub-sample [N750a]. Oblique rotation – component
correlation matrix
Component 1 2 3 4 5 6
1 1.00 0.58 0.50 0.41 0.42 0.27
2 0.58 1.00 0.38 0.29 0.23 0.22
3 0.50 0.38 1.00 0.36 0.26 -0.01
4 0.41 0.29 0.36 1.00 0.28 0.02
5 0.42 0.23 0.26 0.28 1.00 0.11
6 0.27 0.22 -0.01 0.02 0.11 1.00
Rotation method Promax with Kaiser normalisation. Correlation coefficients ≥ 
│0.40│are shown in bold; correlations of the component that was found to be non-
significant by Horn’s analysis have been shaded in grey.
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PCA analysis on [N750b]
Table A8. Significant components of CORE-OM identified by Principal
Components Analysis in study sample [N750b]
Component
PCA: Initial Eigenvalues Horn’s parallel analysis:
Significant mean
eigenvalues (SD)Total % of Variance Cumulative %
1 11.05 32.5 32.5 1.42 (0.03)
2 2.15 6.3 38.8 1.37 (0.02)
3 1.78 5.2 44.0 1.33 (0.02)
4 1.45 4.3 48.3 1.30 (0.02)
5 1.22 3.6 51.9 1.27 (0.02)
6 1.13 3.3 55.2 1.24 (0.02)
7 1.07 3.2 58.4 1.21 (0.01)
Significant eigenvalue levels identified using each approach are provided in bold; SD =
standard deviation
Figure A2. Screeplot of Principal Components Analysis in [N750b]
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Table A9. Findings of Principal Components Analysis on CORE-OM data
in study sample [N750b]. Orthogonal rotation - rotated component matrix
CORE-OM items
Components
1 2 3 4 5 6 7
1. [terribly alone and isolated] .44 .39 .28 .16 .24 .24 -.07
2. [tense, anxious or nervous] .41 .26 .58 -.02 .15 -.04 .00
3. [somebody to turn to for support] .08 .23 .03 .08 .21 .71 .03
4. [felt ok about myself] .34 .58 .09 .13 .12 .22 .02
5. [totally lacking in energy and enthusiasm] .37 .34 .42 .09 .04 .04 -.02
6. [physically violent to others] .05 .11 .02 .18 .03 .09 .79
7. [able to cope when things go wrong] .25 .63 .25 .15 .04 -.04 .14
8. [aches, pains, physical problems] .17 -.22 .59 .08 -.04 .36 -.13
9. [thought of hurting myself] .14 .20 .11 .82 .09 .07 .10
10. [talking to people has felt too much] .25 .24 .47 .03 .12 .26 .10
11. [tension/anxiety prevented doing things] .15 .42 .65 .13 .23 -.05 .14
12. [happy with the things I’ve done] .26 .70 .08 .07 .16 .17 .11
13. [disturbed by unwanted thoughts/feelings] .58 .00 .24 .27 .18 -.00 -.12
14. [felt like crying] .67 .26 .21 .10 .15 -.02 .05
15. [felt panic or terror] .24 .22 .59 .20 .15 -.11 -.01
16. [made plans to end my life] .10 .07 .12 .80 .09 .01 .07
17. [overwhelmed by my problems] .53 .37 .37 .12 .26 -.02 .02
18. [difficulty of getting to sleep/staying asleep] .62 .20 .07 .13 -.12 .14 .07
19. [felt warmth or affection for someone] -.01 .20 .02 .12 .02 .69 .18
20. [problems impossible to put to one side] .60 .29 .27 .03 .20 -.01 .08
21. [able to do most things I needed to] .03 .62 .36 .17 .08 .01 .23
22. [threatened or intimidated another person] .06 -.03 .00 .10 .23 .07 .76
23. [felt despairing or hopeless] .43 .39 .35 .18 .38 .08 .04
24. [thought it would be better if I were dead] .28 .17 .17 .67 .34 .06 -.02
25. [felt criticised by other people] .18 .12 .09 .04 .77 .07 .14
26. [thought I have no friends] .16 .15 .14 .15 .59 .34 .13
27. [felt unhappy] .61 .42 .20 .08 .24 .12 .04
28. [unwanted images/memories distressing] .66 -.01 .11 .28 .15 .01 .06
29. [irritable when with other people] .50 .18 .07 -.01 .27 .12 .34
30. [I am to blame for problems & difficulties] .27 .37 -.04 .23 .50 .04 -.06
31. [felt optimistic about my future] .24 .56 .11 .01 .06 .28 -.18
32. [achieved the things I wanted to] .08 .66 .07 .12 .22 .21 -.01
33. [felt humiliated or shamed by other people] .11 .11 .21 .14 .72 .01 .14
34. [hurt myself physically/risks with health] .14 .06 -.02 .61 .03 .16 .19
Rotation method Varimax with Kaiser normalisation. Loadings ≥ │0.40│are shown in 
bold; loadings on the 3 components that were found to be non-significant by Horn’s
analysis have been shaded in grey.
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Table A10. Findings of Principal Components Analysis on CORE-OM
data in study sample [N750b]. Oblique rotation - pattern matrix
CORE-OM items
Components
1 2 3 4 5 6 7
1. [terribly alone and isolated] .31 .27 .16 .03 .10 .17 -.12
2. [tense, anxious or nervous] .26 .09 .57 -.15 .03 -.09 -.02
3. [somebody to turn to for support] -.06 .19 -.01 .00 .16 .69 -.02
4. [felt ok about myself] .22 .61 -.07 .03 -.06 .15 -.04
5. [totally lacking in energy and enthusiasm] .26 .25 .38 -.01 -.14 -.02 -.04
6. [physically violent to others] .06 .05 -.01 .12 -.08 .08 .79
7. [able to cope when things go wrong] .08 .67 .13 .07 -.16 -.11 .08
8. [aches, pains, physical problems] .08 -.45 .76 .03 -.11 .37 -.11
9. [thought of hurting myself] .01 .13 .01 .84 -.07 .02 .04
10. [talking to people has felt too much] .09 .10 .49 -.09 .07 .22 .08
11. [tension/anxiety prevented doing things] -.18 .31 .66 .01 .12 -.10 .09
12. [happy with the things I’ve done] .09 .77 -.09 -.04 -.01 .10 .04
13. [disturbed by unwanted thoughts/feelings] .63 -.24 .14 .18 .07 -.07 -.14
14. [felt like crying] .73 .08 .05 -.03 -.03 -.11 .03
15. [felt panic or terror] .02 .07 .61 .11 .05 -.15 -.04
16. [made plans to end my life] -.02 -.02 .05 .84 -.03 -.03 .02
17. [overwhelmed by my problems] .43 .21 .24 -.02 .11 -.11 -.03
18. [difficulty of getting to sleep/staying asleep] .78 .09 -.07 .05 -.35 .08 .07
19. [felt warmth or affection for someone] -.12 .20 .03 .07 -.07 .69 .15
20. [problems impossible to put to one side] .60 .12 .13 -.12 .05 -.09 .05
21. [able to do most things I needed to] -.26 .68 .32 .10 -.08 -.04 .16
22. [threatened or intimidated another person] .08 -.16 -.03 .02 .22 .05 .75
23. [felt despairing or hopeless] .25 .23 .22 .04 .27 -.01 -.03
24. [thought it would be better if I were dead] .12 .02 .04 .62 .25 -.01 -.09
25. [felt criticised by other people] -.02 -.07 -.04 -.11 .90 .01 .06
26. [thought I have no friends] -.04 -.03 .06 .02 .64 .29 .06
27. [felt unhappy] .58 .28 .01 -.07 .08 .03 -.00
28. [unwanted images/memories distressing] .81 -.26 -.05 .19 .02 -.07 .05
29. [irritable when with other people] .56 .01 -.08 -.16 .17 .06 .32
30. [I am to blame for problems & difficulties] .12 .30 -.25 .13 .50 -.05 -.15
31. [felt optimistic about my future] .10 .63 -.01 -.07 -.08 .22 -.24
32. [achieved the things I wanted to] -.18 .77 -.07 .04 .12 .15 -.09
33. [felt humiliated or shamed by other people] -.14 -.09 .13 .01 .83 -.05 .07
34. [hurt myself physically/risks with health] .12 -.01 -.10 .63 -.09 .13 .16
Rotation method Promax with Kaiser normalisation. Loadings ≥ │0.40│are shown in bold; 
loadings on the 3 components that were found to be non-significant by Horn’s analysis
have been shaded in grey.
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Table A11. Findings of Principal Components Analysis of CORE-OM data
in study sample [N750b]. Oblique rotation – component correlation
matrix
Component 1 2 3 4 5 6 7
1 1.00 0.60 0.58 0.37 0.57 0.20 0.04
2 0.60 1.00 0.52 0.32 0.54 0.17 0.17
3 0.58 0.52 1.00 0.31 0.45 0.07 0.06
4 0.37 0.32 0.31 1.00 0.38 0.13 0.15
5 0.57 0.54 0.45 0.38 1.00 0.17 0.18
6 0.20 0.17 0.07 0.13 0.17 1.00 0.03
7 0.04 0.17 0.06 0.15 0.18 0.03 1.00
Rotation method Promax with Kaiser normalisation. Correlation coefficients ≥ 
│0.40│are shown in bold; correlations of the 3 components that were found to be
non-significant by Horn’s analysis have been shaded in grey.
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Appendix 6. Rasch category probability curves of
the 34 CORE-OM items before rescoring - [N400a]
dataset
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Appendix 7. Rasch category probability curves for
the 34 CORE-OM items after rescoring – Rasch
analysis on [N400a]
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Appendix 8. Validation of the emotional
component of CORE-6D. Rasch analysis on randomsamples [N400b], [N1500] and [N1500v]
Validation on random sample [N400b]
Table A12. Item-person and item-trait interaction summary statistics –
[N400b]
Items Persons
Location Fit residual Location Fit residual
Mean 0.000 0.227 -0.678 -0.259
Standard deviation 1.312 0.914 1.422 0.775
Item-trait interaction Reliability indices
Total Item chi-square 22.970 PSI 0.65905
Total degrees of freedom 20 Cronbach Alpha N/A (missing data)
Total chi-square probability 0.2903 Power of test-of-fit Good
Table A13. Individual item fit statistics– [N400b]
Item CD Location Residual Chi-square
P-
value
1. [terribly alone and isolated] FC -1.552 -0.363 3.799 0.434
15. [felt panic or terror] SA -0.727 -0.163 6.074 0.194
16. [made plans to end my life] RS 1.932 -0.733 7.462 0.113
21. [able to do most things I needed to] FG 0.454 1.328 4.861 0.302
33. [felt humiliated or shamed by other people] FS -0.106 1.067 0.774 0.942
Residuals ≥ │2.5│are considered high; chi-square probabilities have been assessed using 
Bonferroni adjustment. CD = conceptual domain; FC = functioning-close relationships; FG
= functioning-general; FS = functioning-social relationships; RS = risk/harm-to-self; SA =
symptoms-anxiety
Table A14. Class interval distribution– [N400b]
ITEM CI1 CI2 CI3 CI4 CI5 CI6 CI7
1 34 54 66 73 52 44 54
15 34 54 66 75 53 44 54
16 34 53 65 74 51 44 54
21 33 54 66 74 53 44 53
33 34 52 67 71 52 44 54
CI: Class interval
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Figure A3. Rach item threshold map– [N400b]
Figure A4. Item map – [N400b]
Table A15. Principal Component Analysis of item fit residuals – [N400b]
Item Component
1
Component
2
Component
3
Component
4
Component
5
1 0.15 -0.19 0.95 -0.12 -0.18
15 0.18 0.92 -0.21 -0.14 -0.23
16 0.10 -0.11 -0.11 0.98 -0.09
21 -0.93 -0.18 -0.16 -0.13 -0.25
33 0.30 -0.26 -0.23 -0.13 0.88
Varimax rotation; loadings ≥ │0.40│are shown in bold 
Item 1
Item 15
Item 33
Item 21
Item 16
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Table A16. Residual correlation matrix – [N400b]
Item 1 15 16 21 33
1 1.00
15 -0.29 1.00
16 -0.17 -0.17 1.00
21 -0.19 -0.23 -0.16 1.00
33 -0.27 -0.33 -0.12 -0.39 1.00
None of the correlation coefficients between different items is ≥ │0.40│ 
According to the post-hoc test of unidimensionality, the proportion of
independent t-tests that were significant at the 0.05 level was 1.85%, which
verified the unidimensionality of the emotional component of CORE-6D also in
the random sample [N400b].
Validation on dataset [N1500]
Table A17. Item-person and item-trait interaction summary statistics after
adjustment of sample size to n=500 – [N1500]
Items Persons
Location Fit residual Location Fit residual
Mean 0.000 -0.035 -0.757 -0.246
Standard deviation 1.276 1.489 1.409 0.739
Item-trait interaction Reliability indices
Total Item chi-square 32.475 PSI 0.65990
Total degrees of freedom 35 Cronbach Alpha N/A (missing data)
Total chi-square probability 0.5906 Power of test-of-fit Good
Table A18. Individual item fit statistics after adjustment of sample
size to n=500 – [N1500]
Item CD Location Residual Chi-square
P-
value
1. [terribly alone and isolated] FC -1.514 -1.212 6.761 0.454
15. [felt panic or terror] SA -0.739 -0.245 6.078 0.531
16. [made plans to end my life] RS 1.828 -1.676 8.059 0.327
21. [able to do most things I needed to] FG 0.560 1.773 8.944 0.257
33. [felt humiliated or shamed by other people] FS -0.136 1.182 2.634 0.917
Residuals ≥ │2.5│are considered high; chi-square probabilities have been assessed using 
Bonferroni adjustment. CD = conceptual domain; FC = functioning-close relationships; FG
= functioning-general; FS = functioning-social relationships; RS = risk/harm-to-self; SA =
symptoms-anxiety
331
Table A19. Class interval distribution – [N1500]
ITEM CI1 CI2 CI3 CI4 CI5 CI6 CI7
1 142 172 218 230 186 149 139
15 141 172 218 232 185 150 139
16 142 170 218 229 184 146 139
21 141 168 218 231 186 150 138
33 141 170 218 226 185 148 139
CI: Class interval
Figure A5. Rasch item threshold map – [N1500]
Figure A6. Item map – [N1500]
Item 1
Item 15
Item 33
Item 21
Item 16
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Table A20. Principal Component Analysis of the item fit residuals –
[N1500]
Item Component
1
Component
2
Component
3
Component
4
Component
5
1 -0.20 0.94 -0.18 -0.11 -0.19
15 -0.24 -0.20 -0.19 -0.11 0.93
16 -0.13 -0.10 -0.12 0.98 -0.09
21 -0.21 -0.18 0.93 -0.14 -0.18
33 0.88 -0.24 -0.25 -0.17 -0.28
Varimax rotation; loadings ≥ │0.40│are shown in bold 
Table A21. Residual correlation matrix – [N1500]
Item 1 15 16 21 33
1 1.00
15 -0.27 1.00
16 -0.14 -0.12 1.00
21 -0.24 -0.24 -0.19 1.00
33 -0.28 -0.35 -0.20 -0.30 1.00
None of the correlation coefficients between different items is ≥ │0.40│ 
The post-hoc test of unidimensionality confirmed once again the
unidimensionality of the measure, with the proportion of significant
independent t-tests at the 0.05 level reaching 1.45%.
Validation on dataset [N1500v]
Table A22. Item-person and item-trait interaction summary statistics after
adjustment of sample size to n=700 – [N1500v]
Items Persons
Location Fit residual Location Fit residual
Mean 0.000 0.244 -0.816 -0.244
Standard deviation 1.173 1.298 1.407 0.722
Item-trait interaction Reliability indices
Total Item chi-square 34.745 PSI 0.6724
Total degrees of freedom 30 Cronbach Alpha N/A (missing data)
Total chi-square probability 0.2521 Power of test-of-fit Good
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Table A23. Individual item statistics after adjustment of sample size to
n=70 – [N1500v]
Item CD Location Residual Chi-square
P-
value
1. [terribly alone and isolated] FC -1.422 -0.832 9.073 0.169
15. [felt panic or terror] SA -0.699 0.412 5.527 0.478
16. [made plans to end my life] RS 1.594 -1.324 8.052 0.234
21. [able to do most things I needed to] FG 0.661 1.615 6.984 0.322
33. [felt humiliated or shamed by other people] FS -0.134 1.349 5.108 0.530
Residuals ≥ │2.5│are considered high; chi-square probabilities have been assessed using 
Bonferroni adjustment. CD = conceptual domain; FC = functioning-close relationships; FG
= functioning-general; FS = functioning-social relationships; RS = risk/harm-to-self; SA =
symptoms-anxiety
Table A24. Class interval distribution – [N1500v]
ITEM CI1 CI2 CI3 CI4 CI5 CI6 CI7
1 164 214 257 227 202 149 172
15 165 214 256 230 202 150 171
16 164 214 256 228 199 143 171
21 163 214 253 227 201 148 171
33 164 214 256 228 202 146 171
CI: Class interval
Figure A7. Rasch item threshold map – [N1500v]
Item 1
Item 15
Item 33
Item 21
Item 16
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Figure A8. Item map - [N1500v]
Table A25. Principal Component Analysis of item residuals – [N1500v]
Item Component
1
Component
2
Component
3
Component
4
Component
5
1 -0.19 0.21 -0.16 -0.11 0.94
15 -0.24 -0.91 -0.18 -0.15 -0.23
16 -0.13 0.12 -0.13 0.97 -0.10
21 -0.21 0.17 0.94 -0.14 -0.15
33 0.90 0.25 -0.24 -0.16 -0.22
Varimax rotation; loadings ≥ │0.40│are shown in bold 
Table A26. Residual correlation matrix – [N1500v]
Item 1 15 16 21 33
1 1.00
15 -0.32 1.00
16 -0.13 -0.18 1.00
21 -0.20 -0.22 -0.20 1.00
33 -0.27 -0.32 -0.19 -0.32 1.00
None of the correlation coefficients between different items is ≥ │0.40│ 
The post-hoc test of unidimensionality confirmed the unidimensionality of the
new scale on [N1500v], with the proportion of significant independent t-tests at
the 0.05 level reaching 0.79%.
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Appendix 9. Interviewer booklet used in the
valuation survey of CORE-6D
University of Sheffield - School of Health and Related
Research
Thank you very much for agreeing to take part in this survey. As we explained in the
letter, this is a survey for the University of Sheffield about the way people value
common mental and physical health problems.
You can stop the interview at any time if you do not want to continue. If there are
any questions you do not want to answer tell the interviewer and they will move
onto the next question.
All information you provide is confidential. The information you give will not be
used in any way that could identify you.
We are interested in people’s views, and there are no right or wrong answers.
Please tell us what you think.
Respondent ID _______________
Interviewer ID _______________
Card bloc _______________
Start time _______________
End time _______________
Survey of General Health Values
Interviewer booklet
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SECTION [A] SELF REPORTED HEALTH
BEFORE THE INTERVIEW PLEASE PREPARE THE BLOC OF CARDS THAT ARE
BEING USED.
FILL IN RESPONDENT ID, INTERVIEWER ID, CARD BLOC AND START TIME ON
FRONT PAGE OF THE INTERVIEWER BOOKLET AND SELF-COMPLETION
BOOKLET.
READ ALOUD THE INTRODUCTION ON THE FRONT PAGE.
To start off, I would like you to answer a few questions about your own health and
wellbeing.
There is one question about your life satisfaction. Then there are some statements
about different aspects of your general health and quality of life. The statements are
arranged in groups. For each group, please tick just one statement that best
describes your own health state today.
HAND RESPONDENT SELF-COMPLETION BOOKLET
Please answer the questions in section A1 and A2 and then return the booklet to me.
AFTER SECTIONS A1 AND A2 HAVE BEEN COMPLETED TAKE THE SELF-
COMPLETION BOOKLET FROM RESPONDENT.
MAKE SURE RESPONDENT HAS ONLY TICKED ONE BOX IN EACH GROUP.
HAND RESPONDENT SELF-COMPLETION BOOKLET OPEN AT SECTION A3,
PAGE 3.
CARD BLOC 1 ONLY: Please answer the questions in section A3 and then
return the booklet to me.
CARD BLOCS 2 AND 3 ONLY: Please answer the questions in section A3 and
A4 and then return the booklet to me.
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AFTER THE SECTION(S) HAS BEEN COMPLETED TAKE THE SELF-
COMPLETION BOOKLET FROM RESPONDENT.
THE RESPONDENT CAN CHOOSE WHETHER TO ANSWER THESE QUESTIONS
SO DO NOT CHECK THESE RESPONSES.
GO TO SECTION [B] RANKING EXERCISE
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SECTION [B] RANKING EXERCISE
PLEASE SHUFFLE THE REMAINING 4 GREEN CARDS AND THE PINK CARD
(FULL HEALTH) AND BLUE CARD (DEAD). DO NOT INCLUDE THE CREAM
PRACTICE CARD.
THERE ARE 6 CARDS IN TOTAL.
SHOW PACK OF CARDS TO RESPONDENT
The booklet that you have just completed had questions made up from statements
about health for you to choose from. I now have some cards which describe different
states that you might find yourself in, and each of these is made up by combining the
statements that you have just seen.
For example here is a card which has a description of a state written on it.
GIVE A GREEN CARD TO THE RESPONDENT TO LOOK AT.
If you were living in this state you would… READ CARD ALOUD
CARD BLOC 1: SHUFFLE 4 GREEN CARDS: ST, ZB, MC, GQ
CARD BLOCS 2 AND 3: SHUFFLE ALL 8 GREEN CARDS AND PICK 4 CARDS
OUT AND PUT TO ONE SIDE FOR USE IN SECTIONS D AND E.
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FOR EXAMPLE, for the card pictured below:
YOU WOULD SAY ALOUD: IF YOU WERE LIVING IN THIS STATE YOU
WOULD FEEL TERRIBLY ALONE AND ISOLATED OFTEN, MOST OR ALL THE
TIME, FEEL PANIC OR TERROR ONLY OCCASIONALLY OR SOMETIMES,
FEEL HUMILIATED OR SHAMED BY OTHER PEOPLE ONLY OCCASIONALLY
OR SOMETIMES, ARE ABLE TO DO MOST THINGS YOU NEED TO ONLY
OCCASIONALLY OR SOMETIMES, NEVER MAKE PLANS TO END YOUR
LIFE.
We are now going to use a technique called ranking to find out how good or bad you
think living in some of the states would be. The states that we will show you have
nothing to do with the answers you have just provided about your own health and
well-being.
Now, here is a set of 6 cards. Each of them has a description of a state written on it.
Each card has a different state description on it.
I would like you to place the cards in order of how good or bad you think they are. I
would like you to imagine that you yourself are actually in each state and that you
would live in that state for 10 years. After this time period you must assume that you
would die. Please read each card carefully to see exactly what the state is and how it
differs from the others. When you have finished reading through, please place the
cards in order of how good or bad you think they are. Put the one you think is best at
 You feel terribly alone and isolated often, most or all the time
 You feel panic or terror only occasionally or sometimes
 You feel humiliated or shamed by other people only
occasionally or sometimes
 You are able to do most things you need to only occasionally
or sometimes
 You never make plans to end your life
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the top (POINT TO TOP END), and the one that you think is worst at the bottom
(POINT TO THE BOTTOM END).
PASS CARDS TO RESPONDENT
If you think two states are equal, put them side by side. You will notice that there is a
card which says “dead”. Please also put this with the other cards in order where you
think it belongs. You can change your ordering at any time.
RECORD THE RESULTS OF THE RANKING EXERCISE IN THE TABLE BELOW. IF
MORE THAN TWO CARDS ARE RANKED EQUALLY, CROSS OUT THE NUMBER
IN THE RANK COLUMN AND WRITE THE CORRECT RANK.
RANK CARD CODE e.g. WG
1
2
3
4
5
6
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SECTION [C] VALUATION EXERCISE
C. INTERVIEWER SCRIPT FOR TTO
REMOVE PINK CARD AND BLUE CARD FROM THE PACK OF RANKED
CARDS.
PLEASE SHUFFLE ALL 4 GREEN CARDS (THE 4 CARDS THAT HAVE
JUST BEEN RANKED).
PICK UP PINK AND BLUE CARDS, AND CREAM PRACTICE CARD
HAVE TTO BOARD SIDE ‘1’ FACING UPWARDS.
SET BOARD MARKER FOR LIFE A TO 10 YEARS.
Now we are going to use a technique called the time trade off to find out how
good or bad you think living in some of the health states would be. The time
trade off asks you to compare living in two health states for a maximum period
of 10 years. After this time period you must assume that you would die.
I’m going to start with a practice using a health state which is similar to those
which you have just ranked.
I am going to ask you to make a choice between living in this health state (Life
B – cream card) and living in another health state (Life A – pink card). The
pink scale and the green scale show the number of years you would be in
each state for. Remember, I want you to imagine that you are in these states.
C2a. INTERVIEWER CHECK:
PICK OUT CREAM PRACTICE TTO CARD.
TICK TO CONFIRM CORRECT CARD: __________
PASS CARD TO THE RESPONDENT.
Please read this card carefully.
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b. PLACE CREAM PRACTICE TTO CARD IN POCKET FOR LIFE B.
PLACE PINK CARD IN POCKET FOR LIFE A.
MAKE SURE THAT BOARD MARKER FOR LIFE A IS AT 10 YEARS.
At the moment, each scale says 10 years. This means that you would either
live in Life A for 10 years and then die, or you would live in Life B for 10 years
and then die. Would you prefer Life A or Life B, or are they the same?
Life A 1. GO TO C3
Life B 2.
ASK c.
The same 3.
c. IF ‘LIFE B’ AT b.: Does this mean that you would rather live in Life B for 10
years than in Life A for 10 years?
IF ‘THE SAME’ AT b.: Does this mean that living in Life B for 10 years would
be the same as living in Life A for 10 years?
Yes 1. GO TO C3
No (first time) 2. Repeat b
No (second time) 3. GO TO C3
C3a. CONTINUE WORKING WITH CREAM PRACTICE CARD.
TICK TO CONFIRM CORRECT CARD: __________
b. MOVE BOARD MARKER FOR LIFE A TO 0 YEARS.
Now you would either die immediately, or you would live in Life B for 10 years
and then die. Would you prefer to die immediately or to have Life B, or are they
the same?
Life A 1. GO TO h. (STATE WORSE THAN DEATH)
Life B 2. GO TO c. (STATE BETTER THAN DEATH)
The same 3. GO TO C4
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ASK IF ‘LIFE B’ (code 2) AT b.
c. STATE BETTER THAN DEATH
MARK ‘X’ UNDER 0 ON THE SCALE BELOW.
BETTER 0 1 2 3 4 5 6 7 8 9 10
THAN DEATH
SCALE
CONTINUE TO USE TIME BOARD WITH SIDE ‘1’ UPWARDS
SET BOARD MARKER FOR LIFE A TO 5 YEARS (t=5).
d. Now you would either live in Life A for ‘t’ years and then die, or you would live in
Life B for 10 years and then die. Would you prefer Life A or Life B, or are they
the same?
CONTINUE TO WRITE ON SCALE ABOVE ON THIS PAGE.
IF A:  UNDER ‘t’ MOVE MARKER 1 YEAR TO THE LEFT.
REPEAT d. WITH ‘t’ 1 LESS THAN LAST TIME.
IF B:  UNDER ‘t’ MOVE MARKER 1 YEAR TO THE RIGHT.
REPEAT d. WITH ‘t’ 1 MORE THAN LAST TIME.
IF SAME: = UNDER ‘t’ GO TO C4
REPEAT d. UNTIL:
A) YOU ENTER ‘=’
B) ‘’ AND ‘’ APPEAR NEXT TO EACH OTHER
GO TO C4 OR
GO TO e.
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ASK IF d. ENDED WITH ‘’ AND ‘’ NEXT TO EACH OTHER
e. LET ‘t’ NOW BE HALFWAY BETWEEN THE ADJACENT CROSS AND TICK,
I.E. ‘SOMETHING AND 6 MONTHS’
What if you would either live in Life A for ‘t’ and then die, or you would live in
Life B for 10 years and then die. Would you prefer Life A or Life B, or are they
the same?
Life A 1. GO TO C4
Life B 2. GO TO f.
The same 3. GO TO C4
f. IF ‘LIFE B’ (code 2) AT e.
INTERVIEWER CHECK:
ASK IF THERE IS ‘’ UNDER 9 AND ‘’ UNDER 10
g. Would you be prepared to sacrifice any time in order to avoid Life B?
IF YES: How many weeks?
ENTER WEEKS: _____
ASK IF ‘LIFE A’ (code 1) AT b.
h. STATE WORSE THAN DEATH
MARK ‘’ UNDER 0 ON SCALE BELOW.
WORSE 0 1 2 3 4 5 6 7 8 9 10
THAN DEATH
SCALE
TURN TTO BOARD SIDE ‘2’ UPWARDS.
MOVE CREAM PRACTICE CARD TO TOP LEFT POCKET ON SIDE ‘2’.
PLACE PINK CARD IN TOP RIGHT POCKET ON SIDE ‘2’.
PLACE BLUE CARD IN BOTTOM POCKET ON SIDE ‘2’.
SET BOARD MARKER FOR LIFE A TO 5 YEARS (t = 5).
Now here is a different choice.
IF THERE IS A  UNDER 9 1. GO TO g.
IF THERE IS NOT A  UNDER 9 2. GO TO C4
Yes 1.
GO TO C4
No 2.
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i. Life A is now ‘t’ years of this state (POINT TO THE CREAM PRACTICE CARD)
followed by ’10-t’ years in this other state (POINT TO THE PINK CARD). Or
instead of that you could choose to die immediately (POINT TO LIFE B). Would
you prefer Life A, or to die immediately, or are they the same?
WRITE ON SCALE ABOVE ON THIS PAGE.
IF A:  UNDER ‘t’ MOVE MARKER 1 YEAR TO THE RIGHT.
REPEAT i. WITH ‘t’ 1 MORE THAN LAST TIME.
IF B:  UNDER ‘t’ MOVE MARKER 1 YEAR TO THE LEFT.
REPEAT i. WITH ‘t’ 1 LESS THAN LAST TIME.
IF SAME: = UNDER ‘t’ GO TO C4
REPEAT i. UNTIL:
A) YOU ENTER ‘=’
B) ‘’ AND ‘’ APPEAR NEXT TO EACH OTHER
GO TO C4 OR
GO TO j.
ASK IF i. ENDED WITH ‘’ AND ‘’ NEXT TO EACH OTHER
j. LET ‘t’ NOW BE HALFWAY BETWEEN THE ADJACENT TICK AND CROSS, I.E.
‘SOMETHING AND 6 MONTHS’.
What if Life A was ‘t’ of this state (POINT TO THE CREAM PRACTICE CARD)
followed by ’10-t’ in this other state (POINT TO THE PINK CARD). Or instead of
that you could choose to die immediately (POINT TO LIFE B). Would you prefer
Life A, or to die immediately, or are they the same?
Life A 1.
GO TO C4Life B 2.
The same 3.
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C4a. INTERVIEWER CHECK:
PICK UP PACK OF 4 GREEN HEALTH STATE CARDS (SHUFFLED) THAT
WERE JUST RANKED.
TAKE OUT FIRST CARD TO BE VALUED. ENTER LETTERS OF THE
CARD: _____
PASS CARD TO THE RESPONDENT.
Please read this card through carefully.
b. HAVE TTO BOARD WITH SIDE ‘1’ FACING UPWARDS.
PLACE GREEN CARD IN POCKET FOR LIFE B.
MOVE BOARD MARKER FOR LIFE A TO 0 YEARS.
Now you would either die immediately, or you would live in Life B for 10 years
and then die. Would you prefer to die immediately or to have Life B, or are
they the same?
Life A 1. GO TO h. (STATE WORSE THAN DEATH)
Life B 2. GO TO c. (STATE BETTER THAN DEATH)
The same 3. GO TO C5
ASK IF ‘LIFE B’ (code 2) AT b.
c. STATE BETTER THAN DEATH
MARK ‘X’ UNDER 0 ON THE SCALE BELOW.
BETTER 0 1 2 3 4 5 6 7 8 9 10
THAN DEATH
SCALE
CONTINUE TO USE TIME BOARD WITH SIDE ‘1’ UPWARDS
SET BOARD MARKER FOR LIFE A TO 5 YEARS (t=5).
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d. Now you would either live in Life A for ‘t’ years and then die, or you would
live in Life B for 10 years and then die. Would you prefer Life A or Life B,
or are they the same?
CONTINUE TO WRITE ON SCALE ABOVE ON THIS PAGE.
IF A:  UNDER ‘t’ MOVE MARKER 1 YEAR TO THE LEFT.
REPEAT d. WITH ‘t’ 1 LESS THAN LAST TIME.
IF B:  UNDER ‘t’ MOVE MARKER 1 YEAR TO THE RIGHT.
REPEAT d. WITH ‘t’ 1 MORE THAN LAST TIME.
IF SAME: = UNDER ‘t’ GO TO C5
REPEAT d. UNTIL:
A) YOU ENTER ‘=’
B) ‘’ AND ‘’ APPEAR NEXT TO EACH OTHER
GO TO C5 OR
GO TO e.
ASK IF d. ENDED WITH ‘’ AND ‘’ NEXT TO EACH OTHER
e. LET ‘t’ NOW BE HALFWAY BETWEEN THE ADJACENT CROSS AND
TICK, I.E. ‘SOMETHING AND 6 MONTHS’
What if you would either live in Life A for ‘t’ and then die, or you would live in Life
B for 10 years and then die. Would you prefer Life A or Life B, or are they the
same?
Life A 1. GO TO C5
Life B 2. GO TO f.
The same 3. GO TO C5
IF ‘LIFE B’ (code 2) AT e.
f. INTERVIEWER CHECK:
IF THERE IS A  UNDER 9 1. GO TO g.
IF THERE IS NOT A  UNDER 9 2. GO TO C5
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ASK IF THERE IS ‘’ UNDER 9 AND ‘’ UNDER 10
g. Would you be prepared to sacrifice any time in order to avoid Life B?
IF YES: How many weeks?
ENTER WEEKS: _____
ASK IF ‘LIFE A’ (code 1) AT b.
h. STATE WORSE THAN DEATH
MARK ‘’ UNDER 0 ON SCALE BELOW.
WORSE 0 1 2 3 4 5 6 7 8 9 10
THAN DEATH
SCALE
TURN TTO BOARD SIDE ‘2’ UPWARDS.
MOVE GREEN CARD TO TOP LEFT POCKET ON SIDE ‘2’.
SET BOARD MARKER FOR LIFE A TO 5 YEARS (t = 5).
Now here is a different choice.
i. Life A is now ‘t’ years of this state (POINT TO THE GREEN CARD) followed by
’10-t’ years in this other state (POINT TO THE PINK CARD). Or instead of that
you could choose to die immediately (POINT TO LIFE B). Would you prefer Life
A, or to die immediately, or are they the same?
WRITE ON SCALE ABOVE ON THIS PAGE.
IF A:  UNDER ‘t’ MOVE MARKER 1 YEAR TO THE RIGHT.
REPEAT i. WITH ‘t’ 1 MORE THAN LAST TIME.
IF B:  UNDER ‘t’ MOVE MARKER 1 YEAR TO THE LEFT.
REPEAT i. WITH ‘t’ 1 LESS THAN LAST TIME.
IF SAME: = UNDER ‘t’ GO TO C5
REPEAT i UNTIL:
A) YOU ENTER ‘=’ GO TO C5 OR
B) ‘’ AND ‘’ APPEAR NEXT TO EACH OTHER GO TO j.
Yes 1.
GO TO C5
No 2.
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ASK IF i. ENDED WITH ‘’ AND ‘’ NEXT TO EACH OTHER
j. LET ‘t’ NOW BE HALFWAY BETWEEN THE ADJACENT TICK AND CROSS,
I.E. ‘SOMETHING AND 6 MONTHS’.
What if Life A was ‘t’ of this state (POINT TO THE GREEN CARD) followed by
’10-t’ in this other state (POINT TO THE PINK CARD). Or instead of that you
could choose to die immediately (POINT TO LIFE B). Would you prefer Life A,
or to die immediately, or are they the same?
Life A 1.
GO TO C5Life B 2.
The same 3.
C5a. TAKE OUT SECOND CARD TO BE VALUED. ENTER LETTERS OF THE
CARD: _____
[process repeated as above – where ‘GO TO C5’ replace by ‘GO TO C6’]
C6a. TAKE OUT THIRD CARD TO BE VALUED. ENTER LETTERS OF THE
CARD: _____
[process repeated as above – where ‘GO TO C5’ replace by ‘GO TO C7’]
C7a. TAKE OUT FOURTH CARD TO BE VALUED. ENTER LETTERS OF THE
CARD: _____
[process repeated as above – where ‘GO TO C5’ replace by ‘GO TO SECTION
[D]’]
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SECTION [D] SECOND RANKING EXERCISE
PLEASE SHUFFLE THE 4 GREEN CARDS AND THE PINK CARD (FULL HEALTH)
AND BLUE CARD (DEAD). DO NOT INCLUDE THE CREAM PRACTICE CARD.
THERE ARE 6 CARDS IN TOTAL.
SHOW PACK OF CARDS TO RESPONDENT
We are now going to repeat the exercises you have just done for a different set of
cards. First we are going to use a technique called ranking to find out how good or
bad you think living in some of the states would be. Again, the states that we will show
you have nothing to do with the answers you have just provided about your own
health and well-being.
Now, here is a set of 6 cards. Each of them has a description of a state written on it.
Each card has a different state description on it.
I would like you to place the cards in order of how good or bad you think they are. I
would like you to imagine that you yourself are actually in each state and that you
would live in that state for 10 years. After this time period you must assume that you
would die. Please read each card carefully to see exactly what the state is and how it
differs from the others. When you have finished reading through, please place the
cards in order of how good or bad you think they are. Put the one you think is best at
the top (POINT TO TOP END), and the one that you think is worst at the bottom
(POINT TO THE BOTTOM END).
CARD BLOC 1 ONLY: SHUFFLE REMAINING 4 GREEN CARDS KX, RL, WA,
NV
HAND RESPONDENT SELF-COMPLETION BOOKLET OPEN AT SECTION
A4, PAGE 4.
Please answer the question in section A4 and then return the booklet to me.
AFTER SECTION A4 HAS BEEN COMPLETED TAKE THE SELF-
COMPLETION BOOKLET FROM RESPONDENT.
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PASS CARDS TO RESPONDENT
If you think two states are equal, put them side by side. You will notice that there is a
card which says “dead”. Please also put this with the other cards in order where you
think it belongs. You can change your ordering at any time.
RECORD THE RESULTS OF THE RANKING EXERCISE IN THE TABLE BELOW. IF
MORE THAN TWO CARDS ARE RANKED EQUALLY, CROSS OUT THE NUMBER
IN THE RANK COLUMN AND WRITE THE CORRECT RANK.
RANK CARD CODE e.g. WG
1
2
3
4
5
6
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SECTION [E] SECOND VALUATION EXERCISE
E. INTERVIEWER SCRIPT FOR TTO
REMOVE PINK CARD AND BLUE CARD FROM THE PACK OF RANKED
CARDS.
PLEASE SHUFFLE ALL 4 GREEN CARDS (THAT HAVE JUST BEEN
RANKED) AND PLACE ON ONE SIDE.
PICK UP PINK AND BLUE CARDS.
HAVE TTO BOARD SIDE ‘1’ FACING UPWARDS.
SET BOARD MARKER FOR LIFE A TO 10 YEARS.
Now we are going to use a technique called the time trade off to find out how
good or bad you think living in some of the health states would be. The time
trade off asks you to compare living in two health states for a maximum period
of 10 years. After this time period you must assume that you would die.
I am going to ask you to make a choice between living in this health state (Life
B – green card) and living in another health state (Life A – pink card). The pink
scale and the green scale show the number of years you would be in each state
for. Remember, I want you to imagine that you are in these states.
E2a. INTERVIEWER CHECK:
PICK OUT FIFTH CARD TO BE VALUED. ENTER LETTERS OF THE CARD:
_____
PASS CARD TO THE RESPONDENT.
Please read this card carefully.
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b. PLACE GREEN TTO CARD IN POCKET FOR LIFE B.
PLACE PINK CARD IN POCKET FOR LIFE A.
MAKE SURE THAT BOARD MARKER FOR LIFE A IS AT 10 YEARS.
At the moment, each scale says 10 years. This means that you would either
live in Life A for 10 years and then die, or you would live in Life B for 10 years
and then die. Would you prefer Life A or Life B, or are they the same?
Life A 1. GO TO E3
Life B 2.
ASK c.
The same 3.
c. IF ‘LIFE B’ AT b.: Does this mean that you would rather live in Life B for 10
years than in Life A for 10 years?
IF ‘THE SAME’ AT b.: Does this mean that living in Life B for 10 years would
be the same as living in Life A for 10 years?
Yes 1. GO TO E3
No (first time) 2. Repeat b
No (second time) 3. GO TO E3
E3a. CONTINUE WORKING WITH GREEN CARD
[process repeated as in section C4 – where ‘GO TO C5’ replace by ‘GO TO E4’]
E4a. TAKE OUT SIXTH CARD TO BE VALUED. ENTER LETTERS OF THE
CARD: _____
[process repeated as in section C4 – where ‘GO TO C5’ replace by ‘GO TO E5’]
E5a. TAKE OUT SEVENTH CARD TO BE VALUED. ENTER LETTERS OF THE
CARD: _____
[process repeated as in section C4 – where ‘GO TO C5’ replace by ‘GO TO E6’]
E6a. TAKE OUT EIGHTH CARD TO BE VALUED. ENTER LETTERS OF THE
CARD: _____
[process repeated as in section C4 – where ‘GO TO C5’ replace by ‘GO TO
SECTION [F]’]
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SECTION [F] BACKGROUND CHARACTERISTICS
1. Some people have said that they found it quite difficult to answer the questions I
have asked you. Others have said that they found it quite easy. How about you – did
you find the ranking question – (READ ALOUD)
Very difficult…….…….….……
Quite difficult………….…..…...
Neither difficult nor easy….......
Fairly easy…….……….……....
Or very easy …….…….……....
2. How about you – did you find the time trade off questions – (READ ALOUD)
Very difficult…….…….………..
Quite difficult………….….…....
Neither difficult nor easy…...….
Fairly easy…….……….…….....
Or very easy …….…….……....
3. Did you find the second ranking question –
Easier than the first ranking question…….…………
More difficult than the first ranking question……..…
About the same…………………….………….….…..
4. Did you find the second set of time trade off questions –
Easier than the first set of time trade off questions…….…..…..…
More difficult than the first set of time trade off questions……..…
About the same………………………………...….……….…….…..
I would now like you to answer some background questions about yourself. This
information will help us to understand your answers better. If you have any comments
to make about this interview, please feel free to use the last page of the booklet.
HAND RESPONDENT SELF-COMPLETION BOOKLET OPEN AT SECTION [F]
BACKGROUND CHARACTERISTICS AND HEALTH SERVICE USE
AFTER SECTION [F] HAS BEEN COMPLETED TAKE THE SELF-COMPLETION
BOOKLET FROM THE RESPONDENT
FILL IN “END TIME” ON FRONT PAGE OF INTERVIEWER SCRIPT
Thank you very much for your cooperation and your time.
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SECTION [G] INTERVIEWER FEEDBACK TO BE
COMPLETED AFTER THE INTERVIEW
1. How well do you think the respondent understood and carried out the first ranking
exercise during the interview?
Understood and performed exercises easily…….…………………….....
Some problems but seemed to understand the exercises in the end......
Doubtful whether the respondent understood the exercises…….….…..
2. In terms of effort and concentration, which one of the following statements best
describes the way the respondent undertook the first ranking exercise?
Concentrated very hard and put a great deal of effort into it….…
Concentrated fairly hard and put some effort into it…….………...
Didn’t concentrate very hard and put little effort into it…….….….
Concentrated at the beginning but lost interest/concentration before reaching the
end….……………………………………………………..…………..
3. How well do you think the respondent understood and carried out the second
ranking exercise during the interview?
Understood and performed exercises easily…….………………….…....
Some problems but seemed to understand the exercises in the end.....
Doubtful whether the respondent understood the exercises……..……..
4. In terms of effort and concentration, which one of the following statements best
describes the way the respondent undertook the second ranking exercise?
Concentrated very hard and put a great deal of effort into it….…
Concentrated fairly hard and put some effort into it…….………...
Didn’t concentrate very hard and put little effort into it…….……..
Concentrated at the beginning but lost interest/concentration before reaching the
end….……………………………………………………..……..…...
5. How well do you think the respondent understood and carried out the first set of
time trade off exercises during the interview?
Understood and performed exercises easily…….…………………….....
Some problems but seemed to understand the exercises in the end.....
Doubtful whether the respondent understood the exercises….….……..
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6. In terms of effort and concentration, which one of the following statements best
describes the way the respondent undertook the first set of time trade off exercises?
Concentrated very hard and put a great deal of effort into it……
Concentrated fairly hard and put some effort into it…….………..
Didn’t concentrate very hard and put little effort into it…….…….
Concentrated at the beginning but lost interest/concentration before reaching the
end….……………………………………………………………..….
7. How well do you think the respondent understood and carried out the second set of
time trade off exercises during the interview?
Understood and performed exercises easily…….………………….…....
Some problems but seemed to understand the exercises in the end…..
Doubtful whether the respondent understood the exercises….….……..
8. In terms of effort and concentration, which one of the following statements best
describes the way the respondent undertook the second set of time trade off
exercises?
Concentrated very hard and put a great deal of effort into it….….
Concentrated fairly hard and put some effort into it…….….….…..
Didn’t concentrate very hard and put little effort into it……..….….
Concentrated at the beginning but lost interest/concentration before reaching the
end….……………………………………………………………...….
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Appendix 10. Ethical approval for the valuation
survey of CORE-6D
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Appendix 11. Self-completion booklet provided to
participants in the valuation survey of CORE-6D
University of Sheffield - School of Health and Related
Research
This questionnaire contains questions which ask about various aspects of your
health and about you. You may feel that some of these questions do not apply to
you, but it is important that we ask everyone the same questions. Also a few
questions are similar; please excuse the apparent overlap and try to answer
each question independently.
Please read each question and consider your answers carefully. For each
question, please read all answers and select one answer that best describes you.
There are no right or wrong answers; what we want is your opinion.
You can stop the interview at any time if you do not want to continue. If there are
any questions you do not want to answer leave them blank and move onto the
next question.
Respondent ID _______________
Interviewer ID _______________
Card bloc _______________
Survey of General Health Values
Self-completion booklet
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SECTION [A] YOUR HEALTH
[A1] Life satisfaction
1. Thinking about your own life and personal circumstances, how satisfied are you
with your life as a whole?
Completely
Dissatisfied Neutral
Completely
Satisfied
0 1 2 3 4 5 6 7 8 9 10
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[A2] Your own health in general
The following questions ask about your health in general. There are five
groups of statements, each covering a different aspect of health. Please
tick one statement in each group to show the statement which best
describes your own health state TODAY.
Please tick one in each group
1. Mobility
I have no problems in walking about…………...….
I have some problems in walking about………..….
I am confined to bed………………………………...
2. Self-care
I have no problems with self-care..……………..……….
I have some problems washing or dressing myself…....
I am unable to wash or dress myself……..…….....…....
3. Usual activities
(e.g. work, study, housework, family or leisure activities)
I have no problems with performing my usual activities.…..….
I have some problems with performing my usual activities.…..
I am unable to perform my usual activities...……………….......
4. Pain and discomfort
I have no pain or discomfort...………......
I have moderate pain or discomfort….....
I have extreme pain or discomfort.…......
5. Anxiety/Depression
I am not anxious or depressed..……………...
I am moderately anxious or depressed.……...
I am extremely anxious or depressed……......
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[A3] Your own health
The following questions ask about your health. There are five groups of
statements. Please read each statement and think how often you felt that
way last week. Please tick one statement in each group to show the
statement which best describes your own health state DURING THE PAST
WEEK.
1. Close relationships
I have never felt terribly alone and isolated....................................
I have felt terribly alone and isolated only occasionally.................
I have felt terribly alone and isolated sometimes...........................
I have felt terribly alone and isolated often.....................................
I have felt terribly alone and isolated most or all the time..............
2. Anxiety
I have never felt panic or terror…………………..............
I have felt panic or terror only occasionally……..............
I have felt panic or terror sometimes…………….............
I have felt panic or terror often……………………...........
I have felt panic or terror most or all the time……...........
3. Social relationships
I have never felt humiliated or shamed by other people………………....……
I have felt humiliated or shamed by other people only occasionally…………
I have felt humiliated or shamed by other people sometimes…….................
I have felt humiliated or shamed by other people often………………...........
I have felt humiliated or shamed by other people most or all the time…........
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4. Functioning
I have been able to do most things I need to most or all the time................
I have been able to do most things I need to often………………….............
I have been able to do most things I need to sometimes…………..............
I have been able to do most things I need to only occasionally………........
I have not been able to do most things I need to...…………………............
5. Risk/Harm to self
I have never made plans to end my life..………...................
I have made plans to end my life only occasionally…..........
I have made plans to end my life sometimes..………...........
I have made plans to end my life often..………....................
I have made plans to end my life most or all the time..….....
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[A4] Your own health
The following question asks about your health. Please read each statement
and think how often you felt that way last week. Please tick one statement to
show the statement which best describes your own health state DURING
THE PAST WEEK.
1. Physical health
I have never been troubled by aches, pains or other physical
problems…...……...............
I have been troubled by aches, pains or other physical problems only
occasionally…………….....
I have been troubled by aches, pains or other physical problems
sometimes…………….……
I have been troubled by aches, pains or other physical problems
often.………........................
I have been troubled by aches, pains or other physical problems most or all the
time......................................
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SECTION [F] Background characteristics and health service
use
1. Are you:
Male….…….
Female…….
2. What is your age?
3. Are you:
Single …………….……
Married/Partner.…........
Divorced/Separated…..
Widowed…………........
Not known…………......
4. Which of the following best describes your main activity?
In employment or self-employment.......
Retired……………….………………..…
Housework…………………….…..…….
Student…………………….….………....
Seeking work/ Unemployed....……..…..
Long-term sick……….…………….…....
Other (please specify)……………….…. _______________
5. Did your education continue after the minimum school leaving age?
Yes………..…..
No………….....
6. Do you have a Degree or equivalent professional qualification?
Yes………..…..
No………….....
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7. How would you define your ethnic origin?
White (British)……………………….………
White (Irish)……………………………….....
White (Other)……………………………..…
Mixed (White and Black Caribbean)...…….
Mixed (White and Black African)….…..…..
Mixed (White and Asian)……......................
Mixed (other)……………………………......
Asian (Indian)...............................................
Asian (Pakistani)……………………............
Asian (Bangladeshi)………………..............
Asian (Chinese)..………………………..…..
Asian (other)………………………...…........
Black (Caribbean)………………………......
Black (African) ………………………..........
Black (other) ……………………….…….....
Other…………………………………….......
8. How often do you talk to any of your neighbours?
On most days….……………....
Once or twice a week…...........
Once or twice a month…..........
Less than once a month...........
Never….……………….............
Don’t know….………................
9. How often do you meet friends or relatives who are not living with you?
On most days….……………....
Once or twice a week…...........
Once or twice a month………..
Less than once a month...........
Never….……………….............
Don’t know….………................
10. Generally speaking, would you say that most people can be trusted, or that
you can’t be too careful in dealing with people?
Most people can be trusted.……………............
Can’t be too careful in dealing with people……
It depends on people/circumstances.…............
Don’t know.…….................................................
11. Have you experienced serious illness due to physical health?
in you yourself…………….Yes .……….No 
in your family……………...Yes .……….No 
in caring for others………..Yes .……….No 
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12. Have you experienced serious illness due to mental health?
in you yourself…………….Yes .……….No 
in your family……………...Yes .……….No 
in caring for others………..Yes .……….No 
13. During the past 2 weeks, did you talk to a GP or family doctor on your own
behalf for any reason at all?
Yes……….…..
No…………....
Don't know…..
14. Have you had any time off work due to your health in the last 4 weeks?
Yes……….….. How many days?
No………….....
Don't know…..
15. Does your household:
own your home outright, or with a mortgage………
rent from a local authority………………………...….
rent from the private sector……………………….....
If you have any general comments you would like to make about this interview please
write them in the space provided below.
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
……………………………………………………
Thank you very much for your participation.
Please give the booklet to the interviewer.
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Appendix 12. Plausible health states of the
emotional component of CORE-6D, as identified by
inspection of the Rasch item threshold map
Health state 1
I never feel terribly alone and isolated
I never feel panic or terror
I never feel humiliated or shamed by other people
I am able to do most things I need to often, most or all the time
I never make plans to end my life
Health state 2
I feel terribly alone and isolated only occasionally or sometimes
I never feel panic or terror
I never feel humiliated or shamed by other people
I am able to do most things I need to often, most or all the time
I never make plans to end my life
Health state 3
I feel terribly alone and isolated only occasionally or sometimes
I feel panic or terror only occasionally or sometimes
I never feel humiliated or shamed by other people
I am able to do most things I need to often, most or all the time
I never make plans to end my life
Health state 4
I feel terribly alone and isolated only occasionally or sometimes
I feel panic or terror only occasionally or sometimes
I feel humiliated or shamed by other people only occasionally or sometimes
I am able to do most things I need to often, most or all the time
I never make plans to end my life
Health state 5
I feel terribly alone and isolated only occasionally or sometimes
I feel panic or terror only occasionally or sometimes
I feel humiliated or shamed by other people only occasionally or sometimes
I am able to do most things I need to only occasionally or sometimes
I never make plans to end my life
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Health state 6
I feel terribly alone and isolated often, most or all the time
I feel panic or terror only occasionally or sometimes
I feel humiliated or shamed by other people only occasionally or sometimes
I am able to do most things I need to only occasionally or sometimes
I never make plans to end my life
Health state 7
I feel terribly alone and isolated often, most or all the time
I feel panic or terror often, most or all the time
I feel humiliated or shamed by other people only occasionally or sometimes
I am able to do most things I need to only occasionally or sometimes
I never make plans to end my life
Health state 8
I feel terribly alone and isolated often, most or all the time
I feel panic or terror often, most or all the time
I feel humiliated or shamed by other people often, most or all the time
I am able to do most things I need to only occasionally or sometimes
I never make plans to end my life
Health state 9
I feel terribly alone and isolated often, most or all the time
I feel panic or terror often, most or all the time
I feel humiliated or shamed by other people often, most or all the time
I am able to do most things I need to only occasionally or sometimes
I make plans to end my life only occasionally or sometimes
Health state 10
I feel terribly alone and isolated often, most or all the time
I feel panic or terror often, most or all the time
I feel humiliated or shamed by other people often, most or all the time
I am not able to do most things I need to
I make plans to end my life only occasionally or sometimes
Health state 11
I feel terribly alone and isolated often, most or all the time
I feel panic or terror often, most or all the time
I feel humiliated or shamed by other people often, most or all the time
I am not able to do most things I need to
I make plans to end my life often, most or all the time
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Appendix 13. SPSS syntax for calculation of CORE-
6D utility values from CORE-OM data
*Deriving a CORE-6D utility score from CORE-OM data*
*Author: Ifigeneia Mavranezouli, December 2010*
*Based on Mavranezouli et al., MDM 2013; 33(3): 381-95*
*NOTES*
*Utility score is based on CORE-OM items 1, 8, 15, 16, 21, 33
*These are assumed to be named cof01, cos08, cos15, cor16, cof21, cof33 according
to their domain
*Scores for item 21 are assumed to be reversed already [positive item]
*These must be converted to CORE-6D items co6D01, co6D08, co6D15, co6D16,
co6D21, co6D33 (different levels of response)
*missing data are coded as 9
*total raw score of CORE-6D is named CORE6Dsc (note this EXCLUDES physical
item 8)
*total utility score of CORE-6D is named CORE6Dut
*Converting CORE-OM items into CORE-6D items*
Compute co6D01=cof01.
IF (cof01=0) co6D01=0.
IF (cof01=1) co6D01=1.
IF (cof01=2) co6D01=1.
IF (cof01=3) co6D01=2.
IF (cof01=4) co6D01=2.
IF (cof01=9) co6D01=9.
IF (cof01<0) OR (cof01>4) co6D01=9.
Execute.
Compute co6D08=cos08.
IF (cos08=0) co6D08=0.
IF (cos08=1) co6D08=1.
IF (cos08=2) co6D08=1.
IF (cos08=3) co6D08=2.
IF (cos08=4) co6D08=2.
IF (cos08=9) co6D08=9.
IF (cos08<0) OR (cos08>4) co6D08=9.
Execute.
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Compute co6D15=cos15.
IF (cos15=0) co6D15=0.
IF (cos15=1) co6D15=1.
IF (cos15=2) co6D15=1.
IF (cos15=3) co6D15=2.
IF (cos15=4) co6D15=2.
IF (cos15=9) co6D15=9.
IF (cos15<0) OR (cos15>4) co6D15=9.
Execute.
Compute co6D16=cor16.
IF (cor16=0) co6D16=0.
IF (cor16=1) co6D16=1.
IF (cor16=2) co6D16=1.
IF (cor16=3) co6D16=2.
IF (cor16=4) co6D16=2.
IF (cor16=9) co6D16=9.
IF (cor16<0) OR (cor16>4) co6D16=9.
Execute.
Compute co6D21=cof21.
IF (cof21=0) co6D21=0.
IF (cof21=1) co6D21=0.
IF (cof21=2) co6D21=1.
IF (cof21=3) co6D21=1.
IF (cof21=4) co6D21=2.
IF (cof21=9) co6D21=9.
IF (cof21<0) OR (cof21>4) co6D21=9.
Execute.
Compute co6D33=cof33.
IF (cof33=0) co6D33=0.
IF (cof33=1) co6D33=1.
IF (cof33=2) co6D33=1.
IF (cof33=3) co6D33=2.
IF (cof33=4) co6D33=2.
IF (cof33=9) co6D33=9.
IF (cof33<0) OR (cof33>4) co6D33=9.
Execute.
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*Estimating total raw CORE-6D score – excluding physical item*
COMPUTE CORE6Dsc=(co6D01+co6D15+co6D16+co6D21+co6D33).
IF (co6D01=9) CORE6Dsc=99.
IF (co6D15=9) CORE6Dsc=99.
IF (co6D16=9) CORE6Dsc=99.
IF (co6D21=9) CORE6Dsc=99.
IF (co6D33=9) CORE6Dsc=99.
IF (co6D08=9) CORE6Dsc=99.
EXECUTE.
*Estimating total utility CORE-6D score*
Compute CORE6Dut=(CORE6Dsc+co6D08).
IF (CORE6Dsc=0) AND (co6D08=0) CORE6Dut=0.95.
IF (CORE6Dsc=1) AND (co6D08=0) CORE6Dut=0.94.
IF (CORE6Dsc=2) AND (co6D08=0) CORE6Dut=0.87.
IF (CORE6Dsc=3) AND (co6D08=0) CORE6Dut=0.80.
IF (CORE6Dsc=4) AND (co6D08=0) CORE6Dut=0.72.
IF (CORE6Dsc=5) AND (co6D08=0) CORE6Dut=0.64.
IF (CORE6Dsc=6) AND (co6D08=0) CORE6Dut=0.55.
IF (CORE6Dsc=7) AND (co6D08=0) CORE6Dut=0.47.
IF (CORE6Dsc=8) AND (co6D08=0) CORE6Dut=0.38.
IF (CORE6Dsc=9) AND (co6D08=0) CORE6Dut=0.30.
IF (CORE6Dsc=10) AND (co6D08=0) CORE6Dut=0.24.
IF (CORE6Dsc=0) AND (co6D08=1) CORE6Dut=0.92.
IF (CORE6Dsc=1) AND (co6D08=1) CORE6Dut=0.90.
IF (CORE6Dsc=2) AND (co6D08=1) CORE6Dut=0.84.
IF (CORE6Dsc=3) AND (co6D08=1) CORE6Dut=0.77.
IF (CORE6Dsc=4) AND (co6D08=1) CORE6Dut=0.69.
IF (CORE6Dsc=5) AND (co6D08=1) CORE6Dut=0.61.
IF (CORE6Dsc=6) AND (co6D08=1) CORE6Dut=0.52.
IF (CORE6Dsc=7) AND (co6D08=1) CORE6Dut=0.43.
IF (CORE6Dsc=8) AND (co6D08=1) CORE6Dut=0.35.
IF (CORE6Dsc=9) AND (co6D08=1) CORE6Dut=0.26.
IF (CORE6Dsc=10) AND (co6D08=1) CORE6Dut=0.20.
IF (CORE6Dsc=0) AND (co6D08=2) CORE6Dut=0.81.
IF (CORE6Dsc=1) AND (co6D08=2) CORE6Dut=0.80.
IF (CORE6Dsc=2) AND (co6D08=2) CORE6Dut=0.73.
IF (CORE6Dsc=3) AND (co6D08=2) CORE6Dut=0.66.
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IF (CORE6Dsc=4) AND (co6D08=2) CORE6Dut=0.58.
IF (CORE6Dsc=5) AND (co6D08=2) CORE6Dut=0.50.
IF (CORE6Dsc=6) AND (co6D08=2) CORE6Dut=0.41.
IF (CORE6Dsc=7) AND (co6D08=2) CORE6Dut=0.32.
IF (CORE6Dsc=8) AND (co6D08=2) CORE6Dut=0.24.
IF (CORE6Dsc=9) AND (co6D08=2) CORE6Dut=0.16.
IF (CORE6Dsc=10) AND (co6D08=2) CORE6Dut=0.10.
EXECUTE.
VARIABLE LABELS CORE6Dut "CORE-6D preference-based utility".
EXECUTE.
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